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Abstract 
This research critically analyses the different types of clinical data representation used in 
modelling Clinical Information Systems (CIS) and their limitations.  It identifies space 
complexity, information overload, performance degradation, erroneous data retrieval and 
transmission as some of the main challenges caused by inappropriate data representation.  
Literature reviewed, indicated that object-oriented Health Level 7 (HL7), Entity Attribute 
Value (EAV), Advanced ERD with XML, and ERD –FOL (First Order Logic) are some of 
the contemporary methods used in modelling and optimising CIS. However, these approaches 
do not address the space complexity and information overload issues because of the multi-
dimensional, complex large-scale nature of clinical datasets. Therefore, this research 
proposes a unique framework that uses object-oriented (UML) technique and combinatorial 
multiple attribute utility theory (CMAUT) as a new clinical data re-representation.  In the 
CMAUT framework, the human organs, their multiple attributes and relationships are 
modelled using classes. The attributes of each organ class are written as logical expressions 
using CMAUT concepts, which are linked to each other with logical connectors AND for 
complementary organs such as cardiovascular and OR for substitutable organs like kidneys.  
The logical expressions are converted into mathematical format, which serves as the utility 
objective function that is optimised using linear programming method subject to a set of 
constraint matrix. The constraint matrix is generated by transforming the multiple attributes 
in the CMAUT expressions into algebraic expressions by applying an algorithm that uses unit 
matrix and Raman transformation table. The output of the framework gives a set of attribute 
values, which optimal value maximises the overall utility of the objective function in the 
combinatorial organs. The algorithm maps the resultant attribute values to the appropriate 
attributes of the organs to determine the optimal amount of data required to be retrieved for 
primary health care investigation. The framework retrieves and transmits only needed data 
for investigation thus reducing the information overload and space complexity in the CIS.  
The framework was implemented using the MATLAB software and validated with clinical 
data from the cardiovascular disease survey in England report. Functionality test conducted, 
revealed that for complementary organs the space complexity is θ (n + 1) using the 
framework and θ (2n) without the framework. Substitutable organs gave an exponential 
expansion of θ (2n) in both cases. Simulation conducted showed that the mean size of the data 
retrieved for investigation using the framework is 463.5 bytes as compared to 1216.6 bytes 
without it.  Statistical tests carried out using the output data from the framework gave a p-
value of 0.000. Hence the hypothesis that the amount of data required for primary care health 
investigation can be reduced when the clinical data is re-represented with UML/CMAUT and 
optimised using LP based algorithm is statistically significant.   For hypertension disease, by 
converting the optimal values from the framework into percentages give results similar to the 
percentage risk of the user been hypertensive.  The output values were benchmarked against 
Framingham web based heart risk calculators and statistically analysed. Hence, the novelty of 
the framework is that it can be used for optimising CIS, as a multi-attribute decision tool and 
as an epidemiological prediction model for detecting high blood pressure diseases.                                                                                                                          
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Chapter 1: Introduction 
 
1.0 Chapter Introduction: 
 
This chapter starts with an overview of how the modern computer technology enables 
companies to capture, accumulate and store excessive amount of data in different formats.  
The concept of accumulation of excessive amount of data in computer systems for current or 
future use is known as “Big Data” (Chen et al., 2012). The chapter explains about how the 
huge data that has been accumulated and stored can be used to add value to the organisation’s 
business processes and assist in decision making.  It then discusses the application of Big 
Data in three data intensive industries, namely the financial institutions, health industries and 
social networking sites. The chapter argues that there are challenges associated with Big Data 
in life and mission critical applications. It focuses on information overload in CIS, which is 
life critical application and outlines some methods used to address these problems.  It 
establishes that the contemporary approaches used to address the issues of information 
overload do not work and therefore this research proposes a new hybrid technique that uses 
UML to capture clinical data and formalise it with CMAUT to reduce space complexity in 
information overload. The optimisation framework can also be used to determine the 
percentage risk of users been hypertensive. The chapter also outlines the aim, the objectives 
and contribution to knowledge as well as the structure of the Thesis. 
1.1 Research Background 
 
In present era, computer technology and the Internet are the key drivers of day to day life.  
These computer technologies are used for capturing and processing raw data, which is 
converted into meaningful format known as information for different activities and purposes.  
The Internet is used for the transmission of data and exchange of information for all types of 
applications.  The advent of these new technologies also allows computer users to capture 
and accumulate huge amount of data in different formats. For example, the gigantic amount 
of structured, semi structured and unstructured data that are accumulated by organisations 
over many years is known as Big Data (Zikopoulos et al., 2012).  
 
According to IBM Report (2013), 2.5 quintillion bytes of data are created every day, this data 
comes from social media sites, computer devices that are used to collect climate information, 
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business transaction records, digital images and videos and mobile phone GPS signals among 
others.  The report also suggested that 90% of the Big Data in the world was generated in the 
last two years, which confirms the fact that people are becoming data dependant because of 
the advent of new computers and Internet technologies. The Big Data system is complex in 
nature and it is an untapped data source, which is valuable to many institutions although the 
continuous storage of Big Data is associated with many challenges (Agarwal et al., 2011). 
 
The main benefit of this huge untapped data source is the ability to extract value from this 
Big Data using analytical tools and data mining techniques to identify trends and patterns for 
business applications (Herodotou et al., 2011). The Big Data systems are used for decision 
making, marketing, and creating Decision Support Systems (DSS). The advent of new 
technologies enables users to capture different applications, store and retrieve huge data for 
business intelligence, e-business and e-commerce purposes.  These analytical processes 
empower users to add value to their Big Data set (Chen et al., 2012).   Software houses such 
as Oracle and Microsoft have developed platforms with tools that allow the Big Data to be 
integrated with existing Databases and Data Warehousing.  Examples of Big Data platforms 
with analytical tools are Hadoop, MyNoSQL and Starfish, which are used to improve 
efficiency and cost effective data retrieval from the Big Data. These Big Data analytical tools 
also eliminate delay and add value to the organisation’s operations (Russom, 2011). 
 
 In spite of the success stories associated with the advent of the new computer technologies, 
Internet and Big Data, they have also created many challenges that must be addressed in 
order to facilitate their efficient and effective usage. Some of the challenges are security 
issues, information highway and information overload, which leads to the accumulation of 
excessive voluminous amount of data and information, errors in data transmission and 
problems with data storage (Floridi,  2012).  
1.1.1 Big Data and Information Overload in Data Intensive Industries 
 
The Big Data issues are mainly associated with industries that use data intensive applications 
such as financial institutions, the health industries, insurance, social networking websites and 
electronic media houses.  This research analyses Big Data and information overload in the 
financial institutions, health industries and social networking sites.  These organisations 
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generate huge amounts of data, which must be kept for many years for data analysis, decision 
making and business transaction purposes (Bawden et al., 1999). 
 
Examples of Social networking sites that enable users to capture their day to day activities in 
multimedia format, store and exchange them for social purposes are the Facebook, Twitter 
WhatsApp and YouTube.  Again, these social networking and media websites use 
applications that enable the creation of complex images and multimedia games that require 
large storage space, complex data retrieval mechanisms and data transmission techniques.  
These popular social networking sites create Big Data that are used for marketing, 
identification of users’ behaviour pattern and data retrieval purposes.  However, since these 
activities are not life or mission critical applications therefore the accumulated data can be 
archived or deleted to prevent information overload (Billinghurst and Starner, 1999).   
 
In the financial institutions, such as the Banks, the data of each customer, which include their 
personal details, their daily business transactions and other activities are kept for a period of 
time and then archived for future purposes.   Similarly, other financial organisations such as 
insurance companies, also capture, transmit and store all customers’ transactions for a long 
period of time for decision making and Business Intelligence purposes. However, as the data 
size increases some financial institutions apply the delete policy to prevent information 
overload and improve the performance of their computer systems because they are not 
mission critical applications (Van Velsen et al., 2013).   
 
In the health sector, each patient’s personal detail and information are recorded and kept 
during each visit to the health centre.  Each patient’s record are captured and stored as 
clinical report and or history in different formats for medical decision making.  With the 
invention of many new techniques in the medical sector, complex images and data are also 
captured and stored for diagnoses and prognoses purposes.  Unfortunately, although the 
accumulated amount of data continues to increase, the delete policy discussed in section 1.2 
cannot be applied in the medical sector because this is a life critical environment (Van Velsen 
et al., 2013).  This research focuses on information overload in medical and clinical data 
intensive applications and investigates the challenges in the medical environment with a view 
to propose a solution. 
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1.1.2 Challenges of Big Data and Information Overload in CIS 
 
According to Fernandes et al., (2012) the definition of Big Data in Health Information 
System (HIS) is the collection of large data sets in different formats, which have the three (3) 
Vs namely the volume, velocity, and variety.  In this research, Big Data is defined as the 
collection and accumulation of very large and complex data sets with different data formats, 
which is difficult to process using the traditional database management system and 
contemporary data retrieval techniques. 
 
In Fernandes et al. (2012) definition, the volume refers to the rapid rate at, which the amount 
of collected data is growing and the need to develop techniques and software for processing 
and managing the Big Data. The term “velocity” stands for the increasing frequency at which, 
data is captured and exchanged and therefore create information overload. In healthcare, 
variety means the capture of different forms of data, which include text; scanned documents, 
email, patient record and images that are accumulated and stored in the Big Data system. 
 
The issues identified and discussed in the above definitions can be observed in all medical 
and CIS applications.  For example in the medical field many new inventions are been 
introduced therefore medics write and store patients information in electronic format, which 
include variety of images and different data formats.  Currently, patients’ details and day to 
day reports are recorded and stored in different electronic format, which increases the volume 
of patients’ records.  The use of Internet and computer networks in health care environment 
to exchange and retrieve medical record for disease management, health care delivery and 
research purpose confirms the speed of change of data in medical field (Driscoll et al., 2013). 
 
Again, in all healthcare information systems, like other data intensive industries, the creation 
and accumulation of Big Data leads to gigantic data storage problems, security issues, 
overloaded computer traffic, information highway, information overload, data transmission 
and retrieval problems (Billinghurst and Starner, 1999).  The two main challenges associated 
with Big Data are Information Highway and Information Overload (IBM Report, 2013). 
 
Information Highway is the process of transmitting and receiving excessive processed data or 
information through the Internet, which leads to information overflow. The presence of 
information overflow in the Internet based working environment is mainly associated with 
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search engines, social media website and exchange of email (Goulding, 2001). The 
challenges of information highway include the creation and exchange of irrelevant messages 
and information that cause poor computer performance and storage problems. 
 
According to Fernandes et al., (2012), the main issue with Big Data is to attempt to make 
sense out of the information overload that has been created by the accumulation of excessive 
amount of data.  Another issue with Big Data and information overload is to provide new 
insights into the growing volumes and sources of data in order to answer business, 
operational, and clinical questions in future. Problems created by information overload 
include performance degradation, security, retrieval, storage space and time complexity 
challenges (Ho and Tang, 2001).  This research addresses the challenges caused by 
Information overload in CIS but will not examine the issues associated with Big Data and 
Information Highway. 
 
1.2 Types of Information Overload Solutions  
 
To address the issues associated with Information Overload, two main solutions namely the 
contemporary and supplementary solutions are recommended (Ho and Tang, 2001).   The 
contemporary solution that is also known as temporary solution uses hardware, software 
techniques and data delete policy to address problems associated with Information Overload.  
The delete policy specifies that users must delete all files within a specific period else the 
computer system will automatically delete and or archive the files (Bertot, 2013).   This 
method prevents the creation of information overload on the company’s computing system.  
These solutions are temporary because as the volume of the accumulated data size increases 
the solutions are not able to resolve the Information Overload problems (IBM Report, 2013).  
 
The second approach is known as supplementary solution. This involves the use of data 
aggregation and database optimisation techniques, the application of XML with user profile 
techniques, and the introduction of standard Clinical Client/Server Architecture (Velde, 
2000).  The data aggregation method uses advance SQL and data retrieval technique to store 
and search for information from big databases. These approaches are discussed in chapter 2 
section 2.5.2 but they do not resolve issues associated with of information overload (IBM 
Report, 2013). The proposed Clinical Client/Server Architecture is made up of standard 
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medical application software, which is divided into three tiers namely; the view, domain and 
backend layers. This approach ensures that optimisation is carried out at the backend layer, 
which is the database. However, database optimisation and the application of object oriented 
(O-O) database do not address the information overload problem because the introduction of 
O-O models create an increase in the volume of data in the backend (Silberschatz, 2001).  
 
The user’s profile and XML technique captures and stores data in the user’s requirement 
format that allows user specific information to be retrieved using XML techniques (Park et 
al., 2003). The user’s profile technique unlike the Clinical Client/Server Architecture and 
database system facilitate the storage of the user’s full data but only allows the partial 
retrieval of the stored data.  This is further discussed in chapter 2. 
 
1.3 Existing Research Gap in Clinical Information System 
 
Different researches have been conducted on optimisation of Clinical Information Systems; 
however they all focus on optimising the client interfaces using XML technique (Park et al., 
2003).  The user profile system facilitates the retrieve of only relevant information instead of 
the entire data, therefore minimising the amount of data to be retrieved and reducing 
information overload.  Database optimisation and data aggregation techniques are used to 
address information overload in clinical databases, however these methods are not very 
efficient (Safran and Chute, 1995) (Silberschatz, 2001).   
 
The alternative approach is the application of data representation techniques where clinical 
data are captured using coding and medical languages. Some of the medical coding 
techniques such as ICD, SNOMED, READ and UMLS are used to capture and store clinical 
data therefore facilitate the easy retrieval of data using search techniques (Coiera, 2003). This 
medical coding technique resolves the problem of clinical data standardisation and exchange 
of clinical information between healthcare computer systems.  However, these medical 
languages cannot be used in heterogeneous computing environment; therefore the Health 
Level Seven (HL7) data representation technique was introduced. The NL7 uses object 
oriented methodology to capture and represent clinical data.  In addition it addresses the issue 
of standardisation and interoperability but does not resolve the issue of information overload 
in in CIS (Taylor, 2006).   This is further discussed in chapters 2 and 3. 
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The current approach is the use of data re-representation technique where information is 
captured and re-represented in a format that can be used to model the information system, 
(Haimowits et al., 1988). This data re-representation technique was applied by De Keizer et 
al., (2000b), where they developed an ER diagram with a First Order Logics as a new form of 
data re-representation after studying the different types of medical coding and languages used 
in CIS.  This new re-representation technique has not been implemented and it is discussed in 
Chapter 4.  The second method is the use of Entity Attribute Value (EAV) and the enhanced 
Object Oriented Class Relationship (EAV/CR).  This technique has been researched on and 
implemented in some USA health institutions (Nadkarni, 2002). Although this is an effective 
clinical data re-representation technique, it has a lot of performance limitations which are 
discussed in Chapter 4.  The aforementioned methods have inbuilt CDSS systems but they do 
not have seamless information retrieval system and do not have optimisation mechanism that 
reduces space complexity and addresses the problems associated with information overload. 
 
1.4 Scope and Objectives 
 
The goal of this research is to address the issue of information overload by extending the 
concept of data re-representation technique in order to capture clinical data using UML class 
model.  The data from the class model is written in mathematical format, using Combinatorial 
Multi Attribute Utility Theory (CMAUT) and logical connectors that is optimised with Linear 
Programming (LP) algorithm to reduce information overload in CIS. This framework is also 
used as an epidemiological tool to determine the percentage risk of a user been hypertensive 
or not.  The aim and hypothesis of this research are presented in chapter 3 section 3.2.1. 
 
 Objectives: 
 
To achieve the goal of this research the following objectives are used: 
 
1. Conduct detailed research to establish the problems associated with information 
overload in clinical information systems. 
2. Discuss the methodologies used to address the information overload challenges 
and confirm the application of CMAUT optimisation Framework as a solution.  
3. Conduct research on the application of class model and CMAUT as new form of 
clinical data re-representation technique for the development of CDSS in CIS. 
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4. Develop Diagnosis and Prognosis CardioVascular Disease (CVD) frameworks for 
optimising CIS. 
5. Conduct mathematical operations and simulations using the frameworks to 
establish the data reduction in the CIS and information overload. 
6. Conduct series of simulations using the two frameworks to determine Absolute 
Percentage Risk (APR)  and Predictive Percentage Risk (PPR) in CIS 
7. Using the clinical data from HSE 2006 survey, compare the PPR results of 
participants with hypertension from the CMAUT framework with results from the 
CVD calculators and Framingham algorithm. 
8. Discuss and conclude the research.  
 
This research has created a new optimisation framework that uses UML class model to 
capture multiple attribute clinical data in problem disease domain as a new form of re-
representation technique.  The proposed framework uses a radical different approach and has 
made contributions to knowledge, which are discussed in chapter 10, section 10.3. 
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1.5 Structure of Thesis 
 
This Thesis started with an overview of the problems encountered in the use of Computer and 
Internet technologies and the creation of Big Data and information overload in Health 
Information Systems (HIS).  Chapter 2 focuses on CIS and presents a detailed literature 
review on the challenges of excessive data in CIS.  Chapter 2 discusses the modern 
techniques used in CIS to address the information overload and their limitations. The 
reviewed literature highlights that these techniques, cannot be applied in Big Data and CIS to 
resolve the information overload issue therefore demands new optimisation techniques. 
 
The methodology Chapter 3 summarises the gaps in the literature reviewed in Chapter2 and 
states the hypothesis which forms the basis of this Thesis.  This Chapter also discusses the 
methodology used to prove the hypothesis, which include quantitative and statistical 
methods.  Demographic and clinical data from the Health Survey for England report (HSE, 
2006) are used for the research. The six success criteria used to validate the output of 
CMAUT optimisation framework and verify the hypothesis are also presented.  
 
In chapter 4, the two clinical data re-representation techniques namely; the ERD/FOL and the 
EAV/CR data re-representation techniques are analysed.  This is followed by a review of 
three contemporary Clinical Decisions Support Systems (CDSS), which are Outranking, 
Analytical Hierarchy Process (AHP) and Multi-attribute utility theory (MAUT).  The Chapter 
finishes with an explanation of how the proposed UML-CMAUT framework is used to 
capture clinical data that can be optimised to reduce information overload.  
 
Chapter 5 discusses the design and implementation of the Cardiovascular Diagnosis 
optimisation framework using the data re-representation concepts described in Chapter 4.  
The framework is verified by using the Kappa and Prevalence calculations, to determine the 
framework that should be selected for discussion in this research.   
 
The Chapter 6 discusses the storage space complexity and data size reduction in the CIS, 
when the CMAUT Optimisation Framework is used.  This is done by conducting statistical 
analysis of the clinical data sizes before optimisation and after optimisation using the 
CMAUT framework. 
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In Chapter 7, the design and implementation of CMAUT Prognostic optimisation framework 
are discussed. The validation and verification of the efficiency of the CMAUT Prognostic 
framework are discussed in this chapter. 
 
Chapter 8 discusses the assessment of the CMAUT optimisation framework with two existing 
Web-based CVD risk prediction calculators and three Framingham algorithms.  The outputs 
values from the risk predictors are presented in tabular and graphical formats with 
explanations, before the validation and verification of the Framework are discussed. 
 
The Chapter 9 starts with a summary of success criteria and benchmarks used to prove the 
hypothesis of this research.  This is followed by discussion on the research findings and 
review of the Clinical Data Re-representation using the proposed UML-CMAUT framework.  
The results from the CVD Internet based calculators and the Framingham equations were 
benchmarked against the results from the CMAUT Prognosis framework.  This was followed 
by the discussion on the calibrations and discrimination analysis of each of the frameworks.   
 
The results of the predictive percentage risk (PPR) values from the CMAUT Prognosis 
framework were compared with the PPR values from Framingham equations and CVD Risk 
calculators and analysed.  The accuracy of the prediction models using sensitivity and 
specificity are discussed using the NICE criterion of 20% as the basis for the comparison.  
This is followed by the discussion and evaluation of the Area Under the Curve (AUC) and 
Likelihood Ratios of each of the CVD prediction models.   
 
Finally, Chapter 10 outlines the summary of the research including the proposed 
recommendation and further works. Significant contributions to knowledge have also been 
summarised in this chapter.  
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Chapter 2: Literature Review - Information Overload in 
CIS 
2.0 Introduction  
 
This chapter presents an overview of the current state of the art of Clinical Information 
System (CIS). It discusses the different types of CIS architecture and the components that 
make up a CIS.  It argues that Client Server System forms the basis of CIS and that the 
middle tier is also known as the application server. The middle tier serves as the Clinical 
Decision Support System (CDSS).  From the discussion in Chapter 1, CIS captures different 
types of clinical data, stores and processes them for analysis and decision making.  Therefore, 
the various forms of capturing clinical data are discussed in this chapter in order to identify 
their strengths and weaknesses. The Chapter also examines issues encountered in the 
application of the existing clinical data representation methods and how they are addressed. 
CIS challenges such as, information overload, performance degradation and erroneous data 
transmission in distributed CISs are discussed.   The chapter finishes with an evaluation of 
the contemporary and supplementary methods used to address information overload issues.   
 
2.1 Taxonomy of Health Information Systems 
 
Health Information Systems (HIS) is defined as the application of computer technology to 
capture, store and retrieve medical data as well as automate health care business processes to 
deliver cost effective health care (Raymond and Dold, 2001).   In order to deliver efficient 
health care, manage patients’ records and satisfy the requirement of healthcare customers, all 
hospital business processes must be computerised.  The hospital business processes that must 
be computerised include duty rotas, pathology, laboratory reports, epidemiology, e-
perception, e-health (Page, 2012) (Steve, 2006).  This research focuses on CIS, which is a 
subset of medical information systems as shown in Figure 2.1 below.  CIS deals with the 
management and delivery of patient care as well as patients’ medical needs.  It focuses on the 
anatomy of the patient rather than the hospital settings and the health care infrastructure.  
 
The Taxonomy of Health Information System (HIS) captures all the business activities, 
which are automated in the hospital environment (O’Carroll, 2003).  In addition, HIS handles 
health care activities, such as laboratory tests, surgical and pharmaceutical activities.  The 
block diagram for the taxonomy of Health Information Systems is presented below. 
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Figure 2.1: – Taxonomy of Health Information Systems (HIS). 
 
In Figure 2.1, the Health Information System comprises of hospital information a system, 
which is made up of the primary care, secondary care and tertiary hospitals (aka university 
hospitals where medical practitioners are trained and medical research carried out.  In UK, 
Primary care is also known as GP and it is the first point of call for all patients.  Another 
subsystem in Health Information Systems is e-health, which deals with the application of 
Internet or web based health care delivery (Granger, 2006).   
 
Electronic Health (e-Health) deals with health activities and procedures, which are presented 
over the Internet or use e-commerce infrastructure (Hsieh et al., 2012).  E-Health systems use 
the Internet and web applications to implement health care, conduct medical investigations as 
well as manage and deliver efficient health care.  Examples are e-referral, e-prescriptions and 
e-epidemiology.  M-health, on the other hand is the application of mobile technology in the 
delivery of healthcare. These types of HIS are real time processes that require large amount 
of streamed data between medical centres (Hartvigsen and Pedersen, 2012).  These examples 
show that there are many challenges in the use of Big Data and  information overload in HIS 
application software as stated in section 1.1  (Fernandes et al., 2012). 
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2.2 Architecture of Clinical Information Systems and CDSS 
 
In healthcare delivery there are different forms of computer system configurations that are 
tailored to HIS requirements as shown in Figure 2.1.  There is the standalone CIS  where 
clinical data are captured by interviewing the patient and the data recorded in text format 
using natural language, which is then stored as documents.  Another type of computer 
configuration is the distributed CIS, which is used in the secondary and tertiary health 
information system (Mattmann, 2003).  The distributed CIS allows GPs to link to the other 
centralised hospitals for information exchange.  The third type of CIS, is the heterogeneous 
and integrated CIS, where hospitals and GPs with different hardware and software settings 
can link up with each other to share and exchange patient details.  This system is used by the 
NHS in their CIS, and it is discussed in section 2.3 below (Velde, 2000).   
 
In all these CIS configurations, the advent of new technology allows medics to capture, store 
and exchange accurate information on the patients’ medical condition for efficient healthcare 
management.  However, in some cases, the clinical data is captured using clinical images, 
such as digital image communication system also known as DiCom and PACs (Picture 
Archiving and Communications systems), which takes a huge amount of storage space and 
create huge processing overhead (Hoelzer et al., 2003) .  Many different methods have been 
used for the development of CISs with a view to address the above issues, but they are all not 
optimised, hence the issue of information overloads still exist.   
 
2.2.1. Clinical Decision Support Systems (CDSS) 
 
The architecture of CIS is made up of Client Server Systems (CSS), which consist of three 
layers (Velde, 2000). The medic interacts with the automated information system via an 
interface which is known as the application layer.  The middle layer which is the logical layer 
or middle tier houses the CDSS.  In the CDSS are the business processes that the CIS is 
required to execute in order to perform the different clinical functions that the system is 
designed for. In software terms the middle layer is also known as application server or 
middleware while the third layer is the storage area, where the patient’s details and records 
are stored.  
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The CDSS layer stores the business logics or algorithms needed to execute the functionalities 
that the system is designed to perform (Massimo, 1998). These functionalities include clinical 
data retrieval, capture of the clinical data, data exchange, mapping of clinical data to clinical 
codes, booking clinical appointments and e-prescription are some of the functions performed 
by the middle layer. There are different types of CDSS, which include the use of Artificial 
Intelligence (AI) and automatic searchable indexes technique (Brownin et al., 2002). These 
CDSS techniques and their implementation are discussed in Chapters 3 and 4.   
 
The CDSS is made up of two components, the logical component, which is the software and 
the physical component known as the hardware. To address the issue of information overload 
in CIS that is caused by the capture and storage of huge amount of clinical data, the 
contemporary hardware solution techniques are used.  An alternative approach is to use 
distributed application servers, which allows different functions to be installed on different 
hardware at different sites.  This is discussed in example 2.2.2 under the Standard Clinical 
Client/Server Architecture that has been proposed by Velde, (2000).  
 
 
 
Figure 2.2:  Framework for Clinical Information System (Velde, 2000). 
 
The CIS architecture shown in figure 2.2 was proposed, to standardise the different types of 
CIS architecture, used in Europe and across the world.  This is because the non-standard CIS 
architecture creates many problems such as, interoperability issues, erroneous data transfer, 
extendibility and scalability.   
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The proposed CIS standard architecture is based on Object Oriented Database that uses 
CORBA, as a middleware and HTML with Java application, as an interface.   Images and 
other medical data are stored in the Object Oriented Database.  This standard integrated 
architecture was implemented and the results were found to be efficient but have performance 
limitations, due to information overload from the accumulation of clinical data (Velde, 2000).  
2.2.2 Examples of Clinical Information Systems Architecture 
 
Below is a summary of the three examples of the types of architecture used for the 
development of CIS. These examples illustrate the nature of the non-standard CIS 
architecture used in healthcare delivery in UK with their limitations. 
 
 Example 2.1: NHS Medical information system architecture: 
 
In UK, the NHS has its own HIS architecture, which uses the three tier model. An example is 
the Figure 2.3 below.  This HIS architecture used by NHS has an interface as the front end 
and the middle tier is Vision Software that integrates all heterogeneous GP CIS together.  The 
backend is a database where all the medical information is stored.  This system was designed 
to capture and integrate all hospitals and GPs in the UK (Spronk, 2007). 
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Figure 2.3: The NHS Spine – NHS Medical Information System Architecture (Spronk,  (2007). 
 
However, research conducted using the NHS architecture revealed that although it allows the 
CIS in the individual GPs to be connected to the secondary healthcare computer systems, it 
has performance limitations.  These issues include network delay, error in data transmission 
and interoperability problems (Steve, 2006).   
 
 Example 2.2: Microsoft Three logical layer reference architecture 
 
The Microsoft Company has proposed three tier architecture for healthcare delivery (Hsieh et 
al., 2012).  The Microsoft architecture in Figure 2.4 comprises of a user interface, which is a 
Microsoft browser, a middle tier that uses a dot NET middleware with SharePoint services 
and at the backend is the Microsoft database storage server.  In this three logical layer 
reference architecture, the middle layer performs two functions: the provision of web services 
and integration of Microsoft system with other clinical information applications. This 
architecture is known as homogenous system, because all the components in it are Microsoft 
products therefore it cannot interoperate with other non- Microsoft Systems unless a third 
party software is added to the system (Hsieh et al., 2012).   
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This means any non-Microsoft application that needs to be integrated with the Microsoft 
architecture requires third party software to facilitate the integration. Therefore this 
architecture has interoperability and integration problems. 
 
 
Figure 2.4: Microsoft three logical layer reference architecture (Hsieh et al., 2012). 
 
 Example 2.3: EMIS Architecture for GP surgery 
 
The third type of HIS architecture is the EMIS Solution (Electronic Medical Information 
System).  The EMIS architecture Figure 2.5 is used by GPs in the UK.  It is a standalone 
three tier architecture, which when installed in a clinical setup enables the users to have a 
user friendly interface. The middle tier has the software that performs all the basic 
functionalities that is required for the day to day operations in a GPs primary care set up.  The 
backend is a Relational Database where all the patient records are kept.  Although this EMIS 
is a standalone system, it can be integrated to the Spine of the NHS architecture described in 
Example 2.1, through the Internet connection known as Network 3 (N3) (Funk et al.,  2009).  
 
According to EMIS, their architecture can be converted into distributed system with 
optimised concurrency control and advanced fault tolerance systems and therefore makes the 
EMIS more reliable and easily scalable.   The use of HL7 facilitates easy exchange of clinical 
information between the CIS and auxiliary systems (Funk et al., 2009).   
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However, experience users indicate that EMIS architecture has performance issues. Therefore 
NHS has recommended that the operation and installation of the EMIS Solution should be 
discontinued (Steve, 2006).  
 
 
Figure 2.5: EMIS Architecture and Database at GP surgery (Funk et al., 2009). 
 
2.3 Benefits and Challenges of Medical Information Systems and CIS 
 
The Medical Information System covers all aspects of health care namely the public health, 
personal health, health care, disease prevention, eradiation and epidemiology.  The key 
benefits of medical informatics (Granger, 2006) include the following: 
 
 The use of electronic medical records for patients instead of the paper based records.  
 The secure electronic networks for the delivery of real-time medical data at anytime 
and anywhere the patient and or clinician need them.  
 Electronic transmission of error free medical and clinical test results.  
 Electronic prescribing of medications, treatments, and tests without errors.  
 Decision Support Systems (DSS) that provide clinicians with latest information on the 
best practices and treatment options.  
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 The use of electronic devices such as handheld computers to make information 
available at the point of care to reduce space complexity. 
 
In addition to the above, Medical Information System (MIS) aka medical informatics is 
crucial for improving the quality, safety, and effectiveness of the healthcare.  This real-time 
and comprehensive clinical data provide accurate information for decision making rather than 
the existing paper-based systems (Steve, 2006).  The use of electronic information system 
results in better medical treatment and decisions making with fewer medical errors.  It 
encourages active involvement of patients themselves, resulting in more patient-specific and 
patient-centred care.  This method leads to improvement in the quality of patient care and 
increases the productivity of clinicians. However, in spite of these benefits, CISs have 
challenges, which are discussed below (Granger, 2006). 
 
2.3.1. Challenges and Issues in Clinical Information Systems 
 
Clinical Information Systems suffer from a number of problems and challenges, which must 
be addressed by the systems of tomorrow (Steve, 2006).  Some of the issues to be addressed 
include; accurate data exchange and seamless interoperability among all parties and computer 
systems in patient care (Bath, 2008).  There is also a need to have interoperability between 
different HISs as well as improve the areas listed below. 
 
 Develop Intelligent DSS and maintain all obsolete medical systems, 
 Increase the domain data size  and reduce rate of information  exchange, 
 Support domain experts to have direct control over the information system design and 
handle change management in health care delivery. 
 
Although all countries are trying to reduce the healthcare costs, by restructuring the delivery 
of healthcare services, it is evident that, these challenges can only be achieved through 
effective information system.  According to Ganger, (2006) the provision of right clinical 
information at the right time and place, to the right person will help to resolve the healthcare 
problems.  
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This research analyses CIS challenges which include: interoperability and data exchange 
security; data standardisation and comparability; data quality and erroneous data transmission 
and information overload and storage of huge amounts of clinical data, as discussed in 
section 2.6.  Security issues are not addressed because it is beyond the scope of this research 
work (Anderson and Street,1996). 
 
 Interoperability and data exchange 
  
Interoperability is the ability of one system to exchange data with another system regardless 
of their configuration, hardware and software constitution. Healthcare computer systems 
utilise many different information systems, both within an organization and across 
organizations.  Physicians working in hospitals, also have different systems in their offices, 
but need to access data of their patients from the hospital.  These different systems must be 
able to exchange data between themselves (Winsten, 1996). 
  
To achieve interoperability between different information systems, standard messaging 
systems must be implemented (Taylor, 2006).  The implementation of these standard systems 
is costly and time-consuming and therefore restricts their adoption by small GPs. To address 
the issue of interoperability in healthcare, semantic Web Services and ontology are proposed 
but Microsoft uses Health Level Seven (HL7) clinical standard (Werner et al., 2003).    
 
 Data standardisation and Compatibility  
 
In clinical application, data compatibility requires that the meaning of data is consistent when 
shared among different parties. Lack of compatible data can cause an impact on patient care 
(Taylor, 2006).  Standard healthcare vocabularies ensure that data shared across systems are 
comparable at the most detailed level. However, MIS vendors and healthcare providers can 
create their detailed vocabularies, but it must conform to one or more of the standard clinical 
coding and languages discussed in section 2.4 below.   For example, the EMIS group whose 
architecture was discussed in section 2.4 has proprietary set of terms, which is compatible 
with the READ code for all clinical areas and it is explained in section 2.4 (Coiera, 2003).  
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 Data Quality and Erroneous Medical Data 
 
It is difficult to measure the quality of healthcare data, however, every provider points to 
cases where, data quality was suspected to be incorrect or could not be validated. Many CIS 
do not incorporate sufficient data editing capability, uniformity of the units of measurement 
and other controls into their CIS architecture. This leads to error in the data and loss of data 
for patient care (Pietra et al., 2005).   Again, the absence of unique identifier on some 
patient’s record leads to erroneous medical data storage, retrieval and data exchange. The 
Administrative Simplification Provisions of Health Insurance Portability and Accountability 
Act (HIPAA) recommend the use of unique identifier all patients’ records.  
 
However, there is concern that the introduction of unique identifier for patients will give easy 
access to the entire records of a particular patient (Coiera, 2003). The standards of medical 
vocabulary and coding are discussed in section 2.7 but standard message format and security 
systems are not covered in this research. 
 
2.4 Information and Data Representation in CIS  
 
According to Cimino et al. (2002), CIS is a branch of medical informatics that deals with the 
use of information technology for monitoring, diagnosing and analysing clinical problems in 
order to make decision and eradicate diseases.  Advances in computer technology, has been 
deployed in many fields but limited applications can be found in clinical informatics.   This is 
because of the complex structure and the nature of clinical data, which makes them sensitive, 
dynamic and multidimensional.  For example, human organs have multiple attributes that can 
be measured in continuous variables and stored as real-time data for future use.  Therefore the 
size of clinical data is gigantic and has space complexity issues (Rassinoux, 1998).   
 
Two common methodologies used to capture clinical data, are the use of Natural Languages 
(NL) and Digital Image Communication System (DiCom) or Picture Archiving and 
Communications System (PACs) (Hoelzer, 2003). Each of these methods has its limitations. 
For example, the Natural Language (NL) uses two approaches, which are either the patient’s 
data is captured by using manual handwriting that can be difficult to read or the use of 
computerised data processing method.  
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In both cases the data must be accurate and adhere to the standard Clinical Nomenclatures or 
coding and must be stored for future purposes. The DiCom and PACs allow medics to 
capture medical data in the form of images or pictures, although these methods give precise 
information, they create high processing overheads, storage space issue and complex retrieval 
problems (Cimino et al., 2002).  Thus, these techniques used to capture clinical data, 
contribute to Big Data and information overload. 
 
2.4.1. Clinical Coding and Data Representation:  
 
To resolve the issues raised in section 2.3, standard medical terminologies, vocabularies and 
nomenclatures are developed and maintained by standardisation organizations.  These clinical 
coding, Medical Language and clinical Data Representation include ICD-10, SNOMED, 
Unified Medical Language System (UMLS) and READ among others (Rodrigues, 2009). 
 
These Clinical Coding/Language and Clinical Data Representation methods are used to 
capture and represent clinical data using High Level Languages or Natural Languages. The 
clinical coding ensures that there is standardisation in the use of medical terminologies and 
vocabularies, when clinical data are captured and exchanged between clinicians (Taylor, 
2006).  Most Data Representation systems have inbuilt clinical coding mechanism, that 
facilitate the mapping of medical concepts to the appropriate standard medical code, to ensure 
data compatibility between users and reduce errors in medical records (O’Carroll, 2003). 
 
The clinical coding and Medical Languages use different data structures, to capture as well as 
represent and retrieve clinical data. Some of the data structures used for clinical coding/ 
languages are shown in Table 2.1 below. The advantages of using these data structures are; 
they are scalable, user friendly and provide easy to search facilities.  However, as the size of 
the clinical coding or medical languages increase, the search and retrieval mechanisms 
become complex and less user friendly. Again, the advance coding language such as UMLS 
use is_a link to connect different medical and clinical concepts and therefore complex 
retrieval mechanisms are required to search for information in these systems (Taylor, 2006). 
These limitations and other challenges such as the introduction of Health Level Seven (HL7) 
to address the problems of interoperability are discussed under each of the five commonly 
used medical coding below. 
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1. ICD-10 from World Health Organization (WHO) 
  
One of the significant international coding and classification system, known as International 
Statistical Classification of Diseases (ICD) was developed and maintained by the World 
Health Organisation (WHO).  The ICD-10 stands for the International Statistical 
Classification of Diseases and Related Health Problems, 10th revision.  This Tenth Revision 
is a series that was formalized in 1893, to record and analyse Diseases as well as list the 
International causes of Death (Manchikanti et al., 2013).  
 
The data structure of the ICD Revision 10 comprises of a multiple-axis classification system 
with 21 chapters, which covers various diseases. The first volume contains the disease 
classification, which are located at the three-character and four-character levels. Other 
classifications are listed under special tabulation such as mortality, morbidity, definitions of 
medical concepts, and the nomenclature regulations. There is a special volume that includes 
report on the International Conference for the Tenth Revision, which covers the entire 
complex deliberations but could not be included in the ICD -10 coding. The Final volume has 
alphabetical index with introductory information on practical advice on how to make the best 
use of the index. To facilitate efficient coding and code searching, the index includes 
commonly used diagnostic terms as synonyms for the terms formally accepted for use in the 
classification (Asghari and Mahdavian, 2013). 
 
The ICD is an international Clinical Coding system but different counties have modified the 
coding to meet their local medical and clinical standards. For example, the Ninth Revision 
with Clinical Modification (ICD-9-CM) was developed in the United States to provide a 
method of classifying morbidity data for indexing of medical records. It also includes medical 
case reviews, basic health statistics and other programmes.  Similarly, the International 
Statistical Classification of Diseases and Related Health Problems, Tenth Revision was 
modified by Australia and called (ICD-10-AM) to meet their local needs (Conrick, 2006). 
Again, ICD versions 11 and 12 were introduced to address the compatibility and 
interoperability issues as well as other health care challenges (Gjertsen et al., 2013).  
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2. SNOMED from College of American Pathologists (CAP) 
 
SNOMED stands for Systemised Nomenclature of Medicine and was developed by the 
College of American Pathologists (CAP) in the USA.  SNOMED CT enables the retrieval of 
medical information for disease management, medical research and performance analysis in 
order to improve quality of care. It also facilitates access to clinical information wherever it is 
needed across the world, whenever it is needed by any authorized user (Templin, 2006). 
  
SNOMED is a hierarchical; multi-axial classification design system with eleven (11) axes 
and each of the eleven axes captures a medical concept or medical nomenclature. The 
SNOMED system is organised in monolithic tree structure that comprises of Topography (T) 
which is made up of T2800 for lung, T3200 for heart and  M for organs, cells etc. there are 21 
chapters on each axis that represent diseases  or medical problems.  For example, chapter IX 
represents diseases that are related to the Coronary System and in it is block 1.3 with block 
110, which gives detail description of the hypertension disease and denoted as 
Hypertension_IS_A  Heart disease.  SNOMED also has 311,000 concepts and each concept 
has a unique identifier (ID) for the organised using IS_A acyclic Taxonomy (Conrick, 2006). 
  
There are two main versions of SNOMED developed for use in electronic health records. 
SNOMED® RT is the next generation clinical coding with reference terminology (RT).   The 
SNOMED RT facilitates easy transition of health care records from paper records to 
electronic records (Conrick, 2006).  The second type is SNOMED® CT, which was created 
through collaboration between the CAP in USA and the United Kingdom’s National Health 
Service (NHS) to combine SNOMED RT and Clinical Terms Version 3 of the NHS thesaurus 
of health care terms.  The agreement created an international approach for computerizing 
scientific terms for physicians, nurses, and other health professionals to be used for the 
management of patient records and medical communication. The SNOMED CT has been 
adapted as the standard terminology scheme for the National Programme for IT (NPfIT) 
(Templin, 2006). 
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3. READ Codes 
 
READ coding system is used to classify medical activities and it offers the means by which, 
patient’s clinical records will be transferred from one GP to another GP in future.   The 
READ system uses Linnaean classification of species of medical activity, which include 
illness names, operations and procedures. The aim is to allow easy transfer of information 
between GPs, secondary and tertiary hospitals for health care purposes. It also makes it easy 
for healthcare professional, clinical staff and planners to use the code (Wilcox et al., 2007).  
 
The READ coding system is a strictly hierarchical tree structure, which comprises of 
branches that represent each medical classification and concepts with detail medical 
descriptions.  It has 2 types of code descriptions  namely;  the ‘Preferred’ term,  which gives a 
list of options and the ‘Synonymous’ term, which may give numerous options for one code.  
For example, if you enter READ code G30 the browser will give the user, a number of 
options such as Heart attack, Coronary thrombosis, and Cardiac rupture – MI so that the user 
can select their preference (Taylor, 2006).  
 
Example of READ codes used in the EMIS software package is shown in the Figure 2.6 
below: other examples of READ codes in EMIS format can be seen in (Hippisley et al., 2007)   
 
READ Clinical coding for Body Mass Index measurement 
229.. O/E is height and 22A.. O/E is weight while Body Mass Index (BMI) is 22K..% 
 READ Clinical coding for Blood Pressure (BP) measurement 
     246.. O/E - BP reading 
  246R. Sitting diastolic blood pressure 
  246Q. Sitting systolic blood pressure 
 
Figure 2.6: Examples of CVD READ codes in EMIS format (Taylor, 2006) 
 
In spite of these advantages, the READ coding system has many limitations, which include 
high maintenance cost and training time. Again, the codes are updated every quarter to 
incorporate current changes in medical field.  As mentioned for SNOMED/CR, the READ 
code is not internationally accepted clinical coding and therefore it is used mainly for primary 
care sector in UK.   
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The READ coding system has data compatibility and interoperability problems because it 
does not have inbuilt mechanism that can convert the READ code into SNOMED or ICD for 
statistical and other analysis (Rodrigues, 2009). 
 
4. Unified Medical Language System (UMLS)  
 
The Unified Medical Language System (UMLS) was developed by the USA National Library 
of Medicine and distributed as a multi-purpose, electronic "Knowledge Sources" with 
associated lexical programs.   The UMLS has a Metathesaurus that contains information 
about biomedical concepts and terms from accepted controlled standard vocabularies and 
classifications.  The UMLS system is used for patient records, administrative health data, 
bibliographic and full-text databases and expert systems (Coiera, 2003).  
 
Unlike the other clinical coding systems discussed, the structure of UMLS is based on 
Semantic Network, which has 134 semantic types that are linked by 54 different relationships 
such as `is_a' link. The semantic structure helps to preserve the names, meanings, 
hierarchical contexts, attributes and inter-term relationships in the data source vocabularies 
(Friedman et al., 2001). However, UMLS is a repository, which collects biomedical 
information from different data sources and uses the Semantic Network expressions to link 
them. See details in Table 2.1. UMLS is an ideal model that is used for research but it cannot 
be used as a clinical coding tool and therefore this research will not focus on it.   
 
5. The HL7 (Health Level Seven) - Data Representation 
 
HL7 (Health Level Seven) is a medical coding standard for the exchange of clinical and 
administrative data between medical information systems.   Health Level 7 is an ANSI-
accredited Standards Developing Organizations (SDOs) that is used  in healthcare domain 
such as pharmacy, medical devices, imaging or insurance (claims processing) transactions. 
Again, the Health Level 7 standard is designed to handle clinical and administrative data that 
operate on the highest application level of the ISO/OSI (International Standards Organization 
of Open Systems Interconnection) communications model.  The HL7 application level 
specifies the definition of the data to be exchanged, the timing of the interchange, and the 
communication of certain errors to the application (Taylor, 2003).  
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 HL7 structure and Data Representation 
 
The HL7 structure is based on object oriented technology and it uses the Class Model in 
UML to model clinical data. The primary building blocks of HL7 are the Data Models that 
consist of the Reference Information Model (aka RIM) and the HL7 Version-3 Meta-Model.  
The RIM stores the metadata of the HL7 architecture.  According to Taylor, (2003), HL7 
consists of 6 main classes, which are shown in Figure 2.7 and explained below: 
 
In Figure 2.7, the Actor is the actions that are implemented and documented in the model for 
example, the clinical observation.  The Entity is any physical thing or being that is in the 
problem domain under consideration such as a person, who takes part in healthcare activities. 
The Role is the role that the entity plays in the healthcare actions.  RoleLink describes the 
relationship between different entities and the roles they play.   Participation is known as the 
environment where the action takes place.  Action Relationship indicates the relationship 
between the different actions that are performed (Jenders, 1997).  
 
Each of the classes in Figure 2.7 is made up of attributes, which describes the characteristics 
of each class and their association with the RIM in the HL7 architecture.  Moreover, each of 
these classes can also be expanded to include sub classes, where details of each of the classes 
are captured from the designer perspective (Taylor, 2006).  
 
 
Figure 2.7: the RIM and the classes in the HL7 (adapted from Taylor, 2006) 
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The HL7 system uses SQL queries to retrieve clinical data from the CIS.  The classes in the 
HL7 are converted into entities, as in databases to create Entity relational (ERD) or object 
oriented databases.  SQL statements are written to retrieve relevant clinical data from the 
HL7 database through the RIM.  For example, using the standard SQL query  language and 
the RIM standard data model, a SQL-like query syntax, can be written as ‘SELECT last 
observation_value_text FROM clinical _observation WHERE abbreviation_name ISA ‘blood 
sugar’. This SQL-like query will allow the last observation value for blood sugar to be 
retrieved from the database (Jenders, 1997). 
 
 Advantages and Disadvantages of HL7 
 
Some of the advantages of HL7 are, it facilitates easy data exchange between heterogeneous 
MISs and uses object oriented technology, to implement the medical applications.  The HL7 
is a reference model and therefore, it can be used by any organisation to model clinical 
information systems.  The disadvantage of HL7 is that the RIM class in the framework is 
changed periodically in order to incorporate modern development in the medical field 
therefore the core of HL7 is not stable.  Another disadvantage is the sizes of the set of queries 
used to retrieve information are larger than the conventional relational database.  It denotes 
that, as the data size in the database increases the query size also increases (Taylor, 2006).  
This leads to performance degradation and therefore query optimisation techniques must be 
used to enhance the performance of HL7.  Again, the HL7 design structure uses the star 
schema, which is scalable therefore it increases the storage space requirement and creates 
information overload in the CIS (Jenders, 1997). 
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Table 2.1 Types of Clinical Coding and Data Representation Methods 
Clinical terminology  system Propose Data structure and  
representation ( ontology) 
ICD International 
Classification of Diseases  
To collect and analyse clinical 
data for statistical purposes  
 ICD-10 is multiple-axis 
classification system with 21 
chapters for diseases 
READ CODE For auditing clinical processes in 
primary  care (procedure) in UK  
This is a strictly hierarchical 
classification system 
SNOMED (Systematized 
nomenclature of medicine) 
general-purpose computer-
processable terminology to 
represent and index all  events in  
medical record 
a hierarchical, multi-axial 
classification system. Terms are 
assigned to one of eleven 
modules, 
(UMLS) Unified Medical 
Language System  
Links the international 
terminologies into a common 
structure and  provide translation 
mechanism between them 
Uses Semantic Network  
with134 semantic types that are 
linked by 54 different 
relationships such as  `IS_A' 
link; 
HL7 (Health Level Seven) standard for the exchange of 
clinical and administrative data 
Interoperability  
Uses Object Oriented technique 
with RIM class as the core class 
and 6 associated classes. 
 
2.4.2 Challenges of Data Coding and Representation in CIS 
 
Modern CISs are designed and built using the digital image representation methods namely 
DiCOM, or clinical coding such as SNOMED and ICD as discussed above.  These clinical 
coding and languages describe clinical concepts and their relationships.  However, according 
to De Keizer et al., (2000), they are limited because they are designed with strict hierarchical 
structure or semantic network semantic and are developed for specific applications. The 
implementation of clinical data representation is limited because of the complexity of their 
knowledge content and the structure of the clinical data (Hoelzer et al., 2003). To address 
these complexities, the HL7 uses object oriented technique and UMLS uses descriptive logic 
with semantic network. There are also areas specific coding methods namely, Medical 
Subject Heading (MeSH) for United States and GALEN for Europe but they are not 
discussed in this research (Coiera, 2003).   
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These methods solve the interoperability and standardisation problems in clinical data 
representation but they do not address the information overload problem (Friedman, 2001). 
 
2.5 State of the Art Solutions used for Information Overload  
 
The clinical data representation techniques discussed in section 2.4 above do not incorporate 
optimisation mechanisms hence medics are compelled to retrieve the entire clinical data for 
diagnosis or prognosis (Taylor, 2006).  Therefore the process of retrieving the entire data of 
instead of the relevant information needed for medical analysis, create information overload 
in the CIS environment. The alternative approach is to use contemporary solution or the 
supplementary solution which, includes optimisation techniques (Tveito and Hasvold, 2002). 
 
2.5.1 Temporary and Contemporary Solutions for Information Overload  
 
To address the issue of storage space complexity associated with Big Data and information 
overload in CIS, contemporary solution and or temporary solution are recommended. The 
three main recommended techniques are hardware solution, which includes distributed data 
centres and Cloud servers; the use of software solution that cover databases and data 
warehouse and the Delete Policy Solution (Ho and Tang, 2001). These solutions were 
mentioned in chapter 1 and their limitations are discussed below. 
 
Hardware Solution: This approach is based on distributed data centres and Cloud servers. The 
hardware solution proposes that the computer hardware systems must consist of super 
computers (i.e. high capacity computers); distributed data centres and currently the cloud 
computing system.  The concept is to have powerful distributed computing systems that can 
store the big amount of data, as well as improve the performance degradation and the bottle 
necks created in the computing network due to information overload (Velde and Van de, 
2000).  The disadvantage of this solution is that the failure of any of these data centres will 
lead to disaster in life critical applications, such as CIS.  Another limitation of the hardware 
solution is that as the data sizes increase the computers in the networks start degrading and 
hence affect their performances (Ho and Tang, 2001). 
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Software solution uses database and distributed data warehouse, to store huge amounts of 
data and use SQL to retrieve data from these data sources to improve efficiency (Yoo et al., 
2003).  Data warehouses allow multi-dimensional gigantic information to be stored at one 
location using a well-defined schema (Wang et al., 1997).  This approach uses data 
optimisation techniques to address the problems caused by poor database performance and 
improves the information retrieval process.  However, there are still issues that relate to data 
warehouses and therefore, distributed data warehouse systems are implemented in order to 
store excessive data in the cloud computing environment.  To address the data retrieval 
problems, the database search engines use XML with user profile and artificial intelligence 
techniques to reduce the delay caused by information retrieved from the Big Data sets (Park 
et al., 2003) but this does not address the data overload issue. 
 
The Data Delete Policy Solution is a policy put in place by many data intensive organisations, 
such as banks, financial and medical institutions (Denton and Richardson, 2012).  The policy 
states that employees must delete any information that creates information overload on the 
computing system.  Workers are instructed to delete emails, huge files otherwise their user 
accounts are blocked.  In medical and financial institutions this policy can have adverse effect 
on institution’s operation. This is because mission critical application, information is cannot 
be deleted but it must be archived for future purposes.  In the medical application, patient 
records and details are not supposed to be deleted, even though the size may continue to grow 
bigger. Therefore suitable solution must be found to address data overload in mission critical 
computing environment (Bertot and Choi, 2013).   
 
From the above examples, it is inferred that the three approaches discussed cannot address 
the information overload and optimisation problems in CIS.  Therefore alternative 
supplementary optimisation solutions have been recommended, which are discussed below. 
2.5.2 Supplementary Optimisation Solutions used in CIS 
 
The supplementary solution includes the use of database optimisation techniques and Clinical 
Client/Server Architecture (Deutsch et al., 2003).   In this research, optimisation denotes the 
re-organisation or rewriting of the algorithm used in the CIS framework to improve its 
retrieval and or processing efficiency.  
                                                                                                 CMAUT-UML Framework for Optimisation of CIS                                                     
 
 
32 
 
Another definition of software program optimization is the process of modifying a software 
system to make some features work more efficiently or use fewer resources.  Hence a 
computer framework can be optimized, so that it executes faster with improved time 
complexity or operate with reduced space complexity, which is less memory storage spaced 
(Winsten  and Carroll, 1996).  In this research, optimization is defined as improving one or 
more aspects of performance of the system under consideration.  The limitation and trade-off 
of optimization is that improvement is done at the expense of others (Fenton et al., 2003).  
Some of the optimisation techniques used to address the Information Overload include: 
optimisation of Clinical databases; the application of Best Fit Clinical Information System 
Architecture; and Data Aggregation. 
 
 Optimisation of Clinical Databases 
 
Research conducted using 59 clinical databases in Denmark concluded that to get the 
maximum output from the clinical databases, it must be joined together and optimised to 
facilitate effective data retrieval (Green, 2011).   According to Sujansky et al., (1994) because 
of the data structure and schema of clinical data it is difficult to optimise clinical databases 
using the conventional database optimisation techniques.   Therefore, they proposed the 
mapping of the Functional Relationship model (FRD) and Extended Relational Algebra 
(ERA).  However, their evaluation and findings state that additional work must be done to 
achieve the required optimisation of the database in the CIS. 
 
Johnson, (1996) proposed a generic data modelling that is used to create a database, which is 
better than the conversional database models and can hold large-scale clinical repository for 
CIS.  However, this technique does not indicate how the database can be optimized to reduce 
information overload caused by scalability and also improve the performance of data storage.  
Thieke, (2007), conducted research on the storage and retrieval of Intensity-Modulated 
Radiotherapy (IMRT) in clinical database. It was concluded that the process is time-
consuming and has many errors.  Therefore, from these discussions it is established that it is 
difficult to invent the “best” database that can deliver an optimal CIS.   
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 Best Fit Clinical Information Systems Architecture:  
 
To address the problems of information overload caused by the increase of the sizes of users’ 
records and various applications in CIS, different types of clinical architectures have been 
proposed.  The proposed architecture is a standard Healthcare Information System that uses 
DHE middleware to handle the functional aspect of the CIS and integrates different medical 
applications used in healthcare delivery (Massimo, 1998). 
 
Another proposed architecture is a three-tier CIS model that uses data driven component-
based system approach.  In this architecture, the clinical components are designed as business 
objects that uses HL7, which is linked to the ERD database see section 2.2 (Hsieh et al., 
2012).  The third type is the Standard Clinical Client/Server Architecture,  which uses object 
oriented technology for its implementation and was discussed in section 2.2 (Velde, 2000). 
These two architectures tend to increase the amount of data in the CIS because they add 
complex object layer onto the existing layers.  For example, the application of HL7 and 
CORBA middleware that use object oriented technology are good but their development and 
implementation create extra three data layers namely the name, attribute and methods.  These 
layers add to the existing information overload in CIS and affect its performance.    
 
 Data Aggregation – User Profile Using XML 
 
Data aggregation is the process of collecting data from different sources and presenting them 
in a summarised format for intelligent decision making or statistical analysis.  A CIS 
application of data aggregation is to gather a lot of information about particular groups of 
patients based on specific variables such as age, profession, diet or life style for medical 
analysis. This method was applied by Park et al., (2003) to collect information about users, 
which was then used to retrieve personal details of users based on their known profile. The 
User Profile Data aggregation technique uses extendable Mark-up language (XML) 
technology that is applied in social media website and Internet search engine (Denton and 
Richardson, 2012).   
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2.5.3 Limitations of Existing CIS optimisation techniques   
 
In CIS where Big Data is used, it is imperative to collect data from different sources, analyse 
and present them without losing their importance.  Therefore the techniques used in clinical 
data aggregation include placing ‘relevance’ weightings on variables in the meta-data or 
allocating ‘reliability’ weightings as data values to facilitate easy retrieval process (Jacobson 
et al., 1991).  Another technique used, is the Artificial Intelligence (AI), which include fuzzy 
logic representation method for recording of questionnaire responses.  Bayesian networks, 
genetic algorithm and neural network algorithms are AI techniques used to study the 
relevance weights and patterns in systems, for predictive proposes (Friedman, 2000).  It is 
inferred from this discussion that data aggregation techniques do not address information 
overload issues but are used for partial data retrieval. 
 
It is established that the current techniques used for the capture and clinical data 
representation such as ICD, HL7 and UMLS do not address the information overload in CIS.  
The use of these methodologies in the design of CDSS does not address the information 
overload and optimisation issues in CIS (Fernandes et al., 2012). Hence, contemporary 
solution namely hardware, software and delete policy were suggested but these are only 
temporary solutions thus, supplementary solutions were proposed.  The supplementary 
solution include using the Best fit  CSS Architecture,  database optimisation techniques and 
Data aggregation  discussed  in section 2.5.2.  It was subsumed that the optimisation 
techniques used do not resolve the information overload issue (Winsten  and Carroll, 1996). 
2.6 Summary   
 
In this chapter the role of Client Server System, as a model for designing the Architecture of 
CIS and role of the middleware, as decision making tool within the CDSS, were discussed.  It 
was identified that the methods of capturing clinical data, which consist of complex multiple 
dimensional structure are inadequate. Again, the application of clinical data representation 
techniques in medical information systems, lead to the creation of Big Data and Information 
overload in CIS.  Therefore, the existing research issues in CIS include Big Data, information 
overload; storage space complexity; and security issues.  From this literature review, it is 
subsumed that further research are required on optimisation of CIS and  clinical data 
representation to address information overload and to enhance clinical  decision making, 
disease management and eradication. 
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Chapter 3: Methodology for UML -CMAUT Optimisation 
Framework  
 
3.0 Introduction 
 
This chapter 3 starts with an evaluation of the alternative conventional and contemporary 
Decision Making models used in the design of CDSS for CIS.  This is followed by the 
discussion on the hypothesis, which includes the building of CMAUT prediction framework 
that forms the basis of this research and the methodology used to prove the hypothesis. The 
methodology includes the application of quantitative and statistical analysis methods, which 
are used in this Thesis. According to Fenton et al, (2000), Prediction Framework consists of 
mathematical models that work together with a set of prediction procedures for determining 
unknown parameters and interpreting the results. The demographic and clinical CVD data of 
21,399 participants from the Health Survey for England report (HSE, 2006) were used to 
design and build the CMAUT prediction framework for hypertensive users.  The six success 
criteria used to validate and verify the results of the investigation conducted using the 
proposed UML-CMAUT optimisation framework are presented.  Finally, the discrimination 
and calibration methods used to confirm the hypothesis are discussed. 
 
3.1 Clinical Decision Support System and Decision Making Models  
 
According to Gondy and Hsinchun, (2006), in CIS architecture, the middle layer houses the 
CDSS and the middleware component, which is made up of algorithms that present the data 
to the medical decision maker. The CDSS assists in the provision of diagnosis and prognosis, 
which are required to evaluate diseases and recommend the requisite medical interventions.   
 
The two main categories of decision support systems are the model for retrieving the raw 
medical data from the database for decision making and the model that deals with data 
computation and mapping the input data to the output results for decision making (Smith,  
2000).  The limitations of these two DSS are that they use advanced, inflexible, complex 
algorithms, which the designer cannot modify to meet changes in the system requirement.   
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Therefore, the research issues in medical decision support systems and their algorithms are 
contemporary fields that needs more research work (Fenton et al, 2000).  Below are critical 
analyses of the different decisions making models used for medical decision support systems: 
 
Analytical Decision Models for CIS: There are three types of traditional analytical healthcare 
decision making models: the multiple criteria decision model that deals with many decisive 
factors that are involved in decision making process (Fenton at al., 1997).   The uncertainty 
decision making models deal with situation where the data that should be used for making the 
decision is incomplete. The third is the risk decision models where the resultant outcomes of 
a decision leads to risk irrespective of the decisive factors used and the uncertainty nature of 
the situation.  The first two models use weights allocating techniques, while the utility 
function technique is used for the risk decision models (Sanderson et al., 2006). 
 
3.1.1 Conventional Clinical Decision Making models  
 
Conventional multiple criteria decision making models used in CDSS: When making 
decisions in health care management setting there is the need to take into consideration the 
multiple characteristic structures of clinical data (Fenton et al., 1997).    In cases, where there 
is more than one criterion, the decision making requires detail analysis to find the best out of 
many solutions.  Medical decision making involves many criterions therefore different 
categories of techniques are used in making multi-criterion decisions in medical decision 
models.  According to Sanderson et al., (2006) these techniques include:  
 
 Utility function or Satisfaction:  also known as satisfying or utility that means setting a 
standard, which must be met by the individuals or functions in the decision making 
criterion.  This is defined as the number of characteristics or attributes that every given 
option must meet to be considered in the solution (Duetsch et al., 1994).  In econometrics, 
utility is used to measure the satisfaction that a customer gets after consuming a product. 
Utility function is also used in health decision making models (Sanderson et al. 2006). 
 
 Weighting:  In the weighting process, each attribute in the model is given a weight 
depending on the score or preference allocated to the attribute and this is compared to the 
required criterion to categorise the attribute as being part of the solution or not.   
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Weighting is used in medical applications where the medics decide, which attributes in 
the multi-criterion should be given higher or lower weight.  In some scenarios the overall 
sum of the individual weights or scores is equal to 100% and this value is divided among 
the attributes depending upon their preferences (Fenton et al., 1997). 
 
 Sequential Elimination:  In this model, different options are given ranking, depending 
upon their importance in the problem domain.  The options with the highest ranking are 
kept and those with the lowest are eliminated until two options are left to be analysed.  
This model is used when the attributes involved are not measureable and are difficult to 
put values on them (Sanderson et al. 2006).  This model is not used in this research. 
 
Limitations of Conventional Decision Making Models 
 
In addition to the above, the other Decision Making Models used in medical DSS are the 
Games Theory, Decision Tree and Decision Graph.  Games Theory is used to solve problems 
that have one criterion but most problems in medical application are multi-criterion 
(Sanderson et al., 2006).  The Decision Tree model is based on the tree structure, where each 
branch is labelled with the probability of the nature or state of the problem actually occurring 
or not. The Decision graph allows the user to plot the stages involved in the decision making 
process from the beginning of the process to the end (Duetsch et al., 1994). 
 
The above decision models are designed to solve problem with one criterion but most clinical 
applications involve solving multi-criterion problems (Sanderson et al., 2006).  Again, these 
models are subjective and they cannot be used to solve multi-criterion problems unless they 
are converted into single criteria problem by applying the weighting system.  This method 
makes the problem solving process complicated.  Therefore in this research, the utility 
function technique is used because it is transparent and it is not subjective as compared to the 
sequential elimination, weighting methods and Games Theory (Duetsch et al., 1994). 
 
3.1.2. Contemporary Clinical Decision Making models and their Limitations  
 
Artificial Intelligent (AI) techniques such as Neural Network (NN) and Expert System (ES) 
are some of the techniques used in CDSS and other clinical applications (Duetsh, et al 1994).  
                                                                                                 CMAUT-UML Framework for Optimisation of CIS                                                     
 
 
38 
 
AI is a field of science and technology that uses multi- discipline techniques to design and 
build intelligence machines.  AI systems are designed to collect knowledge and or data from 
a specific clinical application and develop system that act and behave as human being.  AI 
application software and computers are developed to operate with human intelligence and 
behaviour such as to reason, learn and solve problem (Laudon and Laudon, 2011).  Two 
commonly used AI techniques in CDSS are NN and ES, their advantages and limitations are 
discussed below.  
 
1. The Expert System in CDSS 
 
Expert system (ES) is a computing system that is programmed to store knowledge and make 
inferences for prediction and decision making. For example, ES helps doctors diagnose 
diseases based on the patient’s symptoms.  According to Laudon and Laudon, (2011), a 
classic ES is made up of the following component parts: 
 
The knowledge acquisition system is used to capture the experts’ knowledge and the 
knowledge base is where the facts and knowledge are stored. The Inference engine is the 
application software that processes the knowledge and recommends the requisite action to be 
taken (Deutsch et al, 1994).  The user interface program communicates with the end user and 
the explanation program in order to explain the reasons for the decision taken for the end user 
(Laudon and Laudon, 2011).  See Figure 3.1 for the typical ES layout. 
 
 Advantages and limitations of Expert System 
 
The advantages of ES include the fact that it captures the expertise of the medical expert or 
group of experts and convert them into a computer-based information system. As an 
information system it is faster and more consistent than an expert and can store knowledge 
from multiple experts. The limitations of ES include their inability to learn new developments 
and changing trends in the medical field.   These computer based systems are designed to 
solve only specific types of problems in a particular knowledge domain and therefore they 
have limited application.  Again, many maintenance problems are associated with ES because 
it is designed to use the data and knowledge captured from Experts hence updating ES is a 
problem.  The Knowledge Base, Inference Engine and rules must be changed to match the 
new changes and the functionalities that are required, makes it difficult to modify ES. 
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Therefore it is recommended that instead of modifying the existing Expert System a new 
system must be built for all applications (Deutsch et al, 1994). 
 
 
Figure 3.1 Expert System Layout and its Components Parts (Laudon and Laudon 2011) 
 
2. Application of Neural Network (NN) in CDSS 
 
Neural networks (NN) are computer system that functions like the human brain. Neural 
networks computers are modelled after the brain’s mesh-like network of interconnected 
processing elements (aka neurons). They are composed of interconnected processors that 
operate in parallel and interact with each other to allow the network to learn from the data it 
processes (Deutsch et al, 1994).    For the purpose of simulation, the Neural Net is modelled 
as a graph with at least three or more layers that trains the neurons until the correct output 
prediction pattern is identified (Laudon and Laudon, 2011).  
 
For CDSSs that use NN application, the neurons in the input layer accept binary pattern that 
represents the presence (1) and absence (0) of the symptoms. The neurons in the output layer 
represent the diseases that the NN has been trained to recognize, where the value of 1 denotes 
that the diagnosis shows the present of CVD disease (Hripcsak, 1988).  Alternatively, a value 
of 0 denotes that the patient has not got the CVD disease (Deutsch et al, 1994).  For example, 
in the Figure 3.2, the NN system has neurons 1, 2 and 3 that represent the symptoms fever, 
cough and headache. The hidden layer has three hidden neurons 4, 5 and 6 that receive 
signals from the input neurons and then send messages to the output neurons. The output 
neurons 7 and 8 represent two possible CVD diseases in the final output pattern.   
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 Benefits and Limitations of Neural network (NN) 
 
In the Neural Net, the knowledge acquired is stored in the structure of the network and the 
weights are associated with each link that connects the neurons in the adjacent layer.  The 
neural net structure learns the weight by continuous training the neurons using the pattern of 
specific disease or group of diseases. The advantage of NN is that if the training of the 
neurons is successful, then the net is able to map its findings into diagnoses without using any 
disease decision making mechanism. To improve the accuracy of NN, backward prorogation 
is used whereby the errors from the output neurons are sent back to the input layer to modify 
the connection strengths in order to minimise the system error (Deutsch et al. 1994). 
 
Although, the NN decision support systems do not rely on probabilistic approach or logical 
statements they have limitations in their clinical application.  A study conducted by Baxt. 
(1991) using neural net in CDSS revealed that the outputs of NN are not precise but only 
indicates the likelihood of the presence or absence of acute myocardial infarction disease in a 
patient with chest pain.  According to Baxt, (1991) after the NN have been trained and learnt 
the disease pattern from the input data, it performs with 92% sensitivity and specificity of 
96%. These results are acceptable but Lisboa and Taktak, (2006) stated that these values are 
overestimated. However, NN software solutions are portable and hence can be installed on 
smart handheld devices that can be carried around by the medics for diagnoses.  
 
According to Deutsch et al. (1994), the performance evaluation of NN is not accurate because 
they lack vigorous statistical analysis and do not include the evaluation of prevalence and 
Receiver Operating Characteristics/Area under the Curve (ROC/AUC) of the NN framework.  
Therefore in this research, the performance accuracy of the proposed CDSS CMAUT 
framework is verified by applying the prevalence, sensitivity, specificity, Likelihood ratio 
and ROC/AUC metrics. These metrics are discussed under methodology section 3.6 below. 
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Figure 3.2 NN structure with connections, link weights and output neurons (Duetsh et al, 1994) 
 
3.2. Research Gaps in Optimisation of Clinical Information Systems (CIS) 
 
From the literature reviewed in chapter 2, it was established that the application of medical 
coding/languages as a technique used for data representation does not resolve the issue of 
information overload and storage space complexity in CIS (Hoelzer et al, 2003). Similarly, 
the use of the hardware, software and clinical database optimisation techniques are temporary 
solutions used to address information overload in CIS (Green, 2011).  Again the application 
of standard CIS architecture, AI techniques and other analytical models for developing CDSS 
also have performance problems (Deutsch et al., 1994).   
 
Therefore, this research adopts the clinical data re-representation approach to create a new 
Combinatorial Multi-Attribute Utility Theory technique that is used to build CVD 
optimisation Framework for CDSS.  The research gap is addressed by using UML class 
model and combinatorial clinical components to implement prediction framework that applies 
CMAUT clinical decision support system for the prediction of the percentage risk of 
cardiovascular disease (CVD) and also reduces the information overload and space 
complexity in CIS.   
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3.2.1 Aim and Objectives: 
 
 The aim of this research is; to investigate and create an optimisation framework that uses 
Combinatorial Multiple Attribute Utility Theory (CMAUT) to re-represent and express 
clinical data in a mathematical format. Then design an algorithm that uses utility function, 
unit matrix or Raman transformation table (Raman et al., 1991) and LP techniques to 
determine the optimal amount of clinical data required for disease analysis and management.   
This CMAUT framework reduces the information overload, communication and space 
complexities encountered in CIS and improve performances. 
 
Hypothesis: - The hypothesis to be proven is that: Clinical data can be re-represented using 
UML and converted into CMAUT mathematical expression with OR/AND logical 
connectors. The CMAUT expression can be formalised into an algorithm in a framework that 
can be optimised with LP technique to reduce space complexity in CIS and to predict the 
percentage risk of users been hypertensive as an Epidemiological Tool. 
 
The hypothesis has been rephrased into three parts to facilitate easy referencing as follows: 
“1st part: Clinical data can be captured with     and combinatorial multiple-attribute utility 
theory (CMAUT), which can be converted into logical mathematical expression using the 
data re-representation framework. 2nd part: The expression in the CMAUT framework is 
optimised using the linear programming (  ) technique subjected to a set of constraint matrix 
to reduce the data size and space complexity in      3rd part and to be used as an 
epidemiological tool for the prediction of Clinical absolute percentage risk and or Predictive  
percentage risk of user been hypertensive”. 
 
3.2.2 Research questions: 
 
 Can CMAUT be applied in clinical decision support system CDSS? 
 
 How can the CMAUT be used for the representation and manipulation (aka formalisation) 
of clinical data in order to address the reduction of information overload in CIS? 
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 Which clinical applications can the CMAUT clinical data representation be used to 
address? Can CVD and Kidney systems be used because of their mathematical structures? 
 
 Can CVD or Kidney related disease application domains be used to illustrate how 
CMAUT can be applied in CDSS to predict the percentage risk of users been 
hypertensive? 
   
 How can the new technique and framework be verified to confirm the consistency of the 
output results and validated to establish the accuracy of the prediction framework by 
comparing the model performance with others using the same data? 
 
 Will the results from the framework be benchmarked with other existing CVD risk 
predicator and Web CVD risk calculator? 
 
The methodology that is used to answer these questions are analysed and discussed in section 
3.4 below.    
 
3.3 Methodology used for the Research 
 
Different research methods have been adopted in this research because of the multi-discipline 
nature of the topic.  Some of the fields that are covered in this research include Clinical 
Decision Support System, clinical data representation paradigm, risk determination, software 
development and combinatorial theory.  The statistical and quantitative methods used are also 
discussed (Kremelberg, 2011). 
  
Step 1: Systematic Analytical Review of modern CDSSs 
 
A comprehensive systematic analytical review is conducted, to investigate and identify the 
state of the art methodologies used in the capture of clinical data re-representation, design 
and development of risk prediction models that operate with multiple attribute clinical data in 
CDSS.    Comprehensive literature search was conducted in order to select and evaluate the 
three different methods used for the optimisation of CIS.   
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The main purpose of this investigation is to conduct in-depth research on optimisation of CIS 
and establish the methods and metrics used for the evaluation of risk prediction model. 
Again, this research process facilitates the identification of the strengths and weaknesses of 
the modern CIS optimisation methods.  It is intended to compare and contrast these methods 
in order to identify, whether they address the problems specified in section 3.3. 
 
 Risk determination and decision making models in CDSS  
 
Risk is defined in Software Engineering as anything or any event that prevents the normal 
operation of software and or hardware (Fenton et al., 1997).  In health care, risk is known as 
any activity or behaviour that endangers person’s wellbeing.  According to Sanderson et al., 
(2006), the risk decision making models used in health settings that can handle multi-
attributes clinical data are Outranking, Analytical Hierarchy Process (AHP) and Multi-
attribute utility theory (MAUT). These models are discussed in Chapter 4.   
 
In medical application, the three types of risks are absolute, predictive and relative risk 
(Sanderson et al., 2006).  In this research absolute risk is defined as the probability of a 
person having a disease based on their current multiple attribute values, which are measured 
during the time of their medical examination. Predictive risk is the possibility of a person 
developing a disease such as CVD over a specified time-period for example 5 or 10 years 
based on their present circumstances and the values of their measured multiple attributes.  
Relative Risk is the comparison of risk between two different groups of people under 
consideration (Panagiotakos and Stavrinos, 2006). 
 
This research focuses on clinical Absolute Percentage Risk (APR), which is associated with 
diagnosis of a user based on the clinical conditions when during medical examination and the 
recorded multiple risk attributes values at the time of examination.  Predictive percentage risk 
(PPR), on the other hand is, the percentage possibility that a participant undergoing medical    
examination would develop the CVD disease over a specified period of 5 or 10 years based 
on their present circumstances and the values of the measured multiple risk attributes.    
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Step 2: Development and Creation of a new CMAUT optimisation framework 
 
A feasibility study was conducted to determine whether the existing clinical data 
representation can be extended using CMAUT and mathematical representations.   
Then comparative analysis of different data representation methods, which include 
descriptive modelling, data formalism with First Order Logic and mathematical 
representation with CMAUT were performed.  Based on the findings from the comparative 
analysis, a framework was developed incorporating the identified unique characteristics 
needed to address the problems associated with the optimisation of CISs.  
 
3.3.1. Domain scenarios for modelling the CMAUT Prediction Framework 
 
The two domain scenarios that will be used to develop and verify the framework are: Kidney 
and Heart related diseases: -  
 
Scenario 1:- The first case study focuses on kidney related diseases, which involves the two 
kidneys that can perform the function of each other.  In the human system, each kidney can 
replace or substitute the other during their operation.  According to Guyton and Hall (2006), 
kidney related diseases are classified into two groups, which are acute renal failures, where 
the kidneys stop waiting entirely or may stop for a period but may recover back to its normal 
function. Secondly, is the chronic renal failure where is progressive loss of function with 
more nephrons that gradually decreases overall kidney function.  This research focuses on 
Interarenal acute renal failure, which is the result of abnormal behaviour of the kidney itself.    
 
Scenario 2:  The second case study is based on heart related diseases, which are heart failure, 
hypotension, hypertension and angina.  This research focuses on hypertension (aka high 
blood pressure) and hypotension (aka low blood pressure). The hypotension and hypertension 
diseases affect the three primary organs namely the heart, kidney and Ant Diuretic Hormone 
(AHD) in the brain, which complements each other in their operations.  Figure 3.3 shows the 
cardiovascular system and the main organs namely Kidneys, lungs and brain, which are used 
in this research.   These diseases were selected because they are complex and they affect 
more than two organs, furthermore there are a lot of data on them that can be used for 
validation of the framework (Guyton and Hall, 2006).  
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Figure 3.3 the cardiovascular system and the main organs, (Guyton and Hall, 2006) 
 
3.4 Data Collection and Analysis  
 
Stage 1:- Clinical data for the heart disease specified in the scenario was collected from 
medical literature, which include (Guyton and Hall, 2006) and (Templin, 2006).  According 
to Templin, (2006), clinical data have acceptable measurable parameters used to analyse and 
manage CVD diseases. The minimum and maximum boundary values of CVD risk 
parameters are recorded in Table 3.1. These clinical data are used in the algorithm to 
determine the optimal amount of data required for CVD disease analysis.  These data values 
are used to test the soundness of the CMAUT clinical data re-representation and to validate 
and verify the optimisation algorithm in the CMAUT framework.   
 
Stage 2:- The anonymous demographic data provides the description of each participant’s 
age, height, weight and sex but their names and other personal details are excluded.  The 
clinical data describes the participant’s disease and the measured attribute values required to 
analyse and management heart disease.  The results of the APR and PPR values from the 
CMAUT framework will be benchmarked against the values of from the Internet based CVD 
Calculators that use Framingham algorithm and comparative analysis carried out (Sheridan et 
al., 2003). 
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The data set used to design and build the CVD optimisation risk prediction framework, was 
the primary raw data from the 21,399 individual records of people who participated in the 
2006 cardiovascular disease (CVD) survey conducted by Health Survey for England (HSE).  
The data from the HSE, (2006) report was filtered to include the relevant data required for the 
designing and modelling of the optimisation framework, which is further discussed below.  
3.4.1 Data for modelling and simulation of CMAUT CVD Framework (HSE, 2006) 
 
The demographic details and clinical data used in this research are from Health Survey for 
England (HSE) report undertaken by University College London (UCL) in 2006 on 
cardiovascular disease and risk factors in England (HSE, 2006). The full survey report with 
the detailed data of all the 21,399 individual participant records was given out for this 
research work with the permission of the authority of National Centre for Social Research for 
UK Data Archive. The original data, which was in SPSS, was exported into MS Excel spread 
sheet for analysis.  According to Craig et al.,(2006a), the methodology used for the data 
collection, includes measuring each variable three times, compute the mean value and 
crosschecking the values with the specialists. Other techniques used to ensure that the 
individual levels of information collected are accurate are discussed in Craig et al., (2008).  
The report also states that two samples were used namely the core sample, which are adults 
of over 16 years and boost sample of children between the aged 2 to 15 years. 
 
 HSE Data used for designing the CMAUT Framework 
 
From the HSE, (2006) report in SPSS, the demography and clinical data of all participants 
who provided complete detailed data were first filtered out. Therefore out of the full data 
provided only the relevant demography data was included in the preliminary filtering process. 
The initial stage of the data analysis was to filter out and eliminate all incomplete data from 
the original survey report that comprise of 21,399 individual records. Only participants whose 
full clinical data were measured and recorded were selected (see Appendix 3.1C for the 
HSE06ai full data in Excel Electronic format). 
 
The First stage of the filtering process for relevant data from the 21,399 individual records 
was carried out as follows: it was identified that only 9194 participants had full clinical and 
demographical data that were relevant to the development of prediction models. Therefore 
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these participants’ data sets were filtered to ensure that all clinical data attributes required, 
were included. The first data sheet is made up of the core adult sample, which are over 16 
years old and some of the boost children between the 2and 15 years old, who refused to have 
the HDL test. (See Appendix 3.2C for the HSE06ai filtered data of 9194 records in Electronic 
format). 
 
The second stage of the filtering process was to eliminate all children, under the age of 16 
years from the data sheet.  This is because the Framingham’s equations for CVD risk analysis 
and prognosis have been designed for adults of over 20 years old (Sheridan et al, 2003). The 
result of the filtering process gave the list of adult participants who are over16 years old as 
shown in the Excel spread sheet Appendix 3.3.  The total number of participants in the 
records is 4316.  (See Appendix 3.3C CVD data set of participants of over 16 years old for 
Model I with 4316 records in Electronic format). 
 
The third stage of the filtering process was the elimination of non-directly related clinical 
CVD variables or attribute values, such as household size, income among others.   Therefore 
only the measurable and non-measurable clinical CVD risk prediction variables and attributes 
were kept.  Again, research conducted on Internet CVD risk calculators, which are discussed 
in chapter 8 and used for benchmarking the results from the CMAUT framework, are 
designed for people between the ages of 32 and 72 years (Chuang et al, 2007). Owing to this 
constraint, the (HSE, 2006) was filtered to exclude all participants who are less than 30 years. 
Therefore the final individual records used in this research to test the CMAUT framework 
models 1 and 2 are 3645 participants. (Appendix 3.4C is the CVD data set of the 3645 
participants over 30 years old records used for Model 2 and simulation in Electronic format). 
 
3.4.2 Design and Implementation of the CMAUT Framework; 
 
The two prediction models built in this research were designed and implemented using the 
Variables in the Equation from SPSS logistic regression. To build the CVD risk prediction 
framework, the binary logistic regression method in SPSS was used and beta coefficient 
determined for the formation of the structural equation model.  This is further discussed in 
chapter 5, where the diagnosis framework is modelled and in Chapter 7 where the prognosis 
framework is discussed (Kremelberg, 2011).  
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The first CMAUT model 1 was built using “Variables in the Equation” obtained from 
analysing the data of 4316 adults over 16 years who provided full clinical data see Appendix 
3.4 (HSE, 2006). This is because the first core sample used for the CVD survey was based on 
adults who are over 16 years old.  Again medical literature on clinical analysis and 
management of CVD include adults who are over 16 years old age group (Craig et al., 2006a) 
and (Craig et al., 2008). 
 
The second CMAUT model 2 was built using “Variables in the Equation” obtained from 
statistical analyses of the HSE 2006 data of 3645 participants who are over 30 years with full 
clinical data.  The APR and PPR results from the CMAUT framework are compared with the 
percentage predictive risk (PPR) results from other Framingham equation and web 
calculators. This is discussed in chapter 8. 
 
 Rationale for the selection of CVD risk parameters for CMAUT Framework:  
According to Anderson et al., (1991), the probability of a person developing CVD disease 
over a period of time is computed using the measurable and non-measurable risk factors.  The 
Framingham CVD algorithm uses mainly non-measurable risk factors such as age, sex, HBP, 
ethnic origin, Diabetic and Smoking to predict the percentage risk (Wilson et al. 1998).  This 
is confirmed in the CHD Web Risk Calculators research conducted by Sheridan et al., (2003).  
 
 However, this research subsumes that the development in medical science requires that 
precise and accurate risk factors must be used for the prediction of CVD disease.   The risk 
parameters used for this research are the recommended CVD factors in (NICE, 2006) report.   
These risk parameters are a combination of measurable and non-measurable risk factors.  
The selected risk factors for the framework in Table 3.1 and Table 5.1 are explained below.  
1. The selected demographical data includes each participant’s series number, age sex, 
ethinda (i.e. ethnic origin);  
2. The main clinical data used include HB, HDL, BMI, TC, HDL BPH, BPL, MAP, 
ECG/LVC and CVD, Diabetic and Smoking.   
The parameters were selected to maintain consistency, when benchmarking the PPR results 
from CMAUT models with the Framingham equations and Web Risk Calculators results. 
Secondly, in CIS, prediction models are verified using discrimination and calibration 
techniques therefore these risk parameters were selected to ensure that there are similarities 
between the risk factors used by the different existing prediction models to avoid prejudices.  
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Table 3.1: The measurable Clinical data used in the research (source: HSE, 2006) 
Attributes 
Used in work  
Medical name READ 
code 
Baseline 
value  
Min value in 
HSE 
Max value in 
HSE 
OmpulvalHB Heart Pulse Rate (Beats 
Per Minute) 
NA 50 BPM 20.50 136.50 
BMI Body mass index 22K..% 25.5 kg/m2 13.20 49.66 
OmsysvalBPH Sitting systolic blood 
pressure 
246R. 140 mmHg 84.00 225.00 
OmdiaBPL Sitting diastolic blood 
pressure 
246Q. 90 
mmHg 
39.00 117.50 
Hdlval1HDL High-density 
lipoprotein (HDL) 
cholesterol 
NA 1.2 
mmol/L 
0.50 4.40 
OmmapvalMAP Mean Atrial Pressure  NA 100 
mmHg 
58.50 140.00 
CholvalTotalChol
estrol 
Total cholesterol 
measurement 
44PH. 5.5 
mmol/L 
2.10 11.40 
 
 Packages used for the development and implementation of CMAUT Framework 
The CVD clinical data was analysed using the Statistical SPSS Software package version 15.  
The SPSS was used to determine the “Variables in the Equation” that is required for the 
construction of the structural equation model and implementation of the CMAUT framework.  
The CMAUT Prognosis and Diagnosis prototype frameworks were built using the MATLAB 
(Mathematical Laboratory) software version 2007b.  The MATLAB software has toolboxes 
such as bioinformatics, optimisation and statistical for analyses.   MATLAB was also used to 
generate tables, reports, charts and conduct complex statistical analyses.  The algorithm in the 
frameworks was designed with utility function and Unit Matrix that use the LP technique in 
MATLAB software. The SPSS, Excel and the MATLAB statistical tool were used to evaluate 
the hypothesis that: “the clinical data representation can be re-represented using CMAUT 
expression in mathematical formalism that serves as input to an optimisation algorithm”.  
 
The Rational Rose software was used to model the organs in the disease domain.  The class 
diagram was used to model the organs and the relationship between them. The substitutable 
organs in the domain were modelled as sub-classes and the complementary organs were 
modelled as direct associations.    The multiple attributes of each organ were represented as 
the clinical data and the functions of the organ denoted as methods in the class diagram.   
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3.5. Application of Statistical and Quantitative Methods  
 
In this research, a combination of statistical and quantitative methods was used to design, 
implement and evaluate the CMAUT framework.  To achieve the research objectives, the 
following metrics and methods were used. They are Clinical Absolute Percentage Risks 
(APR) and Predictive Percentage Risks (PPR); computation of the Prevalence and Kappa 
values;  determination of space complexity, computation of the data sizes before and after 
optimisation using P-value; calculation of sensitivity and selectivity; determination of the 
accuracy of prediction models using AUC/ROC and  Likelihood Ratio. 
3.5.1. Statistical Methods 
 
Statistical methods were used to compute the correlation and relationship between the 
different variables in the CVD data set from the HSE, (2006) report.   The independent 
variables used to predict the output percentage risk, were based on risk factors selected from 
existing CVD risk prediction models. The existing prediction models are Framingham 
equations and Web based CVD Risk calculators, discussed in Chapter 8. The independent 
variables used in the CMAUT framework are HB, HDL, BMI, TC, HDL BPH, BPL, 
ECG/LVC and CVD, Diabetic and Smoking.   The dependent variables are the output from 
the optimisation framework which are the Clinical Absolute Percentage Risk (APR) and 
Predictive Percentage Risk (PPR) (Kremelberg, 2011). 
 
To prove the data size reduction part of the hypothesis, the P-value was used to determine the 
difference between the data sizes before optimisation and after optimisation with CMAUT 
framework. The statistical significance analysis uses the independent pair samples T-test 
technique, which are the difference between the two groups of data sets before and after 
optimisation (Kremelberg, 2011).   The pair T-test, was conducted using a random sample 
data set of 402 participants,  which is approximately 10% of the total number of 3645 
participants who submitted full CVD data and were selected from the (HSE, 2006) report.  
 
Functional performance measures the storage space change in the prediction framework 
before and after the framework has been enhanced (Fenton et al., 2007).  The space 
complexity is used to validate the amount of data needed for management of the CVD before 
and after optimisation using the CMAUT framework.   
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 The aim of this research is to determine if the memory space and space complexity have 
increases or reduces before and after the application of the CVD predictive risk model in CIS.  
The evaluation is conducted using the Big O notation, which is discussed in chapter 6 and 9. 
This is followed by the statistical analysis of the data sizes before and after optimisation 
using the CMAUT framework. 
3.5.2 Quantitative Methods 
 
1. Cohen Kappa 
The Cohen Kappa is used to measure the degree of agreement between the predicted results 
from the framework and the GP suggested diagnosis.  Kappa statistic is defined as the 
measure of a system based on the degree of reliability of the agreement between two 
predictors. According to Viera, (2005), Kappa is a method of the determining the degree of 
agreement between two predictors using quantitative measure.  Kappa is an important 
validation because it reduces the possibility of chances in the prediction.  In this research, 
kappa is use to determine the degree of agreement of the actual percentage risk results from 
the HSE, (2006) survey and the risk results for the two CMAUT Framework models.   
 
The Table 3.2 is built using the output risk results from the two predictors.  The kappa   
value is computed using the formula from (Cunningham el at., 2009) and (Viera, 2005). 
These formulae (3.1) are explained and used in chapter 5 and 7. 
 
Table 3.2: Table for computation of Cohen Kappa statistic: 
 
   Predictor 1 
CMAUTF 
 
  Yes No  
Predictor 2 
Actual 
Yes a b a +b =   
 No c d c +d=   
Totals  a+c =   b+d =   N 
 
 The formula is     
     
    
    where  
                                      and                    (3.1) 
2. Prevalence 
The computed Prevalence value indicates the presence of hypertension disease in the 
population of participants who took part in the HSE, 2006 survey. Prevalence is used by 
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medics, health providers and epidemiologists to estimate how common the disease under 
consideration is found in the population and in an area at a particular time (Campbell, 2007).  
To compute the prevalence value the generic mathematical formula is: Prevalence = a / (a+b) 
and for this research the formula used is: 
 
                                                         (3.2) 
 
 In these equations, ‘a’ or ‘GPbpyes’ is the number of participants in the surveyed population 
who were diagnosed as been hypertensive during the survey. The ’ b or GPbpno’ represents 
the people in the surveyed population who were not hypertensive during the survey. This 
equation is used in chapters 5 and 7. 
 
the NICE, (2006) threshold is used to determine, whether a participant has hypertension (i.e.  
BPyes)  or does not have hypertension (ie BPno).   According to NICE (2006), the threshold 
of the percentage risk of CVD must be less than 20%.  Therefore any person whose 
percentage risk value is higher or equal to 20% must be diagnosed as hypertension YES 
while any person with risk value of less than 20% must be declared as hypertension NO.  For 
the purpose of diagnosis and prognosis, the GP identified hypertension are marked YES (1) 
and non-hypertension marked NO (0). These values are compared to the results from the 
Prediction Model based on the NICE 20% recommendation to avoid any prejudices.   
 
3. Sensitivity and Specificity:  
According to Campbell et al. (2007), the accurate methods for the validation of medical risk 
prediction models are the use of sensitivity, specificity analysis and its associated receiver 
operating characteristic with the area under the curve (ROC/AUC) method.  Sensitivity is 
also known as True Positive Rate (TPR). Sensitivity is expressed in percentage and it is 
defined as the probability that when the test results of participant is positive then it indicates 
that the participant has the CVD disease. Specificity is known as False Positive Rate (FPR).  
Specificity is expressed in percentage and it shows the probability that when the test result of 
participant is negative then the participant does not have the CVD disease.  
 
The formulae for calculating the Sensitivity and Specificity or TPR and FPR are as follow: 
 
  Sensitivity = TPR = TP/ (TP + FN); and the Specificity = FPR = TN / (FP + TN);   (3.3) 
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In the formula (3.3), True Positive (TP) is the fraction of the population who were accessed 
and classified as having the hypertensive disease.  The False Negative (FN) is the fraction of 
the population, who were accessed and classified as not having the hypertension disease. 
However, there is a portion of the population who are without the hypertension disease and 
have been classified as negative (TN) also known as True Negative fraction.  While others 
who are without the hypertension disease but are classified as False Positive fraction also 
known as positive (FP). 
 
An MS Excel procedure was used to determine the TPR and FPR of each Risk prediction 
model, which is explained in Figure 3.4 below.  The threshold for the CVD percentage risk is 
20% (NICE, 2003).  Therefore the calculation of the TPR and FPR is done by comparing the 
individual percentage risk value from the CMAUT framework with the recommended 20%.   
 
1. Copy the percentage risk valves from the Risk model  into an Excel Spread-sheet 
2. Create a column that records the values that exceed the NICE risk of 20% and name it 
as “Exceed”.  In this column, if any value is greater than the 20% threshold it is 
entered as 1 else input 0. 
3. Create another column called “Non Exceed”. In it enter 0 if the percentage risk is less 
than the 20% threshold else enter 1. 
4. Using the formulae (3.3) below  calculate  the TPR and FPR: 
 TPR = Sum (Exceed 2: All Exceed) /Sum (Exceed 1: All Exceed) 
 FPR = Sum (Non Exceed 2: All Non-Exceed) /Sum (Exceed 1: All Non- Exceed) 
5. The results are depicted in model Tables 
 
Figure 3.4: The procedure for computation of Sensitivity (TPR) and Specificity (FPR) 
 
The sensitivity and specificity values from the CMAUT framework and CVD risk calculators 
were computed using the procedure above. In this research, the sensitivity and specificity 
values give an indication of how the probability of having a disease can change when there is 
a positive or a negative outcome.  
 
4. Positive and Negative Likelihood Ratio (LR+) (LR-) 
The sensitivity and specificity values were used to compute the probability of a participant 
having the CVD disease when there is a change in their LR results from positive to negative.   
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Likelihood ratio is used to determine the optimal risk cut-off value of the CVD Risk 
prediction models based on the NICE recommended value of 20%.  The Positive Likelihood 
Ratio (LR+) and Negative Likelihood Ratio (LR-) values are calculated using the sensitivity 
and specificity results as follows.   
 
Likelihood ratio positive (LR+ ) = Sensitivity/ (1 – specificity); 
Likelihood ratio negative (LR- )  = (1- Sensitivity) / specificity;           (3.4) 
 
The equations in (3.4) are expressed as Positive Likelihood ratio that is LR+ = (TPR/1-TNR) 
while Negative Likelihood ratio is LR- = (1-TPR/TNR).  In graphical format all the Positive 
and Negative Likelihood ratio values are plotted on the Y-axis and the participant 
identification (PIND) of each participant is plotted on the X-axis.  The interception of the 
Positive and Negative Likelihood Ratio curves are compared against the criterion value.  
When the values of (LR+) are higher, they are considered as better while lower values of 
(LR-) are better (Campbell 2007).  
 
5. Receiver Operating Characteristics and the Area under the Curve (ROC/AUC) 
The Delong Approximate Trapezoidal method was used to determine the area under the 
curve. In this technique the first step is to plot the TPR against the FPR values as a curve for 
each model. Then the best curve fit method is used to find the equation that best fit the curve. 
This is followed by applying the Trapezoidal rule where the area under the curve is split into 
a number of trapeziums and their areas calculated. Finally the summation technique is used to 
determine the approximate value of the area under the given curve.  The Area under the curve 
AUC is computed using the Trapezoidal formulae: 
 
                                                                               .   (3.5) 
 
In this expression, the dialogical reference line gives a value of 0.5, which is half of the 
square of the area under consideration (Cui, 2009). 
3.6 Validation and Verification of the CMAUT-CVD CIS Framework 
 
 
In this research, the CMAU framework was evaluated using medical validation and 
verification techniques.   In this context, verification means the process of confirming that the 
output of CMAUT framework is viable.  
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Validation means the degree of accuracy of the output PPR values from the framework when 
they are compared with the HSE, (2006) CVD results. According to Sanderson, (2006), in 
medical models, validation is used to establish the relationship between the results from the 
predictive framework and the theoretical concepts.  
 
The method used for the validation of CVD epidemiological model is calibration, which 
measures how the PPR values agree with the actual results suggested by the GP 
(Panagiotakos and Stavrinos, 2006). The metrics used for calibration of predictive model are 
Kappa, which measures the degree of agreement between predicted results from the 
framework and GP’s suggested diagnosis. The second metric is Prevalence, which depicts the 
presence of hypertension disease in the population of participants who took part in the HSE 
2006 survey (Campbell, 2007).   The third metrics is the computation of the sensitivity and 
specificity values of each of the prediction models using the NICE threshold value of 20%. 
This is used to benchmark the PPR values from the CVD -CMAUT framework against the 
results from the Internet CHD calculators and Framingham CHD algorithms. 
 
Verification also means if the output risk values from the prediction models are consistent 
with the observed results from the GP predicted CVD YES or NO as well as other Web based 
CVD calculators (Sanderson, 2006). For epidemiological models, verification is carried out 
using discrimination method (Panagiotakos and Stavrinos, 2006). Discrimination is the ability 
of prediction model to assign higher probability values to participants who have the CVD 
disease as compared to those who do not have the CVD disease. This metric is used to 
quantify the discriminatory ability of models are C-statistic and receiver operating 
characteristics (ROC). In this research, ROC/AUC deals with the degree of the accuracy of 
results from the prediction models.  The discrimination ability of a model is also determined 
using the Likelihood Ratio, which indicates how changes in the test results of a participant 
will have effect on the probability the participant having the disease or not.  
 
Incidence is another form of verification metric and it is defined as the measure of risk of 
people in a given population that will develop a particular disease over a specific period of 
time (Campbell, 2007).  This incidence measurement is expressed as occurrence rate of the 
disease happening over a period of time such as 5 or 10 years. This validation method 
requires that a follow-up survey is conducted.  
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At the time of writing this thesis the HSE, (2006) the follow up survey report had not been 
released therefore, incidence rate is not included in this research.  
3.7 Summary  
 
In this chapter, the CDSS was discussed. It was established that MAUT would be suitable for 
modelling CDSS to facilitate the capture of the appropriate amount of data required for 
clinical analysis.  From the literature review conducted it is proposed that the extension of 
data re-representation technique with a hybrid of Combinatorial theory and MAUT  will 
resolve the information overload issue and create a new CDSS modelling  paradigm in CIS.  
Therefore in section 3.2, a research gap with aims and objectives was established.  
 
To achieve the objectives, a set of methodologies were discussed in this chapter, which 
include the design and implementation of the proposed CMAUT framework for hypertension 
user.  Again, six success criteria have been identified for the verification and validation of 
CVD prediction models.  The PPR results from the CMAUT framework would be 
benchmarked against existing CVD risk prediction models such as Framingham algorithms 
and Web based Risk calculators.  Finally, the calibration and discrimination ability of the 
proposed diagnosis and prognosis CMAUT frameworks as well as the other CVD risk 
prediction models are discussed in evaluation chapter 9. 
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Chapter 4: Optimization and Clinical Data Re-
representation in CIS 
 
4.0. Introduction 
 
In this Chapter, the two clinical data re-representation techniques, ERD/FOL proposed by De 
Keizer and Abu-Hanna, (2000) and Entity Attribute Value /Class Relationship (EAV/CR) are 
evaluated.  This is followed by a detailed review of the different decision making models 
used in medical and Clinical Decisions Support Systems (CDSS) namely Outranking, 
Analytical Hierarchy Process (AHP) and Multi-attribute utility theory (MAUT). 
 
The Chapter finishes with an explanation of how the proposed UML- CMAUT framework is 
used to capture clinical data that can be optimised to reduce information overload. This is 
followed by using examples to illustrate how the framework models kidney and CVD disease 
using UML class diagram. It explains how the multiple attributes represented in classes and 
applied to write CMAUT mathematical expression using utility unit and logical connectors. 
 
4.1 Modern Clinical Data Re-representation Methods 
 
The two modern clinical Data Re-representation techniques are FOL/ERD and the EAV with 
object oriented enhancement (EAV/CR).  These clinical data re-representation applications 
are based on the Data Re-representation method proposed by Haimowitz et al., (1988).  In the 
article “Representing Medical Knowledge in Terminological Language is Difficult", 
Haimowitz  et al., (1998) presented the concept of capturing  and  re-representing medical  
data structure with appropriate format in order to facilitate cost effective modelling and 
design  of  medical framework.   
4.1.1 First Order Logic/Entity Relationship Diagram (FOL/ERD) 
 
Data re-representation technique is a computing problem that has been researched on and 
adapted by De Keizer and Abu-Hanna, (2000) to address the issue of clinical data 
standardisation and compatibility.  De Keizer et al., (2000) analysed the ontology and 
structure of different medical languages and highlighted their limitations.  Then they 
proposed a new clinical data re-representation that uses Entity Relationship Diagram (ERD) 
formalism to express clinical concepts and the relationship between them.  
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To complement the conceptual model, De Keizer and Abu-Hanna, (2000) used first order 
logic (FOL) as an expressive instrument and formal specification (i.e. mathematical format) 
to avoid ambiguity.  The two component parts of FOL/ERD are the ERD, which is the 
conceptual model while the FOL is used as the retrieval mechanism.  Figure 4.1 shows the 
data re-representation format for ICD, which is different from the original mono-axe 
hierarchy structure of ICD. This approach increases the usability of CIS and confirms the fact 
that using only descriptive logics is not enough for modelling CIS (Ceustersa et al., 2003).   
 
 The FOL/ERD Conceptual Model: 
 
The conceptual model in Figure 4.1 indicates the main data representation where the medical 
concepts are represented as squares while the attribute of each of the concepts are shown as 
oval. The relationship between the concepts is shown using arrows with the nomenclature 
such as “Is_a”. Other associations between different concepts are Extension and the 
Designate code.  Again, when a concept is a subordinate concept of the main concept the 
relationship between them is represented as self-reflective relationship and it is termed 
“Direct_Is_a”. This paradigm of Data Re-representations is discussed in details in (De Keizer 
et al., 1999), (De Keizer et al., 2000a) and (De Keizer et al., 2000b). 
 
 
Figure 4.1: Clinical Data Re-representation of ICD using FOL/ERD (De Keizer et al, 2000a) 
 
The FOL is based on relational calculus, which is used to capture the relationship between the 
different concepts in Data Re-representation framework as shown in Figure 4.1. This is 
followed by algebraic calculus that medics can use to retrieve data for decision making.  In 
this decision making technique, the request in the disease domain is expressed in formal 
specification using first order logic (FOL) and presented by algebraic calculus in a  
mathematical format to avoid ambiguity (De Keizer et al., 2000a). 
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For example, each concept and its relationship as shown in Figure 4.1 as 0 to 4 is written in 
FOL as                                as in the Figure 4.2. This expression cannot be 
written by non-specialist; therefore the framework has not been implemented in real life.   In 
the ERD, relational algebra is used to write the data to be retrieved for decision making in 
formal specification however, this requires complex query expression.  More information can 
be seen in De Keizer et al., (2000b). 
 
 
Figure 4.2: Clinical Data Re-representation of ICD using FOL/ERD formalism with relational 
calculus (De Keizer et al., 2000a) 
 
 
Limitations and Challenges of FOL/ERD are: 
 
1. The FOL/ERD clinical Data re-representation method is a user friend conceptual 
framework as shown in Figure 4.1 because it follows the basic notations and models used 
in Data Flow Diagram, ERD and oriented objected database.  For example, in the 
conceptual schema, medical concepts and codes are represented as squares while 
attributes are indicated as oval that are attached the squares. Arrows indicate the flow and 
association between the medical concepts and codes.  Although, this framework is 
helpful, it has many limitations that create anomalies and ambiguity. 
2. Although the FOL was introduced to address the anomalies and ambiguity issues, it 
requires excellent knowledge of Formal Methods to write them (Charatan and Kans 
2003).  Again, this procedure must be incorporated into the Clinical Decision Support 
System to make it effective. The dynamic nature of clinical data means the FOL based 
system must be written for real-time application. 
 
Lastly, the FOL/ERD has not been implemented for real life application therefore its 
performance cannot be established (Abu-Hanna et al., 2004).  
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Abu-Hanna et al. (2004) designed and implemented a prototype FOL/ERD system using 
Protégé. However, the prototype does not have an optimisation system therefore the 
challenges of Information Overload using this framework still remain unresolved.  
4.1.2 Entity Attribute Value/Class Relation (EAV/CR) and ER Model: 
 
To address the issues of big data in clinical environment and facilitate the efficient storage of 
multidimensional clinical data, Entity Attribute Value was introduced by Nadkarni, et al., 
(2001).  This concept was enhanced by incorporating object oriented technology, which is 
called Entity Attribute Value/Class Relation–EAV/CR.  The main advantage of EAV/CR is 
to facilitate the storage of clinical data and its relationship with other classes.  The EAV/CR 
captures the values and attributes of the classes, with respect to time (Nadkarni and Brandt., 
1998).  For example a patient can be seen by different doctors many times in a day and 
different clinical data values measured and recorded in the EAV database simultaneously.  
The EAV allows the storage of this data without overriding the previous data.  
 
The Entity–Attribute-Value Model is a standard data model used in the electronic healthcare 
because of its unique multiple attribute characteristic (Anhøj, 2003).  In the EAV model, each 
row in the table represents triple components, which are the entity, an attribute and an 
attribute value.  For instance, in Table 4.1 below the entity “patient” has the attribute “DOB” 
a value of which would be text “30-08-85”. 
  
In contrast to EAV, the Entity Relation Diagram (aka ERD) is used for the design of 
conventional databases (Silberschatz, 2001).  ER database is a two dimensional container in 
which data is stored in columns and rows.  In an ER model, entity represents a discrete object 
or concept and the relationship between entities are known as association. ER Model is a 
conceptual schema that uses relational model where an entity is implemented as table and the 
attributes of the object are implemented as columns in the Table. The relationships between 
the different entities are shown with arrows and implemented either as separate tables or 
foreign key columns in an entity table in Table 4.2.  
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Table 4.1: Conventional ERD schema - Relational Database Design 
Patient ID Name DOB 
1 William Henry 30-08-85 
2 Peter Jackson 02-12-85 
 
Table 4.2: Entity Attribute Value (EAV) Database Design 
 
Patient ID Attribute value 
1 Name William Henry 
1 DOB 30-08-85 
2 Name Peter Jackson 
2 DOB 02-12-84 
 
 Querying Clinical Data in EAV: 
 
From point of view database, querying EAV database is similar to querying the conventional 
ERD database because they both use Structured Query Language (SQL).   For example, 
querying Table 4.1 to retrieve information about a patient whose name starts with William 
and who was born before 1985 is simple as shown in Figure 4.3.  However, the EAV 
database query requires more predicates because both the attribute column need to be 
specified.  In the EAV database query, the Table 4.2 needs to be self-joined in order to return 
the name of the patient as shown in Figure 4.4 below. Therefore generating queries for EAV 
model is more complex as compared to conventional database (Anhøj, 2003). 
 
 
SELECT *  
FROM Table 4.1 
WHERE Name LIKE ‘William%’ 
AND DOB < ‘1985’; 
 
Figure 4.3: SQL for data retrieval from Conventional ERD Table 
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To retrieve the same result from the EAV table requires more complex SQL: 
 
SELECT d1.patient ID AS patient ID, 
                d1.value AS name, 
                 D2.value AS DOB  
FROM Table 4.2 AS d1 INNER JOIN Table2 AS d2 
USING (patient ID) 
WHERE d1.attribute=’name’ 
AND          d1.value LIKE ‘William%’ 
AND           d2.attribute =’DOB’ 
AND            d2.value< ‘1985’; 
 
Figure 4.4: SQL for data retrieval from EAV Table 
 
 
 Entity Attribute Value/Class Relations using Object Oriented Technology: 
 
The object-oriented method for modelling EAV is known as EAV/CR and it enhances the 
EAV framework by defining classes and their relations in the problem domain (Zhang, 1995). 
The EAV/CR schema in Table 4.3 is an example where the super-class and their attributes are 
defined and held in the fields. The Class Hierarchy table shows the relations between the 
classes. The attribute table stores the records of the class, which the attribute belongs to and 
their data types.  An attribute is the characteristic of a class and it is defined by the attribute 
type.  The instance of a class (aka objects) is recorded in the Object table and the instance 
fields are recorded in the Data Table, which is similar to the EAV, models (Zhang, 1995). 
 
According to Robert and Fiona, (2007) EAV model has several advantages which, include: 
 
 Flexibility: There are no limits to the number of attributes can be captured per entity 
therefore the logical database schema can grow without affecting the physical schema.  
 Storage: In a clinical database thousands of parameters are available but only a few 
may be recorded for each patient. The EAV design does not need to reserve space for 
attributes with NULL values, which may lead to empty (NULL) fields in ER model.  
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Table 4.3: EAV/CR Database tables an example of the EAV schema with classes and 
relations (Hellman, 2001). 
 
 
Class table   
className   
Person   
ClassHierachy table   
superClassID subClassID  
Person Patient  
Attribute table   
ClassID AttributeName DataType 
Patient Name Text 
Patient Date-of-birth Date 
 
 
However, the drawback of EAV/CR design is that the system administrator must have 
excellent understanding of the object-oriented technology in order to design the EVA classes. 
An EAV/CR database is therefore not user’s friendly and flexibility for the average clinician 
or researcher (Hellman, 2001). 
 
To retrieve information from the EVA/CR tables require complex SQL, which includes the 
use of INTERSECT operation or self-join for each attribute, where self-join means a join of a 
table with itself.   Besides the complexity of retrieving data from EVA/CR tables and the 
unfriendly nature of EAV to the end users, the querying operations and performance are 
slower than the SQL query statements used is conventional ER model (Johnson et al., 1997). 
 
 Limitations of Entity Attribute Value/Class Relations: 
 
The limitations and challenges encountered in the use of Entity Attribute Value/Class 
Relations (EAV/CR) was researched and fully documented in “Exploring Performance Issues 
for a Clinical Database Organized Using an Entity-Attribute-Value Representation” by 
Roland et al., (2000).   
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Roland et al., (2000) conducted series of experiments using EAV/CR and the conventional 
ERD database. They concluded that although EAV/CR has a lot of benefits, it has many 
performance limitations which include complex query structure and poor performance 
(Rolands and Chen, 2009).  
 
To address the poor query performance of EAV/CR the following were suggested by Robert 
and Fiona, (2007).  Transform the EAV data schema into many conventional tables and make 
the query design ease for the end users to write simple SQL. Use query optimization 
techniques to increase the efficiency and breakdown the complex SQL statements into 
smaller parts to increase the query speed (Johnson et al., 1997) (La et al., 2005).   
 
According to Nadkarni et al. (2001), the speed of retrieving data from conventional databases 
(ERD) using SQL queries is faster than retrieving data from an EAV/CR.  Again, the 
performance of EAV/CR can be improved by using powerful hardware with extra storage 
memory. This discussion confirms the research gap that exist in Data Re-representation 
technique do not address the information overload and optimisation problems in CIS. 
4.2 Current Techniques for modelling Clinical Decision Support Systems 
 
The techniques used to model and design decision support systems (DSS) in health 
information systems are Outranking, Analytical Hierarchy Process (AHP) and Multi-attribute 
utility theory-MAUT, which were mentioned in Chapter 3. The operations and limitations of 
the DSS techniques were analysed before the new CMAUT technique and the UML class 
diagram Data Re-representation are discussed. 
 
 Outranking - Multiple Attributes Decision Making Technique: 
 
Outranking is a decision making technique used in Software Engineering and health 
applications.  According to Fenton et al., (1997), Outranking is a process of solving problems 
by ranking the solutions from the best to the worst in order to identify the best option. In this 
technique, outranking relation is defined as a binary relation of a set of actions, where the two 
actions are (a and b). According to Roy, (1996), there are two steps in the implementation of 
Outranking, which are the following:  
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1. Step1: is to develop and establish the outranking relation between two actions for 
decision making (Sanderson et al.  2006).  
2. Step 2: is the evaluation of the relation between the two actions in the problem domain by 
using statements (Fenton et al. 1997):  
 
Again, according to Sanderson et al. (2006) the calculation of the concordance index is 
complex and time consuming.  This is because when the numbers of attributes in the problem 
domain are increased the technique does not function correctly.   In this research, the 
outranking technique is not used because although it reduces the assumptions that are made 
when handling multi-attribute utility problems, the procedures are implemented differently by 
different groups hence there is no commonalty (Fenton et al, 1997).   
 
 Analytical Hierarchy Process (AHP) 
 
The AHP technique was developed by Saaty, (1980) to resolve problems that are related to 
multi-attribute utility (MAUT).  AHP begins by representing the problem to be solved as a 
hierarchy tree, where the top node is the main objective problem while the bottom nodes are 
the actions to be taken.   The decision maker starts from the top node and at each level of the 
hierarchy makes a pair-wise comparison based on how much contribution each node gives to 
the next higher node that it is connected to.  The pair-wise comparison conducted using either 
the preference ratios or importance ratios, which are evaluated using numerical scale namely 
numbering system of 10 or percentages (100%) (Fenton et al., 1997).  
  
Another approach is to form a pair-wise comparison matrix that comprises of criterion in the 
rows and their attributes in the columns. The values in the matrix are normalised by 
multiplying each value by the weights recommended by the decision maker. Finally the 
normalised attributes values are arithmetical summed up and the values added up to 1.0 
(Sanderson et al., 2006).   
 
 Advantages and Limitations of AHP 
 
AHP was used to conduct the reliability safety assessment of programmable logic 
components by NASA.  Again, NASA uses AHP to determine and choose the best safety 
feature of the space shuttle (Fenton et al. 1997).    
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However, the limitations of the AHP method include the following: AHP was criticised 
because it permits the decision maker to select inconsistent set of weights when normalising 
the matrix. This denotes that if two criteria are given equal weight then the weighting of the 
two criteria will be the same in relationship to the others criteria in that same problem domain 
(Sanderson et al., 2006).  
 
In analytical decision model, the performance ratings are converted into preference scores. In 
this research the measured preference values are converted into utility unit using a new 
proposed utility function.   The AHP method uses weights that are selected based on the 
assumptions that they are subjective and are not supported by scientific methods (Sanderson 
et al., 2006).   This research uses statistical approach that is based on logistic binary 
regression, which is used to generate the beta coefficients from the real life data (HSE, 2006).  
4.3 Multi-Attribute Utility Theory-MAUT 
 
According to Fenton et al. (1997), in medical application, all problems are either multiple-
objective or multi-attribute.  Therefore these problems have to be solved using techniques 
that consider the multi-dimensional nature of the medical problem.  Multi-attribute utility 
theory (MAUT) was developed to allow the decision maker to put different utility values (i.e. 
unit) on each of the multi-attribute in the form of weighting.   According to Sanderson et al, 
(2006), this procedure is difficult and not applicable in medical applications because different 
weights or utility units must be computed for the multiple attributes in the problem domain.   
4.3.1 Implementation of Multi-attribute Utility Theory: 
 
In this research, the Multi-attribute utility theory (MAUT) is used for the implementation of 
the CDSS because it takes into consideration the constraints in the problem domain.  The 
technique also addresses the subjective judgement that decision makers encounter when 
selecting the best option from different alternative solutions (Sanderson et al. 2006 pp 115).  
However, in MAUT the decision maker needs to maximise or minimise the objective 
function that has the various criteria or attributes (Fenton et al. 1997).  The procedure for 
implementing the MAUT technique for decision making is as follows:  
 
1. Define the relevant attributes and their alternatives in the problem domain. 
2. Evaluate each attribute and remove irrelevant or dominated alternatives.  
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3. Assign relative weights to each of the attributes and determine their utility. 
4. Sum the attribute weights and determine their overall utility to evaluate each alternative. 
5. Perform sensitivity analysis and make a decision. 
 
The procedure for the implementation of MAUT is as follows: first determine the utility 
function , which is the sum of all the individual function    based on their    values.  This 
is then transformed into unit interval       that is used to form a matrix, in which each 
column adds up to one (Fenton et al., 1997).   One method is to define the function   , by 
allocating weights to each of the attributes in the problem domain and the total value of the 
weights should sum up to      .  An alternative approach is to define the function  , as the 
transformation onto the unit matrix      .  
 
The utility of each attribute in the problem domain is determined by using an option where 
the greatest utility should be ranked top by the decision maker and selected as the optimal 
solution (Sanderson et al., 2006). The final result is determined by summing the utility 
functions of each of the attribute under consideration using the following expression:   
Total utility function                                The total utility function is 
solved using optimisation techniques. 
 
 Optimisation of utility function in MAUT: 
 
Optimisation is the process of writing a new algorithm or modification of exiting algorithm to 
improve the efficiency of data retrieval, processing or performance of a system.  According to 
Fenton et al., (1997), in multi-criteria decision making, the key problem is optimising the   
function.   Optimisation is the process whereby the optimal value of the objective function   
is determined in order to satisfy the conditions specified in the problem domain.  In the 
problem domain the objective function    optimises one or more attributes of the elements, 
  , where the   , maybe the objects, decisions, candidates etc.   In this research, optimisation 
is defined as the process where one or more attributes of the elements of    in the       
function are optimised in order to satisfy the specified constraints in the problem.  Therefore 
the total utility function                              is optimised using Linear 
Programming Optimisation Technique to determine the optimal solution (Fenton et al. 1997). 
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4.3.2 Challenges of Multiple Attribute Utility Theory; 
 
The main advantage of MAUT is that it brings order and consistency in solving problems 
with multiple criteria and multiple attributes (Fenton et al, 1997).  This technique permits 
transparency when allocating weights to each criterion in the problem domain.   Another 
advantage is that MAUT gives the decision maker the ability to select the optimum solutions 
for a problem with many objectives and multi-criterions.  It also allows the user to put 
different scores or weights on the multiple attributes in the problem domain to determine the 
best optimum solution.  This technique has been used in many applications but not in CDSS 
(Sanderson et al., 2006).   
 
The disadvantages of MAUT model include the difficulties involved in applying the 
appropriate weighting techniques because of its subjective nature weight allocation.  The 
utility method is subjective and is defined differently by different people and therefore it is 
difficult to implement the MAUT in medical application (Sanderson et al, 2006).  Sequential 
elimination is easy to implement, however it has many trade-offs when short-listing the most 
optimal solution as discussed in chapter 3.  This makes it difficult to implement the 
Sequential elimination and MAUT techniques in clinical decision support systems (Fenton et 
al. 1997).  Other challenges associated with the implementation and applications of MAUT 
are data representation and construction, which are discussed below: 
 
 Representation of problem: the user must determine the properties or attributes in the 
problem domain that must meet or satisfy the decision maker’s preferences, such that it 
can be represented by a function, which has a prescribed analytical format (Fenton, 1997). 
 
 Construction of problem: deals with how must the maximisation or minimisation of the 
objective function be formulated or constructed such that the optimal values can be 
determined and the various parameters estimated (Fenton et al, 1997). 
 
To address the above challenges, this research has adopted a new system which is known as 
Combinatorial Multi-Attribute Utility Theory that is discussed in section 4.5 below.   
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4.4 Proposed new Clinical Data Re-representation using UML and CMAUT 
 
The research gap that is work addresses is the creation of a new clinical data representation 
mechanism with an optimisation algorithm for the implementation of clinical decision 
support systems for cardiovascular disease (CVD). The remaining chapters of this Thesis will 
tackle the issue by proposing the following:- 
 
1. That problem in the clinical domain can be modelled using the class diagram in the UML 
and formulated it with CMAUT and logical connectors (AND/OR).  In this research, this 
technique would be known as CMAUT Clinical Data Re-representation mechanism. 
2. The Construction problem is addressed by developing an algorithm, which has objective 
utility function that is optimised using LP techniques subject to the constraint identity 
matrix or unit matrix.  
3. The output of the optimisation function can be mapped to the various attributes, which are 
the nominal standard values and the optimal value is converted into percentage value. 
 
The above procedure will be used to model and build the prediction framework, which 
consists of a clinical class Re-representation model and CMAUT mathematical formalisation. 
The prediction framework uses LP prediction algorithm to determine the CVD percentage 
risk, the comparative output attribute variables and their interpretations. 
4.4.1 The New Clinical Data Re-representation Mechanism 
 
In this research, the class diagram is used to model the multiple attributes and the association 
between the human organs in order to create the new re-representation mechanism (Edoh et 
al, 2011).  The human organ re-representation uses the class diagram as a conceptual model 
and the CMAUT theory to express problem applying formal specification technique to avoid 
ambiguity.  CMAUT is a decision making tool used in econometrics but it is not utilised in 
medical application because of its complexity (Sanderson et al. 2006).  
 
In the NL7 CIS, class diagram is used to model and represent the relevant classes required to 
handle patient-centred activities in the problem domain.  The NL7 type of modelling does not 
focuses on disease as a concept nor captures the organs, their relationship and the multiple 
attributes.  This is a data representation problem that must be address in future NL7 model. 
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For instance, Balaa, (2008) attempted to capture the kidney and its attributes using class 
diagram but the model is not comprehensive. This confirms the criticism that the NL7 does 
not incorporate a methodology for modelling disease, organs and their relationship in RIM 
(Taylor, 2006). 
 
This research has developed a new framework for optimizing CIS with emphasis on the 
diseases, patient organs, their attributes and association between the organs. The framework 
subsumes that a patient is an object, which is made up of six subsystems namely the 
respiratory, cardiovascular, neurological, coagulation, hepatic and renal as used in the Sepsis-
related Organ Failure Assessment (SOFA) algorithms (Vincent et al., 1996). 
 
Figure 4.5: Clinical Disease representation using the CMAUT Framework  
 
SOFA is a decision making algorithm used in Intensive Care Unit (ICU) to determine the 
malfunctions subsystem in patient’s organs (Ceriani et al., 2003). The SOFA representation 
in Figure 4.5 is an extension of the CMAUT concept and UML diagrams. In SOFA the 
subsystems complement each other in their operation to achieve the requisite homeostatic of 
the human body.  In the CMAUT framework, organs that complement each other in their 
operation to achieve their predefined goals are called complementary organs. These organs 
are linked with the AND connectors and their prescribed goals are known as utility function. 
Likewise organs that can substitute each other in their operation in order to achieve their 
utility function are known as substitutable organs and are represented with an OR connectors.  
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In figure 4.5, a disease can affects a patient class, which is made up of six (6) subsystems 
where each subsystem complements the other and are connected with the AND logical 
connector.  In this conceptual model the association between organs are represented with 
combinatorial logical operators (OR) and (AND) while the attributes are captured with 
multiple attributes (MA) theory is called combinatorial multiple attributes (CMA).  For 
instance a hypertension disease that affects the organs; heart, kidney and brain while 
complementing each other to ascertain that the correct amount of blood and pressure flows 
through the body to achieve  homeostatic are known as complementary organs. Again, pair 
organs such as kidneys, liver, eyes are substitutable organs because when one is mal-
functioning the other act as a substitute to achieve their utility function (Edoh et al., 2011).   
 
The CMAUT conceptual model uses the class diagram in O-O methodology to model the 
human organs and their relationship and also capture the multiple attributes of the organs.  
This data representation can be converted in programming language using the formal 
methods Z or VDM approach (Charatan and Kans, 2004).  The CMAUT approach is unique 
because; 1. It allows CIS to be optimised in order to determine the appropriate amount of data 
that can be mapped and retrieved for disease assessment. 2. It enables clinical data to be 
analysed using mathematical based algorithm. 3. It can be used as an epidemiological 
mechanisms to assess the risk of having CVD disease such as Framingham, QRISK and 
ASSIGN methodology; 4. It can be expanded to include newly discovered attributes in the 
framework because of its multiple attribute nature (Ceriani et al., 2003). 
 
 
 
Figure 4.6: New CMAUT clinical Data Re-representation (Imafidon et al., 2009) 
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4.4.2 New Clinical Data Formalisation using CMAUT for CDSS 
 
The new CMAUT Data Re-representation uses propositional logic and combinatorial human 
components and their multiple attributes to model the disease.  Each component or organ in 
the human body is classified as an object. This is based on the following assumptions. 
 
 
Assumption 1: - Clinical human objects, Entities and Diseases  
 
1. In Software Engineering, an object is defined as anything that information can be 
stored about it and it must have a name, attribute and functions (Fenton et al, 1997). 
Therefore in this research, every component or organ in the human body is known as 
an object. However, the human objects have multiple attribute values; hence they are 
multiple attribute objects. Again, all human objects have names and functions which, 
includes get heart size, replace knee etc.  
2. Entities in this research are defined as two dimensional containers in which data are 
stored in column (aka field or attributes) and rows (aka records). 
3. Disease is defined as an object or the component parts of the body in the problem 
domain which measured attribute values are different from the specified acceptable 
standard value. 
 
This new clinical Data Re-representation technique is based on the notion that problems in 
any domain can be modelled and represented using propositional logics (Wenting, 1995). In 
propositional logic the main components are represented by literals and they are linked 
together using logical connectors such as AND, OR, XOR. Examples of these applications 
are discussed in Wenting, (1995), where problems in e-auction domain are described using 
propositional logic and the results manipulated before they are transferred into Conjunction 
Normal Form (CNF) expressions (Edoh, 2004).  
 
The optimal value of a combination of components is determine by using LP techniques after 
the maximum output CNF expressions have been analysed and converted into set of 
inequalities (i.e. algebraic calculus).  The CNF expressions in the proposed clinical Data Re-
representation are transformed into algebraic calculus using the Table recommended (Raman  
and Grossmann, 1994). In this research constraint matrix in the form of Inequalities Table 
recommended by Raman  and Grossmann, (1994) are used and discussed in chapters 5 and 6. 
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The first step of the clinical Data Re-representation technique is the application of the 
combinatorial multiple attribute concept (aka CMA) (Sanderson et al. 2006). In this 
technique, diseases and their symptoms are described using propositional logic and multiple 
attributes.  The various attributes in the combinatorial expressions are converted into 
common utility unit using the MAUT (Edoh, 2005). To demonstrate the operation of this new 
Clinical Data Re-representation technique, disease is defined as the abnormal behaviour of 
the human organ. Also disease is when the attribute values of the human clinical object under 
consideration are different from the specified values or norm.  The body parts or objects in 
the problem domain (i.e. disease) are described using propositional logic, which depict the 
relationship between the various body parts affected.   
  
Assumption 2: - Combinatorial multiple attribute utility theory (CMAUT) for CDSS. 
 
This assumption is based on the fact that every human organ or body part has many 
attributes, which are associated with their behaviour.  In clinical application these attributes 
are used to define and describe the symptom of a disease (Deutsch et al., 1994).  Some of the 
clinical measurable attributes used in this research are the continuous variables, 
temperature   , heart rate (HB) , blood pressure    , resistance     and volume     
 
In this research, utility function       is the service that an organ or combination of organs 
provide as a contribution to the total output of human body (Deutsch et al. 1994).  Therefore 
the utility function of an organ or combination of organs is determined using the attribute 
values of each organ (Fenton et al., 1997).   Utility unit      is an instance of the utility 
function and it is determined by using utility function of each human object or group of 
objects and the multiple attribute utility theory (MAUT) concepts.  Therefore the utility unit 
     of each human object is calculated as the ratio of the difference between the measured 
attribute value of object and the specified acceptable standard value of the object.  
 
The utility unit identifies the relationship between an organ’s attribute value from the 
specified standard value in clinical practice (NICE, 2006). It is subsumed that each of the 
object’s attributes can be converted into common utility function, which is used to denote the 
behaviour of the organ. For complementary organs, the total utility unit is the arithmetical 
sum of the utility units of all the attributes of each organ in the disease domain.  
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However, the total utility unit of substitutable objects in a combinatorial is the sum of the 
individual object’s utility units and not the arithmetical total sum of all the attribute values. 
This is because substitutable human objects work individually to achieve their utility 
function. 
 
Assumption 3:- Relationship between clinical human objects and propositional logic 
 
 Complementary organs:  
The third assumption is that, all parts of the human body have a relationship with each other, 
which are complementary, substitutable or high valued. The complementary organs assist 
each other in performing their duties and are therefore linked to each other using the AND 
connector. For example, combinatorial components with multi-attributes (CCMA) expression 
using logic connector AND is written as: 
 
                         (4.1) 
 
In the expression (4.1) the disease   affects the body parts    and    where    and exhibit the 
attributes   , and   , while organ    has attributes    and   .   This research focuses on 
complementary organs because most of the parts human body complement each other rather 
than substitute them as discussed in chapter 5 and 7.  The generic expression for 
combinatorial components with multiple attributes (CCMA) using AND connector is: 
 
                              (4.2) 
 
Similarly, the generic expression for two or more body parts which complement each other 
but has only one attribute is called combinatorial components with single attribute (CCSA) 
and it is written as 
                           (4.3) 
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 Substitutable organs:   
Substitutable organs are the body parts or objects that work together and can operate in place 
of the other or can work as replacement organs for the others particularly when one of the 
pair of organs is malfunctioning. These organs are called combinatorial substitutable objects 
or organs and are connected with the OR connector. In the human body, substitutable organs 
are designed such that when one fails the other can work on their behalf (Guyton and Hall, 
2006). Some of the organs are the pair of noses, ear, kidneys, lungs, ovaries, legs, eyes, 
hands, urethras (i.e. tubes), adrenal grand and gallops tubes lobes among others. Therefore 
when two body parts or organs act as replacement for each other and have many attributes 
they are expressed as: 
 
                         (4.4) 
 
When combinatorial substitutable organs have only one attribute, then they are known as 
combinatorial components with single attribute (CCSA) and it is written as           
               . In this expression, the single attribute    is the pressure in each of the 
objects.  The generic expression for combinatorial components with substitutable and 
multiple attributes (CCMA) is written as 
 
                               (4.5) 
 
 Highly valued substitutable organs using XOR connector – Brain or the Heart 
 In CMAUT clinical Data Re-representation technique, the high valued parts such as the heart 
or the brain are connected to other organs with the “exclusive or” (XOR) connector 
(Wenting, 1995).  Medical research has established that a person is clinically dead when their 
brain creases to function however other school of thought argues that it is only when the heart 
ceases to function that a person is  clinically dead (Guyton  and Hall, 2006).   
 
This research will not cover this issue but will assume that the two high valued organs are the 
heart and the brain. Therefore the following example subsumes that the brain is the only high 
value part of the body while the other organs assist or substitute each other.  Therefore for 
instance a disease X that affects the brain    and the heart   is written as: 
 
                          (4.6) 
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In this research with the exception of dead brain, the connector XOR will not be used because 
the patients are considered clinically dead. Thus the focus would be on complementary and 
substitutable body parts or organs only.  CMAUT expression for     is written as follows: 
 
                                   (4.7) 
 
                  The expression (4.7) indicates the common utility value of the two 
highly valuable organs when their individual attributes i.e. blood pressure and volume are 
combined it gives a total utility value of   . 
4.4.3 Conversion of Multiple Attributes into Utility Unit in       
 
The attribute values used in this research are the measureable parameters, which were 
discussed in chapter 3 and 5.  The CVD clinical data is from the HSE, (2006) report, peer 
reviewed literature and the medical source (NICE, 2006).  All the standard clinical values 
used in this research are from the NICE documents and other literature discussed in section 3. 
 
 Methods of Allocating weight to attributes in CMAUT Combinatorial.  
 
There are two main methods of allocating weights to each attribute in multiple attribute data 
sets. These are explained in the section below. 
Method 1: The weight ranking system (aka performance preference) is a process where the 
medical experts recommend appropriate percentage or weight that must be allocate to each 
attribute in the disease domain. This depends on their individual preferences but the 
arithmetical sum of all the attributes in the combinatorial must add up to 100%. This concept 
is used in risk factor categories analysed by Wilson et al, (1998) and in Risk factor scoring 
technique (Hence, 2003).  However, Beswick and Brindle, (2006) cautioned that decision 
made by health experts using scoring and preference allocation values lead to overestimation. 
 
Method 2: this is the use of binary logistic regression approach; this is also referred to as the 
statistical method of building prediction models (Pencina, 2009).  In this method each 
attribute is allocated    coefficient value that is generated from the regression structural 
equation obtain by statistically analysing a given data.  The study case in this research uses 
the HSE, (2006) data set and SPSS to analyse and generate the    coefficient values.  
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According to Terrin, (2003), the use of logistic regression to develop prediction model gives 
accurate results as compared to the application of Artificial Intelligence (AI) methods. 
 
To convert the multiple attributes in       expression into a utility unit and at the same 
time take into consideration the weight each attribute must have in the CDSS of     the 
following equation is proposed. 
                                
     
  
        (4.8) 
   is the estimated value and    is the actual measured and recorded value in the expression. 
              
                     
              
                                                               
IF                          which means this attribute will not be in the objective 
function because any weight allocated to it will have a resultant zero value. 
 
 Example of converting        expression into utility unit:  
The expression below is for complementary organs with multiple attributes as shown in (4.1). 
 
                                              
 
Using the principle of converting attributes into utility units (4.8) the following are obtained: 
                           ∑                                
    ∑                                
    ∑                                
 
The    is the weight for the pressure,   ,    are the weight for the volume and Total 
cholesterol. Now the       expression in the expression framework above can be 
transformed into mathematical Mixed Integer Program (   ) for evaluation.  In Chapter 6.2, 
an algorithm is developed that converts the expression into conjunctive normal form (   ). 
The CNF expressions are then translated into set of inequalities for evaluation.  The 
expressions are evaluated using LP techniques.  In chapter 5 and 7, the simplex LP technique 
in MATLAB 7.x is used to optimise the objective function generated from the above 
expressions.   
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4.5 UML Clinical Data Re-Representation with CMAUT formalisation 
 
To illustrate the CMAUT operations the logical expression for the complementary organs    
and    with the attributes as    and    are first written as             . The substitutable 
organs, which is    or    with the attribute   and    is expressed as             . Two 
examples from two different clinical application domains are explained below: 
 
Application of UML and CMAUT to two domain scenarios 
 
The domain scenarios used to illustrate the application of UML class model and CMAUT in 
CIS are Kidney and Heart related diseases. These scenarios were selected because they 
clearly depict the relationship between the different organs and their operations.  According 
to Guyton et al. (2006), the two kidneys can work independent and therefore form well-
defined actual subclasses with an abstract super-class known as kidney.  
 
Similarly, the main organs that contribute to cardiovascular disease (CVD) are identified as 
heart, kidneys and the brain.  These organs have been modelled in different mathematical 
formalism in order that they can be simulated for research purposes.  However, they have not 
been modelled using CMAUT and class diagrams.  Therefore this research focuses on how 
the organs that complement each other can be designed and modelled to create homeostatic in 
the human body during their operation as discussed in Guyton et al., (2006).  
4.5.1 UML Clinical Data Re-representation of Kidney Diseases: 
 
Scenario 1: the kidney disease involves the two kidneys working together to perform the 
function of regulating the flow and extraction of liquid in the human body.  As stated in 
section 4.4.2, each kidney can replace or substitute the other during their operation.  
According to Guyton et al. (2006), kidney related diseases are acute renal failures and chronic 
renal failure.  This research work focuses on interregnal acute renal failure, which is the 
result of abnormal behaviour of each kidney.  In the class diagram Figure 4.7, the kidney is a 
super class with two subclasses which are the left and right kidneys that are linked with the 
OR connector.  The subclasses inherit the characteristics of the super-class as shown in 
Figure 4.7. 
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Figure 4.7: Clinical Data Re-representation of Kidney using UML (Edoh et al., 2011) 
 
In Figure 4.7, the two sub-kidneys can supplant each other and have many attributes, hence 
they are expressed in CMAUT data re-representation using the OR connectors as: 
 
                         (4.7) 
 
In expression (4.7)     are the organs and   ,   ,   ,    are the attributes.  The generic 
expression for these substitutable organs with multiple attributes is written as           
                    
 
For substitutable organs, there are two representations 
 
1. At the junction where the two subclasses (left and right kidneys) meet the total utility unit 
of the kidney is the arithmetical sum of the individual attributes.  This is used to form the 
objective function to be optimised and it is written as  
   ∑                    
 
 
 
 
2. For the distinct individual subclasses the utility unit of the individual attributes are not 
arithmetical summed together but remain as independent attribute with individual utility unit.  
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For example there are two separate kidneys; the left kidney has its attributes and utility units 
while the right kidney has separate attributes and utility units. Therefore after computation 
the objective function for each kidney will be written as follows: 
 
The objective function for Left Kidney =     ∑                     
 
   
 
The objective function for Right Kidney =     ∑                     
 
   
 
The objective function for the Right Kidney and Left Kidney are optimised subject to the unit 
constraint matrix, using the 1 and 0 mentioned above.  The optimisation algorithm is written 
in MATLAB and it is used to determine the optimal value, which is the percentage risk. 
Again, the input attributes values can be mapped to the output variable from the framework to 
identify the attributes in the combinatorial, which attributes need to be analysed and focused 
on for further medical investigation.  This area of study is not covered in this research and it 
is recommended for further works. 
 
4.5.2 UML Clinical Data Re-representation of Cardiovascular Diseases (CVD): 
 
Scenario 2: this research focuses on hypotension and hypertension diseases,  A hypertensive 
case is described as hypertension (G) is caused by the high rate of pumping of the heart (H), 
which creates excessive blood pressure on the walls of the arteries (A) and sends appropriate 
signals to the brain (B) to regulate the flow of fluid in the kidneys (K); Hence the 
hypertension disease affects three primary organs which are the heart, kidney and the brain 
component (aka Ant-diuretic hormone ADH), which complements each other in their 
operations. Figure 4.8 depicts a class diagram with the three main organs and their attributes.  
The association between them is represented with the AND operator.  In this model the 
combinatorial organs with multi-attributes is expressed using logic connector AND in CMA 
data re-representation as: 
 
                                  (4.8) 
 
In the expression (4.8), the disease    affects the body parts  ,    and    where    exhibits 
the attributes   , and   , while organ    has attributes     and    etc.  
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The generic expression for combinatorial clinical organs with multiple attributes using 
              is                              .  The logical expressions (4.7) 
and (4.8) serve as the input to the optimization framework discussed in Chapter 5. 
 
 
 
Figure 4.8: Re-representation of heart diseases with UML 
 
Disease    that affects the 3 organs is written as                                   .  
To convert these attributes into utility function     use the procedure as 
  ∑                   
     
  
  (4.9) 
The    is the standard expected blood pressure while the patient’s measured blood pressure is 
   hence the utility unit    of the organ   is shown in expression (4.10) below as: 
   ∑                                   (4.10) 
 
Hence the disease    is expressed in       format as                         . 
From expression (4.10) it is subsumed that this new algorithm takes into consideration the 
relationship between expected value    of the organ and the actual measured at any time   . 
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The baseline value is the standard acceptable value when the organs are performing normally 
with respect to the person’s age, sex, height, weight and they are specified in medical 
literature (Guyton et al. 2006).  The baseline value     used for calculating the    when the 
heart is working normally are from Guyton et al. (2006).  The systolic and diastolic pressures 
are as follows; for adults who are over 20 years the values are 140/90mmHg and for diabetics 
patients the values are 130/60mmHg.   According to NICE (2006), in UK the generic 
standard blood pressure is 140/90 mmHg and the heart rate or heart beat is between 70 to 80 
beat per minute.  Similarly, the volume of filtrate formed by the two kidneys each minute is 
glomerular filtration rate (GFR) is about 125ml/min (i.e. 180 litres) a day.   The renal blood 
flow is maintained at constant diastolic pressures of 80 to 200 mmHg. Again since the 
framework is benchmarked against Framingham algorithm, the ADH in the brain was not 
measured but specified as Boolean value.  Similarly the parameters in the kidney class in 
Figure 4.8 are not considered.  This is further discussed in Chapter 5 and 7 because this 
research focuses on hypertension, which is a cardiovascular (CVD) disease. 
 
4.6. Summary 
 
This Chapter 4 discusses two medical data re-representation techniques, which are EAV/CR 
and FOL-ERD.  It also reviews the limitations of these data re-representation techniques and 
how they can be conceptually improved. The EAV/CR model is used for the design of 
clinical databases.  However, it is designed for specific application and it is complicated 
model with a complex information retrieval mechanism. The chapter also examines decision 
making models used in CDSS, which include Outranking, Analytical Hierarchy Process 
(AHP) and Multi-attribute utility theory-MAUT. These decision making models cannot 
efficiently handle clinical data, which are multi-attribute in nature.  These CDSS models are 
not optimised and therefore cannot solve the information overload problem in CIS. 
 
In this chapter a new Data Re-representation technique that uses UML class model and 
CMAUT was presented. The application of this new technique to model CVD and Kidney 
diseases are illustrated and explained in chapter 5.  The CMAUT framework can also be used 
as CDSS model for analysing and predicting hypertension disease.   
 
 
 
                                                                                                 CMAUT-UML Framework for Optimisation of CIS                                                     
 
 
84 
 
Chapter 5: CMAUT Optimization Framework for CVD 
Risk Diagnosis: 
 
5.0 Introduction 
 
The chapter starts with a discussion on the operation of the CVD diagnosis framework using 
the heart disease scenario described in Chapter 3.  The second part of the chapter 
demonstrates how the framework is used as epidemiological tool to determine the percentage 
risk of users been hypertensive. As mentioned in chapter 4, this new optimisation framework 
is made up of two subsystems, which are the Data Re-representation mechanism and the 
CMAUT optimisation algorithm that uses LP technique to determine the optimal data 
required for clinical analysis.  
 
5.1 CIS Optimization Framework. 
 
The CIS optimisation framework is made up of the Data Re-representation mechanism, 
which utilises UML class diagram and the LP optimization algorithm that is designed with 
the utility function.  In this framework, the relationships between the organs in the disease 
domain are described using logical connectors and the multiple attributes of the organs.  This 
is shown in the class model Figure 5.2 and expressed in CMAUT mathematical format.  The 
weight allocated to each attribute is determined using the beta coefficient values from the 
SPSS binary logistic regression analysis and incorporated into the expression   ∑     . 
The CMAUT expressions formulated from the multiple attributes in the class diagram are 
converted into mathematical format which serves as input to the LP optimisation algorithm. 
 
The procedure used to convert the CMA expressions from the class model into CMAUT 
mathematical format is discussed in section 4.4.3:   The Data Re-representation mechanism 
and algorithm in the framework works as follows: 
 
The stepwise procedure is:  
1. Write the relations to be optimized in the disease domain using logic expression;   
2. Group the attributes and calculate the utility function using                  
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3. Use symbolic manipulation, to convert the logical expressions into conjunctive normal 
form (CNF) using the U for each attribute;   
4. Translate the logic expressions in CNF into linear mixed integer variables and set of 
inequalities (aka constraints) using unit matrix or Raman's Transformation table. 
5. Establish the objective function to be maximize or minimize   
6. Use the LP algorithm in the framework to optimise the objective function:       
7. Convert the evaluated value after the optimisation process to percentage    
8. Map the optimal Xi values from the optimisation process with the attributes. 
 
The activity diagram 5.1 below depicts the operation of the CMAUT Framework: 
 
Figure 5.1: Flowchart and activity diagram of the CMAUT Framework 
 
Input patient 
details and data
write the relation in 
logical form
Input AND norm 
data and weight
Input OR norm 
data and weight
Calculate OR 
utility function
Calculate AND 
utility function
Formulate objective 
fun for OR
Formulate objective 
fun for AND
Create OR constraints 
[1,0] matrix
Create AND constraints 
[1,0] matrix
XOR organsOR organs
AND organs
Map  optimal  xi values 
with attributes
Convert optim 
value to % risk
optimise objective_fun 
with LP algorithm
optimise objective func 
with LP algorithm
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5.2 Data Re-Representation Mechanism using UML 
 
The Data Re-representation mechanism is made up of two components namely: 
1. A subsystem for modelling clinical data using UML class diagram and  
2. A CMAUT subsystem for the Re-representation of the clinical data in logical format and 
formalising them for mathematical manipulation and optimisation using LP method.  
 
The first subsystem uses class diagram to model the organs, their multiple attributes and the 
relationship between the organs in the disease domain.  In class diagram, the association 
between the complementary organs are modelled using the AND logical connectors.  
Substitutable organs on the other hand are shown as subclasses that inherit the attributes of 
the super-class, which is an abstract class in human physiology. The subclasses are the two 
real kidneys, ears, eyes, noses (Guyton and Hall, 2006).  This concept is used in UML class 
modelling, where the super-class is known as the abstract class because it does not exist. The 
substitutable organs are represented using the OR logical connector, which shows that the 
organs can replace each other in their operations (Edoh et al., 2011).  
 
 CMAUT data representation system and formalism 
 
To illustrate the operation of the CMAUT data representation, three complementary organs 
namely     and    and    with multiple attributes   ,   , for organ   ,    ,   , for organ    
and   ,   for organ                First the clinical data representation is written in the 
CMAUT logical expression as   the disease X1 that affects three complementary organs 
is    (                            ). These attributes are converted into utility units 
using the utility function       and the procedure used is as follows: 
 
                             
     
  
        (5.1) 
 
In the expression (5.1), the Po is the expected pressure and the patient’s measured blood 
pressure is Pi therefore the utility unit U1 of the organ G1 is shown in expression (5.2) as: 
 
   ∑                                      (5.2) 
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This research focuses on hypertension, which is a cardiovascular (CVD) disease. The 
hypertension disease X1 is written in CMAUT format as                         . 
Where the           are the utility units of the measurable CVD attributes and risk factors. 
From expression (5.1) it is evident that the CMAUT algorithm takes into consideration the 
difference between expected standard attribute value    of the organ and the actual measured 
   recorded at the time of clinical exanimation     .  As stated in section 4. 5, the expected 
standard value    is the measure of the normal performance of an organ with respect to the 
person’s age, sex, height, weight as indicated in NICE, (2006) report and medical literature 
(Guyton et al., 2006). 
 
Therefore the CVD baseline values    used to calculate the utility unit    in this research are: 
For systolic and diastolic pressures of adults over 20years the values are 140/90mmHg and 
for diabetic patients the values are 130/60mmHg.  The acceptable heart rate is between 70 
and 80 beat per minute but in this research, the standard value used is 50 beats/minutes.  The 
ADH in the brain was not used because it is not applicable in CVD prediction models. This 
research focuses on hypertension as a cardiovascular disease (CVD) therefore the 
demographic and clinical data used are shown in Table 5.2 below. 
 
 Clinical data CVD Re-representation with UML and CMAUT; 
 
The scenario below shows how blood flows through the cardiovascular system (CVD) of the 
human body (Guyton et al. 2006). This research applies the heart disease scenario to describe 
the behaviour pattern of hypertension and presents the disease pattern using the CMAUT 
logic format: 
 
Hypertension disease is described as follows: - Hypertension (G) is caused by the high rate of 
pumping the heart (H), which creates excessive blood flow with pressure (P) on the walls of 
the arteries (A) that sends signals to the AHD in brain (B) and the kidneys (K) to regulate the 
blood flow and maintain haemostatics. The UML class model re-representation of the CVD is 
shown in Figure 5.2 below.  
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In this research, two sets of CMAUT models are designed and built using the MATLAB 
software for diagnosis and prognosis of CVD.  The models are built based on the above 
hypertension CVD scenario and the models are simulated using the HSE, (2006) clinical data 
discussed in chapter 3.  
 
5.3 Application Cardiovascular Disease (CVD) in the CMAUT Framework 
 
To illustrate the operation of the CMAUT framework, the Cardiovascular Disease scenario 
discussed in Chapter 3 was re-formulated as follows: that the hypertension disease      “is 
caused by” high rate of pumping blood by the Heart        that “sends” excessive high 
pressure blood to the Atrial     which “send signal to” the Ant Diuretic Hormone (ADH) in 
the Brian     to regulate the flow of fluid to the kidneys         The organs in  this scenario  
are complementary organs because they assist each other in performing their duties.  
 
In this scenario the CVD clinical data of two participants (a female and a male) selected from 
HSE, (2006) data in appendix 3.4 and shown in Table 5.1 are used: 
 
Table 5.1- The three participants used for illustration and the simulation exercises are: 
 
Pserial no. Grp Bp1 Age Sex Ethnic HB BMI BPH BPL HDL MAP DIA TC SMK CVD ECG 
13,956,102.00 No No 60 Women White 34.00 13.20 122.50 88.50 1.80 100.00 No 5.20 Yes No Yes 
63,535,102.00 Yes Yes 30 Women White 46.00 13.71 120.00 74.00 1.40 89.50 No 4.50 Yes Yes No 
42,831,101.00 No No 35 Men White 64.50 18.15 135.00 70.50 1.70 92.00 No 4.10 Yes No No 
 
 
Simulation 1: the data of the two selected participants (a female and a male) from HSE, 
(2006), which are the Age, Sex, BMI, HB, BPH, HDL, TC and MAP were input into the 
framework. The framework computes the value of the Absolute Percentage Risk (APR) of 
each of the participants to verify if they have hypertension and the results are recorded in 
Table 5.9A and Table 5.9B.  Again, the attributes in the combinatorial that have the optimal 
utility values, are determined and the output variables mapped to the respective attributes as 
indicated in Table 5.9A and Table 5.9B. 
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The CVD scenario discussed in chapter 3 is modelled using the UML class diagram and 
CMAUT re-representation technique in Figure 5.2.  The Figure 5.2 depicts the CVD risk 
factors and multiple attributes used by existing Web CVD risk calculators that are designed 
with the Framingham equations (Sheridan et al., 2003): 
 
 
 
Figure 5.2: Re-representation of CVD risk factors for CMAUT framework 
 
 The combinatorial organs and multi-attributes in Figure 5.2 are written in       format 
using the logic connector AND as follows: 
 
   [(  ٨  ٨  ٨  )                                                           ]   (5.3) 
 
   [(  ٨  ٨  ٨  )                           ] (5.4) 
 
In expression (5.3), the hypertension disease G1 affects the organs     ,  , and   , which 
have the attributes     , and   , that are  converted into utility units    as in expression (5.4). 
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The proposed CMAUT framework in section 5.1 was converted into an epidemiological 
CVD risk prediction model. The new CMAUT framework transformed into risk prediction 
model by applying the same CVD risk factors as used in existing Web risk calculators and 
Framingham equations (Sheridan et al., 2003).  This approach enables the risk results from 
the CMAUT framework to be compared with risk results from existing CVD risk prediction 
tools such as Web calculator and Framingham equations (Chuang et al., 2007).  The multiple 
attributes used in the Framingham prediction model and for the simulation exercises in this 
research are: HB -  , BPL -   , BPH -   , MAP – , BMI -  , HDL -   and TC- .   
 
As discussed in Chapter 4, for the CVD scenario the brain acts as a catalyst and therefore its 
attributes are not considered in the CMAUT framework class diagram. Likewise the Atrial 
system that carries the blood, is not be modelled in the class model. However, the MAP 
values are calculated as the difference between BPH and BPL and modelled as an attribute of 
the heart (Guyton et al, 2006). Therefore the expression (5.3) is modified accordingly to (5.5) 
 
   [(  ٨  ٨  )                                                           ]   (5.5) 
 
 For the purpose of comparison with other CVD risk calculators, the expression (5.5) is 
rewritten using Utility Units as shown in (5.6) to reflect only the classes in the UML class 
diagram and the attributes used for the development of the CVD - CMAUT framework: 
 
   [(  ٨  ٨  )                           ]  (5.6) 
 
The expression (5.6) is used as the input for modelling the CMAUT optimisation algorithm in 
the framework and also to determine the percentage risk of a user having hypertension.  
5.3.1 The CMAUT Optimisation Algorithm: 
 
The CMAUT logical expression written from the data re-representation mechanism is 
converted into mathematical formalisation using algebraic calculus that serves as input into 
the algorithm.  For complementary organs, the utility units of the individual attributes are 
arithmetically sum together to form the objective function. The function is written as  
  ∑                    
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This objective function is optimised subject to the constraint matrix, generated in the unit 
matrix formation or Table 5.3. The Table 5.3 depicts the attributes that are measured and used 
in the optimisation process as 1 and those not used in the inequalities as 0. 
5.3.2 Determination of Initial Clinical Absolute Percentage Risk (APR) in CVD 
 
In CVD health care, diagnosis is the first stage of disease management. Therefore in clinical 
settings, the determination of CVD risk assists in the timely intervention of the cause of the 
CVD disease, thus the prediction of Initial clinical Absolute Percentage Risk (APR) is 
essential (Guyton et al. 2006).  In this research, Absolute Percentage Risk (APR) is defined as 
the percentage probability of a participant being hypertensive in the current state based on 
their clinical measurable data. This absolute percentage risk (APR) is used for early diagnosis 
of CVD and it is not directly related to time (Panagiotakos and Stavrinos, 2006).   In 
prognosis, predictive percentage risk (PPR) is defined as the measure of the likelihood of a 
participant developing a disease over a specified time period.  Relative Risk (RR) on the 
other hand is the measure of the chances of risk occurring in two different groups of people 
(Anderson et al., 1991).  
 
 CVD data used for modelling the CMAUT Framework  
 
From the HSE (2006) report, the demographic and clinical data of all participants who 
provided detail complete data were filtered out and used in this research.   The demographic 
data used are the participant’s serial number (PIND), age, sex, ethinda (i.e. ethnic origin).  
For benchmarking, the APR results from the CMAUT framework are compared with the 
results from existing Framingham equation and web calculators. The clinical data used for the 
development and evaluation of the CMAUT model are HB, HDL, BMI, TC, HDL, BPH, 
BPL, ECG/LVC and CVD, Diabetic and Smoking.  These are shown in the Table 5.1 and 
Table 5.2. 
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Table 5.2: Demography and Clinical data used in this research: 
 
Attributes 
Used in work 
Medical name READ 
code 
Baseline 
value 
Min value in 
HSE 
Max value in 
HSE 
OmpulvalHB Heart Pulse Rate 
(Beats Per Minute) 
NA 50BPM 20.50 136.50 
BMI Body mass index 22K..% 25.5 kg/m2 13.20 49.66 
OmsysvalBPH Sitting systolic blood 
pressure 
246R. 140 mmHg 84.00 225.00 
OmdiaBPL Sitting diastolic blood 
pressure 
246Q. 90 
mmHg 
39.00 117.50 
Hdlval1HDL High-density 
lipoprotein (HDL) 
cholesterol 
NA 1.2 
mmol/L 
0.50 4.40 
OmmapvalMAP Mean Atrial Pressure NA 100 
mmHg 
58.50 140.00 
CholvalTotalChol
estrol 
Total cholesterol 
measurement 
44PH. 5.5 
mmol/L 
2.10 11.40 
Diabetic Doctor diagnosed 
diabetes 
C10F.% N/A NO YES 
Smoking Current smoker 137R N/A NO YES 
ECG/LVC Had electrical 
recording ECG  of the 
heart. 
NA N/A NO YES 
CVD Family history 12...% N/A NO YES 
Bp1 Doctor diagnosed high 
blood pressure 
hypertension 
G2 and 
105 
N/A NO YES 
P_serial No Participant serial 
number 
NA N/A 10,102,102.0
0 
82,056,101,0
0 
SEX Participant sex - N/A N/A N/A 
Age Participant Age - Years 16 Years 92 Years 
ethinda Participant ethnic 
origin 
9i0..% to 
916E. 
N/A N/A N/A 
 
5.4 Modelling of the CMAUT Framework 
 
To transform the optimisation framework to CVD risk prediction model, two types of CVD 
risk prediction models namely; the Web based heart risk calculators and Framingham Risk 
equations were discussed in chapters 3 and 8 (Wilson P, 1998) (Brindle 2003).  It was 
identified that these prediction models use both measureable and non-measureable attributes.  
The CMAUT framework uses only measureable attribute values for the computation of APR.  
Therefore    ,   ,    ,    ,    ,    and     which are measurable attributes that leads to  
hypertension disease      were selected see Table 5.2 and Figure 5.3.  Table 5.3 is a unit 
matrix where 1 represents attribute values measured and 0 indicates the attribute measured 
but not included in the inequality statement.  The objective function to be optimized is; 
 
  ∑                     
 
   (5.7) 
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Table 5.3: Shows attributes values for organs 
 
Utility 
 
Attrib 
 
X1 
 
X2 
 
X3 
 
X4 
 
X5 
 
X6 
 
Xn 
HB 1 0 0 0 0 0 0 
BMI 0 1 0 0 0 0 0 
BPL 0 0 1 0 0 0 0 
BPH 0 0 0 1 0 0 0 
HDL 0 0 0 0 1 0 0 
MAP 0 0 0 0 0 1 0 
TC 0 0 0 0 0 0 1 
 
 
To verify the framework and predict the percentage CVD risk of each participant, the 
demographic and clinical data from HSE, (2006) were used.   
 
Expressions (5.1) and (5.2) were used to calculate the utility unit for each attribute.  First the 
weight allocated to each attribute was assessed. Two methods are recommended for the 
weight assessment: For diagnoses, medics may recommend the percentage weight that must 
be allocated to each attribute depending on their ranking in the disease domain as discussed 
in chapter 4, section 4.2.  Alternatively, the weights are determined with the aid of binary 
logistic regression where the regression equation                   is used to 
allocate the weights for diagnosis and prognosis.  In this research, SPSS was used to analyse 
the clinical records of 3645 participants from the HSE, (2006). The beta coefficient values 
obtained from conducting binary logistic regression are as follows: a constant value of -
10.26, (HBI) 0.211, (BMI) 0.077, (BPH) -0.285, (HDL) 0.200, (MAP) 0.335 and (TC) 
0.0766.  The beta coefficient values were made the weights of each attribute in the equation. 
 
The beta coefficient values were incorporated into the algorithm developed in MATLAB 7.x 
that computes the percentage CVD risk of each participant.  Figure 5.3 is an example of the 
output screen of a participant from the HSE, (2006) report.  The screen depicts the measured 
attribute values of the participant which was converted into utility unit using the formula 
(5.1) and the standard parameters in Table 5.2. The aim of the optimisation algorithm in the 
framework is to find the attribute(s) in the combinatorial organs that has an overall utility unit 
that maximizes the utility value to be retrieved for primary healthcare investigation.  
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 The above optimisation problem is presented in a LP format with an objective function as 
follows:                            and optimised subject to the constraint 
matrix in Table 5.3. 
 
 The output of the MATLAB program of the CMAUT optimisation algorithm is shown in 
Figure 5.3 below. In the program, the standard values of the attributes namely HB = 50, 
BMI= 25, BPH=140, BPL= 90, HDL= 1.2, MAP =100 and TC = 5.00, which were discussed 
in chapter 3 and shown in Table 5. 2 in this chapter were used. The output from the CMAUT 
optimisation framework for the diagnosis of CVD is shown in Figure 5.3 below.  
 
 
 
 
 
Figure 5.3: Output screen of CIS_CMAUT framework from desktop. 
 
The LP optimisation algorithm in MATLAB determines the optimal valuation attribute and 
the maximum value. The results in Figure 5.3 after optimisation are optimal integer 
values        ,        ,       ,      ,        and       .  The solution 
indicates that the maximum value is 14.59 and the optimal values of X1 = 50, X2 = 26, and 
X5 = 51 are the attributes that require investigation.  Hence through mapping the data that 
requires investigation are X1 (HB), X2 (BMI), X5 (MAP) and risk factor value is 14.59 %.   
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The attributes identified for detail investigation are correct if they are compared the attributes 
values in Figure 5.3 based on the normal values of HB1 = 50.0; BMI1 = 25.5; BPH1 = 140.0; 
BPL1 = 90.0; HDL1 = 1.20;   MAP1 = 100; TC1 = 5.0 applied in the optimisation algorithm. 
 
5.5 Implementation of CMAUT Optimisation Diagnosis Framework models 
1 and 2 
 
The CMAUT optimisation model1 and 2 were designed using the following procedure: - first, 
only the measurable risk prediction factors were used instead of entire non-measurable CVD 
risk factors discussed in Chapter 3 and 7. This is because diagnosis prediction models are 
designed to predict the clinical percentage risk probability of a user been hypertensive based 
on their current measurable clinical CVD attributes (Panagiotakos and Stavrinos, 2006).  
Therefore the diagnosis prediction model must have the ability to use current appropriate risk 
factors in the user’s records to analysis and predict the absolute percentage risk (APR). 
Secondly, the binary logistic regression approach was used to model the new prediction 
diagnosis algorithms because it gives relatively accurate results.  The procedure that was 
applied to create the new CMAUT optimisation models uses the CVD risk prediction factors 
and SPSS binary logistic regression, which are explained in the sections 5.5.1. 
 
5.5.1 Determination of APR Risk using CMAUT CVD Framework Model 1 
 
 Determination of the APR using the CVD Model1 CMAUT framework 
In CVD health care, diagnosis is the first stage in disease management while CVD risk 
prediction assist in the timely intervention of the cause of diseases hence clinical risk 
prediction is essential.  In this research, the absolute percentage risk (APR) is defined as the 
percentage probability of a participant being hypertensive in their current state depending on 
their measurable clinical data. The two diagnosis models built in this research used the beta 
values in the Variables in the Equation from SPSS logistic regression.   
 
 
 Model 1 of the CMAUT framework  
 
The design of the CMAUT Diagnosis framework Model 1 was carried out using clinical data 
from HSE, (2006). The data used are from the 4316 participants, who are over 16 years old.  
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The CVD data of the 4316 adults were analysed using SPSS to generate the Table that 
contains the “Variables in the Equation”. This is because the core sample used for the CVD 
survey was participants who are over 16 years (Craig et al, 2006a). 
 
The procedure for conducting the logistic regression in SPSS is as follows: Open the Excel 
spread sheet in SPSS then Select Analyse in the main menu.  In the drop down menu, select 
Regression, then click binary logistic regression.  When the dialog box appears, select the 
Bp1 which is dichotomous value because they are made up of either YES or NO as dependant 
variable. Then select all the other measurable attributes as the Independent values as 
indicated in Figure 5.4 below. 
 
 
 
Figure 5.4: Procedure for determining Logistic Regression in SPSS 
 
The output from the SPSS shows the variables in the equation but excludes the BPL see 
Table 5.4 below. The binary logistic regression analysis gives the results in Figure 5.5: It 
must be noted that OmsysvalBPL is not in the equation Figure 5.5 from SPSS below. 
 
Table 5.4: Classification Table 1(a,b) total 4316 participants 
 
 Observed 
Predicted 
bp1 Percentage 
Correct 0 1 
Step 0 bp1 0 3584 0 100.0 
1 732 0 .0 
Overall Percentage   83.0 
 
a: Constant is included in the model. 
b: The cut value is .500 
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Variables in the Equation 
 
 
 
a  Variable(s) entered on step 1: OmpulvalHB, BMI, OmsysvalBPH, Hdlval1HDL, 
OmmapvalMAP, CholvalTotalCholestrol. 
 
Figure 5.5: Output from the logistic Regression in SPSS 
 
 Variables in the regression equation and Weight allocation: 
 
In this model 1, the regression beta coefficients obtained from the SPSS analysis were used as 
the weights for each attribute.  This is applied in the utility formula (equation 5.1) to calculate 
the utility unit (U) of each specific attribute and the overall utility unit is the sum of all the 
individual utility units.  In the CMAUT model, the objective function which is made up of 
utility units of each attribute are maximised subjected to the inequalities constraint matrix.  
 
First the attributes values, which are βi values in Figure 5.5 are converted into utility units 
using the equation U= wt (P0 – P1)/P0.  Secondly, in this research the CMAUT model uses 
the filtered 4316 clinical data records from (HSE, 2006) and with the individual weights from 
the SPSS binary logistic regression the equation becomes                      
                   .  Thus the coefficient of regression      of each attributes in the 
equation for over 16years participants are shown in Figure 5.5 above as OmpulvalHB = 0 
.211,   BMI = 0.077 OmsysvalBPH = -0.285, Hdlval1HDL = 0.200, OmmapvalMAP = 0.335, 
CholvalTotalCholestrol = 0 .076 and the constant value = -10.261.  The number of attributes 
in the equation is reduced from seven (7) to six (6) because the OmdymaBPL did not appear 
in SPSS output table below. Therefore the above the equation can be written as follows:- 
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The number of measurable attributes entered into SPSS for binary regression analysis was 
seven, therefore the equation should be  
                                      . 
 From the assumption made in section 5.4 and explained in equation 5.7, the seven attributes 
in the CMAUT expression which were used as input into the SPSS for analysis, are:  
 
   [(  ٨  ٨  )                       ]  (5.8) 
 
However, owing to the reduction of the number of attributes from seven to six the final 
CMAUT logical expression is rewritten as follows: 
 
   [(  ٨  ٨  )                   ]  (5.9) 
 
In expression (5.8) the subscripts indicate the organ that each attribute is related to, however 
in CMAUT complementary expression all the attributes complement each other therefore the 
subscripts can be removed and the utility unit of each attribute calculated as below. 
 
 Conversion of the attributes into utility unit 
Example 1:- The participant 2 from the HSE, (2006), has the information in the table below: 
For computation, the attributes are first converted into utility units by converting each of the 
coefficients of regression      into weights using the equation      
     
  
 . 
Pserial no. Grp Bp1 Age Sex Ethnic HB BMI BPH BPL HDL MAP DIA TC SMK CVD ECG 
13,956,102.00 No No 60 Women White 34.00 13.20 122.50 88.50 1.80 100.00 No 5.20 Yes No Yes 
63,535,102.00 Yes Yes 30 Women White 46.00 13.71 120.00 74.00 1.40 89.50 No 4.50 Yes Yes No 
42,831,101.00 No No 35 Men White 64.50 18.15 135.00 70.50 1.70 92.00 No 4.10 Yes No No 
 
Therefore the utility unit for each attribute is calculated as follows:- 
UHB = UR = ((βi (          )) = 0.211 ((50-34)/50) = 6.75 
UBMI = UV= ((βi(          )) = 0.077 ((25.5-13.2)/25.5) = 3.714 
UBPH = UP= ((βi (            )) = -0 .285 ((140-122.5)/140) =- 3.56 
UHDL = UD = ((βi (          )) = 0.200 ((1.2-1.8)/1.2) = -10 
UMAP = UM = ((βi(          )) = 0.335 ((100 -100)/100) = 0 
UTC = UT = ((βi (          )) = 0.076 ((5-5.2)/5) = -0.304 
Box 5.1: Computation of the Utility Units 
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From the utility unit calculation, the expression (5.9) can be rewritten as 
 
   [(  ٨  ٨  )                    ]  (5.10) 
 
This expression shows the relative effect and influence each attribute has on the disease in the 
problem domain.  This is represented in utility units in the expression. The calculated 
  vector values in expression (5.10) only indicate the relative strength of each attribute in the 
disease domain.  Hence, to make the expression (5.10) meaningful, it must be converted into 
a format that can be manipulated and analysis for decision making (Deutsch et al, 1994).  
 
For implementation purpose, the calculated utility unit  , of each vector value is attached to 
their respective variables as     to make the operation meaningful.  This is because the 
organs in the disease domain complement each other and therefore the overall or total utility 
unit is the arithmetical sum of the individual utility units.  Hence the expression (5.10) and 
the calculated individual utility units with their respective attributes are rewritten as 
    ∑                     
 
 . This expression is then formulated as the objective 
function that must be maximized and the constant value (a) in the SPSS regression equation 
is incorporated into the objective function. The generic objective function is expressed in 
equation (5.11) as follows: 
 
  ∑                                    
 
   (5.11) 
 
When the individual calculated utility units are substituted into the objective function (5.11), 
the final function will be as: 
 
  ∑ (                                                         )
 
  (5.12) 
 
The objective function (5.12) is maximised subject to the set of inequalities or constraints 
discussed in section 5.4.  In these constraints, each inequality means the measured attribute 
must be less than or equal to the normal value in order to meet CVD standard set by NICE in 
their guidelines.  For example, the variable    for Heart Beat must be less or equal to 50 beat 
per minute to satisfy the NICE, (2006) condition. 
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〖CX〗_R+ 0     + 0   + 0    + 0     +0≤50 
0   +CX_B + 0   +  0   + 0    +0≤25.5 
0 + 0 + CX_PH +0   +    0   +     0≤140 
0 +     0 +0 +CX_H +     0 +0 ≥ 1.2 
0 + 0   + 0    + 0    + 〖CX〗_M +0 ≤100 
0    + 0 + 0 + 0 + 0 +   〖CX〗_T≤5 
 
 
Box 5.2:  Set of inequalities for the constraints matrix 
To solve the above optimisation problem the linear programming method in LINPROG 
MATLAB is used. First all the coefficients in the objective function are formatted as in Box 
5.3 below: 
 
                                                
A = the coefficient in the unit constraint matrix; 
                              
                  
Secondly, the program calls a linear programming routine in MATLAB library. 
[X,fval, exitflag, output, lamba] = Linprog (f, A, b, [],[],1b); 
Box 5.3:  The CVD Optimisation algorithm using linear programming in MATLAB 
 
In Box 5.3, the set of inequalities A, in the linear programming function is expressed using 
identity matrix or unit matrix format as shown below:  
 
A =
      
      
      
      
      
      
 
 
Box 5.4:  Set of Inequalities unit matrix A used for Optimisation in MATLAB  
 
The unit matrix in Box 5.2 and Box 5.4 were used to develop the MATLAB CVD 
Optimisation algorithm shown in Box 5.3.  The full Optimisation algorithm was written using 
MATLAB source code shown in Figure 5.6 below.  The results of the CVD risk after 
executing the MATLAB Optimisation program is shown in Figure 5.7 below. 
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Figure 5.6: CMAUT Source code from the MATLAB editor 
 
 
 
 
Figure 5.7: Output GUI for the CMAUT framework MODEL-I 
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5.5.2 Determination of APR Risk using CVD CMAUT Framework Model 2 
 
 Determination of the APR using the CVD Model2 CMAUT framework 
The Model-2 of the CMAUT framework was developed using the data from the HSE, (2006) 
report, which was filtered to include only participants who are over 30 years old.  This is 
because research conducted on Web CVD risk calculators, which were used to benchmark the 
CMAUT framework, are designed for adults between the ages of 32 to 72 years (Chuang et 
al. 2007). Thus model 2 was designed with the 3645 participants’ data in Appendix 3.4C. 
 
 Model 2 of the CMAUT framework  
This second CMAUT model 2 was built using the Variables in the Equation obtained from 
statistical analysis of the HSE, (2006) data of 3645 participants who were over 30 years with 
full clinical data. This was done to compare the results from the Framingham equation and 
web calculators with the CMAUT Framework.  
 
Example 1: Participant 2 from the HSE, (2006), has the following information: 
The attributes of Participant 2, were first converted into utility unit by transforming each of 
the coefficients of regression      into percentage using the equation      
     
  
 . 
 
Pserial no. Grp Bp1 Age Sex Ethnic HB BMI BPH BPL HDL MAP DIA TC SMK CVD ECG 
13,956,102.00 No No 60 Women White 34.00 13.20 122.50 88.50 1.80 100.00 No 5.20 Yes No Yes 
63,535,102.00 Yes Yes 30 Women White 46.00 13.71 120.00 74.00 1.40 89.50 No 4.50 Yes Yes No 
42,831,101.00 No No 35 Men White 64.50 18.15 135.00 70.50 1.70 92.00 No 4.10 Yes No No 
 
 
In the CMAUT model the objective function, which uses the utility units (U) and their 
attributes are maximised subject to the inequality constraint matrix.  
 
The procedure in the Figure 5.8 below was used to determine the logistic Regression 
coefficients with the SPSS.  The binary logistic regression analysis conducted gave the SPSS 
results in Table 5.5 and Figure 5.9.  
 
 Again, it was noted that OmsysvalBPL, which is the Low Blood pressure is not in the 
equation as shown in Figure 5.9, although the entire risk factors were input into SPSS for 
binary logistic regression analysis. 
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Figure 5.8: Procedure for determining logistic Regression in SPSS 
 
 
The model 2 was built using the regression coefficients obtained from the SPSS procedure 
discussed in section 5.5 and in Figure 5.8. The regression coefficients obtained from the 
SPSS as shown in Figure 5.9 are the weight attached to each attribute.  This is applied in the 
utility function formula (equation 5.1) to calculate the utility unit (U) of each specific 
attribute and the overall utility unit is the sum of all the individual utility units. 
 
Table 5.5: Classification Table 2(a,b) Total participants = 3645 
 
 Observed 
Predicted 
bp1 Percentage 
Correct 0 1 
Step 0 bp1 0 2968 0 100.0 
1 677 0 .0 
Overall Percentage   81.4 
a  Constant is included in the model. 
b  The cut value is .500 
 
 
Variables in the Equation 
 
 
 
a  Variable(s) entered on step 1: OmpulvalHB, BMI, OmsysvalBPH, Hdlval1HDL, 
OmmapvalMAP, CholvalTotalCholestrol. 
 
Figure 5.9: Output from the logistic Regression in SPSS 
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In the CMAUT model 2, the attributes in the expression below are converted into utility units 
using the weight percentage equation     
     
  
. 
 
   [(  ٨  ٨  )                       ]  (5.13) 
 
Since the simulation of the framework model 2 is based on the data from HSE,(2006), the 
individual weights are from the binary logistic regression based on SPSS where      
                                  . The coefficient of regression      of 
each attribute in the equation after the SPSS analysis of over 30 years old participants’ data 
are shown in Figure 5.9 above. The weights of attributes are OmpulvalHB = 0.174,   BMI = 
0.076, OmsysvalBPH = -0. 229, Hdlval1HDL = 0.216, OmmapvalMAP = 0.279, 
CholvalTotalCholestrol = 0.058 and the constant value = -10.076.  The number of attributes 
in the equation is reduced to six since the OmdymaBPL does not appear in the SPSS results. 
 
Therefore the above equation (5.13) can be written as follows: 
 
                                                             (5.13) 
 
 Conversion of the attributes into utility unit 
 
For the conversion of attributes into utility unit the first procedure is that each of the 
coefficients of regression      is converted into utility function using the equation      into 
percentage using the equation      
     
  
 .  Therefore the utility unit for each attribute is 
calculated as follows: 
 
UHB = UR = (βi (          )) = 0 .174 ((50-34)/50) = 5.568 
UBMI = UV= ((βi(          )) = 0.076 ((25.5-13.2)/25.5) = 3.665 
UBPH = UP= ((βi (            )) = - 0.229 ((140-122.5)/140) = -2.86 
UHDL = UD = ((βi (          )) = 0.216 ((1.2-1.8)/1.2) = -10.8 
UMAP = UM = ((βi(          )) =0 .279((100 -100)/100) = 0 
UTC = UT = ((βi (          )) = 0.058 ((5-5.2)/5) = -0.232 
Box 5.5: Computation of the Utility Units 
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From the utility unit calculation, the expression (5.13) can be rewritten as 
 
   [(  ٨  ٨  )                     ]  (5.14) 
 
From the calculated utility unit the expression (5.14) can be rewritten as  
 
   [(  ٨  ٨  )                    ]  (5.15) 
 
The expression (5.15) shows the relative effect and influence each attribute has on the disease 
under consideration. The calculated    vector values in expression (5.14) indicate the relative 
strength of each of the attribute in the disease domain and must be converted into a formal 
expression that can be manipulated and analysed for decision making (Deutsch et al., 1994). 
The calculated utility unit    , of each attribute is a  vector value, which is attached to the 
respective attribute variables in the format      .  Since the organs in the disease domain 
complement each other the overall utility unit is the arithmetical sum of the individual utility 
units. Therefore the above expression (5.15) and the calculated individual utility units with 
their respective attributes can be written       ∑                     
 
 . This 
expression is formulated as the objective function that must be maximised and must include 
the constant as well as the beta values from the SPSS regression. In generic terms the 
objective function for both model 1 and 2 are expressed as follows: 
 
  ∑                                    
 
   (5.16) 
 
When the individual calculated utility units for model 2 are substituted into the objective 
function, the final function is as follows: 
 
  ∑ (                                                               )
 
  (5.17) 
 
The objective function in expression (5.17) is maximised subject to set of inequality 
constraints matrix.  In this set of inequality constraint matrix, each inequality stands for  the 
measured attribute that must be less than or equal to the acceptable value, which meets the 
CVD standard risk factors stated in NICE, (2006) guidelines.   
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   + 0     + 0   + 0    + 0     +0≤50 
0   +C   + 0   +  0   + 0    +0≤25.5 
0 + 0 +      +0   +    0   +     0≤140 
0 +     0 +0 +C    +     0  +0  ≥ 1.2 
0 + 0   + 0    + 0    +     +0 ≤100 
0    + 0 + 0 + 0 + 0 +      ≤5 
 
Box 5.6:  Set of inequalities for the constraints matrix 
To solve the above optimisation problem using the model 2 results the LP LINPROG method 
in MATLAB is used. First all the coefficients in the objective function are formatted as in 
Box 5.7 below: 
F = -10.076 + 5.568 + 3.665 -2.86 -10.8 + 0 + -232 
A = the coefficient in the unit constraint matrix; see below 
b = [50, 25.5, 140, -1.2, 100, 5]; 
1b = zeros (6, 1); 
Secondly, the program calls a linear programming routine in MATLAB library. 
[X,fval, exitflag, output, lamba] = Linprog (f, A, b, [],[],1b); 
Box 5.7:  The CVD Optimisation algorithm using linear programming in MATLAB 
 
In Box 5.6, the set of inequalities A, in the linear programming function is expressed using 
identity matrix or unit matrix format as shown below  
  
A =
      
      
      
      
      
      
 
 
Box 5.8:  Set of Inequalities unit matrix A used for Optimisation in MATLAB  
 
The unit matrix in Box 5.6 and Box 5.8 were used to develop the MATLAB CVD 
Optimisation algorithm shown in Box 5.7.  The full Optimisation algorithm was written using 
MATLAB source code shown in Figure 5.10 below.  The results of the CVD risk after 
executing the MATLAB Optimisation program is shown in Figure 5.11 below. 
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Figure 5.10: Source code for CVD CMAUT MODEL – II 
 
 
 
Figure 5.11 Output screen from CVD CMAUT MODEL – II  
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5.6 Validation of CMAUT framework using Prevalence and Kappa statistic 
 
To validate the two CMAUT models, Prevalence and Kappa criteria, which indicate the 
percentage agreement between hypertensive NO and YES status of the participants were 
used. The kappa values indicate the degree of agreement between the results of the APR from 
the CMAUT models and the results of the GP identified hypertensive NO and YES status.   
The diagnosis risk results were validated using the results of the GP identified hypertension, 
which are marked (1) for YES and non-hypertension marked (0) for NO as compared to the 
NICE, (2006) recommendation of 20%.  
 
5.6.1 Prevalence Computation  
In this research, prevalence is the extent to which hypertensive disease can be found in the 
population of participants who took part in the HSE 2006 survey (Sanderson et al. 2006). 
This research compares and contrasts the prevalence value from the HSE, (2006) and the 
results from the two CMAUT diagnosis models. To compute the prevalence value the 
formula for Prevalence = a / (a+b), which was explained in Chapter 3 and used in this chapter 
(Campbell et al., 2007). 
 
 Actual computed  Prevalence from the (HSE, 2006)  report: 
 
The total population of participants who took part in the survey were 21,399.   As discussed 
in section 5. 5 above 4165 people who were over 16 years old and provided complete 
information are used for model 1. The 3645 participants who were over 30 years old and 
submitted all the CVD data as well as diagnosed by the GP were used for model 2. 
 
To determine the number of people in the HSE population, who were identified as been 
hypertensive by the GP a statistical analysis was conducted.  In the report, the participants 
who were diagnosed by GP that they had hypertension were marked YES or (1) and non-
hypertension participants were marked NO or (0) in the spread sheet and SPSS respectively. 
 
From the Excel spread sheet that contains the 3645 participants, using Advance filter tool, it 
was identified that 677 people were diagnosed as been hypertensive YES while 2968 were 
hypertension NO. The prevalence of GP identified hypertensive from the report also known 
as actual prevalence was computed as follows: 
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                                                         (5.18) 
 
= (677/(677+2968)) = 0.1857.    Therefore the Actual Prevalence = 0.1857 
 
 
 Prevalence value for CMAUT Model 1: 
 
As discussed above in section 5.5, model 1 was designed using participants who are over 16 
years old and have who fulfilled all the inclusive requirements. After building the prototype, 
it was used to determine the percentage clinical risk for each of the 4165 participants.  For the 
purpose of comparison only participants were over 30 years old were used for the analysis in 
order to prevent any prejudice. 
 
According to NICE, (2006), the CVD percentage risk threshold value of a participant been 
hypertensive YES must be 20% or higher.  Whereas any person that has CVD percentage risk 
value of less than 20%, must be declared as hypertension NO.  Based on this concept, the 
percentage risk value of each participant was computed and grouped as follows: 
 
 If clinical percentage risk value is >= 20% then the participants is hypertension YES 
else when the percentage risk value is <20% then the participant is hypertension NO.  
 
The condition and computation of the Prevalence value for CMAUT Model 1 was 
programmed in MS Excel software and the results are in Box 5.9 below: 
 
Number of BPYes (based on 20% threshold) = 43 
Number of BPNo(based on 20% threshold) = 2714 
Percentage agreement between model 1 and Actual 
Percentage agreement of YES between model 1 and Actual GP YES 
Agreed Yes (model1)/Actual YES * 100 % = (43/ 677)* 100 = 6.35% 
Percentage agreement of NO between model 1 and Actual GP NO 
Agreed No (model1)/Actual No * 100 % = (2714/ 2968)* 100 = 91.44% 
 
Box 5.9: Computation of Prevalence value for CMAUT Model 1 
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Therefore using the expression (5.18) and converting the equation to match the CMAUT 
framework model 1 the following is obtained: 
The Prevalence value for Model 1 = Model1 bpyes/ (Model1 bpyes + Model1 bpno)  
 = (43/(43+2714)) = 0.1857.  Therefore the Prevalence for CMAUT model1 = 0.1857 
 
 Prevalence for the CMAUT  Model 2: 
 
As discussed above, model 2 was designed using the data of the participants who are over of 
30 years and fulfilled all the inclusive requirements. The prototype built was used to 
determine the APR value for each of the 3546 participants.  For the purpose of comparison 
only participants who are over 30 years old were used for the analysis to prevent prejudice. 
 
Again based on the (NICE, 2006) recommendation, the threshold percentage risk value of a 
participant been hypertension YES must be 20% or higher.  When a participant has a CVD 
percentage risk value of less than 20%, they must be declared hypertension NO.  Based on 
this concept, the percentage risk of each participant was computed and grouped as follows: 
 
 If clinical percentage risk value >= 20% then the participants is hypertension YES 
else when the percentage risk value is  <20% then the participant is hypertension NO.  
 
The condition and computation of the Prevalence value for CMAUT Model 2 was 
programmed in MS Excel software and the results are in Box 5.10 below: 
 
Number of BPYes (based on 20% threshold) = 30 
Number of BPNo (based on 20% threshold) = 2889 
Percentage agreement between model 2 and Actual 
Percentage agreement of YES between model 1 and Actual GP YES 
Agreed Yes (model1)/Actual YES * 100 % = (30/ 677)* 100 = 4.4313% 
Percentage agreement of NO between model 1 and Actual GP NO 
Agreed No (model1)/Actual No * 100 % = (2889/ 2968)* 100 = 97.3383% 
 
Box 5.10: Computation of Prevalence value for CMAUT Model 2 
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 Prevalence for Model 2 
 
Using the expression (5.18) above and converting it to match model 2 the following is 
obtained.   Prevalence for Model 2 = Model2bpyes/ (Model2bpyes + Model2bpno)  
 = (30/ (30+2889)) = 0.0103.   Therefore the computed Prevalence for model2 is 0.0103. 
5.6.2 Computation of Kappa statistic  
 
Kappa is the measure of a prediction model’s ability to determine the degree of the agreement 
between two predictors (Campbell et al. 2007).  According to Viera, (2005), Kappa is a 
method used to determine the degree of agreement between two predictors using quantitative 
measure.  In this research, kappa statistic is use to determine the degree of agreement of the 
actual results from the HSE survey and the results from the two CMAUTF models.   
 
To compute the kappa value the number of participants with and without hypertension as 
diagnosed by the GPs as well as the resultant values from the CMAUT models were 
presented in a tabular format  as shown in Table 3.2.  Using Table 3.2, the kappa value   is 
computed using the formula    
     
    
    where                            
          and              (Viera, 2005) (Cunningham el at, 2009). 
 
 
 Kappa statistics for MATLAB Model I 
 
As discussed in section 5.6, according to NICE, (2006) the threshold value of a participant 
been hypertensive is equal or greater than 20%.  Based on the 20% threshold the number of 
participants predicted hypertension YES are those that have percentage risk value of over 
20% was 43 and participant with less than 20% risk was 2968. From the survey report, the 
results revealed that the diagnosed hypertension YES was 677 and hypertension NO was 
2714. These values are entered into the Table 3.2 and presented in Table 5.6 below. 
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Table 5.6 
 Yes No Total 
Yes 677 2968 3645 
No 43 2714 2757 
 720 5682 6402 
 
 Computation of Kappa value for model 1 
 
Using the information from Table 5.6 and Kappa formula discussed above the following steps 
are used to calculate the Kappa (k) for model 1: 
   
     
    
 
                     
          
                                     
                                                      
          
                             
         
 
Box 5.11: Computation of Kappa value for CMAUT Model 1 
 
From the Kappa Interpretation Table in Viera, (2005) and Cunningham el at, (2009) the    
        means the models slightly agree with each other. This means the APR values from 
CMAUT model 1 slightly agree with the actual GP diagnosed hypertension YES and NO. 
 
 Kappa statistics for MATLAB Model II  
 
The same method was used to determine the kappa for model 2 using the NICE 
recommended percentage risk threshold value of 20%.  For model 2, the number of predicted 
hypertension YES that is the percentage risk, which is more than 20%, was 30 and those less 
than 20% was 2889. From the survey results, it is revealed that for the diagnoses, the 
hypertension YES was 677 and hypertensive NO was 2714. These values are entered into the 
Table 3.2 and presented in Table 5.7 below. 
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Table 5.7 
                                                                         
 Yes No Total 
Yes 677 2968 3645 
No 30 2889 2919 
 707 5857 6564 
 
 
 Computation of Kappa value for model 2 
 
Using the information from Table 5.7 and the kappa formula discussed above the following 
steps are used to calculate the kappa value for model 2: 
 
= [(OA –expected agreement)/ (100% –expected agreement)] 
= [((677+2889)/50 – 0.50) / (1 – 0.50)] 
= [(0.71-0.50)/(1-0.50)] 
= 0.42  
Box 5.12: Computation of Kappa value for CMAUT Model 2 
 
Using the same Kappa Interpretation Table in Viera, (2005) the k value of      means the 
results from the CMAUT model 2 fairly agrees with the percentage risks results from the 
actual GP diagnosed hypertension YES and NO. 
 
5.7 Simulation Results for CMAUT Diagnosis Framework model 1 and 2  
 
5.7.1 Simulation Results, Tables and Figures for CMAUT Diagnosis model 1  
 
The Tables and Figures in this section are the results of inputting the demographic and 
clinical data of each of the selected 3654 participants into the CVD CMAUT Diagnosis 
framework model 1.  
 
The Table 5.8A is the raw data of the first 10 participants from the list of 3654 participants 
that is repeated for reference purposes.  Table 5.8B, which is at the end of this Thesis 
contains the data of the first 30 participants and the data of the entire group is in Appendix 
Table 5.8C in electronic format. This is followed by Table 5.9A, which contains the results of 
the calculated APR values and the variable attribute values of each of the first 10 participants 
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from Model I 3645 data sets.  The Table 5.9B, at the end of the Thesis contains APR values 
of the first 30 participants and the results of the entire group are in Appendix Table 5.9C in 
electronic format. 
 
To evaluate the CMAUT CVD Diagnosis framework models 1 and 2, the criteria metrics 
True Positive Rate (TPR), False Positive Rate (FPR), Positive Likelihood ratio (LRP) and 
Negative Likelihood ratio (LRN) were calculated and presented in Table 5.3.  Table 5.10A 
shows the results of the computation of TPR, FPR, LRP and LRN for the CMAUT CVD 
Diagnosis model 1 using the APR values for the first 10 participants from the 3645 data set.   
The Table 5.10B, at the end of the Thesis contains results of the first 30 participants and the 
results of the entire group are in Appendix Table 5.10C in electronic format.    
 
MATLAB Model I for 3645 participants in the category of over 16 years old. 
 
Table 5.8A: Raw data of the first 10 participants 
 
Pserial no. Grp Bp1 Age Sex Ethnic HB BMI BPH BPL HDL MAP DIA TC SMK CVD ECG 
13,956,102.00 No No 60 Women White 34.00 13.20 122.50 88.50 1.80 100.00 No 5.20 Yes No Yes 
63,535,102.00 Yes Yes 30 Women White 46.00 13.71 120.00 74.00 1.40 89.50 No 4.50 Yes Yes No 
71,831,101.00 No No 66 Women White 89.00 14.32 159.00 70.00 1.90 99.50 No 6.90 No No Yes 
34,031,101.00 No No 84 Women White 48.50 16.17 112.00 63.50 2.20 80.00 No 5.00 Yes Yes Yes 
72,604,102.00 No No 59 Women White 36.50 16.19 109.50 73.00 2.00 85.00 No 6.00 No No No 
13,008,101.00 Yes Yes 50 Women White 43.00 16.65 117.00 74.00 1.70 88.50 No 6.00 Yes Yes Yes 
39,139,101.00 No No 34 Women White 48.00 16.81 102.00 54.00 1.80 70.00 No 6.50 Yes No No 
47,856,102.00 No No 51 Women White 44.00 16.85 100.50 56.50 1.90 71.00 No 5.10 No No No 
37,710,101.00 No No 61 Women White 43.00 17.43 120.00 77.00 1.20 91.50 No 5.50 No No No 
 
Table 5.9A: Absolute percentage risks and variable attributes values for the first 10 
participants 
Pserial no. Grp Bp1 Age Sex X1 X2 X3 X4 X5 X6 %PR 
13,956,102.00 No No 60 Women 50.0 25.5 0.02 0.00 50.00 5.22 -14.6 
63,535,102.00 Yes Yes 30 Women 45.8 25.9 4.15 0.00 100.19 4.28 -15.4 
71,831,101.00 No No 66 Women 0.0 25.5 140.00 0.00 100.00 0.00 -16.7 
34,031,101.00 No No 84 Women 50.0 25.5 0.00 0.00 100.00 5.30 -18.0 
72,604,102.00 No No 59 Women 50.0 25.5 0.00 0.00 100.00 0.00 -18.9 
13,008,101.00 Yes Yes 50 Women 50.0 25.5 0.00 0.00 100.00 0.00 -16.3 
39,139,101.00 No No 34 Women 50.0 25.5 0.00 0.00 100.00 0.00 -21.4 
47,856,102.00 No No 51 Women 50.0 25.5 0.01 0.00 100.00 5.23 -21.9 
37,710,101.00 No No 61 Women 50.0 25.5 0.00 0.00 100.00 0.00 -15.2 
54,256,101.00 No No 31 Women 50.0 25.5 0.00 0.00 100.00 5.30 -14.1 
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Table 5.10A: Calculation of TPR, FPR, LRP, and LRN, for the MATLAB Model I for the 
first 10 participants 
Pserial no. Grp Bp1 Age Sex %PR EX NEX TPR FPR LRP LRM 
13,956,102.00 No No 60 Women -14.6 0 1 1 0.9997 3574 0 
63,535,102.00 Yes Yes 30 Women -15.4 0 1 1 0.9994 1787 0 
71,831,101.00 No No 66 Women -16.7 0 1 1 0.9991 1191.33 0 
34,031,101.00 No No 84 Women -18.0 0 1 1 0.9988 893.5 0 
72,604,102.00 No No 59 Women -18.9 0 1 1 0.9985 714.8 0 
13,008,101.00 Yes Yes 50 Women -16.3 0 1 1 0.9982 595.666 0 
39,139,101.00 No No 34 Women -21.4 1 0 0.9966 0.9982 510.571 0 
47,856,102.00 No No 51 Women -21.9 1 0 0.9932 0.9982 446.75 0 
37,710,101.00 No No 61 Women -15.2 0 1 0.9932 0.9979 397.11 0 
54,256,101.00 No No 31 Women -14.1 0 1 0.9932 0.9976 357.4 0 
 
 
Figure 5.12 shows the graphical representation of the computed APR values of each of the 
3645 participants against their individual Participant Identification Number (PIND). This data 
used for plotting the graph is from Table 5.8C.    
 
Figure 5.13 is the prediction accuracy graph of the computed TPR value against the FPR 
value of each of the 3645 participants. This data used for plotting this graph is from Table 
5.9C. From the ROC graph, the Area under the Curve (AUC) for model 1 is calculated, by 
the summation of all the APR data points using the trapezoidal method. The actual area is 
obtained by subtracting the sum of all the APR data points from the sum of all the diagonal 
reference data points. See details in chapter 3 and 9.   
 
Figure 5.14 shows the graph of the discriminatory ability of the Diagnosis model 1.  This was 
constructed by first computing the sensitivity (aka TPR) and selectivity (aka FPR) of each of 
the 3645 participants. See Table 7.10C for the results of the computation of the TPR and FPR 
values for model 1.  A graph of the sensitivity and selectivity are plotted against the 
recommended criterion.  In this research NICE, (2006) the recommended criterion of 20% is 
used while the interception and the degree of accuracy are discussed in chapter 9. 
 
Figure 5.15 shows the graph of the performance accuracy of the APR of each participant’s 
value from the Diagnosis framework model 1. The procedure used to calculate the value of 
the positive Likelihood ratio LR+ = (TPR/1-TNR) and the negative Likelihood ratio LR- = 
(1-TPR/TNR) for all the 3645 participants. See Table 5.10C for the results of the computation 
of the positive Likelihood ratio LR+ and the negative Likelihood ratio LR- for model 1.   
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All the positive LR and negative LR values were plotted on the Y-axis and the PIND of each 
participant on the X-axis. The graph is shown in Figure 5. 15 and it is discussed in chapter 9. 
 
Plots for 3645 data sets for model I 
 
Figure 5.12 Absolute Percentage Risk for CMAUT Model – I  
 
ROC and AUC 
 
 
Figure 5.13: ROC/AUC curve of absolute percentage risk Model - I 
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Figure 5.14: Sensitivity and specificity for Model - I 
 
 
 
Figure 5.15: Maximum likelihood ratio model - I 
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5.7.2 Simulation Results, Tables and Figures for CMAUT Diagnosis model 2  
 
The Tables and Figures in this section are the results of inputting the demographic and 
clinical data of each of the selected 3654 participants into the CVD CMAUT Diagnosis 
framework model 2   The Table 5.9A, contains the results of the calculated APR values and 
the variable attribute values of each of the first 10 participants from Model II 3645 data sets.  
The Table 5.9B, at the end of this Thesis contains the first 30 participants and the APR results 
of the entire group are in Appendix Table 5.9C in electronic format. 
 
To evaluate the CMAUT CVD Diagnosis framework models, the criteria metrics TPR, FPR, 
LRP and LRN were calculated and presented in Table 5.10.  Table 5.10A shows the results of 
the computation of TPR, FPR, LRP and LRN for the CMAUT CVD Diagnosis model 2 using 
the APR for the first 10 participants from the 3645 data set.   The Table 5.10B, at the end of 
this Thesis contains the results of the first 30 participants and the results of the entire group 
are in Appendix Table 5.10C in electronic format.    
 
 CMAUT Model II for 3645 participants in the category of over 30 years old  
 
 
Table 5.11A: Initial absolute percentage risks and attributes variable values for the first 10 
participants Model II 
 
Pserial no. Grp Bp1 Age Sex X1 X2 X3 X4 X5 X6 %PR 
13,956,102.00 No No 60 Women 50.1 22.6 31.4 1.0 50.3 3.3 12.8 
63,535,102.00 Yes Yes 30 Women 45.1 26.3 4.0 1.0 99.5 4.1 14.4 
71,831,101.00 No No 66 Women 10.3 14.1 102.7 1.0 19.2 6.5 12.2 
34,031,101.00 No No 84 Women 30.8 19.4 30.2 1.0 88.8 3.4 14.4 
72,604,102.00 No No 59 Women 35.7 9.1 34.4 1.0 76.7 6.5 13.4 
13,008,101.00 Yes Yes 50 Women 41.6 21.7 25.4 1.0 89.3 2.9 13.5 
39,139,101.00 No No 34 Women 36.1 21.3 2.4 1.0 100.2 2.7 19.1 
47,856,102.00 No No 51 Women 41.9 21.4 3.8 1.0 100.1 3.4 19.4 
37,710,101.00 No No 61 Women 48.9 24.4 3.4 1.0 98.7 5.4 14.1 
54,256,101.00 No No 31 Women 42.0 19.7 33.6 1.0 68.1 3.9 11.7 
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Table 5.12A: Calculation of TPR, FPR, LRP, and LRN, for the MATLAB Model II for the 
first 10 participants 
Pserial no. Grp Bp1 Age Sex %PR EX NEX TPR FPR LRP LRM 
13,956,102.00 No No 60 Women 
12.8 0 1 1 1.000 3571.43 0 
63,535,102.00 Yes Yes 30 Women 
14.4 0 1 1 0.999 1785.71 0 
71,831,101.00 No No 66 Women 
12.2 0 1 1 0.999 1191.90 0 
34,031,101.00 No No 84 Women 
14.4 0 1 1 0.999 893.66 0 
72,604,102.00 No No 59 Women 
13.4 0 1 1 0.999 714.80 0 
13,008,101.00 Yes Yes 50 Women 
13.5 0 1 1 0.998 595.59 0 
39,139,101.00 No No 34 Women 
19.1 0 1 1 0.998 510.46 0 
47,856,102.00 No No 51 Women 
19.4 0 1 1 0.998 446.83 0 
37,710,101.00 No No 61 Women 
14.1 0 1 1 0.997 397.14 0 
54,256,101.00 No No 31 Women 
11.7 0 1 1 0.997 357.40 0 
 
 
Figure 5.16 shows the graph of the computed APR value for each of the 3645 participants 
against their individual PIND. This data used for plotting the graph is from Table 5.11C.    
 
Figure 5.17 is the prediction accuracy graph of the computed TPR against the FPR values of 
each of the 3645 participants. The data used for plotting this graph is from Table 5.11C. From 
the ROC graph, the AUC for model 2 is calculated, by using the summation of all the APR 
data points and applying the trapezoidal method. The area is obtained by subtracting the sum 
of all the APR data points from the sum of all the diagonal reference data points. See details 
in chapter 3 and 9.   
 
Figure 5.18 show the graph of the discriminatory ability of the Diagnosis model 2.  This was 
constructed by calculating the sensitivity (TPR) and selectivity (FPR) values for each of the 
3645 participants. See Table 7.12C for the results of the calculation of TPR and FPR for 
model 2.  A graph of the sensitivity and selectivity are plotted against the NICE, (2006) 
recommended criterion of 20% and the interception and the degree of accuracy are discussed 
in the evaluation chapter 9. 
 
Figure 5.19 shows the graph of the performance accuracy of the APR for each participant 
from the Diagnosis framework model 2. The formulae used for the computation are LR+ = 
(TPR/1-TNR) and the LR- = (1-TPR/TNR).  Table 5.12C shows the result of the calculation 
of the positive and negative Likelihood ratio for all the 3645 participants using the model 2.  
The positive and negative LR values were plotted on the Y-axis and the PIND of each 
participant are on the X-axis. The graph is in Figure 5.19 and it is discussed in chapter 9. 
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 Plots for 3645 data sets for model II 
 
 
 
Figure 5.16:  Absolute Percentage Risk Model – II  
 
ROC and AUC 
 
Figure 5.17: ROC/AUC curve of Absolute Predication Risk Model – II 
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Sensitivity and specificity 
 
 
Figure 5.18: Specificity and Sensitivity versus criterion for Model - II 
 
Likelihood ratio 
 
 
Figure 5.19: Maximum Likelihood ratio and percentage risk for Model – II  
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5.8 Summary:  
 
Inferring from the calculation in section 5.6, it is deducted that the kappa for model 2, which 
is 0.42 is better than that of model 1 of 0.15. These values are further discussed in the 
evaluation chapter 9, however it must be stated that based on Viera, (2005) and Cunningham 
el at. (2009), model 2 is better than model 1, which is slightly agreeable as compared to 
model 2, which is fairly agreeable.  Therefore, this research will use model 2 to implement 
the prototype, which will be discussed in chapter 9.  According to Cook, (2007), sensitivity, 
and specificity analyses as well as (ROC/AUC) must be computed for each model. These 
analyses were carried out and they are discussed and evaluated in Chapter 9. 
 
Incidence analysis is not conducted in this research because it is not one of the objectives; it 
is therefore recommended for further work.  A provisional exercise was conducted where a 
prototype CMAUT Framework model 2 was implemented and uploaded to Amazon Cloud.   
The URL is http://ec2-79-125-90-51.eu-west-1.compute.amazonaws.com/NHS2_1/. This is 
also recommended for further work. 
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Chapter 6: Space Complexity and Clinical Data Reduction 
in CMAUT Framework 
 
6.0 Introduction 
 
Chapter 6 discusses the space complexity and data size reduction in the CIS when using the 
CMAUT Optimisation Framework.  Mathematical operations were used to verify the number 
of constraints generated by the optimisation framework when the numbers of organs in each 
combinatory are increased.  The chapter analyses the complementary and substitutable organs 
in the human system.  The results of the constraint matrix generated from the CMAUT 
framework and the non-CMAUT data representation are compared.  The Big O notation is 
used to verify the space complexity when clinical data is represented with the CMAUT 
framework as compared with non- CMAUT framework such as EAV and ERD techniques. 
 
Again, in Chapter 6, the data size before optimisation and after optimisation were analysed 
using the CMAUT framework. The CVD clinical data of 400 randomly selected cohorts from 
the HSE, 2006 were used to conduct the statistical analysis.   Two data sets were analysed 
statistically using the pair T-Test method to determine their P-value and Confidence Interval 
(CI) values.  The resultant P-value was used to prove the hypothesis that “the difference 
between the data sizes before and after optimisation using the CMAUT framework is 
statistically significant or not. The graph of the data sizes before and after optimisation was 
drawn to further confirm the data reduction when the CMAUT framework is used. 
 
6.1        Frameworks 
 
In      , the clinical data in the disease domain are modelled using                   
and formalised using       linked with logical connectors as discussed in chapter 4 and 5.  
The output expression from the framework is written in mathematical format and optimised 
using    based algorithm. The optimal results of the framework are used to determine the 
percentage risk of the participant getting the disease in the problem domain. Again, the output 
variables are mapped to the input multiple attributes of the clinical dataset of each participant. 
The framework is also used to analyse the clinical data and to determine the organ in the 
combination that the output has the optimal utility value in       or optimal attribute in 
           system.  
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The       data representation technique in the framework is used to model clinical data 
and       algorithm is used to analyse the Big Data in clinical setting.  The framework on 
receiving the input clinical data (i.e. attributes) perform the following operations: 
 
1. Converts the various attributes into a common utility unit     using weights and 
multi-attribute utility theory (    );  
2. Attach the requisite organs in the logical statement to the   using the equivalent 
logical connector; 
3.  Then converts the logical expressions into conjunctive normal form (   ); 
4. Transforms the     into a set of inequalities or constraints matrix using the Table 6.1 
in Raman, (1991); 
5. Determine the organ that has the optimal value, the sum of the utility unit of each 
organ, becomes the coefficient of objective function of the organs in the Combinatory; 
6. Determine the percentage risk of users; the framework has an inbuilt CMAUT 
algorithm that optimises the objective function using the    technique.  For the 
constraint matrix, all used attribute values are given 1 and the non-used attributes 
values are given 0. 
 
The       framework was designed and developed using MATLAB 7.x optimisation 
toolbox.  The difference between           and CMAUT are as follows: In this context, 
the       system is where the entities or objects in the disease domain are captured using 
class diagram and re-represented in CMAUT mathematical format.  However, for the 
          system, an object or entity may have many attributes but these attributes are 
not converted into a common utility function or utility unit as proposed in this research. Some 
examples of the Non-CMAUT data representations are           and       , which were 
discussed in chapter 4. 
 
6.1.1 Space Complexity and the Application of Mathematical Operation  
 
Mathematical operation was used to determine the space complexity of the new CMAUT 
data re-representation techniques for the complementary and substitutable organs.   The big O 
function and notation were used to evaluate the space complexity of the CMAUT and non-
CMAUT data representation. 
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To determine the space complexity the following mathematical operation was performed: 
The attributes in the algebraic expression were converted into utility unit as     (  ٨  )    
   . The expressions were transformed into conjunctive normal form (   ) and a set of 
inequalities (aka constraint matrix) using equation calculus and Raman's transformation 
Table 6.1  Raman et al, (1991) instead of       matrix used.  The optimisation is carried out 
by maximising the objective function    ∑     
 
  subject to the generated constraint matrix. 
The output of the algorithm and the constraint matrix are optimised using LP technique to 
determine the MAX clinical data required for CVD clinical investigation. 
 
For ease of computation, the clinical object and components in this chapter are represented 
with    for the mathematical operation.  First the mathematical operation is conducted for 
two complementary organs and the numbers of constraints generated through the 
mathematical operation are entered into Table 6.2 below. Then the numbers of 
complementary organs were increased from 3 to 17 and the numbers of inequalities (aka 
constraints) generated are entered into the Table 6.2.  Finally, the MATLAB software was 
used to plot a graph of the numbers of organs against numbers of constraints generated see 
Figure 6.1. In order to determine the space complexity of the complementary organs, the 
equation of the graph was generated using the BEST FIT function in MATLAB 7.x. 
 
According to Fenton et al. (1997) the space complexity of the operation is determined by the 
highest power value specified in the BEST FIT equation. This is written as          
where n is the highest power in the equation and the concept is known as the big   notation. 
This method is used in the mathematical operations discussed in the section 6.2 below to 
determine the space complexity of the complementary and substitutable organs. This method 
is used to analyse the CMAUT data representation and those that does not use CMAUT 
approach are called Non-CMAUT in this research. 
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6.2 The Mathematical Operation Procedures 
 
In this section is a summary of the mathematical algorithm and operation conducted and the 
reasons for carrying out the procedure.   The steps used for the mathematical operation are:  
 
1. Determine the number of constraints generated by the algorithm as the number of 
organs in       system increases and compare the results with those from     
      (this denotes comparing the space complexity of       and     
     ); 
2. Confirm the constraints (i.e. inequalities) obtained using CMAUT data re-
representation mechanism and optimisation algorithm in the framework in section 
6.2.1. This is used to determine the organs with optimal value in the       and 
          system; 
3. Determine the attribute values in the combinatory that needs further clinical analysis 
and use the       framework to find the  predictive percentage risk in CVD CIS ; 
4. Conduct  benchmark analysis, to determine the consistency of the resultant percentage 
risk obtained from the       framework; 
6.2.1 Conversion of the       logical expressions into Set of Inequalities: 
 
The basics of the data re-representation mechanism in the       framework are as follows:  
first convert the different attributes into a common attribute utility unit        Then use the 
logical equivalence operator to rewrite the combinatorial logical expressions such that each 
organ in the combinatory has an equivalent utility unit attached to it that add up to the overall 
utility unit.  For example, the       expression                            is rewritten 
using the equivalence operator as:                   Inferring from section 6.1, it is seen 
that    in the expression is the overall utility unit of all the attributes in the combinatory. 
Thus if    is the utility unit for organ    and    is utility unit for organs    and then the 
overall utility unit for the combinatory is           . 
 
6.2.2 Algorithm for Conversion of        expression to Set of Inequalities 
 
First the multiple attributes in       expression is converted into utility units using the 
weight allocated to each attribute and the following equation (6.1). 
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  (6.1) 
In this expression     is the standard recommended value and    is the actual measured value.  
An example of the conversion process for       expression is as follows: 
                                                 
Using the principle and formula (6.1) for converting the attributes to utility units, gives: 
    ∑                                
    ∑                                
    ∑                                
The    is the weight allocated to blood pressure,    ,    are weights for blood volume and 
Total cholesterol. For mathematical operation reasons, the arithmetical sum of all the 
individual weights placed on all the attributes in the expression should be equal to 100. 
                            
              
                     
                    
 The       expression in the framework is transformed into mathematical mixed integer 
program (   ) for analysis.  In this chapter 6, an algorithm is developed to convert the 
expression into conjunctive normal form (   ), which are translated into set of inequalities 
for analysing the expressions. 
The proposed algorithm converts the logical       expressions into a set of inequalities, 
using the Table 6.1 from Raman et al, (1991) to facilitate the transformation. These 
inequalities are used for evaluating the amount of memory space the data occupies. 
 
The algorithm is: 
1. Eliminate all the equivalences ( ) and implications ( ) by using the 
correspondence expressions in terms of    ,   , and    ; 
2. Move the   connective inside the brackets (apply the De Morgan’s Law) For 
example                 
3. Distribute the    ( ) over     ( ).  This is done by applying the distribution law 
i.e.                      . For example                       
        . 
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4. Repeat steps 1, 2 and 3 until the literals are connected by   (  ) in the brackets and 
between the brackets are   (   ). 
5. Use the Table 6. 1 below to convert each of the expressions in the brackets or (the 
conjunctive clause) to inequalities. 
 
Table 6.1 Representation of logical relations with linear inequalities Source (Raman et al., 1991): 
Logical relation Pure logical expression Representation as linear 
inequalities 
Logical “    ”                               
Logical “     ”                   ;      ;       
Implication                    
Equivalence                           ;        ; 
      
Exclusive   /                                   
 
6.3 Generation of Constraints for Complementary organs using CMAUT 
 
In this mathematical operation the complementary CMAUT expression is used to determine 
the number of constraints that [(       ) equivalent  ], will generate when the CMAUT 
transformation algorithm is applied.  The number of constraints generated is recorded in 
Table 6.2.   The mathematical operation is repeated and the number of organs in the 
expression changed and likewise the results are recorded in Table 6.2 below. 
6.3.1 Generation of Constraints for Complementary organs with CMAUT 
 
 CMAUT Complementary system with two organs: 
Example 1: The       expression for the complementary organs is                 
         .  The attributes             are converted into attribute utility units 
               using the utility formula 6.1. The expression is written as [(       ) 
equivalent  ] and converted from                         into     and using Table 6.1.  
The transformation operation from      into set of inequalities (or constraints) is as follows:   
 
                    and then express as               . 
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The CMAUT expression is transformed into logical statement using equivalence operator and 
proposition with pure logic operators; 
 
(           )              
                            
 
Then the DeMorgan’s law is use to remove the bracket, so that it gives     as below: 
 
                                         (6.2) 
 
To transform the clauses in the     expression into set of inequalities, first each expression 
in the clause is compared with those in Table 6. 1.  Then the pure logic operators with literals 
are converted into mathematical expression with variables, by using the Table 6.1. This gives 
the set of inequalities below. 
The first clause in the expression (6.2) is converted into a set of inequalities, using the 
following operation: 
                    
                    , multiplying  
   on both sides of 
the expression and change the signs, the following is obtained: 
                   (6.3) 
The second clause in the expression (6.2) is converted into a set of inequalities as follows: 
         
                               
                  (6.4) 
The third clause in the expression (6.2) is converted into a set of inequalities as follows: 
         
                               
                        (6.5) 
When all the set of inequalities from (6.3), (6.4, (6.5) are put together the following 
inequalities are obtained. 
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 CMAUT Complementary system with Three (3) organs 
Example 2:  The same procedure was used to convert the CMAUT expression with three 
organs, which is                                        into a   set of inequalities. 
First convert the attributes                      into utility units                      
using the utility formula (6.1).  The resultant expression                               is 
transformed into     and then into a set of inequalities (or constraints) using Table 6.1. The 
result of simplifying the clauses using the algorithm in section 6.2 is as follows: 
           
           
           
               
 
In Appendix 6 are examples of how the algorithm in section 6.2 and Table 6.1 were used to 
convert the       expressions into set of inequalities with explanation. 
 
 Results from generating the constraints for       complementary organs  
 
Using the expressions in examples 1 and 2, series of mathematical operations were conducted 
to determine the numbers of inequalities generated for each set of complementary organs and 
their attributes.  The numbers of organs were changed in the expression and the numbers of 
inequalities generated were recorded in Table 6.2.  The results in Table 6.2 were used  to 
draw the graph in Figure 6.1. 
Table 6.2:  CMAUT complementary organs 
No. of complementary 
(AND) organs 
No. of laterals 
including the Utility 
unit 
No. of  constraints 
(inequalities) 
2 3 3 
3 4 4 
4 5 5 
5 6 6 
6 7 7 
7 8 8 
8 9 9 
11 12 12 
12 13 13 
15 16 16 
16 17 17 
17 18 18 
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It is observed from the computed data and the graph drawn that the relationship between the 
numbers of organs in the combinatory and inequalities generated is      ,        .   
This is shown in Figure 6.1, where the results of constraints CMAUT CIS generated are 
plotted.   The results are discussed in chapter 9. 
 
       ,         
 
Figure 6.1: Graph of number of organs against number of constraints generated; 
 
6.3.2 Generation of Constraints for Complementary organs with Non- CMAUT 
 
In the          , the       expression has only one attribute, which may be either 
blood pressure or total cholesterol as explained in section 6.3.  In this research, only blood 
pressure values are used and therefore in the mathematical operation and algorithm every 
expression has pressure    attached to the organ.   
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 Non- CMAUT Complementary system with two organs 
Example 3: In this example, there are two organs with individual attribute that is pressure P, 
therefore the expression would be                                      and the result will 
be as follows: 
1. (           ) 
2. (          ) 
3. (           ) 
4. (          ) 
Transforming the clauses in the     above into a set of inequalities, using Table 6.1, the 
results will be: 
                
                
                
               . 
 Non- CMAUT Complementary system with three organs 
Example 4:  For the purpose of comparison the attribute used in this example is the blood 
pressure (P), which is set to be equivalent to the utility unit of the organ.  This denotes that 
the utility unit    is computed with the blood pressure and the expression used is: 
                                                         and instead of the attribute      
the    is used and the result of eliminating the high level operations shown below as:  
 
 (                             )                   
                                                         
 
To transform the clauses in the     into a set of inequalities, Table 6.1 was used and the 
results are presented below as: 
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It is observed that in all the transformation operation the numbers of clauses in the       
expression are equal to the number of inequalities the CMAUT expressions generate.  In 
Appendix 6 are examples of how the algorithm in section 6.2 and Table 6.1 were used to 
convert the       expressions into set of inequalities with explanation. 
 
 Results of Constraints generated for Complementary organs in            
 
Using the expressions in Examples 3 and 4, series of mathematical operations were 
conducted to determine the numbers of inequalities generated for each set of complementary 
organs and their attributes using Non-CMAUT system.  Then the numbers of organs were 
change in the expression and the numbers of inequalities generated are recorded in Table 6.3.  
The computed results in Table 6.3 were used to draw the graph in Figure 6.2. 
 
Table 6.3:            based     using complementary organs: 
No of complementary 
      organs 
No of laterals 
including the Utility 
unit 
No of  constraints 
(inequalities) 
2 2 4 
3 3 6 
4 4 8 
5 5 10 
6 6 12 
7 7 14 
8 8 16 
 
It is observed from the computed data and the graph plotted that the relationship between the 
numbers of organs and the inequalities generated is:             ,             .   
This is shown in the graph Figure 6.2, where the results of Non-CMAUT CIS are plotted.  
It is subsumed from this equation that the space complexity for non-CMAUT is       
      or        . 
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Figure: 6.2: Shows a comparison of           using complementary organs      . 
The comparison between Non-CMAUT and CMAUT data representation indicates that the 
constraints generated as the numbers of organs are increased are higher in Non-CMAUT than 
in the CMAUT system. The computed results are used to plot the comparative graph in 
Figure 6.2, which is evaluated in chapter 9.  
6.4 Generation of Constraints for substitutable organs with CMAUT 
 
Unlike the            , the substitutable organ comprises of two or more sub organs that 
work in place of the other when one is malfunctioning, which subsumes  one organ can  stand 
in for the other. Therefore the individual attributes and utility units are unique to each organ. 
Hence they are not the arithmetical sum of the utility units of each organ.  An example is the 
two kidneys in the human body they work independently to regular the flow of fluid in the 
human being (Guyton et al. 2006).  In CMAUT representation they are modelled as 
subclasses in Figure 4.7. The       expression for substitutable organ is written as follows: 
                        
Using the utility formula 6.1 the expression can be rewritten as                   which 
represents one complete combinatorial clinical data.  In this expression, the flow of attributes 
from the two organs must meet at one joint so the overall utility unit will be   and under this 
condition, the attributes are measured at the junction.  The second method of expressing the 
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substitutable in     is to attach the individual utility unit to their respective organs.  This is 
written as                     or in other words as                   .  
This expression denotes that each independent organ has their utility unit. For example, 
organ1 has a utility value of    and organ 2 has utility value of    , in this scenario their total 
utility unit cannot be the sum of the utility values of the individual organs. 
6.4.1 Substitutable organs using CMAUT Framework  
 
This section explains the two ways of expressing the substitutable organs in      .  The 
first operation uses the expression                       to generate the constraints.  This 
is followed by the second option that uses the expression: 
                                           for both       and non-CMAUT.  
The second expression is used for both       and non-CMAUT because from the 
discussion in chapter 4, it is subsumed that both systems use the same data representation. 
 
 The first method of expressing substitutable organs in       using    logical expression 
is presented below as: 
                      
             
Transforming the equivalence operators to pure logic operators would give the following: 
 
                           
                            
 
The  DeMogran law is used to remove the bracket, so that it gives the      below: 
 
                          
                              
 
The set of inequalities with integer variables that is computed would be as follows:  
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 CMAUT substitutable system with two organs using the second approach: 
This research uses the second approach for analysing the substitutable organs where the 
individual utility units are attached to their respective organs.  This expression is written as 
                    or in other words as                    .   
 
Example 5:  This second method is used for both       and           systems where 
the individual organs have their own blood pressure values or utility units attached to them.  
This example 5 is based on CMAUT data representation with 2 organs and it is written 
as:                                       .  The attributes in the expression are converted into 
utility units, which are             
 
The final expression is written as:                              , which is expressed as: 
                    or                    . 
 
When this expression is simplified the numbers of clauses obtained are: 
 
                                                                                                  
Therefore the list of clauses will be as follows: 
 
                        
                        
                        
                         
 
The set of inequalities with integer variables would be as follows: 
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 CMAUT substitutable system with three organs 
Example 6:  This second example converts three substitutable organs with different 
attributes, which are transformed to utility unit and then into a set of inequalities.  The 
example uses the expression                                 to generate the 
constraints.  This expression is rewritten in CMAUT format as:   
                                                         
The attributes in the expression are converted into utility units, which are                 
In this research, the CMAUT expression for 3 organs is written using utility units as follows: 
                                            
The set of inequalities with integer variables computed from the above expression would be 
 
                     
                     
                     
                     
                     
                     
                     
                     
 
Examples of how the CMAUT algorithm in section 6.2 was used to convert the       
expressions into set of inequalities are shown in Appendix 6. 
 
 Results of constraints generated for substitutable organs (OR) 
 
Using the expressions in Examples 5 and 6, series of mathematical operations were 
conducted to determine the number of inequalities that are generated for each set of 
substitutable organs and their attributes applying the CMAUT data representation.  The 
numbers of organs in the expression are changed and the corresponding numbers of 
inequalities generated are recorded in Table 6.4.   The results in Table 6.4, was used to draw 
the graph in Figure 6.4. 
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6.4.2 Constraints Generation for substitutable organs with Non- CMAUT 
 
As explained in section 6.4.1, the same expression is used for both CMAUT and Non-
CMAUT data representation. The expression used for Non-CMAUT is     
                                            and the numbers of organs in the 
expression was increased at every stage during the computation exercises.  Below in Table 
6.6 are the results of the numbers of constraints generated and Figure 6.6 shows the graph 
that was plotted from the results.  It was observed that for substitutable organs the 
relationship between the number of organs in the combinatory and the number constraints 
computed is       therefore      . This is explained in the evaluation chapter 9. 
 
Table 6.4:  CMAUT using substitutable organs (OR) also called partial substitutable organs 
No of substitutable  
(OR) organs 
No of laterals 
including the Utility 
unit 
No of  constraints 
(inequalities) 
2 2 4 
3 3 8 
4 4 16 
5 5 32 
6 6 64 
7 7 128 
8 8 256 
 
 Non- CMAUT substitutable system with two organs (OR) 
For Non-CMAUT CIS, the blood pressure values (P) were associated with each of the 
individual organs.  This is unlike       where each substitutable organ has its own set of 
attributes, which are converted into utility unit. To prove that the results from the non-
CMAUT and CMAUT are the same, the following example with the same expression is used.   
Example 7:- A non-CMAUT with two organs and associated pressure is expressed 
as                              .  The list of clauses after simplification is shown as: 
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The set of inequalities with integer variables would  be: 
 
               
               
               
               
 
 Non- CMAUT substitutable system with three organs (OR) 
 
Example 8:- Similarly the             with three organs is expressed as 
                                               and the number of clauses obtained 
after simplification is as follows:  
 
The set of inequalities with integer variable expressions would be as follows: 
 
                     
                     
                     
                     
                     
                     
                     
                     
 
Examples of how the algorithm in section 6.2 was used to convert the           
expressions into set of inequalities are shown in Appendix 6.  Comparing the results from 
CMAUT with the results from       CIS, it is inferred that the clauses and the set of 
inequalities are the same. Therefore for substitutable organs  where OR is used, the same 
expression can be used for both       and            data representation. 
 
 Results of constraints generated for substitutable organs (OR) – Non CMAUT 
 
Using the expressions in examples 7 and 8, series of mathematical operations were conducted 
to determine the numbers of inequalities generated for each set of substitutable organs and 
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their attributes in Non-CMAUT system.  The numbers of organs in the expression were 
changed and the numbers of inequalities generated recorded in Table 6.5.  The results in 
Table 6.5 were used to draw the graph in the Figure 6.4.  
 
Table 6.5: Non-CMAUT using substitutable organs (OR) - partial substitutable organs 
No of substitutable  
(OR) organs 
No of laterals including the 
Utility unit 
No of  constraints 
(inequalities) 
2 2 4 
3 3 8 
4 4 16 
5 5 32 
6 6 64 
7 7 128 
8 8 256 
 
Figure 6.4; shows the comparison of the results obtained from using substitutable organs 
(OR) for Non- CMAUT and CMAUT data representations.  From Figure 6:4, the 
substitutable organs have a relation of      that is        this indicates that as the 
numbers of organs increase the numbers of constraints also increase.  This is discussed in 
evaluation chapter 9. 
 
Figure 6.3: Non – CMAUT CIS statement using substitute OR organs 
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6.4.3 Summary of the Space Complexity for CMAUT Framework  
 
From the graphs in Figure 6.1 and Figure 6.2, it is observed that for complementary organs   
when the numbers of organs in the combinatory are increased the number of constraints also 
increases. For complementary organs that use       data representation the computational 
space increases with function of      , while CIS with Non-CMAUT data representation 
increases in order of      .  Using the Big O notation, from the results of the functional 
performance test it is subsumed that the space complexity            system is         
as compared to the CIS system without               .  This is discussed in Chapter 9.  
 
Similarly, Figure 6.3 shows that when the numbers of organs and attributes in the 
substitutable combinatorial expression using the OR connector are increased the number of 
constraints also increases.  Therefore for CIS where substitutable organs expression are used 
both in the       and Non CMAUT data representations have the same space complexity 
of       which is      .  From the functional performance test results the space 
complexity of both substitutable organ data representation methods is      .  These results 
are discussed in the evaluation chapter 9. 
6.5 Analysis of clinical data sizes before and after optimisation  
 
For the analysis of the clinical data sizes before and after optimisation 402 participants were 
selected from the 3645 participants and their records retrieved from the (HSE, 2006) and 
stored in plain text format.  This approach was used to avoid any increase of data size caused 
by the files format such as .doc, .docx etc. Each of the clinical data of the selected 402 
participants was input into the CMAUT framework and executed to determine the APR 
values as well as their hypertension status.  This is also used to identify the attributes in the 
combinatory that needs investigation.   
 
The output file of each participant was stored in text file and the data size measured and 
recorded against the corresponding Participant Identification Number (PIND).   The clinical 
data sizes before and after optimisation was input into an Excel file and presented in Table 
6.6. This is followed by the determination of the P_value using the T-test in the SPSS 
package. 
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6.5.1 Statistical Analysis of data size before and after optimisation with CMAUT. 
 
The hypothesis of this research states that; the application of CMAUT and logical connectors 
using mathematical expression that is optimised with LP technique will reduce the space 
complexity and amount of data required for CVD decision making. The first part of this 
chapter, explained how the use of CMAUT data re-representation and logical connectors 
improves the space complexity.  This section focuses on the second part of the hypothesis 
that the optimisation framework reduces the amount of data needed to determine the 
percentage risk of a participant been hypertensive. 
 
 Procedure for analysing data size reduction in CMAUT Framework: 
 
In chapter 5, it was established that the CMAUT model 2 will be used to analyse the CVD 
framework because it has better kappa and prevalence values as compared to the CMAUT 
model 1. This denotes that model 2 has a higher level of agreement with the GP diagnosis as 
compared with model 1. Based on this pretext, 10% of the 3645 participants, which is 364, 
were selected as the sample participants for the data size investigation and the data reduction 
trial.  However for approximation purpose, the clinical data of 402 participants were used. 
 
 Data size before optimisation 
 
The CVD data for each of the 402 participants was exported from Microsoft Excel spread 
sheet into text files.  This is because text files eliminate all the formatting and configuration 
that are associated with the different types of files such as PDF, Excel, and Word.  The data 
size of each participant before optimisation was input into text file and the results are 
measured and recorded.  The size of each of participant’s file before optimisation is recorded 
against the participant’s serial number (Pserial no.) in Excel sheet as indicated in Table 6.6.  
The attribute values of the 402 participants before optimisation were entered into text file and 
measured on UNIX platform using the input command for the purpose of consistency. To 
compare the data sizes before and after optimisation the same measurement operation was 
performed after optimisation using the CMAUT framework and the values recorded.  This is 
discussed below. 
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 Data size after optimisation 
 
The CVD clinical record of each of the 402 participants was simulated using the CMAUT 
optimisation framework and the optimised output results stored in individual text files.  The 
size of each participant’s file after optimisation were stored  in  ZIP file that was exported 
into Excel sheet and recorded against the participant’s  Pserial number.   The output records 
of all the 402 participants were input into text file after optimisation and measured.  Figure 
6.4 is one of patient’s records, which is stored and displayed in text file format for data 
analysis.   
 
Figure 6.4: Percentage risk for heart disease calculation on the text file. 
6.5.2 Statistical Analysis of the Results using Pair T-test in SPSS 
 
The pair T-test statistical method was used because this method allows the comparison of the 
two groups of data sizes, which maybe either continuous dependant or independent variables.  
Therefore, the difference between the data sizes of the selected 402 participants before and 
after optimisation using the CMAUT framework were verified with the pair T-test method.  
Again, the pair T-test technique was used instead of the ANOVA method because this 
research deals with two groups of data sizes of continuous dependant variables and not the 
comparison of three or more groups. 
 
In this research, samples dependant pair t-test was used because the data sizes of the same 
participants were compared at different period (i.e. before and after optimisation).  
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This is different from independent sample t-test, which compares two different groups of 
participants (Campbell, 2006).  
 
 Procedure for determining T-Test in SPSS 
 
Figure 6.5 depicts the procedure used for conducting the pair sample T –test analysis.  In 
SPSS version 15, the Analyse menu was selected and then the Compare Means clicked. This 
is followed by selecting the Pair samples T-Test in the drop down menu.  There appears a 
screen in which the data sizes before and data sizes after optimisation appear as variables. 
The two variables were selected and moved into the Pair Variables box on the right side, and 
then the OK button was selected and clicked. The output Table 6.5 then appear as the 
resultant calculation from the IBM SPSS package. 
 
 
Figure 6.5: Procedure for conducting dependant samples t-Test in SPSS 
 
 Output from SPSS and interpretation of the results 
 
The results from the SPSS software after the operation are shown below Table 6.5.  The 
SPSS software gave the statistical significant value of the P_value as 0.00 at a probability 
level (2-tailed). The significant P_value of 0.00 is less than the 0.01 or 0.001, which is the 
acceptable standard value in medical application (Campbell, 2006).  Therefore the difference 
between file sizes before and after Optimisation is statistical significant. 
 
Table 6.5 the Output results of the Paired Samples Statistics: 
 Mean N Std. Deviation Std. Error Mean 
 
Pair 1 
File size  before 
Optimisation (In bytes) 
1216.66 402 21.801 1.087 
File size after 
Optimisation  (In bytes) 
463.50 402 .916 .046 
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Paired Samples Correlations: 
 N Correlation Sig. 
Pair 1 File size  before 
Optimisation (In bytes) & 
File size after 
Optimisation  (In bytes) 
402 -.029 .557 
 
Paired Samples Test: 
 Paired Differences t df Sig. 
(2-
tailed) 
Mean Std. 
Deviation 
Std. 
Error 
Mean 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
 
 
Pair 1 
Size  before 
Optimisation 
size after 
Optimisation 
(In bytes) 
753.162 21.847 1.090 751.020 755.304 691.219 401 .000 
 
From Table 6.5, it was observed that the mean values of the data sizes before optimisation is 
1216.66 bytes and after optimisation is 463.50 bytes.  The standard deviation between the 
two sizes is 21.801 and 0.916 but there is a negative correlation between them.  The data 
sizes after optimisation were found to be lower than the data sizes before optimisation with 
the calculated t score at 691.219, degree of freedom of 401. The statistical significant P value 
is less than 0.001 for the probability level of 2-tailed, which is expressed as (             
                  ).  
 
The CI for the clinical data before and after optimisation using the CMAUT framework is 
751.020 for the lower boundary and 755.304 for the upper boundary.  Therefore, the actual 
difference in value between the lower and upper boundaries is 753.16 Bytes.  The T-test 
analysis gave a p-value of 0.000, which is less than 0.01, which denotes that the results are 
statistically significant.  Hence the null hypothesis is rejected and the alternative hypothesis, 
which states that the clinical information can be optimised using CMAUT framework to 
reduce the amount of data required for primary care investigation thus reducing information 
overload is accepted.  This is confirmed in Figures 6.6 and 6.7 and discussed in Chapter 9.  
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Table 6. 6A: Data size for 10 participants before and after optimisation with CMAUT 
No. Of participants Pserial no. Data size before 
optimisation ( bytes) 
Data size after 
optimisation (bytes) 
1 10,902,101.00 1256 465 
2 10,846,103.00 1251 464 
3 11,039,102.00 1251 463 
4 11,046,101.00 1251 465 
5 11,239,101.00 1245 464 
6 11,249,102.00 1244 464 
7 11,306,101.00 1249 464 
8 11,313,101.00 1245 463 
9 11,349,102.00 1243 464 
10 11,356,101.00 1262 464 
 
 Graphical Representation of the data size before and after optimization: 
 
Using the data values from the Table 6.6B in the appendix and the information of all the 402 
participants’ data set in table 6.6C Appendix 6, the graphs in Figure 6.6 were drawn.  From 
the individual graphs it is subsumed that the data sizes before optimisation that has a mean 
value of 1216.66 bytes are higher than the 463.50 bytes, which is the size after optimisation.  
 
Again, the comparison graph in Figure 6.6 shows that there is a great difference between the 
two set of data, which is confirmed in the statistical analysis discussed during the T-Test. It is 
therefore subsumed that the difference between the data size before and after optimisation 
using the CMAUT is physical and statistically significant. 
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Figure 6.6: Before (red curve) and after optimisation (blue curve) of patient record data file 
Figure 6.6 shows the results of the optimisation of 402 participants’ records. Since the results 
were generated using the CMAUT model, the results are acceptable for the entire CVD 
participants’ records. These results are further discussed in the evaluation chapter 9. 
 
Figure 6.7: Comparison of CVD Participants records file sizes (in bytes) 
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6.6 Summary 
 
The space complexity challenges of the CMAUT framework was analysed and confirmed in 
sections 6.3 and 6.4.  It was established that the amount of clinical data required for CVD 
analysis and decision making using the CMAUT risk prediction model is significantly 
reduced in the CVD framework.  This was proved using mathematical analysis, graphical 
representation and statistical significant techniques.  From the space complexity analysis 
conducted, it was observed that the proposed CMAUT clinical data re-representation method 
generates less constraint expressions as compared to the non-CMAUT system for 
complementary of organs.  However, for substitutable organs both systems generate equal 
amount of constraints. This is acceptable because in the human body there are more 
complementary organs compared with the substitutable organs (Guyton and Hall, 2006). 
 
The statistical analysis revealed that using the CMAUT optimization framework reduces the 
data size that is retrieved from the data source for clinical decision making by approximately 
700 Bytes for each participants.  This is because the mean difference between the data sets 
before and after optimization is 753.16 Bytes. Therefore for a million patients’ records that 
are transmitted every day this will lead to a reduction of approximately 700 million Bytes. 
This is a huge cost effective technique, which also reduces the information overload in the 
computer network and the amount of data that medics need for decision making.   Finally this 
confirms the first part of the hypothesis, which states that the use of the CMAUT 
optimisation framework will reduce the clinical data size and space complexity required for 
decision making in CIS.  This is further discussed in the evaluation chapter 9. 
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Chapter 7: CMAUT CVD Risk Prognosis Framework 
 
7.0 Introduction: 
 
This chapter discusses the second part of the hypothesis, which states that CMAUT CVD 
optimisation framework, can be used to predict the percentage risk (PPR) of a user been 
hypertensive. The modelling of the Prognosis framework and the  simulations  are carried out 
using the  CVD data collected from the HSE survey conducted in 2006 (HSE, 2006).  This 
chapter is related to chapter 5, where the diagnosis framework was discussed.  In this chapter 
two prognosis models are designed and implemented in MATLAB and their outputs are 
verified using the same 3654 participants from HSE survey data used in Chapter 5.  The PPR 
results in chapter 7 are compared with the results from chapter 8 and evaluated in chapter 9. 
 
7.1 CVD Predictive Percentage Risk and CMAUT Prognosis framework  
 
According to Jackson (2005), the predictive risk of cardiovascular disease is the probability 
that an individual will have cardiovascular event in a specific period.  In this definition, an 
event denotes the chances that a participant will have cardiovascular disease in 5 or 10 years 
depending on their CVD risk factors and predictors condition. In prognosis, PPR is defined as 
the measure of the likelihood of a patient developing a disease over a time period, while 
relative risk measures the chances of risk occurring in two different groups of people.  
  
As discussed in Chapter 5, there are two types of  CVD predictive risk namely the clinical 
initial absolute percentage risk (APR), which is used to estimate the likelihood of user been 
hypertensive based on their current  measurable clinical parameters. This evidence based 
clinical prediction model is used for clinical diagnosis and it is based on measurable clinical 
parameters. The measurable parameters used in this research are blood pressure (HB), BMI, 
BPH, BPL, MAP, HDL and TC. The diagnosis framework in Chapter 5 uses only 
measureable attribute values for the computation of the absolute percentage risk (APR) 
(Panagiotakos and  Stavrinos, 2006).   
 
The second type of CVD risk predictor is the predictive percentage risk (PPR), which is the 
measure of the chances that an individual will develop CVD disease over a specified time 
based on their measurable and non-measurable attributes or  risk factors (Campbell, 2006). 
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The PPR values are used in prognosis to forecast the chances of individuals or group of 
people in a population becoming hypertensive over a period of time. This is also used as an 
epidemiological tool for CVD risk prediction (Sanderson, 2007).   
 
In this research, for the purpose of designing the CVD prognosis framework two types of 
CVD risk predictors namely the Web based heart risk calculators and Framingham Risk 
equations were analysed (Wilson P, 1998) (Brindle 2003).  It was identified that these two 
types of prediction models use both measureable and non-measureable attributes.   The risk 
predictors used in these prognosis models are Age, Sex, HB, BMI, BPH, BPL, HDL, MAP, 
Diabetic, Total Cholesterol, Smoking, Existing CVD and ECG (Sheridan et al, 2003).  
Therefore this research uses the same risk predictors for verification proposes. For 
consistency the predictive percentage risk in 10 years is the arithmetic sum of the absolute 
percentage risk (APR) and the computed predicted risk in 10 years (Edoh et al. 2011).   
 
 CMAUT Diagnosis framework and Absolute Percentage Risk (APR) 
 
In chapter 5, the operation of the CMAUT framework was discussed and it is summarised as 
follows: - The framework comprises of two subsystems, which are the CMAUT clinical Data 
Re-representation mechanism that uses class model and LP based CMAUT optimisation 
algorithm implemented in MATLAB.   The data re-representation mechanism is made up of   
subsystems that capture the clinical data using class model. The CMAUT system re-
represents the clinical data in logical format and formalise it for mathematical manipulation 
and analysis.  In this subsystem, only the measurable clinical parameters discussed above are 
modelled and used to determine the beta coefficients. These coefficient values constituent the 
weighting applied in the utility function and in the formulation of the objective function. 
  
The optimisation algorithm: - The CMAUT logical expressions from the data re-
representation mechanism are converted into mathematical formalisation, which serves as 
input into the algorithm. This research focuses on complementary organs, where the utility 
unit of the individual attributes are arithmetically sum together to create the objective 
function to be optimised. This is written as    ∑                     
 
 .  This 
objective function is optimised subject to the generated unit matrix. In this algorithm the 
attributes that are used in the inequality matrix are depicted as 1 and those not as 0.   
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The optimisation algorithm was written in MATLAB and used to determine the clinical 
absolute percentage risk (APR) of a user been hypertensive.  In prognosis, the initial absolute 
percentage risk (APR) is known as the Initial clinical percentage risk value, which is denoted 
as (u).  The framework allows each output variable to be mapped to their corresponding 
attribute, which enables the decision maker to identify the attributes in the combinatory that 
needs to be analysed for further medical investigation.  The CMAUT framework and its 
operation were discussed in chapter 5. 
  
7.2 The CMAUT Prognosis Framework  
 
The CIS prognosis framework is made up of the data re-representation mechanism and the LP 
optimization algorithm, which is designed using the utility function.  In this framework, the 
probability of a disease occurring at a specified time is identified by the abnormal values of 
measurable and non-measurable attributes from the specified norm (i.e. baseline) in the 
disease domain.  The method used to model and re-represent data is the same as discussed in 
Chapter 5 under the CMAUT diagnosis framework.  The relationship between the organs in 
the disease domain is described using combinatorial logical connectors and the attributes of 
the organs expressed with multiple attributes as in UML class model.  The multiple attributes 
in the expressions are used to calculate the utility unit     of each of the organ using the 
Utility Unit formula. The CMAUT expression formulated from the multiple attributes in the 
class diagram are converted into mathematical format, which serves as input to the LP 
optimisation algorithm.  The output percentage risk value of the first part of the framework is 
the Initial clinical percentage risk value which is     . 
 
In prognosis framework, both the measurable and non-measurable CVD risk factors are used 
to calculate the predictive time value     . The resultant percentage risk is the added of the 
Initial clinical percentage risk value (u) and the predictive risk factor      to obtain the 
predictive percentage risk      in 10 years for each participant. 
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The stepwise procedure for computation of CVD Predictive Percentage Risk is written in the 
Box below:  
1. Capture the relations to be optimized in the disease domain with UML- CMAUT  
2. Identify the measurable Risk factors or attributes in the problem domain  
3. Group the attributes and calculate the utility function using                  
4. Translate the logic expressions in CNF into a set of inequalities using unit matrix.  
5. Establish the objective function to be maximize using the Utility Units     
6. Use the LP algorithm in the framework to optimise the  objective function 
7. Convert the evaluated value after the optimisation process to percentage aka{u}  
8. Identify all the Risk factors in the problem domain and build statistical model; 
9. Calculate the Predictive Percentage Risk (PPR) by adding:                     
10. Map the optimal   values from the optimisation process with the attributes. 
 
In this section, is an illustration of the operation of the proposed Prognosis CVD framework: 
In this example the Prognosis framework is used to determine the predictive percentage risk 
(PPR) of CVD disease for the same participants used in Chapter 5. The first part of the 
framework is to model the CVD disease using class diagram and express the measurable risk 
factors or attributes in CMAUT formalization.  The second step is to calculate the utility unit 
for each attribute in the expressions using the utility function formulae.  Since the organs in 
the CVD are complementary the total utility unit is the arithmetical sum of the individual 
utility unit, as shown in the objective function expression (7.0). The objective function is 
optimised subject to the unit matrix Table 7.1 below, where 1 represents the attribute value 
measured and 0 indicates the measured attribute but not included in the inequality matrix. 
 
  ∑                                      (7.0) 
 
Table 7.1: Shows attributes values for organs 
Utility 
 
Attrib 
 
XR 
 
XB 
 
XPH 
 
XH 
 
XM 
 
XT 
HB 1 0 0 0 0 0 
BMI 0 1 0 0 0 0 
BPL 0 0 1 0 0 0 
BPH 0 0 1 0 0 0 
HDL 0 0 0 1 0 0 
MAP 0 0 0 0 1 0 
TC 0 0 0 0 0 1 
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In the CMAUT prognosis framework, the weight allocated to each attribute is assessed using 
the binary logistic regression in SPSS.  The measureable attribute values were entered into 
the SPSS to determine the beta coefficient values that are used for the computation of the 
initial clinical absolute risk   .  The Location parameter     was calculated by inputting the 
measureable and non-measurable attribute values into SPSS to determine the beta coefficient 
of each attribute.  Then for the computation of the predictive time factor     , a statistical 
structured regression equation                   was created using the binary 
logistic regression technique in SPSS.  The results of the clinical absolute risk     and the 
factor      were incorporated into the CMAUT algorithm and programmed in MATLAB to 
compute the PPR value for participant been hypertensive in 10 years.   
 
As part of the illustration, two sets of simulations were conducted using the two Prognosis 
CMAUT models 1 and 2. The first part of the simulation is to determine the clinical absolute 
risk     and the second part of the simulation is the computation of the predictive time factor 
     for 10 years.  The arithmetical sum of the clinical absolute risk     and predictive time 
factor      gives the Predictive Percentage Risk (PPR) value of the participant in 10 years.   
The simulation is based on the hypertension CVD scenario and the (HSE, 2006) clinical data 
discussed and analysed in chapter 3. 
 
 Data for CVD for modelling CMAUT Prognosis Framework  
The demographic data, CVD clinical data and the methodology used to develop the Prognosis 
framework are from HSE, (2006) report and Craig et al., (2006a).    The demographical data 
used are each participant’s series number, age sex, ethinda (i.e. ethnic origin) and clinical 
data were HB, HDL, BMI, TC, HDL BPH, BPL, ECG/LVC and CVD, Diabetic and 
Smoking.  These parameters were selected for the development of the CMAUT prognosis 
framework because the Framingham equation and web CHD calculators that the output of the 
Prognosis framework will be benchmarked against use the same parameters, see Table 5.2.  
 
To illustrate the operation of the prognosis framework models 1 and 2, a participant from the 
HSE, (2006) data sheet was used see Appendix 3.3 and 3.4. The demographic and CVD 
clinical data of the select participants, which are Age, Sex, HB, HDL, BMI, TC, HDL BPH, 
BPL, ECG/LVC and CVD, Diabetic and Smoking were entered into the prognosis  
framework. 
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First the framework computes the initial absolute percentage risk (APR) aka     of the 
participant been clinical hypertensive.  The second part of the prognosis framework, uses the 
same participant’s data to determine the total predictive percentage risk of the participant in 
10 years’ time. The framework also indicates the attributes in the combinatorial that has the 
optimal utility values and maps the output variables to their respective attributes.  The same 
simulation exercise was repeated for both model 1 and 2 using the selected 3654 participants’ 
data for the purpose of comparison.  The PPR results of the first 10 participants are shown 
Tables 7.2A and 7.3A while the computed results of the 30 participants and results of the 
entire groups are in the Appendix 7.    
 
 Domain scenario used for modelling CMAUT CVD Prognosis Framework  
 
To illustrate the operation of the framework, the CVD scenario discussed in Chapter 3 was 
used and formulated as follows: the hypertension disease      “is caused by” high rate of 
pumping blood by the Heart        that “sends” excessive high pressure blood to the 
Atrial     which “send signal to” the Antidiuretic hormone ADH in the Brian     to regulate 
the flow of fluid to the kidneys        These organs are complementary because they assist 
each other in performing their duties. In this example, three participants were selected from 
HSE, (2006) as shown in Table 7.2.  
 
Simulation: Using the clinical data for the same participants in Table 7.2, the predictive 
percentage risk (PPR) value of each of the participants in 10 years’ time was determined and 
recorded.  The results of the first 30 participants and the entire groups are shown in the 
Appendix 7.    
 
Table 7.2: The CVD data for the participants used for the illustration and simulations are:  
Pserial no. Grp Bp1 Age Sex Ethnic HB BMI BPH BPL HDL MAP DIA TC SMK CVD ECG 
13,956,102.00 No No 60 Women White 34.00 13.20 122.50 88.50 1.80 100.00 No 5.20 Yes No Yes 
63,535,102.00 Yes Yes 30 Women White 46.00 13.71 120.00 74.00 1.40 89.50 No 4.50 Yes Yes No 
42,831,101.00 No No 35 Men White 64.50 18.15 135.00 70.50 1.70 92.00 No 4.10 Yes No No 
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7.3 Principle of Modelling CMAUT Prognosis Framework 
 
Diagnosis is the first stage in disease management. Therefore in CIS, Initial clinical absolute 
Percentage Predictive Risk (APR) is essential because it assists medics in the timely 
intervention of the cause of the disease (Panagiotakos and Stavrinos, 2006).  In this research, 
initial absolute clinical risk (APR) is defined as the percentage probability of a participant 
having hypertension in their current state and the clinical data measured as well as recorded. 
The absolute clinical risk is for diagnosis and it is not based on time. 
 
In prognosis, predictive percentage risk (PPR) is the measure of the likelihood of a patient 
developing a disease over a specific time period based on the measurable and non-measurable 
risk factors (Panagiotakos and Stavrinos, 2006). The probability of an individual developing 
CVD event within a specified time frame depends on risk predictors. The risk factors are 
Age, Sex, OmpulvalHB, BMI, OmsysvalBPH, BPL, Hdlval1HDL, OmmapvalMAP, 
Diabete2Diabetic, CholvalTotalCholestrol, Smoking YN, Cvddefined as ExistingCVDYN 
and EcgbECGYN. 
 
The first subsystem of the CMAUT CVD Prognosis Framework: is the use of the 
optimisation algorithm in the framework to determine the Initial percentage risk of a 
participant been hypertensive.  It is also used to identify the attribute or set of attributes in the 
combinatorial organs, which maximises the optimal valuation percentage risk. The Initial 
clinical absolute percentage risk value (APR) is denoted as (u).  Again, the algorithm flags 
the integer values of the attribute variables listed in the results, which are shown as minimum 
value 0 or the maximum standard value required for medical decision making. 
 
The second subsystem of the CMAUT CVD Prognosis Framework is used to calculate the 10 
years percentage predictive risk values.  This was adapted from the Weibull distribution and 
Framingham equations explained in Anderson et al., (1990) and Anderson, (1991).  In these 
works, it was established that it is feasible to calculate the probability of an event occurring at 
a specific time when given the location parameter     and dispersion parameter     values. 
According to Anderson et al. (1991), the probability of an event occurring with respect to 
time (t) is notated as ( ) and it is known as the predictive time factor, which is given as: 
 
                  (7.1) 
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In equation (7.1), t is the number of years, that the decision maker wants to predict the CVD 
event occurring.   In this research, the Prognosis Framework is designed to predict the CVD 
event occurring in 10 years, but in the diagnosis framework the time t = 0.  Again, in the 
equation (7.1), µ is known as the location parameter and it is the sum of the products of both 
measurable and non-measurable CVD risk factors. This is computed by multiplying the risk 
factors by their corresponding coefficients that were obtained from the statistical binary 
logistic regression analysis in SPSS.  The equation of location parameter µ is shown below: 
 
                                                             
                                   
 
In this equation, βi are the beta coefficients or the weights obtained from the binary logistic 
regression analysis and the    are the values for the CVD risk factors. These are discussed in 
the implementation section 7.4.1 and 7.4.2 below.  
 
Scale (dispersion) parameter     
The scale or dispersion parameter (σ) is the arithmetical sum of the constant value θ0 and the 
initial variable θ1 for CHD from the Table of SBP prediction equation coefficients 
(Anderson1990).  The constant and initial values are from the results of various studies 
conducted using different CVD prediction models by Anderson et al, (1990) and Anderson et 
al. (1991).  According to Odell et al., (1994), log (σ) = θ0+ θ1µ, where θ0 is a constant and 
θ1 the initial variable for the CHD.  In this expression, the dispersion parameter (σ) uses the 
location parameter µ, which depends on the risk factors specified in section 7.2.  
 
In this research, the values θ0 and θ1 for the equation                  , are taken from 
the SBP prediction equation coefficients Table in Anderson et al., (1991).  The SBP values 
were taken from the prediction coefficient Table because all the binary logistic regression 
analysis conducted with SPSS, the DBP were not included in the output variables required for 
the structural equation. For example see “Variables in the Equation” Table 7.3 below. 
Secondly, the values for CHD were selected because the output from the Prognosis 
Framework will be compared to the Web based CHD calculators.  Lastly, the CHD prognosis 
is specific to heart disease whereas the CVD is generic for the entire Circulatory system.   
From the Table the values chosen were              and             .  
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The equation                   can also be written in natural log from as  
                                       (7.2) 
Hence taken the natural log of equation (7.2) and using the values from Anderson, (1991) the 
equation will be:                                            
Furthermore, from equation (7.1), the predictive time factor                        and for 
10years it will be                    .     
 
 Computation of Predictive Percentage Risk – (PPR)  
From Anderson, (1991), it is subsumed that the predicted probability represented as P at the 
time T when the CVD event occurs is greater than the initial time   for the given values of 
location (µ) and scale (σ) parameters.   Hence the assumption that  
                                      (7.3) 
Considering that from equation (7.1)                      then  
                                        
From the equation (7.3) above the predicted probability   for 10 years will be  
                                                          (7.4) 
In summary, from the expression (7.4), the predictive risk at time P(T) is greater than at the 
time P(t). Therefore the P (T), the predictive time in 10years is equal to is the sum of the 
current percentage risk value and the   value in equation (7.1) (Anderson et al (1991). 
 
Therefore the CMAUT prognosis framework was designed using the following concept: 
1. determine the initial clinical absolute risk (APR) or (u) using the CMAUT framework;  
2. Add the outcome to the calculated predictive time value       
3. The PPR or        in 10 years is the sum of the (APR) and       for each participant. 
. 
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7.4 Implementation of CMAUT CVD Prognosis Framework – Model 1 and 2 
 
 
From the HSE, (2006) report, the demographic and clinical data of all participants who are 
over 16 years and provided full CVD data were selected.  The Prognosis  Model 1 was 
designed using the 4316 participants who are  over 16 years old  because they constitute the 
core sample data for the HSE, (2006) survey report (Craig, et al, 2006a) (Craig, et al, 2008).  
 
The Prognosis Model 2 is from the data set of the 3654 participants who are over 30 years old 
and supplied all the requisite CVD data.  This is because all the Web CHD risk calculators 
and the Framingham equations examined in this research were designed for users who are 
over 30 years old.  Therefore adults who are over 30 year’s old group, which constitute model 
2 was selected (Chuang et al., 2007). The two prediction models built in this research are 
based on the “Variables in the Equation” from the SPSS logistic regression. 
 
7.4.1. Implementation of CMAUT CVD Prognosis Framework – Model 1 
 
The demographic and clinical data of the 4316 participants who are over 16 years old were 
used for the design and development of the CMAUT Prognosis model 1.  First, the values of 
the measureable attribute of the entire 4316 participants were input into SPSS and the binary 
logistic regression conducted. The output from the SPSS gave the values of the beta 
coefficients for each measureable attributes, which are -10.26, (HBI) 0.211, (BMI) 0.077, 
(BPH) -0.285, (HDL) 0.200, (MAP) 0.335 (TC) 0.0766.  These values listed in the “Variables 
in the Equation” Table 5.3 were used to form the equation and weights needed to calculate 
the utility unit of each of the measureable attribute.                      
                                                            The formula 
was used to compute the utility unit and the objective function shown in (7.5) was formulated 
using the results from the utility unit calculation.  
 
∑ (                                                         )
 
   (7.5) 
In the CMAUT prognosis framework, the measureable attribute values are used for the 
computation of the initial clinical absolute risk (APR) or {u}. The CVD problem was 
presented in LP format as an objective function as shown in expression (7.5) and optimised 
subject to the constraint unit matrix.  The algorithm was implemented in MATLAB program 
and executed as follows.  
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Implementation Part 1: execution of CMAUT model 1 and results of initial absolute risk        
During the execution of the MATLAB CVD program, the following conditions are checked:  
1. If the participant is male then HDL1 = 5.3, else for female HDL1 = 5.4. 
2. If the participant is diabetic (Yes) then BPH1 = 130; BPL1 = 80 else if not diabetic 
BPH1 = 140; BPL1 = 90. 
 
The aim of the optimisation algorithm in the framework is to find the attribute(s) in the 
combinatorial organs that has an overall utility unit that maximizes the utility value to be 
retrieved for primary healthcare investigation.  Therefore the LP optimisation algorithm in 
MATLAB determines the optimal valuation attribute and the maximum value. The solution 
indicates that the maximum value or the initial clinical absolute risk (u) is 19.729 as shown in 
Figure 7.3 below.  
7.4.2 Determination of CVD PPR using CMAUT Framework Model1  
 
The second part of the simulation extends the first CMAUT program and incorporates the 
formulae for predicting the CVD risk in 10 years.  In this second part, the measurable and 
non-measurable CVD risk predictors as well as the Weibull predictive time factor were used 
to calculate P(t) and add it to the initial clinical absolute risk (u). For both diagnosis and 
prognosis the weight allocated to each attribute were assessed using the logic regression 
method. For prognosis, the weights are the values of the beta coefficient for each risk 
predictor that was calculated with the aid of the binary logistic regression in SPSS.  The 
regression equation used is                          
 
 Part 2 of the CMAUT Prognosis model 1 time based calculation and results   
To determine the Location (µ) and Scale (σ) parameters, the statistical modelling technique 
was used for the computation of the predictive time factor P(t).  The statistical modelling 
concept uses the parametric regression logistic methods for developing the formula. The 
formula estimates the probability of the disease occurring when the level of risk factors are 
given.  It allows the use of standard accelerated failure time model for the computation of 
different duration of follow-up that matches the Weibull distribution (Anderson et al., 1990).  
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Location parameter   
To determine the Location parameter the values of the measureable and non-measurable 
attributes of the 4316 participants in group 1 were input into SPSS and the binary logistic 
regression conducted.  The procedure used is shown in Figure 7.1 below and the attributes 
used are Age, Sex, OmpulvalHB, BMI, OmdiavalBPL, OmsysvalBPH, Hdlval1HDL, 
OmmapvalMAP, Diabete2Diabetic, CholvalTotalCholestrol, Smoke4SmokerYN, 
CvddefExistingCVDYN, and EcgbECGYN.  The generic equation for the Location 
parameter is below and the     represents each of the thirteen (13) risk factors. 
 
                                                             
                                      
The expression takes in consideration the entire measurable and non-measurable attributes 
also known in epidemiological prediction model as CVD risk factors.  The CVD risk factors 
were entered into the SPSS software and the output from the SPSS gave the beta coefficient 
value for all the attributes, except OmdiavalBPL.    The beta coefficient values of the risk 
factors are listed in the “Variables in the Equation” Table 7.3.   The beta coefficients were 
used as the weights in the equation to calculate the Location parameter.  
 
Procedure for determining the binary logistic Regression in SPSS is as follows: 
 
Figure 7.1: Procedure for determining Logistic Regression in SPSS 
From the statistical regression analysis conducted for model 1, the coefficient values in the 
Table 7.3 were identified from using the HSE, (2006) clinical data. Therefore the expression 
below has twelve (12) attributes instead of the thirteen (13) without the OmdiavalBPL. 
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Table 7.3 Variables in the Equation 
  B S.E. Wald df Sig. Exp(B) 
Step 
1(a) 
Age .014 .007 4.476 1 .034 1.014 
Sex(1) -.141 .201 .492 1 .483 .868 
OmpulvalHB .300 .299 1.008 1 .315 1.350 
BMI .108 .022 24.878 1 .000 1.115 
OmsysvalBPH -.429 .448 .918 1 .338 .651 
Hdlval1HDL .064 .267 .058 1 .810 1.066 
OmmapvalMAP .490 .447 1.198 1 .274 1.632 
Diabete2Diabetic -1.644 .376 19.074 1 .000 .193 
CholvalTotalCholestrol .043 .088 .241 1 .623 1.044 
Smoke4SmokerYN -.215 .243 .782 1 .377 .806 
CvddefExistingCVDY
N 
10.096 1.018 98.413 1 .000 24250.272 
EcgbECGYN -1.059 .199 28.270 1 .000 .347 
Constant -18.266 1.505 147.256 1 .000 .000 
 
a  Variable(s) entered on step 1: Age, Sex, OmpulvalHB, BMI, OmsysvalBPH, Hdlval1HDL, 
OmmapvalMAP, Diabete2Diabetic, CholvalTotalCholestrol, Smoke4SmokerYN, 
CvddefExistingCVDYN, EcgbECGYN. 
 
From Table 7.3, the constant βo value is -18.266 and all the βi values are the beta coefficients 
for each of the CVD risk factors from the binary logistic regression analysis.  Below is the 
final expression when all the βi   values obtained from the SPSS analysis are put into the 
Location parameter µ formula for CMAUT model 1:  
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For the computation of Location parameter µ, the female is denoted as 1, while male is 0. 
When the participant is diabetic then the value is 1 else 0, and if the participant is smoking 
then the value is 1 else 0. Again, when the participant had CVD or ECG before then the value 
is 1 else 0. These risk factor values are put into the Location parameter (µ) formula above to 
calculate the predictive percentage risk (PPR) as shown in Figure 7.13 below: 
 
                                                                            
                                                               
                        
             
                                                 
                     0.0149 
                                             
                           
Figure 7.3:  Computation of PPR for CMAUT Prognosis mode1 1 
The Figure 7.3 is the code, which depicts how the SPSS results and the predictive time based 
calculation, which is then incorporated into MATLAB program in Figure 7.4.  The output 
screen for one of the participant from the HSE, (2006) is shown in Figure 7.5 below. The 
screen depicts the measured attribute values of the participant which was converted into 
utility unit using the formula 5.1 and the standard parameters in Table 5.2.  The optimisation 
algorithm is used to find the attribute(s) in the combinatorial organs that has an overall utility 
unit that maximizes the utility value to be retrieved for primary healthcare investigation.   
 
 Determination of CVD PPR value using the Model1 CMAUT framework 
 
The optimisation algorithm was written in MATLAB and used to simulate the CVD data of 
each participant.  The MATLAB program in Figure 7.4 uses each participant’s data and 
computes the 10 years predictive percentage risk (PPR).  The algorithm in the MATLAB 
code shows the arithmetical sum of the {abs P (t)} and {abs (u)}, which is the sum of the 
absolute percentage risk (u) and the time based predictive percentage risk (P (t)). The first 
and second parts of the CMAUT Prognosis model 1, were implemented in MATLAB.  The 
algorithm and formulae used are coded in MATLAB are as follows:    
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const = -18.266; 
n = length(fage); 
mu_val = zeros(1,n); 
u_val = zeros(1,n); 
pr_val = zeros(1,n); 
for i = 1:n   
%     tc_div_hdl = ftc(i)./fhdl(i); 
     
    mu_val(i) = const + 0.014*fage(i) + (-0.141*fsex(i)) + 0.300*fhb(i)+ 
                0.108*fbmi(i) + (-0.429*fbph(i)) + 0.064*fhdl(i) + 
                0.490*fmap(i) + (-1.644*fdia(i)) + 0.043*ftc(i) +  
                (-0.215*fsmk(i)) + (-1.059*fecg(i)) + 10.096*fcvd(i); 
    log_sig = 0.9145 - 0.2784 * mu_val(i); % theta one - theta two * mu 
    sig_val = exp(log_sig); 
    u_val(i) = (log(10) - mu_val(i))/sig_val; 
    if i == 18 
        gg = dpts(i); 
    end 
    pr_val(i) = dpts(i)+abs(u_val(i)); 
end 
pr_val = pr_val'; 
figure(1) 
plot(pr_val); 
 
Figure 7.4:  MATLAB code for CMAUT Prognosis mode1 1 
In part 2 of simulation process, the optimisation algorithm in the CMAUT framework uses 
the entire CVD predictors and the 10 years risk predictive formulae.  When the CMAUT time 
based framework in MATLAB is executed, the results appear in the GUI in Figure 7.5 below. 
The GUI shows the initial Absolute Percentage Risk (APR) and the Predictive Percentage 
Risk (PPR) of the named participant in 10 years’ time.   The output also flags the attributes in 
the combinatory, which are needed for the management of the participant’s CVD disease.  
 
In the GUI, the results after optimisation and the optimal integer values are X1 = 50, X2 = 26, 
X3 = 1, X4 =1, X5 =100 and X6 = 6.  As shown in the GUI solution Figure 7.5, the 
percentage risk is 19.729 % and the optimal values of the attributes are   X1 = 50, X2 = 26, 
and X5 = 100, which are the requisite data for further investigation. When the output 
variables are mapped to the input attributes the results are X1 (HB), X2 (BMI), X5 (MAP) and 
PPR value is the arithmetical sum of the {abs P (t)} and {abs (u)}, which is 20.0112 %.  
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Figure 7.5: Output screen of CIS_CMAUT framework with predictive time for simulation 2 
 
 Simulation Results, Tables and Figures for CMAUT Prognosis framework model1 
The Tables and Figures in this section are the results of entering the demographic and clinical 
data of each of the selected 3654 participants into the CVD CMAUT Prognosis framework 
model 1.  The PPR results from the CVD Prognosis framework model 1 are compared with 
the risk results from the Web based CVD calculators and Framingham equations in chapter 9.  
 
Table 7.3A is the raw data of the first 10 participants from the list of 3654 participants. Table 
7.3B at the end of the Thesis contains the results of the first 30 participants and the group 
results are in the Appendix Table 7.3C in electronic format.  Table 7.4A contains the results 
of the computed 10 years PPR values and the attribute variable values of each of the first 10 
participants from the Model I 3645 data sets. Table 7.4B, at the end of the Thesis is the 
results of the 30 participants and the group is in Appendix Table 7.4C in electronic format. 
 
The Table 7.5A shows the results of the computation of TPR, FPR, LRP and LRN for the 
CMAUT CVD Prognosis framework model 1.  The 10 years PPR values are for the first 10 
participants of the 3645 data set.   The Table 7.5B, at the end of the Thesis contains the first 
30 participants’ results and the group is in the Appendix Table 7.5C in electronic format.   
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MATLAB Model I for 3645 participants in the category of over 16 years old. 
Table 7.3A: the raw data of the first 10 participants used in chapter 7: 
Pserial no. Grp Bp1 Age Sex Ethnic HB BMI BPH BPL HDL MAP DIA TC SMK CVD ECG 
13,956,102.00 No No 60 Women White 34.0 13.20 122.50 88.50 1.80 100.0 No 5.20 Yes No Yes 
63,535,102.00 Yes Yes 30 Women White 46.0 13.71 120.00 74.00 1.40 89.50 No 4.50 Yes Yes No 
71,831,101.00 No No 66 Women White 89.0 14.32 159.00 70.00 1.90 99.50 No 6.90 No No Yes 
34,031,101.00 No No 84 Women White 48.5 16.17 112.00 63.50 2.20 80.00 No 5.00 Yes Yes Yes 
72,604,102.00 No No 59 Women White 36.5 16.19 109.50 73.00 2.00 85.00 No 6.00 No No No 
13,008,101.00 Yes Yes 50 Women White 43.0 16.65 117.00 74.00 1.70 88.50 No 6.00 Yes Yes Yes 
39,139,101.00 No No 34 Women White 48.0 16.81 102.00 54.00 1.80 70.00 No 6.50 Yes No No 
47,856,102.00 No No 51 Women White 44.0 16.85 100.50 56.50 1.90 71.00 No 5.10 No No No 
37,710,101.00 No No 61 Women White 43.0 17.43 120.00 77.00 1.20 91.50 No 5.50 No No No 
 
Table 7.4A Predicative Percentage Risks for 10 years and attribute variable values for the 
first 30 participants (from Model I 3645 data sets) 
Pserial no. Grp Bp1 Age Sex X1 X2 X3 X4 X5 X6 %PR 
13,956,102.00 No No 60 Women 50.0 25.5 0.02 0.00 50.00 5.22 14.9 
63,535,102.00 Yes Yes 30 Women 45.8 25.9 4.15 0.00 100.19 4.28 16.3 
71,831,101.00 No No 66 Women 0.0 25.5 140.00 0.00 100.00 0.00 17.1 
34,031,101.00 No No 84 Women 50.0 25.5 0.00 0.00 100.00 5.30 19.0 
72,604,102.00 No No 59 Women 50.0 25.5 0.00 0.00 100.00 0.00 19.2 
13,008,101.00 Yes Yes 50 Women 50.0 25.5 0.00 0.00 100.00 0.00 17.3 
39,139,101.00 No No 34 Women 50.0 25.5 0.00 0.00 100.00 0.00 21.7 
47,856,102.00 No No 51 Women 50.0 25.5 0.01 0.00 100.00 5.23 22.2 
37,710,101.00 No No 61 Women 50.0 25.5 0.00 0.00 100.00 0.00 15.6 
54,256,101.00 No No 31 Women 50.0 25.5 0.00 0.00 100.00 5.30 14.4 
 
Table 7.5A Calculation of TPR, FPR, LRP, and LRN, for the MATLAB Model I PPR for 10 
years for the first 30 participants (from Model I 3645 data sets) 
Pserial no. Grp Bp1 Age Sex %PR EX NEX TPR FPR LRP LRN 
13,956,102.00 No No 60 Women 15.6 0 1 1 1.000 3278.7 0 
63,535,102.00 Yes Yes 30 Women 16.3 0 1 1 0.999 1639.3 0 
71,831,101.00 No No 66 Women 17.7 0 1 1 0.999 1092.9 0 
34,031,101.00 No No 84 Women 19.0 0 1 1 0.999 819.7 0 
72,604,102.00 No No 59 Women 19.8 0 1 1 0.998 655.7 0 
13,008,101.00 Yes Yes 50 Women 21.0 0 1 1 0.998 546.4 0 
39,139,101.00 No No 34 Women 19.4 1 0 0.997 0.998 545.0 0.0027 
47,856,102.00 No No 51 Women 17.2 1 0 0.995 0.998 543.5 0.0055 
37,710,101.00 No No 61 Women 18.3 0 1 0.995 0.998 465.8 0.0055 
54,256,101.00 No No 31 Women 22.2 0 1 0.995 0.998 407.4 0.0055 
 
Figure 7.3 shows the graph of the computation of the 10 years PPR value of each of the 3645 
participants against their individual Participant Identification Number (PIND). This data in 
Table 7.4C were used to plot the graph is shown in Figure 7.3. 
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Figure 7.4 shows the prediction accuracy graph, which is the computation of True Positive 
Rate against the False Positive Rate of each of the 3645 participants.  This data used for 
plotting the Area under the Curve graph in Figure 7.4 is from Table 7.5C.  The AUC for 
model 1 is calculated, by using the summation of all the PPR data points applying the 
trapezoidal method. The AUC area is obtained by subtracting the sum of all the PPR data 
points from the sum of all the diagonal reference data points.  
 
The Figure 7.5 shows the graph of the discriminatory ability of the CMAUT model 1.  This 
was constructed by first calculating the sensitivity and selectivity of each of the 3645 
participants and recorded in Table 7.5C for the results of the calculation of TPR and FPR for 
model 1.  The graph Figure 7.5 of the sensitivity and selectivity are plotted against the 
recommended criterion, using the NICE, (2006) criterion of 20 %.  The interception and the 
degree of accuracy are discussed in chapter 9. 
 
Likelihood ratio is used to determine the performance accuracy of the model in Table 7.5C.   
The procedure used to calculate the value of the Likelihood ratio LR+ = (TPR/1-TNR) and 
the Likelihood ratio LR- = (1-TPR/TNR) for all the 3645 participants.  The Table 7.5C shows 
the results of the calculation of the LR+ and the LR- for model 1. Figure 7.6 shows the 
graphic of the performance accuracy of the PPR of each participant’s value from the 
Prognosis framework model 1.  The graph in Figure 7.6 was constructed by plotting all the 
positive and negative Likelihood ratio values on the Y-axis and PIND of each participant on 
the X-axis and discussed in chapter 9. 
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Figure 7.3: Predictive 10-years percentage risk for 3645 participants based on CMAUT Model – I 
 
Figure 7.4:  ROC/AUC curve of CMAUT Prognosis Risk Model – I 
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Figure 7.5: Sensitivity and specificity curve of CMAUT Prognosis Risk Model – I 
 
 
Figure 7.6: Likelihood ratio curve of CMAUT Prognosis Risk Model – I 
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7.4.3 Implementation of CMAUT CVD Prognosis Framework – Model 2 
 
 The demographic and clinical data of the 3645 participants who are over 30 years old were 
used for the design and development of the CMAUT prognosis model 2.  First, the values of 
the measureable attribute of the entire 3645 participants were input into SPSS and the binary 
logistic regression conducted. The output from the SPSS gave the beta coefficient values for 
each measureable attribute, which are OmpulvalHB = 0.174,   BMI = 0.076,  OmsysvalBPH 
= -0.229, Hdlval1HDL = 0.216, OmmapvalMAP = 0.279, CholvalTotalCholestrol = 0.058 
and the constant value = -10.076.  The values listed in the “Variables in the Equation” Table 
5.5 were used to form the equation below and the same values used as weights to calculate 
the utility unit of each of the measureable attribute.  
                                                                  
The formula used to calculate the utility unit is the expression (5.1) and the objective function 
formed from the results is in expression (7.4) below. 
  ∑ (                                                               )
 
      (7.4) 
In CMAUT prognosis framework the measureable attribute values are used for the 
computation of the initial clinical absolute risk (APR) or {u}.  The CVD problem was 
presented in LP format as an objective function and optimised subject to the constraint unit 
matrix.  The algorithm was implemented in MATLAB program.   
 
 Implementation part 1:- execution and results of CMAUT model 2 for APR       
During the execution of the MATLAB program, it checks the following conditions that:  
1. If the participant is male then HDL1 = 5.3 else for female HDL1 = 5.4. 
2. If the participant is diabetic (Yes) then BPH1 = 130; BPL1 = 80 else if not diabetic 
BPH1 = 140; BPL1 = 90. 
The LP optimisation algorithm written in MATLAB is used to determine the optimal 
maximum valuation attribute value. The solution indicates that the maximum value, which is 
the initial clinical absolute risk (u) shown in Figure 7.8 as 18.007%.  
7.4.4 Determination of CVD PPR using CMAUT framework Model 2 
 
The second part of the simulation extends the CMAUT program from the first part and 
incorporates the formulae for predicting the risk in 10 years.  In this second part, the 
measurable and non-measurable CVD risk predictors as well as the Weibull predictive time 
factor P (t) are calculated and added to the initial clinical absolute risk (u).   
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For prognosis, the weights are the values of the beta coefficient for each risk predictor as 
calculated using the binary logistic regression in SPSS. The regression equation used 
is:                     :   
 
 Part 2 of the CMAUT Prognosis model 2 time based calculation and results    
To determine the Location (µ) and Scale (σ) parameters required for the computation of the 
predictive time factor the statistical modelling technique was used.  The statistical modelling 
concept uses parametric regression, which is logistic method for developing the formula. The 
formula estimates the probability of the disease occurring when the values of risk factors are 
given.  It allows the use of standard accelerated failure time model for computation of 
different duration of follow-up that matches the Weibull distribution (Anderson et al., 1990).  
 
Location parameter   
The Location parameter was determined by inputting the measureable and non-measurable 
attribute values of the entire 3645 participants into SPSS software and the binary logistic 
regression conducted. The procedure used is shown in Figure 7.7 below and the attributes 
used are Age, Sex, OmpulvalHB, BMI, OmdiavalBPL, OmsysvalBPH, Hdlval1HDL, 
OmmapvalMAP, Diabete2Diabetic, CholvalTotalCholestrol, Smoke4SmokerYN, 
CvddefExistingCVDYN and EcgbECGYN.  The equation for Location parameter is written 
below and in it the xi represents each of the thirteen (13) risk factors. 
 
                                                             
                                      
 
The Location parameter formula uses the entire measurable and non-measurable attributes the 
CHD risk factors used in epidemiological prediction model were input into the SPSS 
software. The output from the SPSS gave the values of the beta coefficients for all the 
attributes, except OmdiavalBPL.    The values listed in the “Variables in the Equation” Table 
7.13 were used to form the equation below and also used as the weights to calculate the 
Location parameter of all the CVD risk factors.  
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Procedure for determining logistic Regression in SPSS 
 
Figure 7.7: Procedure for logistic Regression in SPSS 
From the statistical regression analysis conducted the beta coefficient values in Table 7.12 
were obtained for the HSE, (2006) data for model 2. The expression below has the twelve 
(12) attributes without the OmdiavalBPL instead of 13 attributes put into the SPSS package. 
                                                                   
                                   
Table 7 .12 Variables in the Equation 
  B S.E. Wald df Sig. Exp(B) 
Step 
1(a) 
Age .023 .008 7.619 1 .006 1.023 
Sex(1) -.111 .212 .276 1 .600 .894 
OmpulvalHB .241 .317 .578 1 .447 1.272 
BMI .109 .023 22.052 1 .000 1.115 
OmsysvalBPH -.352 .475 .548 1 .459 .704 
Hdlval1HDL .116 .278 .173 1 .677 1.122 
OmmapvalMAP .419 .475 .778 1 .378 1.520 
Diabete2Diabetic -1.508 .392 14.824 1 .000 .221 
CholvalTotalCholestrol .060 .094 .412 1 .521 1.062 
Smoke4SmokerYN -.063 .265 .057 1 .812 .939 
CvddefExistingCVDYN 10.018 1.021 96.242 1 .000 22419.271 
EcgbECGYN -1.106 .214 26.784 1 .000 .331 
Constant -19.228 1.605 143.457 1 .000 .000 
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a  Variable(s) entered on step 1: Age, Sex, OmpulvalHB, BMI, OmsysvalBPH, Hdlval1HDL, 
OmmapvalMAP, Diabete2Diabetic, CholvalTotalCholestrol, Smoke4SmokerYN, 
CvddefExistingCVDYN, EcgbECGYN. 
 
In Table 7.12, the constant value of βo is -18.266 and all the beta coefficient (βi) values for 
the various CVD risk factors from the binary logistic regression analysis are shown.  Below is 
the final expression when all the βi values obtained from the SPSS analysis are put into the 
Location parameter µ formula for CMAUT model 2:  
 
                                                                        
                                                        
           
For the computation of Location parameter µ, the female is given 1, while male is 0. When 
the participant is diabetic the value given is 1 else 0, and when the participant is smoking then 
give 1 else 0. Give the participant the value 1, if they have had CVD or ECG before else give 
them 0. These values are put into the formula to calculate Location parameter µ and 
predictive percentage risk (PPR) as shown in Figure 7.8 below: 
 
                                                                       
                                                             
                        
             
                                                 
                     0.0149 
                                              
                           
Figure 7.8:  Computation of Location parameter µ and Predictive Percentage Risk 
 
Figure 7.9 is the MATLAB code, which depicts how the SPSS results and the predictive time 
based calculations, which were incorporated into the MATLAB program.  The output screen 
for one of the participant from the HSE, (2006) survey is shown in Figure 7.10 below. The 
output screen shows the measured attribute values of the participant that was converted into 
utility unit using the formula (5.1) and the standard parameters in Table 5.2.  
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The optimisation algorithm in the framework is used to determine the attribute(s) in the 
combinatorial organs that have the overall utility unit that maximises the utility function to be 
retrieved for CVD investigation.   
 
 Part 2 results – Using the CMAUT time based framework for model 2 
The second part of the algorithm for the computation of PPR was written in MATLAB and 
simulated using the clinical data for each participant. The MATLAB algorithm takes each of 
the participant’s data and computes the 10 years predictive percentage risk PPR value of the 
participant.  The formulae in MATLAB are as follows: 
 
const = -19.228; 
n = length(fage); 
mu_val = zeros(1,n); 
u_val = zeros(1,n); 
pr_val = zeros(1,n); 
for i = 1:n 
%     tc_div_hdl = ftc(i)./fhdl(i); 
mu_val(i) = const + 0.023*fage(i) + (-0.111*fsex(i)) + 0.241*fhb(i)+... 
0.109*fbmi(i) + (-0.352*fbph(i)) + 0.116*fhdl(i) +... 
0.419*fmap(i) + (-1.508*fdia(i)) + 0.060*ftc(i) + ... 
(-0.063*fsmk(i)) + (-1.106*fecg(i)) + 10.018*fcvd(i); 
log_sig = 0.9145 - 0.2784 * mu_val(i); % theta one - theta two * mu 
sig_val = exp(log_sig); 
u_val(i) = (log(10) - mu_val(i))/sig_val; 
pr_val(i) = dpts(i)+abs(u_val(i)); 
end 
pr_val = pr_val'; 
figure(3) 
plot(pr_val); 
 
Figure 7.9: MATLAB program for CMAUT Prognosis mode1 2; 
 
 Simulation  results – Using the CMAUT time based framework –model 2 
In part 2 of the simulation process, the optimisation algorithm uses all the CVD risk 
predictors and the 10 years risk predictive P (T) formulae. When the CMAUT time based 
Prognosis framework is executed the results appear in the GUI in Figure 7.10 below. It 
comprises the initial clinical percentage risk, just as in simulation part 1.  The output also 
flags the attributes in the combinatory that are needed for the management of the participant’s 
CVD disease. 
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Figure 7.10: Output screen of CIS_CMAUT framework with predictive time for simulation 2. 
 
The results after optimisation are the optimal integer values shown in Figure 7.10 as follows; 
X1 = 50, X2 = 26, X3 = 1, X4 =1, X5 =51 and X6 = 6.  The computed PPR value is 18.282 % 
while the attribute values X1 (HB) = 50, X2 (BMI) = 26, and X5 (MAP) = 100 needs further 
investigation.  From the results in the GUI Figure 7.10,  the 10 years P (T) of the participant, 
which is the arithmetical sum of the {abs (u) and abs P (t)} is (18.007 + x) = 18.282 %. This 
result denotes that the participant needs attention because the value is close to the 20% 
recommended by NICE, (2006).   
 
The values in Figure 7.10 are comparable to the values specified by NICE, (2006) as HB1 = 
50.0; BMI1 = 25.5; BPH1 = 140.0; BPL1 = 90.0;   HDL1 = 1.20;   MAP1 = 100; TC1 = 5.0 
as used in the CMAUT optimisation algorithm. 
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 Simulation Results, Tables and Figures for CMAUT Prognosis framework model2: 
  
The Tables and Figures in this section are the results of entering the demographic and clinical 
data of each of the selected 3654 participants into the CVD CMAUT Prognosis framework 
model 2.  The results from CVD Prognosis framework model 2 were compared with the 
results from the Web based CVD calculators and the Framingham equations in Chapter 9.  
The raw data of the first 10 participants from the list of 3654 participants is in Table 7.3A 
while Table 7.3B contains the data of the first 30 participants at the end of this Thesis and 
Table 7.3C has the entire group data in electronic format.  
 
Table 7.13A contains the results of the calculated 10 years PPR values and the comparative 
attribute variable values of each of the first 10 participants from the Model I 3645 data sets.  
Similarly, Table 7.13B, at the end of the Thesis contains the results of first 30 participants 
and the results of entire group are in the Appendix Table 7.13C in electronic format. 
 
The Table 7.14A shows the results of the computation of TPR, FPR, LRP and LRN for the 
CMAUT CVD Prognosis framework model 1 based on the PPR values for the 10 years of the 
first 10 participants of the 3645 data set.   Table 7.14B, at the end of the Thesis contains PPR 
results of the first 30 participants and the results of the entire group are in the Appendix 7, 
Table 7.14C in electronic format.   
 Table 7.3A contains the raw data of the first 30 participants used in MATLAB Model 
II for 3645 participants in the category of over 30 years old.  
Table 7.13 Predicative Percentage Risks for 10 years and attribute variable values for the first 
30 participants Model II 
Pserial no. Grp Bp1 Age Sex X1 X2 X3 X4 X5 X6 %PPR 
13,956,102.00 No No 60 Women 50.0 25.5 0.02 0.00 50.00 5.22 14.79 
63,535,102.00 Yes Yes 30 Women 45.8 25.9 4.15 0.00 100.19 4.28 15.53 
71,831,101.00 No No 66 Women 0.0 25.5 140.00 0.00 100.00 0.00 16.42 
34,031,101.00 No No 84 Women 50.0 25.5 0.00 0.00 100.00 5.30 17.64 
72,604,102.00 No No 59 Women 50.0 25.5 0.00 0.00 100.00 0.00 18.26 
13,008,101.00 Yes Yes 50 Women 50.0 25.5 0.00 0.00 100.00 0.00 16.13 
39,139,101.00 No No 34 Women 50.0 25.5 0.00 0.00 100.00 0.00 20.28 
47,856,102.00 No No 51 Women 50.0 25.5 0.01 0.00 100.00 5.23 20.75 
37,710,101.00 No No 61 Women 50.0 25.5 0.00 0.00 100.00 0.00 15.26 
54,256,101.00 No No 31 Women 50.0 25.5 0.00 0.00 100.00 5.30 14.26 
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Table 7.14 Calculation of TPR, FPR, LRP, and LRN, for the MATLAB Model II for 10 years 
for the PPR first 30 participants 
Pserial no. Grp Bp1 Age Sex %PR EX NEX TPR FPR LRP LRM 
13,956,102.00 No No 60 Women 14.79 0 1 1 0.9997 3484.32 0 
63,535,102.00 Yes Yes 30 Women 15.53 0 1 1 0.9994 1745.20 0 
71,831,101.00 No No 66 Women 16.42 0 1 1 0.9991 1162.79 0 
34,031,101.00 No No 84 Women 17.64 0 1 1 0.9989 872.60 0 
72,604,102.00 No No 59 Women 18.26 0 1 1 0.9986 697.84 0 
13,008,101.00 Yes Yes 50 Women 16.13 0 1 1 0.9983 581.73 0 
39,139,101.00 No No 34 Women 20.28 1 0 0.9935 0.9983 577.98 0.0065 
47,856,102.00 No No 51 Women 20.75 1 0 0.9871 0.9983 574.23 0.0129 
37,710,101.00 No No 61 Women 15.26 0 1 0.9871 0.9980 492.07 0.0129 
 
Figure 7.11 shows the graph of the computed 10 years PPR values of each of the 3645 
participants against their individual Participant Identification Number (PIND). This data in 
Table 7.13C was used to plot the graph shown in Figure 7.11.   Figure 7.12, is the graph of 
the computed TPR against the FPR value of each of the 3645 participants. This data used to 
plot the AUC graph is from Table 7.13C and the AUC area for model 2 was calculated, by 
the summation of all the PPR data points using the trapezoidal method. The actual area is 
obtained by subtracting the sum of all the PPR data points from the sum of the of all the 
diagonal reference data points as discussed in chapter 3.  
 
Figure 7.13 shows the graph of the Prediction Accuracy of CMAUT model 2.  This was 
constructed by plotting the sensitivity and selectivity of each of the 3645 participants from 
the values in Table 7.13C.  The graph of the sensitivity and selectivity against the NICE 
(2006) recommended 20% criterion and the interception are discussed in chapter 9.   Table 
7.13C contains the results of the computation of the positive and the negative Likelihood 
ratio for the entire 3645 participants.   
 
The Figure 7.14 shows the graph of the Prediction Accuracy of the PPR of each participant’s 
value from the Prognosis predictive framework model 2.  This is based on the plot all the 
values of the positive and negative Likelihood ratios on the Y-axis and PIND for each 
participant on the X-axis and the graph are discussed in chapter 9. 
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Plots for 3645 data sets for Internet model II  
 
Figure 7.11: Predictive 10-years percentage risk for 3645 participants based on CMAUT Model – II 
 
Figure 7.12:  ROC/AUC curve for CMAUT Prognosis Risk Model – II 
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Figure 7.13: Sensitivity and specificity curve of CMAUT Prognosis Risk Model – II 
 
 
Figure 7.14:  Likelihood Ratio curve of CMAUT Prognosis Risk Model – II 
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7.5 Summary: 
 
In this chapter, two models of the CMAUT CVD prognosis framework were designed and 
built to prove the second part of the hypothesis. The second part of the hypothesis states that 
the framework can be used as an epidemiological tool to determine the percentage risk of a 
user been hypotensive in future. The model 1 was designed with the βi   coefficient values 
from the binary logistic regression analysis of the 4316 over 16 years old participants.  The 
model 2 was designed using the βi coefficient values from the 3645 participants, who are 
over 30 years old. The βi coefficient values were used as weights for constructing the 
objective functions and statistical structured equations of models 1 and 2. 
 
In both CMAUT CVD prognosis models 1 and 2, the Absolute Percentage Risk (u) was first 
computed for each participant. The predictive percentage risk P(T) of each of the 3654 
participants was computed as the arithmetical sum of the Absolute Percentage Risk (u) and 
risk factor P(t) in 10 years’ time. Based on these results the following verification metrics 
namely TPR, FPR, LRP and LRN were computed. 
 
The resultant predictive percentage risk (PPR) values for each participant were used to plot 
the Receiver Operating Characteristics (ROC) to determine Area under the Curve (AUC) for 
models 1 and 2.  Graphs for the sensitivity and selectivity of the participants were plotted 
against the NICE, (2006) of 20 % recommended criterion.    Finally, the values of the positive 
and negative Likelihood ratio values were plotted against on the PIND of each participant. 
The predictive percentage risks from CMAUT models 1 and 2 as well as the graphs were 
presented in this Chapter 7 and also discussed in Chapter 9. 
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Chapter 8: Simulation of PPR with Web CHD Risk 
Calculators and Framingham Algorithms 
 
8.0 Introduction  
 
In this chapter, two CVD risk prediction techniques namely the Web-Based CHD Risk 
Calculators and Framingham Algorithms were analysed and discussed.  First two Web- based 
CHD Risk Calculators, which were designed using Framingham Algorithm, were chosen. 
The two selected CHD Risk Calculators were used to determine the Predictive Percentage 
Risks (PPR) values of the selected 3645 participants discussed in Chapters 5 and 7. This was 
followed by discussing the three different types of Framingham Algorithms, which were used 
for building CVD Risk Prediction models (Wilson et al., 1998).  The results of the PPR from 
the Framingham Algorithms and Web based CHD Risk Calculators were recorded and 
benchmarked against the two Prognosis CVD CMAUT framework models.  The results are 
presented in this chapter and analysed in chapter 9.  
  
8.1 Methodology used for the selection of the CHD web risk calculators 
 
 Internet based CHD risk calculators: E-health is the use of Internet based technological 
systems to manage and delivery health care.  In this research, Internet technology refers to the 
usage of video, websites and scan images to capture clinical data that is used for the 
prognosis and diagnosis of diseases (Chuang et al, 2007).  In computing, Internet is the 
physical internetworking infrastructure and the Web is the logical applications, which 
facilitate the exchange of data and information (Sheridan et al., 2003).  In this research the 
terms Internet and Web will be used interchangeable to refer to the application software that 
resides on the Internet infrastructure.  The PPRs obtained from the CMAUT frameworks are 
used to benchmark against the results from the two Web-Based CHD risk calculators. 
The procedure used to shortlist and select the two CHD risk calculators for the benchmark 
exercise are:  
1. Enter the keywords “CHD web risk calculators” into Google search engine (Sheridan 
et al., 2003).  This gives a list of web based risk calculator and since the aim of this 
research is to compare the different types of Framingham equations. The search was 
narrowed to look for “CHD web risk calculators + Framingham Algorithm”. 
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2. The next step is to search for “UK web risk calculators + Framingham algorithm”. 
This advance search assisted in selecting only UK online risk calculators. The purpose 
for this selection is that the clinical data used for this research is from England hence 
the web calculator must be compatible with it. This process also reduced the search to 
10 web calculators. See list of website in Appendix 8. 
 
3. It was also identified that all the 10 web predictors were designed for different age 
groups starting from 32 to 94 years old. Again, they used different risk predictors and 
since the aim of this research is to predict the percentage risk using the participant’s 
clinical data, two web calculators with maximum clinical data were selected. 
  
Finally the two CHD web risk calculators that were selected are: 
 Internet model – I:- NHS BlackHeath centre (refer: 
http://www.bhgp.co.uk/chdriskresult.asp 
 Internet model – II:- Patient UK User Survey (refer: 
http://www.patient.co.uk/doctor/Primary-Cardiovascular-Risk-Calculator.htm. 
 
The NHS BlackHeath Centre web site was selected because it has the NHS logo on the web 
page, which subsumes that it, was designed using the NICE guideline.  This website also 
refers to Anderson et al, (1991) paper on CVD risk prediction that uses Framingham equation 
as the basis for the development of the CVD website.  
 
Similarly, the Patient UK website was selected because it was designed and implemented 
using the Framingham algorithm (Anderson et al, 1991). Secondly, it was identified that the 
Patient UK website uses the main CVD risk factors required by prediction model for the 
computation of PPR based on the Framingham algorithm.   The ten (10) websites from which 
these two Web-based calculators used for benchmarking were selected from are listed in 
Appendix 8.1. 
 
 Determination of PPR using the Web-Based CVD Risk Calculators:  
 
The data of each of the 3645 selected participants from the HSE, (2006) survey were input 
into the two web risk calculators and their 10 years Predictive Percentage Risk (PPR) values 
determined and recorded in the appropriate Tables.  
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The procedure for calculating the 10 years PPR of the selected 3645 participants using CHD 
web risk calculators is as follows: three participants from the HSE report were selected and 
used to illustrate the operation of the two selected websites.  The same participants were used 
in Chapters 5 and 7 but their data have been reproduced in Table 8.0 for easy of reference. 
 
Table 8.0 Data of participants used for illustration 
Pserial no. Grp Bp1 Age Sex Ethnic HB BMI BPH BPL HDL MAP DIA TC SMK CVD ECG 
13,956,102.00 No No 60 Women White 34.00 13.20 122.50 88.50 1.80 100.00 No 5.20 Yes No Yes 
63,535,102.00 Yes Yes 30 Women White 46.00 13.71 120.00 74.00 1.40 89.50 No 4.50 Yes Yes No 
42,831,101.00 No No 35 Men White 64.50 18.15 135.00 70.50 1.70 92.00 No 4.10 Yes No No 
 
8.1.1 Determination of the 10 years PPR with Internet model 1:- NHS BlackHeath  
 
The NHS BlackHeath website uses all the risk factors in Table 8.0 to compute the PPR values 
as indicated in the Framingham equations and explained in Anderson et al., (1991).  The 
simulation exercise was conducted using the 3645 participants from the HSE, (2006) data set.  
Figure 8.0 below is the website in, which all the measurable and non-measurable risk factors 
for each participant were entered.  
 
 
Figure 8.1: NHS BlackHeath Website for Heart Disease Risk calculator 
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The NHS BlackHeath web Calculator was designed for users, who are 30 to 74 years old. The 
measureable metrics used by the website are age, diastolic, systolic blood pressures, total 
cholesterol and HDL-Cholesterol. The non-measureable metrics are smoking and diabetic. 
 
 The CVD data and Output results  for the first participant: 
 
The data of the first participant on the Table 8.0 was entered into the Heart Disease Risk 
Calculator and below in Figure 8.1 is the result.   The CVD data used are PIND = 
13,956,102.00, woman, white, Age = 60 years;; HB = 34.00 beat/sec, BMI = 13,71;  BPH 
=122.50 mgHH;  BPL = 88.50 mgHH;  HDL = 1.80 mmol; MAP = 100.00 mgHH; diabetic = 
No; TC = 5.20 mmol; Smoking = Yes; CVD = No; ECG = Yes;   The output from the NHS 
BlackHeath Risk calculator is 7% in Figure 8.2: 
 
 
Figure 8.2: The output for participant one from the simulation NHS BlackHeath Website: 
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 The CVD data and Output for the second participant: 
 
The data of the second participant on the Table 8.0 was entered into the Heart Disease Risk 
Calculator and below in Figure 8.1 is the result.  The CVD data used are PIND = 
63,535,102.00, woman, white, Age = 30 years; HB = 46.00 beat/sec, BMI = 13, 71; BPH 
=120.00mgHH;  BPL = 72.50 mgHH;  HDL = 1.40 mmol; MAP = 89.50 mgHH; diabetics = 
No; TC = 4.50 mmol; Smoking = Yes; CVD = Yes; ECG = No;   The output from the NHS 
BlackHeath Risk calculator is 1% in Figure 8.3: 
 
 
Figure 8.3: The output for participant two from the simulation NHS BlackHeath Website: 
When this research was been conducted, the Heart Disease Risk Calculator available on the 
NHS BlackHeath Website was used for the simulation exercises. The results of the first 10 
participants from the simulation exercises carried out using the then existing Risk Calculator 
are recorded in the Table 8.1 below in black colour and the rest of PPRs are in Appendix 8. 
 
However, in the year 2012 and 2013 during the writing of this research, it was observed that 
the PPR results of the same participants have changed. The new Predictive Percentage Risk 
values are recorded in the Table 8.1 below in Red colour.  This denotes that the NHS 
BlackHeath website have been updated to incorporate the new NICE, (2010) regulation 
although the website states that the copyright is for 2002 to 2011.  
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According to regulation in  NICE, (2010), most CVD Risk Calculator websites that use 
Framingham algorithm give overestimated  Predictive Percentage Risk values to users and 
this is discussed in Chapter 9.  In this research the calculated PPR values recorded in the 
Table 8.1 below in black colour are used for the purpose of completeness and consistency.  
This is because before the introduction of NICE, (2010) regulation all the selected Web CVD 
Risk Calculators used the Framingham algorithm so the approach was the same and hence 
facilitates consistent and non-bias benchmarking. 
 
 Simulation Results, Tables and Figures for the Web CVD calculators Model I:  
The Tables and Figures in this section are the results of inputting the demographic and 
clinical data of each of the selected 3654 participants into the Web based CVD Risk  
calculator Internet Model I.   The Table 8.1A is the raw data of the first 10 participants from 
the list of the 3654 selected participants, for the purpose of reference. Table 8.1B at the end 
of this Thesis contains the results of the first 30 participants and the results of the entire group 
are in the appendix Table 8.1C in electronic format. This is followed by Table 8.2A, which 
contains the results of the computed 10 years PPR values of the first 10 participants from 
Internet Model I.  Table 8.2B, at the end of the Thesis contains the results of the first 10 
participants and that of the entire group is in the Appendix Table 8.2C in electronic format. 
 
The Table 8.3A shows the results of the computation of TPR, FPR, LRP and LRN for the 
NHS BlackHeath Website Internet Model I based on the PPR values for 10 years for the first 
10 participants of the 3645 data set.   Table 8.3B, at the end of this Thesis contains the results 
of the first 30 participants and that of the entire group are in the Appendix Table 8.3C in 
electronic format.   
 Internet Model I Results of the 3645 participants in the category of over 30 years old: 
Table 8.1A: Raw data of the first 10 participants 
Pserial no. Grp Bp1 Age Sex Ethnic HB BMI BPH BPL HDL MAP DIA TC SMK CVD ECG 
13,956,102.00 No No 60 Women White 34.00 13.20 122.50 88.50 1.80 100.00 No 5.20 Yes No Yes 
63,535,102.00 Yes Yes 30 Women White 46.00 13.71 120.00 74.00 1.40 89.50 No 4.50 Yes Yes No 
71,831,101.00 No No 66 Women White 89.00 14.32 159.00 70.00 1.90 99.50 No 6.90 No No Yes 
34,031,101.00 No No 84 Women White 48.50 16.17 112.00 63.50 2.20 80.00 No 5.00 Yes Yes Yes 
72,604,102.00 No No 59 Women White 36.50 16.19 109.50 73.00 2.00 85.00 No 6.00 No No No 
13,008,101.00 Yes Yes 50 Women White 43.00 16.65 117.00 74.00 1.70 88.50 No 6.00 Yes Yes Yes 
39,139,101.00 No No 34 Women White 48.00 16.81 102.00 54.00 1.80 70.00 No 6.50 Yes No No 
47,856,102.00 No No 51 Women White 44.00 16.85 100.50 56.50 1.90 71.00 No 5.10 No No No 
37,710,101.00 No No 61 Women White 43.00 17.43 120.00 77.00 1.20 91.50 No 5.50 No No No 
54,256,101.00 No No 31 Women White 40.00 17.72 124.00 84.00 2.00 97.00 No 3.90 Yes No No 
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Table 8.2A: Predicative Percentage Risks for 10 years of the first 10 participants based on Internet 
Model – I NHS BlackHeath centre (ref: http://www.bhgp.co.uk/chdriskresult.asp). 
Pserial no. Age Sex BMI BPH BPL HDL DIA TC SMK ECG % PR 
13,956,102.00 60 Women 13.20 122.50 88.50 1.80 No 5.20 Yes Yes 7  7 
63,535,102.00 30 Women 13.71 120.00 74.00 1.40 No 4.50 Yes No 1 1 
71,831,101.00 66 Women 14.32 159.00 70.00 1.90 No 6.90 No Yes 8  8 
34,031,101.00 84 Women 16.17 112.00 63.50 2.20 No 5.00 Yes Yes 3  NA 
72,604,102.00 59 Women 16.19 109.50 73.00 2.00 No 6.00 No No 3 3 
13,008,101.00 50 Women 16.65 117.00 74.00 1.70 No 6.00 Yes Yes 1 3 
39,139,101.00 34 Women 16.81 102.00 54.00 1.80 No 6.50 Yes No 2 1 
47,856,102.00 51 Women 16.85 100.50 56.50 1.90 No 5.10 No No 11 2 
37,710,101.00 61 Women 17.43 120.00 77.00 1.20 No 5.50 No No 0 11 
54,256,101.00 31 Women 17.72 124.00 84.00 2.00 No 3.90 Yes No 1 0 
 
Table 8.3A: Calculation of TPR, FPR, LRP, and LRN, for the Internet Model I for the first 10  
Participants NHS BlackHeath centre (ref: http://www.bhgp.co.uk/chdriskresult.asp) 
Pserial no. Grp Bp1 Age Sex %PR EX NEX TPR FPR LRP LRM 
13,956,102.00 No No 60 Women 7 0 1 1 0.99968 3125 0 
63,535,102.00 Yes Yes 30 Women 1 0 1 1 0.99936 1562.5 0 
71,831,101.00 No No 66 Women 8 0 1 1 0.999041 1042.753 0 
34,031,101.00 No No 84 Women 3 0 1 1 0.998721 781.8608 0 
72,604,102.00 No No 59 Women 3 0 1 1 0.998401 625.3909 0 
13,008,101.00 Yes Yes 50 Women 1 0 1 1 0.998081 521.1047 0 
39,139,101.00 No No 34 Women 2 0 1 1 0.997761 446.628 0 
47,856,102.00 No No 51 Women 11 0 1 1 0.997442 390.9304 0 
37,710,101.00 No No 61 Women 0 0 1 1 0.997122 347.4635 0 
54,256,101.00 No No 31 Women 1 0 1 1 0.996802 312.6954 0 
 
Figure 8.1 shows the graph of the computed 10 years PPR value of each of the 3645 
participants plotted against their individual PIND. The data used to plot the graph is from 
Table 8.2C. Figure 8.2 is the prediction accuracy graph of the computed results of TPR 
against the FPR of each of the 3645 participants. The data used to plot the AUC graph is from 
Table 8.3C. The AUC area for Internet Model I was calculated, by summing the PPR data 
points using the trapezoidal method. The actual AUC is obtained by subtracting the sum of 
the entire PPR data points from the sum of all the diagonal reference data points as discussed 
in chapter 3.  
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Figure 8.3 shows the discriminatory accuracy or discriminatory ability graph for the Internet 
Model I.  This was constructed by plotting the sensitivity and selectivity values of each of the 
3645 participants in Table 8.3C.  The graph of the sensitivity and selectivity values against 
the NICE, (2006) recommended criterion of 20% and the interception are discussed in 
chapter 9.  Table 8.3C contains the results of the computed positive and the negative 
Likelihood ratio of the entire 3645 participants.  
 
 Figure 8.4 is the performance accuracy graph of the PPR values for each participant’s results 
from the Internet Model I.  This is based on plotting all the values of the positive and negative 
Likelihood ratios on the Y-axis and the PIND for each participant on the X-axis.  The 
performance accuracy graph is discussed in chapter 9. 
 
 
Figure 8.1: Predictive Percentage Risk for 3645 Participants based on Internet Model I 
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Figure 8.2: ROC/AUC for the Internet Model I 
 
Figure 8.3: Sensitivity and specificity of the Internet model I 
                                                                                                 CMAUT-UML Framework for Optimisation of CIS                                                     
 
 
189 
 
 
Figure 8.4: Maximum likelihood ratio for the Internet model I 
8.1.2 Simulation of the 10 years PPR with Internet model 2:- Patient UK 
 
The Patient.co.uk website was designed with the Framingham risk equation by Anderson et 
al., (1991). In addition, the website uses the adjustment proposed by the Joint British 
Societies and all the risk factors in Table 8.1 to compute the PPR values.  The simulation 
exercise was conducted by using 3465 participants from the HSE, (2006) data set.  Figure 8.5 
is the website in which all the measurable and non-measurable risk factors for each 
participant were entered.  
 Determination of the 10 years PPR with Internet model 2 Patient.co.uk:  
Again, each of the selected 3645 participants from the HSE, (2006) report were input into the 
Patient.co.uk, web risk calculator and their 10 years Predicted Percentage Risk computed and 
recorded in Table 8.5.  For the purpose of illustration, two simulation exercises were 
conducted using data set of two participants from the HSE, (2006).  Figure 8.5 is the website 
in which all the measurable and non-measurable risk factors for each of the participant were 
entered. The website is notated as Internet model-II Patient.co.uk: (from 
http://www.patient.co.uk/doctor/Primary-Cardiovascular-Risk-Calculator.htm). 
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Figure 8.5: Patient UK Website for Primary Cardiovascular Risk calculator 
The Patient.co.uk Web CVD Risk Calculator was designed for users, who are between the 
ages 30 and 74 years old. The measureable metrics used by the site are age, systolic, diastolic 
blood pressures, BMI, total cholesterol and HDL-Cholesterol. The non-measureable metrics 
are smoking, diabetic, ethnicity, CVD and ECG. 
 
 The CVD data and Output for the first participant: 
The data for the first participant in Table 8.1 were entered into the Cardiovascular Risk 
Calculator and the result is shown in Figure 8.6.  The CVD data used were PIND = 
13,956,102.00, woman, white, Age = 60 years;; HB = 34.00 beat/sec, BMI = 13,71;  BPH 
=122.50 mgHH;  BPL = 88.50 mgHH;  HDL = 1.80 mmol; MAP = 100.00; diabetic = No; 
TC = 5.20 mmol; Smoking = Yes; CVD = No; ECG = Yes; The output value of the Systolic 
Blood Pressure from Patient.co.uk Web CVD Risk Calculator is 21% as shown in Figure 8.6: 
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Figure 8.6: The output for participant one from the simulation Patient UK Website: 
 
 The CVD data and Output for the second participant: 
The data for the second participant on the Table 8.1 were entered into the Heart Disease Risk 
Calculator and the result is shown in Figure 8.6.   The CVD data used is PIND = 
63,535,102.00, woman, white, Age = 30 years. The other parameters are HB = 46.00 
beat/sec, BMI = 13, 71; BPH =120.00mgHH;  BPL = 72.50 mgHH;  HDL = 1.40 mmol; 
MAP = 89.50 mgHH; diabetics = No; TC = 4.50 mmol; Smoking = Yes; CVD = Yes; ECG = 
No;  The output  PPR value for the Systolic Blood Pressure from the Patient.co.uk Web CVD 
Risk Calculator is 0.5 % as shown in Figure 8.7: 
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Figure 8.7: The output for participant two from the Patient UK CVD Risk calculator: 
 
When this research was been carried out in the year 2010, the old Web CVD Risk Calculator 
version 24 of 2009 was available.  Therefore the simulation exercises were conducted using 
the then existing website and the PPR results are shown in the Tables below and the rest of 
the results are in Appendix 8.  The results of the first 10 participants from the simulation 
exercises carried out on the Risk Calculator version 24 are recorded in Table 8.4A below in 
black colour and the rest are in Appendix 8.    
 
However, in 2011 and 2012, the www.patient.co.uk website was updated and the Qrisk®2 
risk calculator was incorporated into the website in accordance with the NICE, (2010) 
recommendations.  For the purpose of completeness, the Table 8.4A below has the calculated 
PPR values from the current website Qrisk®2, which are entered into the Table 8.4A using 
red colour. However, these results are not used for analysis because the technique used  is 
different from the Framingham algorithm discussed in this research. 
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 Version 24 (2009) and Version 28 (2011) of the www.patient.co.uk website: 
 
In the year 2009 www.patient.co.uk launched a CVD web risk calculator version 24 that uses 
the Framingham algorithm. This site was used to determine the 10 years predictive 
percentage risk values of the participants in the HSE, (2006) report been hypertensive and the 
results were recorded in Table 8.4 below.  
 
However, in the year 2011, www.patient.co.uk updated their web risk calculator because 
according to NICE, (2010) using the Framingham risk algorithm gives an overestimated 
percentage risk values for the UK populations. This is stated in the  NICE Clinical Guideline 
(May, 2008) that was amended in May 2010 therefore www.patient.co.uk now uses Qrisk®2 
as an alternative CVD risk predictor.  Other issues regarding the different between the 
various CVD risk calculator websites and results of the simulation exercises are discussed 
further in chapter 9. 
 
The Table 8.5A shows the results of the computation of TPR, FPR, LRP and LRN for the 
Patient UK Website Internet Model II based on the PPR for 10 years for the first 10 
participants of the 3645 data set.   The Table 8.5B, at the end of this Thesis contains the 
results of the first 30 participants and the result of the entire group is in the Appendix Table 
8.5C in electronic format.   
 
Table 8.4: Predicative Percentage Risks for 10 years for the first 10 participants based on Internet  
Model – II Patient UK User Survey (ref: http://www.patient.co.uk/doctor/Primary-Cardiovascular-
Risk-Calculator.htm) 
Pserial no. Age Sex BMI BPH BPL HDL DIA TC SMK ECG % PR 
13,956,102.00 60 Women 13.20 122.50 88.50 1.80 No 5.20 Yes Yes 9 21 
63,535,102.00 30 Women 13.71 120.00 74.00 1.40 No 4.50 Yes No 4.3 0.5 
71,831,101.00 66 Women 14.32 159.00 70.00 1.90 No 6.90 No Yes 20.9 30 
34,031,101.00 84 Women 16.17 112.00 63.50 2.20 No 5.00 Yes Yes 17.5 NA 
72,604,102.00 59 Women 16.19 109.50 73.00 2.00 No 6.00 No No 11.8 4 
13,008,101.00 50 Women 16.65 117.00 74.00 1.70 No 6.00 Yes Yes 9.3 17* 
39,139,101.00 34 Women 16.81 102.00 54.00 1.80 No 6.50 Yes No 8.7 0.5 
47,856,102.00 51 Women 16.85 100.50 56.50 1.90 No 5.10 No No 10 2 
37,710,101.00 61 Women 17.43 120.00 77.00 1.20 No 5.50 No No 7.5 8 
54,256,101.00 31 Women 17.72 124.00 84.00 2.00 No 3.90 Yes No 4.8 0.5 
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Table 8.5: Calculation of TPR, FPR, LRP, and LRN, for the Internet Model – II for the first 10 
participants Patient UK User Survey (ref: http://www.patient.co.uk/doctor/Primary-Cardiovascular-
Risk-Calculator.htm) 
Pserial no. Grp Bp1 Age Sex %PR EX NEX TPR FPR LRP LRN 
13,956,102.00 No No 60 Women 9 0 1 1 0.9997 3584.22 0 
63,535,102.00 Yes Yes 30 Women 4.3 0 1 1 0.9994 1788.90 0 
71,831,101.00 No No 66 Women 20.9 1 0 0.984848 0.9994 1761.80 0.01516 
34,031,101.00 No No 84 Women 17.5 0 1 0.984848 0.9991 1175.23 0.01516 
72,604,102.00 No No 59 Women 11.8 0 1 0.984848 0.9988 880.90 0.01516 
13,008,101.00 Yes Yes 50 Women 9.3 0 1 0.984848 0.9986 704.97 0.01517 
39,139,101.00 No No 34 Women 8.7 0 1 0.984848 0.9983 587.61 0.01517 
47,856,102.00 No No 51 Women 10 0 1 0.984848 0.9980 503.50 0.01518 
37,710,101.00 No No 61 Women 7.5 0 1 0.984848 0.9977 440.64 0.01518 
54,256,101.00 No No 31 Women 4.8 0 1 0.984848 0.9974 391.58 0.01519 
 
Figure 8.8 shows the graph of the computed 10 years PPR value of each of the 3645 
participants against their individual PIND. The data used for plotting the graph is from Table 
8.4C.   Figure 8.9 is the prediction accuracy graph of the computed values of TPR against the 
FPR value of each of the 3645 participants. This data used to plot the AUC graph is from 
Table 8.4C and the AUC area for Internet Model 2 was calculated, by summing all the PPR 
data points using the trapezoidal method. The area is obtained by subtracting the sum of all 
the PPR data points from the sum of all the diagonal reference data points as discussed in 
chapter 3.  
 
Figure 8.10 is the discriminatory accuracy or discriminatory ability graph of the Internet 
Model II.  This was constructed by plotting the sensitivity and selectivity of each of the 3645 
participants in Table 8.5C.  The graph of the sensitivity and selectivity values against the 
NICE, (2006) recommended 20% criterion and the interception of the graph are discussed in 
chapter 9.  Table 8.5C contains the computation results of the positive and the negative 
Likelihood ratio values for all the 3645 participants.  The Figure 8.11 is the performance 
accuracy graph of the PPR values of each participant’s value from the Internet Model II.  This 
is obtained by plotting all the values of the positive and negative Likelihood ratios on the Y-
axis and the PIND for each participant on the X-axis. The graph is discussed in chapter 9. 
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Figure 8.8: Predictive Percentage Risk for 3645 participants for Internet Model II 
 
Figure 8.9: ROC/AUC of predictive prediction risk for 3645 for Internet Model II  
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Figure 8.10: Sensitivity and specificity for Internet Model II 
 
Figure 8.11: Maximum Likelihood ratio for Internet model II 
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8.2 Framingham Algorithm for the determination of PPR values 
 
The Framingham equation is the second method, which output PPR values were used to 
benchmark the PPR results from the CMAUT Prognosis framework.  In chapter 7, the 
Framingham equation was introduced and it was explained that this CVD prediction 
technique is used for calculating and predicting the probability percentage risk of a person 
having CVD disease over a periodic of time (Anderson et al, 1991).  The Framingham 
algorithm uses the CVD risk factors both clinical measurable attributes such as BPH, BPL, 
TC, HDL, BMI, ECG and the non- measurable attributes risk such as the behaviour of the 
person which are smoking, origin, age and sex to  predict the CVD percentage risk (Sheridan 
et al., 2003).  
 
Framingham algorithm was developed using the regression statistical models.  The algorithm 
was validated  by conducting a series of follow-ups to confirm  the estimated percentage risk 
values after the specified time frame of 4, 10 and 12 years (D'Agostino et al., 2001). In this 
research, three versions of the Framingham algorithm are evaluated and their outcomes 
compared with the CMAUT CVD frameworks.  
 
They are: 
1. The original Framingham algorithm  from  Anderson group (Anderson et al., 1991) 
2. The England version  of Framingham algorithm (Brindle et al.,  2003 ) 
3. The International Task Force version of Framingham algorithm (Zgibor et al., 2006); 
8.2.1 Original Framingham algorithm from USA 
 
The original document from K.M. Anderson group (Anderson et al., 1991), which is known 
as “An updated coronary risk profile; A statement for health professionals” has a step by step 
calculation on the procedure for the determination of CVD Percentage Predictive Risk (PPR). 
In this research, Systolic Blood Pressure (SBP) is used; therefore the equations discussed 
below incorporate the SBP parameters.  Again, after each calculation, the components used in 
the equations are explained. The constants and variables used in these original equations are 
based on the survey conducted by the K.M. Anderson group in USA. They also used the 
statistical regression modelling and follow-up techniques to confirm their findings. 
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 Systolic Blood Pressure Equation 
There are differences in the formulae used for the computation of Predictive Percentage Risk 
(PPR) for men and women; however both calculations start with the same approach.  
 
Step 1: is the computation of the initial value a, which is based on the values of the risk 
factors measurements stated in Anderson et al. (1999). 
a=11.1122-0.9119xlog (SBP)-0.2767 x Smoking - 0.7181 x log (cholesterol/HDL) - 
0.5865 x ECG-LVH                                                     (8.1) 
Step 2: is the computation of the second interim value m, this uses the participant’s age and 
diabetes condition but the equation is different for men and women.  
For men, compute 
m = a - 1.4792x log (age) - 0.1759 x diabetes               (8.2a) 
For women, compute 
m = a - 5.8549+1.8515x [log (age/74)] 2-0.3758 x diabetes                               (8.2b) 
Step 3: is the calculation of the µ and σ for both sexes, which are computed as follows: 
µ =4.4181 + m                                                                                                 (8.3) 
σ = exp (-0.3155-0.2784 x m)                                                                              (8.4) 
Step 4:  is the selection of the number of years (t) required for the risk prediction which is 
between 4 to 12 years. The selected (t) is used to calculate the predictive time factor (u) using 
the computed values of the location (µ) and scale (σ) parameters.  In this work, t = 10 years. 
u = (log (t) - µ))/ σ.                                                                                           (8.5) 
The predicted risk probability for the time t is 
p=1-exp (-eu)                                                             (8.6) 
In percentage the PPR = (p x 100)%. 
 
 Case study for the illustration of the determination of PPR Risk value 
 
In this case study, two participants a male and female both 55-year-old were selected.  For the 
purpose of illustration both have the following measurable and non-measurable CVD risk 
factor values.   
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Their SBP is 130 mm Hg, total cholesterol of 240 mg/dl, HDL cholesterol of 45 mg/dl and 
both smoke cigarettes.  Again, their data indicates that they are neither diabetic nor have been 
diagnosed with ECG-LVH.  
 
In order to compute their PPR in 10 years, the non-measurable risk factors namely  smoking, 
electrocardiographic left ventricular hypertrophy (ECG-LVH), and diabetes are set to 1 when 
present and 0 when absent.  Whereas Systolic Blood Pressure is measured in mm Hg, total 
cholesterol in mg/dl, HDL cholesterol in mg/dl and the age is in years. 
 
 Below is the procedure for calculating the PPR in 10 years for the two participants: 
 
First, we compute a =11.1122-0.9119 x log (130)-0.2767(1) - 0.7181 x log (240/45) = 5.1947 
For a man, the computation: 
m=5.1947-1.4792xlog (55) - 0.1759 x (0) = -0.7329 
µ = -0.7329+4.4181=3.685 
σ = exp [-0.3155-0.2784x (-0.7329)] =0.894 
For a woman, the computation is  
m=5.1947-5.8549+1.8515 x [log (55/74)] 2- 0.3758 (0) = -0.4972 
µ = -0.4972+4.4181 =3.921 
σ = exp [-0.3155- 0.2784x (-0.4972)] =0.8377 
As stated in the case study the prediction time t is 10 years, and the computation for men is: 
u = (log (10) -3.685)/0.894 = 1.546 
p =1-exp (-e-1.546) = 0.192 
For a woman, the computation is  
u = (log (10)-3.921)/0.8377 = 1.932 
p =1-exp (-e- 1.932) = 0.135  
Therefore from the equation the Percentage Predictive Risk (PPR) = (p x 100) % 
For the man the p value is 0.192 and therefore the PPR is 19.2%. 
For the woman the p = 0.135   and therefore the PPR is 13.5 %. 
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8.2.2 Framingham algorithm from British Perspective: 
 
In British, the Framingham Equation was modified and applied by Brindle et al., (2003) in 
their research work;  http://www.bmj.com/cgi/reprint/327/7426/1267.   Below is a brief 
discussion on how Brindle et al., (2003) adapted the Framingham equation in Anderson et al., 
(1999) to analyse CHD among British men.  In their research, Brindle et al., (2003) modified 
some of the constants and variables in the original Framingham equations to match their 
findings in England.  
 
In their equations just as in the original Framingham algorithms, the Systolic blood pressure 
(SBP) values are measured in mmHg, age in years, total cholesterol and high density 
lipoprotein cholesterol in mmol.  Whereas the non-measurable variables such as smoking, 
electrocardiographic left ventricular hypertrophy, and diabetes are set to 1 when present and 0 
when absent.  
 
 For men for England, UK  
Below is the procedure used for the computation of the Percentage Predictive Risk of British 
male having CHD within a specified time. The step wise procedure applied by the 
Framingham risk equations for the determination of coronary heart disease death (B1) and 
coronary heart disease events (B2) in men over 10 years are:- 
 
a. Framingham risk equations for CHD events (B2)  of men within 10 years:  
Step 1: involves the computation of either the coronary heart disease death (B1) or the 
coronary heart disease events (B2);  Both equations, unlike the original Framingham 
equations discussed above combines the measurable and non- measurable attribute values 
together to form one long equation known as µ.   This research focuses on Coronary Heart 
Disease events (CHD) and not the coronary heart death, therefore equation (B2) is used. 
Coronary heart disease mortality calculates (B1)*   as follows: 
   
                                                                                     
                                       
                                                                              
                   
                        (B1) 
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Coronary heart disease events calculate (B2) * 
   
                                                                                     
                                       
                                                                             
                   
                                                          (B2)  
Step 2: For both Coronary Heart Disease events and Coronary Heart Disease (CHD) death 
equations the calculation of predictive time factor (u) is: 
                 In this expression the length of time for follow up is 10 years  
Step 3: The predicted probability is calculated as 
                  
Step 4: the Percentage Predictive Risk (PPR) is  
                        
 
b. Framingham risk equations for CHD events (B2) of women within 10 years  
For the purpose of comparison, the female components of the original Framingham equations 
from Anderson et al., (1991) was modified as below for the computation of the predictive 
percentage risk of female having CHD in 10 years. 
 
Step 1: For coronary heart disease events are calculated as follows 
   
                                                                                     
                                       
                                                                            
                                          (B1)              
 
Use the equation (B2) from Anderson et al., (1991) to calculate m for women and note that 
 a =  .  Therefore for women, the computation is:  
For women, compute 
                                                                          
If the age and diabetes part of the equation are moved into equation (B2) above then the 
expression below is obtained for female as:-  
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Put the above expression into (B2) and note that       therefore the result is 
                                                                         (B21)  
Step 2: Then the result will be (B22) below 
                                                               (B22)  
Step 3: From the equation calculate the predictive time factor (u) as: 
                     in this expression the length of time for follow up is 10 years  
Step 4 : The Predicted Probability Risk is then given as:  
    –                 
The Percentage Predictive Risk (PPR) is therefore  
       –                       
The above formulae were coded in MATLAB and the percentage predictive risk calculated 
for each of the participants selected from the HSE, (2006) and the results are in Table 8.6.  
 
8.2.3 The International version (Zgibor et al., 2006): 
 
An International Task Force working on Coronary Heart Disease and prediction models for 
Type-One diabetes patients proposed the International Framingham equation (Zgibor et al., 
2006).  In this research the results from the CMAUT Prognosis Framework will be 
benchmarked against the International Framingham equation. The procedure used for the 
computation of the PPR is based on the International Task Force approach, which is 
illustrated below.   
 
Step 1:  Computation of the location (µ) parameter for Men and Women that is denoted X1; 
For Men 
                                                                            
                                                                      
For Women  
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The rest of the calculations for the determination of the percentage predictive risk are the 
same for both men and women: 
Step 2:- computation of the predictive time factor (u), which is denoted as X2 is as follows: 
For both men and women: 
                                                       
Step 3:- the probability of CHD risk taken place within 10 years or Percentage Predictive 
Risk (PPR) in 10 years’ time is given as:- 
                –                     
The above formulae were coded in MATLAB and the predictive percentage risk calculated 
for each of the participants selected from the HSE, (2006).  The results of the computation for 
each of the 3645 participants are presented in Tables and graphical format in section 8.3. 
 
 Observation on the PPR values computed from the three Framingham methods. 
After the computation of the predictive percentage risk for the three Framingham methods, it 
was observed that all the three different approaches give approximately the same PPR results 
for each of the selected participants.   The Table 8.6A below shows the PPR values for each 
of the selected participants.  In Table 8.6A the results earmarked as USA_PR   is based on the 
computation from the USA original Framingham equation model I. This is followed by the 
results from the equations created by the International Task Force INT_PR (aka model II), 
while the model III is based on the UK calculation, which has two components namely the 
UKMEN_PR for men only and UK_PR for both man and woman. 
 
8.3 Simulation Results for the Framingham Equations versions I, II and III: 
 
 The Simulation results, tables and figures for the Framingham equations are below; 
 
 The Tables and Figures in the section are the results of inputting the demographic and 
clinical data of each of the selected 3654 participants into the Framingham version equations 
models I, II and III.   
 
The Table 8.6A contains the results of the calculated 10 years PPR values for each of the first 
10 participants using the three versions of the Framingham equations.   
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Similarly, Table 8.6B, at the end of this Thesis contains the PPR results of the first 30 
participants and the PPR results of the entire 3645 participants are in the Appendix 8 Table 
8.6C in electronic format. 
The Table 8.7A shows the results of the computation of TPR, FPR, LRP and LRN for the 
Framingham equation models I – II – III based on the PPR for 10 years for the first 10 
participants of the 3645 data set.   The Table 8.7B, at the end of this Thesis contains the first 
30 participants’ results and the results of the entire group are in the Appendix 8 Table 8.7C in 
electronic format.   
 
Table 8.6A predicative percentage risks for 10 years for the first 30 participants based on 
Framingham equation model I – II – III (I – USA, II – International, III – UK) 
Pserial no. Grp Bp1 Age Sex Ethnic USA_PR INT_PR UKMEN_P
R 
UK_PR 
13,956,102.00 No No 60 Women White 17.58 17.58 0.00 17.58 
63,535,102.00 Yes Yes 30 Women White 0.13 0.13 0.00 0.13 
71,831,101.00 No No 66 Women White 22.55 22.55 0.00 22.55 
34,031,101.00 No No 84 Women White 12.87 12.87 0.00 12.87 
72,604,102.00 No No 59 Women White 2.82 2.82 0.00 2.82 
13,008,101.00 Yes Yes 50 Women White 15.12 15.12 0.00 15.12 
39,139,101.00 No No 34 Women White 0.40 0.40 0.00 0.40 
47,856,102.00 No No 51 Women White 1.22 1.22 0.00 1.22 
37,710,101.00 No No 61 Women White 7.02 7.02 0.00 7.02 
54,256,101.00 No No 31 Women White 0.05 0.05 0.00 0.05 
 
Table 8.7A Calculation of TPR, FPR, LRP, and LRN, for the for the first 30 participants 
based on Framingham equation model I – II – III (I – USA, II – International, III – UK) 
Pserial no. Grp Bp1 Age Sex %PR EX NEX TPR FPR LRP LRN 
13,956,102.00 No No 60 Women 17.58 0 1 1 1.00 2808.99 0 
63,535,102.00 Yes Yes 30 Women 0.13 0 1 1 1.00 1406.47 0 
71,831,101.00 No No 66 Women 22.55 1 0 0.9988 0.9993 1404.7820 0.0012 
34,031,101.00 No No 84 Women 12.87 0 1 0.9988 0.9989 936.0825 0.0012 
72,604,102.00 No No 59 Women 2.82 0 1 0.9988 0.9986 702.3910 0.0012 
13,008,101.00 Yes Yes 50 Women 15.12 0 1 0.9988 0.9982 561.7548 0.0012 
39,139,101.00 No No 34 Women 0.40 0 1 0.9988 0.9979 468.0412 0.0012 
47,856,102.00 No No 51 Women 1.22 0 1 0.9988 0.9975 401.2857 0.0012 
37,710,101.00 No No 61 Women 7.02 0 1 0.9988 0.9972 351.0721 0.0012 
54,256,101.00 No No 31 Women 0.05 0 1 0.9988 0.9968 312.0275 0.0012 
 
Figure 8.12 shows the graph of the computed 10 years PPR values of each of the 3645 
participants against their individual PIND. The data used for plotting the graph is from Table 
8.6C.   Figure 8.13 is the prediction accuracy graph of the computed results of TPR against 
the FPR values of each of the 3645 participants.  
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This data used to plot the AUC graph is from Table 8.7C. The AUC areas of Framingham 
equation models I-USA, II-International and III -UK were calculated, by summing all the 
PPR data points using the trapezoidal method. The actual area is obtained by subtracting the 
sum of all the PPR data points from the sum of all the diagonal reference data points as 
discussed in chapter 3.  
 
Figure 8.14 shows the graph of the discriminatory accuracy or discriminatory ability of the 
Framingham equation models.  This was constructed by plotting the sensitivity and 
selectivity values of each of the 3645 participants in Table 8.7C.  The graph of the sensitivity 
and selectivity against the NICE, (2006) recommended criterion and the interception are 
discussed in chapter 9. Table 8.7C contains the results of the computation of the positive and 
the negative Likelihood ratios for all the 3645 participants.  Figure 8.15 is the performance 
accuracy graph of the PPR values of each participant obtained from the Framingham 
equations.  This is done by plotting the positive and negative Likelihood ratio values on the 
Y-axis and the PIND of each participant on the X-axis. The graph is discussed in chapter 9. 
 
 
Figure 8.12: Predictive Percentage Risks for 10-years for Framingham I – II – III  
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Figure 8.13: ROC/AUC for Framingham I – II – III 
 
Figure 8.14: Sensitivity and specificity for Framingham I – II – III 
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Figure 8.15: Maximum Likelihood ratio for Framingham I – II – III 
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8.4 Summary  
 
In this chapter 8, two different approaches were used to determine the predictive percentage 
Risk (PPR) values of the participants been hypertensive.  The first approach was the use of 
Web based CVD risk calculators, which were designed using the Framingham algorithm to 
compute PPR. The two Web calculators, NHS BlackHeath centre and Patient.co were used.  
The data sets of the 3645 selected participants were entered into each of the CVD risk 
calculators and the PPR values calculated for each participant.  
 
The second approach is the use of Framingham equation to calculate the PPR values of the 
participants been hypertensive.   The three different approaches used for the implementation 
of the Framingham Algorithm are the original Framingham Algorithm proposed by 
(Anderson et al, 1991), the England version by (Brindle et al., 2003) and the International 
Task Force version (Zgibor et al., 2006). 
 
The data of selected 3645 participants were input into the MATLAB program, which were 
designed for each of the three Framingham equations for implementation purposes.  It was 
observed from the results of the computed PPR values, that the three approaches have 
approximately the same PPR value for each of the 3645 participants.   For the 
epidemiological analysis, the PPR values of each participant from the CMAUT Prognosis 
Framework were benchmarked against the web-based CVD risk calculators and the 
Framingham equations.  The results were presented in tabular and graphical formats and they 
are discussed in the evaluation Chapter 9. 
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Chapter 9: Evaluation and Discussion 
 
9.0 Introduction 
 
This chapter starts with an evaluation of the Literature Review.  This is followed by a 
summary of the different success criteria used to prove or disprove the hypothesis of this 
research as described in chapter 3.   To achieve this goal, the results from the simulations 
carried out for each of the 3645 participants using the frameworks in chapters 5, 6, 7 and 8 
were analysed and discussed.  Then each of the success criteria was benchmarked against the 
results in chapter 8 and conclusion drawn.  Finally, the two main component parts of the 
hypothesis were presented, discussed and inferences made. 
  
9.1 Evaluation of Literature Review 
  
 From the literature reviewed, the research gap identified in CIS and CDSS is the need to 
reduce information overload by optimising the CVD clinical data for decision making.  This 
research gap exists because different optimisation techniques have been used to address 
information overload in CIS but they all have limitations (Bertot, 2013).  
 
The clinical data re-representation techniques introduced to address information overload in 
CIS are FOL –ERD and EAV/CR (Abu-Hanna et al, 2004) (Nadkarni et al., 2001).  However, 
according to Roland (2000), EAV/CR technique has low performance rate as compared to the 
traditional conventional database and for its operation the SQL queries are complex and 
therefore it is difficult to implement and use (Nadkarni et al., 2006). Again, these two 
techniques do not have optimisation mechanisms in them therefore they cannot address the 
problem of information overload in CIS.    
 
Therefore this research proposes an alternative solution, which is the application of data re-
representation using UML class model that is formalised with the CMAUT and logical 
connectors.  Based on the proposed solution the following hypothesis was established “that 
clinical data can be modelled using class diagram and re-represented with CMAUT logical 
connectors to reduce the space complexity in CIS and seamless converted them into the 
mathematical format that is optimised using LP algorithm to determine the risk of users been 
hypertensive”.  To prove the hypothesis the following success criteria were used.   
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The criteria used are the Absolute Percentage Risk (APR) and Predictive Percentage Risk 
(PPR); computation of Prevalence and Kappa values;  determination of space complexity, 
data size analysis using P-value before and after optimisation; calculation of sensitivity and 
selectivity; determination of the Accuracy of prediction models using AUC/ROC and  
Likelihood Ratio (Weinstein et al., 2001) (Fenton, 1997): 
 
9.2 Clinical data representation using UML and CMAUT - Success criteria 1  
 
To confirm that there is a relationship between clinical data and multiple attributes, the 
organs in the diseases domain were modelled with UML class diagram.   In chapter 4, it was 
established that clinical data can be captured using class model and expressed in CMAUT 
format, which is seamlessly written in mathematical function. The generic expression for 
diseases, which affect complementary organs are written using the AND logic while diseases 
that are associated with substitutable organs use the OR logical connectors.     
 
The disease associated with substitutable organs that uses OR expressions is kidney.  The 
kidney was used as an example of substitutable organs because two kidneys can replace each 
other and have many attributes.  Therefore the kidney system is represented in UML class 
model as a superclass with two subclasses and expressed in CMAUT using the OR 
connectors as                           .  In this expression          are the organs 
and   ,   ,   ,    are the attributes.  The generic expression for these substitutable organs 
with multiple attributes is written as follows                             . 
 
The disease associated with complementary organs and uses the AND expressions is CVD.   
Complementary organs are modelled in class diagram as unidirectional relation, which 
indicates that each class complements the other.  The relationship between the classes is 
linked to the other class using the association arrow.  In CMAUT data re-representation, the 
complementary organs with multi-attributes are expressed using logic connector AND 
as:                                   :   In this expression the CVD disease    affects 
the body parts  ,    and    where the organ    has the attributes   , and   , whereas organ 
   has attributes    and    etc. The generic expression for combinatorial clinical organs with 
multiple attributes using     is                              .  The logical 
expressions serve as the input to the optimisation framework that was discussed in chapter 5. 
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Convention of multiple attribute values into Utility Units: A disease    that affects three 
organs can be expressed in CMAUT as                                  .  To convert 
the attributes in the expression into utility function     the formula used is  
∑             
     
  
.  In this formula, the    is the expected blood pressure and the 
participant’s measured blood pressure is   .  The utility unit    of the organ    in the 
expression calculated as:    ∑                                  .  Therefore the 
disease    is written in       format as                         . 
                 
The hypothesis of this research states that the application of CMAUT Data Re-representation 
will reduce the space complexity in the CMAUT Optimisation CVD framework as compared 
to the traditional non-CMAUT data representation technique used in FOL-ERD and EAV. 
This was discussed in chapter 4.   
 
9.2.1 CMAUT Diagnosis Framework for CVD Risk Prediction -Success criteria 2 
 
In chapter 5, two models of the CMAUT framework were designed and implemented to 
determine the initial clinical absolute percentage risk (APR) of a user having hypertension 
disease for diagnosis purpose.  In this research, APR is defined as the probability of a 
participant having CVD based on their current multiple attributes values that are measured 
during medical examination.  CMAUT framework model 1 was developed using beta 
coefficients (aka weights) obtained from conducting binary regression in SPSS using 4165 
participants. The model 2 was developed using clinical data of the 3645 participants who are 
over 30 years.  The beta coefficient values for the measurable multiple attributes were used to 
construct objective function that serve as input for the CMAUT algorithm.  The objective 
function was optimised using the MATLAB linear programming technique to determine the 
absolute percentage risk of been hypertensive.  This research used the CVD attribute values 
of the 3645 selected participants who provided full data during the HSE, (2006) survey. 
 
The CMAUT Diagnosis Framework was used to determine the APR value of all the selected 
3645 participants been hypertension YES or NO.  This was done by first determining the 
percentage risk value of each participant and then comparing the results with the NICE, 
(2006) recommended value of 20%.  The criterion states that everyone who has APR value of 
20% or more percentage predicted risk value is prone to hypertension in future.   
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The validation of CMAUT Framework models 1 and 2 was conducted by comparing the 
absolute percentage risk results of the new Framework Diagnosis models with the predicted 
hypertension YES or NO results from the GPs in the HSE, (2006) report. 
 
Figure 9.1: Comparison of Absolute Percentage Risk for 3645 participants based on CMAUT 
Diagnosis Framework Model I-II 
9.2.2 Comparison of APR for CMAUT Model 1 and 2: 
 
The relevance and kappa statistic of the two proposed CMAUT framework models were 
discussed in chapter 5.  In this chapter 9, the comparative results of the CMAUT Diagnosis 
Framework model 1 and model 2 are recorded in Table 9.4C.  For the purpose of comparison, 
the results of the simulation are for only the selected 3645 participants, who are over 30 
years.  The APR results from the CMAUT models 1 and 2 are benchmarked against the 
Prognosis Framework, Web Risk Calculators and the Framingham equations results in 
chapters 7 and 8.  Figure 9.1 and Table 9.4C are summarised graph and tables that depict the 
comparison between the APR values for models 1 and 2.  Table 9.4A is the comparative 
Table of the first 10 participants and the Table 9.4B in Appendix 9 contains the first 30 
participants’ results while the full results are on electronic format in Table 9.4C. 
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Table 9.4B: Comparison of Absolute Percentage Risk values from CMAUT models 1 and 2 
using the first 10 participants: 
Pserial no. Grp Bp1 Age Sex %PR(
M-I 
Abso) 
%PR
(M-II 
Abso) 
%PR(
M-I 
Pre) 
%PR(
M-II 
Pre) 
%PR(I
-I Pr) 
%PR(I
-II 
Pre) 
%PR(
F-I P) 
13,956,102.00 No No 60 Women 14.6 13.8 15.6 14.79 7 9 17.58 
63,535,102.00 Yes Yes 30 Women 15.4 14.6 16.3 15.53 1 4.3 0.13 
71,831,101.00 No No 66 Women 16.7 15.4 17.7 16.42 8 20.9 22.55 
34,031,101.00 No No 84 Women 18.0 16.6 19.0 17.64 3 17.5 12.87 
72,604,102.00 No No 59 Women 18.9 17.3 19.8 18.26 3 11.8 2.82 
31,510,102.00 No No 20 Women 20.1 15.2 21.0 16.13 1 9.3 15.12 
18,633,105.00 No No 16 Women 18.5 19.5 19.4 20.28 2 8.7 0.40 
13,008,101.00 Yes Yes 50 Women 16.3 19.9 17.2 20.75 11 10 1.22 
60,417,102.00 No No 16 Men 17.4 14.3 18.3 15.26 0 7.5 7.02 
39,139,101.00 No No 34 Women 21.4 13.3 22.2 14.26 1 4.8 0.05 
 
For comparison reasons, the clinical APR values of each of the 3645 participants for model 1 
was superimposed on the graph of  the APR results from model 2, which contains the same 
participants. The Figure 9.1 shows that the APR values of the participants in model 1 are 
higher than those in model 2. For example participant number 2329 in model 1 is 34.48% 
whereas in model 2 the value is 29.52%.  Hence it is subsumed that the APR values of model 
1 are higher than those from model 2.  
 
 Kappa  and Prevalence of CMAUT Diagnosis model 1 and 2 and GP Diagnosis 
 
In chapter 5 section 5.6, it was established that the kappa value for CMAUT model 1 is k= 
0.1508 while the kappa value for CMAUT model 2 is 0.42.  Using the Kappa Interpretation 
Table in Viera, (2005) and Cunningham el at., (2009), the          means the APR values 
from CMAUT model 1 slightly agree with the actual GP diagnosed hypertension YES or NO.  
The CMAUT model 2 has k value of        which denotes that the APR risk values from the 
framework model 2 fairly agrees with the actual GP diagnosed hypertensive YES and NO. 
 
In Chapter 5.6, the computed Prevalence for CMAUT model1 is 0.1857 while the Prevalence 
for CMAUT model2 is 0.0103. In percentages, the model 1 has a prevalence value of 18, 
57% of the 3645 participants which denotes that the 677 participants were diagnosed as 
hypertension YES while the 2968 were hypertension NO.  The model 2 Prevalence is 1.01 %, 
which means only 36 of the 3645 participants was identified as hypertension YES while 3609 
participants were hypertension NO. 
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The prevalence from the HSE, (2006) report is 0.1857 or 18.57%, which means 677 
participants were diagnosed as hypertension YES whereas 2968 were hypertension NO.  
Therefore, it is subsumed that the prevalence of model 1 is the same as the actual results from 
the HSE report as compared to model 2, which is lower than the actual prevalence. Based on 
these results the kappa statistic for model 2 is comparative better but the model must be 
enhanced to obtain a better prevalence. 
   
9.3 Performance Evaluation of CMAUT Optimisation Framework  
 
The third success criterion was used to verify the reduction of space complexity in the 
CMAUT optimisation framework.   The technique used to measure the performance of space 
complexity of the optimisation framework is the big O function (Fenton et al, 1997). The 
space complexity analysis was conducted using mathematical operations that identify the 
relationship between the numbers of organs in the substitutable and complementary 
combinatory. The outcome was compared with the numbers of inequalities generated for their 
storage. 
9.3.1 Space Complexity Analysis of CMAUT and Non-CMAUT CIS 
 
As discussed in chapter 6, the Raman et al., (1999) mathematical technique was used to 
generate the set of inequalities for different numbers of substitutable and complementary 
organs in the disease domain.  The mathematical operation was conducted for the CIS that 
uses the new CMAUT clinical data representation technique. The numbers of inequalities 
generated for each combinatory were recorded in Table 6.2. The same mathematical 
operation was repeated for CIS that use the traditional clinical data representation (aka Non-
CMAUT CIS) such as EAV/CR and ERD-FOL discussed in chapter 4.    
 
The numbers of constraints generated by the Non-CMAUT system for each combinatory 
were also recorded in Table 6.3. Table 9.1A is the summary of the constraints generated by 
both CMAUT and Non-CMAUT system for substitutable and complementary combination of 
organs.  Figures 9.2 and 9.3 are the comparative graphs, which were plotted from the data in 
the Table 9.1C below. The full data is in appendix 9.1C. 
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Table 9.1A: No. of CMAUT and Non-CMAUT constraints for substitutable and 
complementary organs 
No of organs  (x) in the 
(OR)/(AND)  
combinatorial  
No of  constraints 
(inequalities) (y) for AND 
with CMAUT 
No of  constraints 
(inequalities) (y) for OR with 
and without CMAUT 
No of  constraints 
(inequalities) (y) for AND 
with Non- CMAUT 
2 3 4 4 
3 4 8 6 
4 5 16 8 
5 6 32 10 
6 7 64 12 
7 8 128 14 
8 9 256 16 
 
 Interpretation of space complexity results for CMAUT and Non-CMAUT CIS 
 
From Table 9.1A and Figure 9.2, it is subsumed that when the numbers of complementary 
organs in the disease domain are increased, the numbers of inequality expressions generated 
for storage by both CMAUT and Non-CMAUT CIS also increases.  Therefore, for CISs that 
use the CMAUT data re-representation the numbers of inequality expressions generated 
increases as the function y = x + 1 as shown in blue colour in Figure 9.2.  The increase can be 
written in space complexity performance function using the big O notation as O(x +1).   
Again, from Table 9.1A and Figure 9.2, it is evident that for non-CMAUT CIS as the  
numbers of complementary organs in the combinatory increases the numbers of inequality  
expressions generated increases as a linear function y = 2x  as shown  in red colour in Figure 
9.2. Similarly for non-CMAUT the increase can be expressed in big O notation as O (2x). 
 
Therefore it is deduced that the CISs that use CMAUT data re-representation technique can 
capture and represent clinical data with half the number of expressions required by the same 
amount of data for the traditional non-CMAUT system.  The deduction is supported by the 
big O notation of O (2x) for non-CMAUT and O(x +1) for the CMAUT.   This deduction is 
evident in Figure 9.2, where the curve for non-CMAUT system indicates that they require 
twice the number of constraints as compared to the CMAUT data representation technique. 
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Figure: 9.2: Shows a comparison of           and           using complementary 
organs      . 
For substitutable organs, the results from the mathematical operation for the different 
numbers of organs in the combinatory shown in Table 9.1B were used to plot the curves in 
Figure 9.3.  From the inequality results in Table 9.1B and Figure 9.3, it is deduced that when 
the numbers of substitutable organs in the combinatory are increased the number of 
constraints also increases in the exponential function.   
 
For  both CMAUT and Non-CMAUT CIS the numbers of inequality expressions generated 
for substitutable organs increases with function  2x , which is expressed in big O notation as 
O(2x).  Figure 9.3 shows that both CIS data representations create the same numbers of 
inequality expressions as the numbers of substitutable organs are increased.  In Figure 9.3 the 
CMAUT curve is shown in blue and the non-CMAUT data representation is in red, this 
means the number of constraints generated for both CMAUT and non CMAUT data re-
representations are the same. Therefore for substitutable organs the storage space complexity 
for CMAUT and Non-CMAUT CIS are the same. 
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Figure 9.3: Shows comparison of Non- CMAUT and CMAUT CIS using substitutable organs (OR) 
9.3.2 Clinical Data Sizes and T-test analysis of CMAUT Optimisation Framework  
 
The second criterion is the comparison of the data sizes when clinical data are optimised with 
the CMAUT optimisation diagnosis framework as against when the data are not optimised.  
This  criterion was used to prove the hypothesis, which states that the application of CMAUT 
framework will reduce the amount of clinical data required for decision making as well as the 
reduce space complexity in CIS.  A cohort size of 402 participants were used for this 
analysis, which is approximately 10% of the 3456 participants that gave complete CVD 
clinical data and are over 30 years of age. The procedure used and the results obtained were 
discussed in chapter 6 and shown in Table 9.2A below.  
 
First the CMAUT framework was used to determine the CVD Absolute Percentage Risk 
(APR) and the comparative attribute values of each of the 402 participants.  In this context, 
the comparative attributes values are the output variables for each attribute and it indicates 
the results of comparing the recorded participant’s attribute values with the standard expected 
values.   The data sizes for each of the 402 participants were captured and measured before 
the optimization process and after optimizing the data with the CMAUT diagnosis 
framework.  The results are in chapter 6 and Table 9.2A is the comparative Table with the 
results of the first 10 participants and Table 9.2B in the Appendix contains the results of first 
30 participants while the full results are on electronic format in Table 9.2C.  
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Table 9.2A: Data size for first 10 participants before and after optimisation with CMAUT 
Framework 
No. Of participants PSerial no. Data size before 
optimisation ( bytes) 
Data size after optimisation 
(bytes) 
1 10,902,101.00 1256 465 
2 10,846,103.00 1251 464 
3 11,039,102.00 1251 463 
4 11,046,101.00 1251 465 
5 11,239,101.00 1245 464 
6 11,249,102.00 1244 464 
7 11,306,101.00 1249 464 
8 11,313,101.00 1245 463 
9 11,349,102.00 1243 464 
10 11,356,101.00 1262 464 
 
 Interpretation of the data sizes results from CMAUT and Non-CMAUT CIS 
 
The data sizes obtained for each of the 402 participants before optimisation and after 
optimisation with the CMAUT framework and recorded in Table 9.2C were used to plot the 
curves in Figure 9.4 below.  In Figure 9.4, the measured and recorded data sizes for each of 
the 402 participants before optimisation are shown in red while the data sizes after 
optimisation are shown in blue.  It is deduced from the Table 9.2C that the average data size 
for the participant before optimization is approximately 1250 Bytes and the average data size 
after optimization with the CMAUT framework is 450 Bytes. This denotes that the average 
difference in data sizes between the two scenarios is 700 Bytes.  
 
Figure 9.4 shows the difference in the data sizes where the data sizes without the CMAUT is 
in red line and the data sizes after optimisation with CMAUT framework are shown in blue.  
The difference in data sizes before and after optimization is proved below using the T-test 
statistical method. 
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Figure 9.4: Before (red curve) and after optimisation (blue) of patient record data file 
 
 Clinical Data Size and hypothesis statistical analysis using T-test 
  
The pair T-test analysis was conducted, to prove the hypothesis that the use of the CMAUT 
Optimisation framework will reduce the clinical data sizes and space complexity required for 
decision making.  The pair T-test was used because in the research two dependant sample 
data sizes of the same participants were compared at different period which are before and 
after optimisation. This is different from the independent T-test, which compares the samples 
from two different groups of participants (Campbell et al., 2006).  
 
The CVD data of the selected 402 participants were used to perform the pair T-test statistical 
analyses in order to determine the confidence interval (CI) and p-value of the data sizes 
before and after optimisation.  The analysis was conducted using the SPSS version 15 
software.  First, the data size of each of the 402 participants was retrieved from the HSE, 
(2006) and the data sizes before optimisation were measured and recorded Table 9.2.  
Secondly, the data sizes after optimisation using the CMAUT framework were measured and 
recorded.  The Table 9.2C in Appendix 9 contains the entire data sizes results. Lastly, using 
the data in the Excel sheet Table 9.2C, the p-value and CI of the model were determined with 
the SPSS software. The result of the dependant pair T-test is shown in section 6.24.  
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Table 9.3 The Output of the Samples Statistics Results for the Paired Samples T-Test: 
 Mean N Std. Deviation Std. Error Mean 
 
Pair 1 
File size  before 
Optimisation (In bytes) 
1216.66 402 21.801 1.087 
File size after 
Optimisation  (In bytes) 
463.50 402 0.916 .046 
 
 Paired Differences t df Sig. 
(2-
tailed) 
Mean Std. 
Deviation 
Std. 
Error 
Mean 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
 
 
Pair 1 
Size  before 
Optimisation 
size after 
Optimisation 
(In bytes) 
753.162 21.847 1.090 751.020 755.304 691.219 401 .000 
 
From Table 9.3, it is observed that the mean values of the data sizes before optimisation and 
after optimisation are 1216.66 bytes and 463.50 bytes.  The standard deviation of the data 
sizes before optimisation is 21.801 and after optimisation with CMAUT Framework is 0.916. 
The mean data size of 1216.66 Bytes before optimisation indicates that for non-CMAUT CIS 
the entire clinical data for each participant must be retrieved for decision making.  In Table 
9.3, the standard deviation of the data size after optimisation using the CMAUT framework is 
0.916. This means the data size required for investigation is less with minimum variation 
because specific data is retrieved for making decision.   
   
The T-test analysis gave a P-value of 0.000, which is less than 0.05, which means that the 
results are statistically significant.  Therefore the alternative hypothesis which states that 
clinical data can be optimised using CMAUT framework to reduce the amount of data 
required for primary care investigation and information overload is accepted.  Figure 9.4 and 
the calculated difference between the maximum data sizes before and after optimisation of 
753.16 Bytes confirm this hypothesis. 
 
Therefore the new CMAUT optimization framework reduces the data size retrieved and 
transmitted for decision making by approximately 700 Bytes for each participant. Thus 
CMAUT reduces information overload and the information needed for decision making.   
This proves the hypothesis, which states that the use of the CMAUT Optimisation framework 
will reduce the clinical data sizes and space complexity required for decision making in CIS. 
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9.4 Risk Prediction with CMAUT Prognosis Framework - Success criteria 2  
 
In chapter 7, the CMAUT framework, was remodelled to determine the predictive percentage 
risk of a user been hypertensive within a period of 10 years.   Again, in this research, 
Predictive Percentage Risk was defined as the probability that a user will develop 
hypertension in a specified period of time based on their present measurable and non-
measurable CVD risk factors. The CVD Risk factors used are Age, Sex, Heart Beat, BMI, 
systolic pressure, diastolic pressure, HDL Cholesterol, MAP blood pressure, Diabetic, Total 
Cholesterol, Smoking , Existing CVD and Existing ECG. 
 
The first part of the optimisation algorithm in the Prognosis framework is used to determine 
the absolute percentage risk (APR) of a participant been hypertensive based on their 
measurable attributes.  The second part is the computation of predictive time factor (u) in 10 
years’ time using both the measurable and non-measurable CVD risk factors.  This was done 
by adapting the Weibull distribution and Framingham methods explained in Anderson et al., 
(1990). The Predictive Percentage Risk aka P (T) is the arithmetical sum of the absolute 
percentage risk (APR) and the 10 years predictive time factor (P (t)). This Predictive 
Percentage Risk approach is similar to the algorithm used for all the three Framingham 
equations and also for the Web based CVD risk calculators. 
9.4.1 Comparison of Predictive Percentage Risk for CMAUT Models 1 and 2: 
 
The simulation results of the CMAUT Prognosis Framework model 1, which was designed 
with the data for the over 16 years’ old participants and model 2 of over 30years old were 
recorded in Table 9.4B.   The PPR results of the selected 3645 participants from the CMAUT 
Prognosis models 1 and 2 are recorded in Table 9.4B before they were benchmarked against 
the Web Risk Calculators and the Framingham equations.   
 
For comparison, the PPR results of each of the 3645 participants for CMAUT Prognosis 
model 1 was superimposed on the graph that depicts the results of the PPR values from model 
2 for the same participants. Figure 9.5 below is the summarised graphs that depict the 
comparison between PPR results from the CMAUT Prognosis models 1 and 2. 
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Figure 9.5: Comparison of Predictive Percentage Risk for 3645 participants based on 
CMAUT Prognosis Framework Model I-II 
 
The Figure 9.5 shows that the PPR values of the selected participants in model 1 are higher 
than the PPR values in model 2.  For example the PPR value for the participant number 2329 
in model 1 is 35.28% while that from model 2 is 30.32%. Therefore it is subsumed that 
comparatively the PPR values for all participants in model 1 are lower than PPR values in 
model 2.  For both Diagnosis and Prognosis CMAUT frameworks, the PPR values for model 
1 are higher than model 2 for the same participant.  It is subsumed that model 1 gives 
overestimated PPR values, which needs redress.  The CMAUT PPR values are compared 
with the results from the Framingham equations and Web risk CVD calculators and they are 
discussed in the conclusion Chapter 10. 
  
 Kappa Statistics and Prevalence for CMAUT Prognosis model 1 and 2 with GP  
 
In chapter 5, section 5.6 the kappa statistics of model 1 and 2 were calculated by comparing 
the results of the APR values from the CMAUT diagnosis Framework with the GP diagnosis 
BP_YES and BP_NO of the HSE, (2006) report.  It was established that Model 2 gives 
realistic APR values as compared to Model 1.  From Figure 9.3 and Table 9.8C, it is 
concluded that Model 1 gives overestimated PPR values.  Therefore emphasis must be placed 
on the analysis of CMAUT framework Model 2, Framingham equations and Web CVD risk 
calculators as CVD prediction models.    
 
Inferring from the above, the CMAUT Prognosis Predictive model 2 results and the GP 
diagnosis BP_YES and BP_NO from the HSE, (2006) were used to calculate the  kappa value 
for the 3645 selected participants. Below are the results: 
                                                                                                 CMAUT-UML Framework for Optimisation of CIS                                                     
 
 
223 
 
 
Percentage _YES = 8.7149  
Percentage _NO=   120.8221 
Table 9.4G: the actual_agree_YES and NO in tabular form 
 Yes No Total 
Yes 677 2968 3645 
No 59 3586 3645 
 736 6554 7290 
 
Using the information in Table 9.4G, the kappa value   is computed using the formula 
   
     
    
 where                                       and               as 
shown in Chapter 5.12. 
 
The calculated kappa value for the CMAUT Prognosis Predictive model II is 0.1695.  
According to Viera et al, (2005) and Cunningham, (2009),               denotes that the 
PPR results from both models have a fair agreement between them.   Hence, it is subsumed 
that the kappa value calculated using the GP hypertension diagnoses model and the CMAUT 
model 2 is 0. 169, that is approximately 0.2.  According to Viera, (2005), the kappa value of 
0.2 means there is a slight agreement between the two prediction models. 
  
The Prevalence of the CMAUT Prognosis Predictive model 2 and the GP diagnoses 
hypertension (YES and NO) was calculated using the data in Table 9.4C: 
 
The GP diagnoses Prevalence was computed using GP YES and GP_NO as follows:   
                                                                 
 
The CMAUT model 2 Prevalence was computed using the results from Table 9.4C, where the 
YES is 59 and NO is 3586: The model 2 Prevalence value was computed as follows: 
                                                                 . 
The prevalence value is the proportion of identified hypertension suffers among the selected 
3645 participants as diagnosed by the GPs as 18.6%, which is higher than the 1.62% 
identified by the CMAUT model 2.   From the results of the kappa statistic, it is subsumed 
that CMAUT model 2 should be enhanced to achieve better prevalence.     
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9.4.2. Benchmarking CMAUT Prognosis framework with other CVD Prediction Tools 
 
To verify the results from the CMAUT Prognosis model 2, first the PPR results are compared 
with the results from the Blackheath and Patient UK websites, which are the two selected 
Internet based CVD calculators.  In Chapter 8, the PPR results of each of the 3645 
participants were determined using the two web based CVD calculators. The PPR values of 
each participant was converted into hypertension YES or hypertension NO using the NICE 
recommended PPR value of 20%.  According to NICE, (2006), when the results of the 
calculated PPR value is greater or equal to 20%, the participant is considered as hypertension 
YES:  Alternately, if the value is less than the 20 percentage then the participant is earmarked 
as hypertension NO.  The PPR results from the CMAUT Prognoses models indicate the 
models 1 and 2 can be used as prediction models and  as an epidemiological tool to determine 
the percentage risk of a user been hypertensive or not. 
 
 Benchmarking CMAUT Prognosis Framework with CVD web risk calculators 
 
In chapter 7, the CMAUT Prognosis Framework had incorporated in it an algorithm that 
calculates the PPR value of a participant been hypertensive in 10 years based on their current 
situation.  This is similar to the CVD Web calculators, which are designed to predict risk of 
hypertension in 10 years’ time. Therefore the PPR values from CMAUT framework in 
Chapter 7 were compared with the Internet based CVD calculators’ results in Chapter 8.    
 
The two Internet CVD Risk calculators that were selected and used are Internet model I: - 
NHS BlackHeath, http://www.bhgp.co.uk/chdriskresult.asp and Internet model II Patient UK 
(ref: http://www.patient.co.uk/doctor/Primary-Cardiovascular-Risk-Calculator.htm. These 
websites have now been updated and they use Qrisk®2 instead of the Framingham equations. 
 
The comparison between NHS Blackheath – Internet model 1 and the Patient UK- Internet 
model 2, revealed that the (10-years) PPR values from Patient UK are lower than the NHS 
Blackheath values. For example the participant with PSerial number of 15415101 or PIND 
1956 in Figure 9.6 was predicted to have 63% risk by NHS Blackheath website but Patient 
UK gave a low value of 13.4%.   
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Further analysis of the simulation results in Table 9.8C confirm that the PPR values from 
Patient UK are lower than the NHS Blackheath values see Table 9.8C in Appendix 9. This 
proves that there are inconsistences in the PPR values calculated by the Internet CVD risk 
calculators.  This led to the NICE, (2010) recommendation that Framingham based prediction 
tools used in UK give higher estimated PPR risk values.  
 
Figure 9.6: Comparison of (10-years) Predictive Percentage Risk for 3645 participants using 
Internet Calculators Model 1-II 
 
 Computation of kappa value for Internet model I and Internet Model II results: 
  
To verify the PPR results from the two Internet CVD risk calculators, the kappa values for 
the two websites, Internet model I: - NHS BlackHeath, and Internet model II Patient UK were 
calculated and analysed as below: 
 
Percentage _YES = 1.0050 
Percentage _NO =   98.8807 
 
Table 9.5: The actual_agree_YES and NO in tabular form 
 Yes No Total 
Yes 398 3127 3525 
No    4         3092         3096 
 402 6219 6621 
 
The result of the computation using the formula    
     
    
  gives a kappa value of 0.1052.  
The kappa value of 0.1052 indicates that there is a slight agreement between the PPR values 
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from the two Internet CVD risk calculators.  The comparison of the risk values from the 
Internet CVD calculators and the Framingham equations are discussed in section 9.5, using 
the results shown in Appendix 8.  
 
 Benchmarking CMAUT Prognosis Framework with Framingham Equations 
 
The results from the proposed CMAUT Prognosis Framework were compared with the three 
selected CVD Framingham risk algorithms used in this research. The three Framingham 
equations are: 
 
 The original Framingham equation from the USA, which  was used because it is still used as 
the basis for designing CVD risk prediction models even though according to NICE, (2010), 
the equation gives over estimate PPR values.  The second equation used is from Brindle et al, 
(2003) because it was proposed for cohorts in England, UK.  The third equation proposed by 
the International Task Force was developed for European countries (Zgibor et al., 2006). 
 
The original Framingham CVD equations  in Anderson et al., (1991) from USA, was used to 
calculate the PPR values for each of the 3645 participants and the results recorded in Table 
9.8C.  Secondly, since the cohorts and the participants used in this research are from England, 
UK, the (Brindle et al, 2003) was used for the male cohort.  The Brindle et al., (2003) 
equation was modified in accordance with the original Framingham equation to cater for 
women in England (Brindle et al, 2006) and the modification was explained in Chapter 8.   
Finally the International equation proposed by Zgibor et al., (2006) was used to calculate the 
PPR values for each of the 3645 participants and the results recorded in Table 8.6C. Below is  
Table 9.8C and the graph that shows the comparative PPR results for the three Framingham 
equations the other results are shown in Appendix 9; 
 
 In chapter 8, it was observed that the calculated PPR values for all the 3645 participants 
using the three different Framingham equations were approximately the same values.   For 
example in Figure 9.7, the PPR for the participant with PIND 2120 (PSerial 37213101) gave 
66, 53% when the UK equation was used but give 68.36% when the USA/International was 
used. Similarly, the participant with PIND 2774 (PSerial of 79633101) had 63, 74% based on 
the UK equation but 63.37% when the USA and International equations were used.   
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In clinical terms, these PPR values are almost the same but according to NICE, (2006) CVD 
guidelines these people should be dead because their percentage risk values are three times 
higher than the recommended value of 20%. The differences in the PPR values from the three 
Framingham equations and the other CVD Prediction models are summarised below: 
 
 For CMAUT model 2, the participant with PIND 2120 ( PSerial 37213101) has PPR 
value of 16.439%, while the participant with PIND 2774 (PSerial of 79633101) has 
10.263%. 
 For Internet model 1, the participant with PIND 2120 ( PSerial 37213101) has PPR 
value of 10%, while the participant with PIND 2774 (PSerial of 79633101) has 17%. 
 For Internet model 2, the participant with PIND 2120 ( PSerial 37213101) has PPR 
value of 8.2%, while the participant with PIND 2774 (PSerial of 79633101) has 5.1%. 
 
From the above analysis, it is concluded that the three Framingham equations have the 
highest PPR values for the same participants, which are over 60%, whereas the CMAUT 
Prognosis framework model 2 has 16% and 10% respectively. The PPR values for the 
Internet model 1 are 10% and 17% while   Internet model 2 has the lowest PPR values of 8% 
and 5% respectively.  It is therefore subsumed that the PPR values for Internet model 1 and 
the CMAUT model 2 are comparable while the other CVD prediction models have different 
PPR values hence more research are required. 
 
Figure 9.7: Comparison of (10-years) Predictive Percentage Risk for 3645 participants using 
Framingham Models 1-II 
When a critical analysis of all the computed PPR values of the entire 3456 participants in 
Table 8.6C were conducted;  it was revealed that the results from the original Framingham 
equation model I of USA and the International equation model II are the same but are 
different in some cases  for the UK equation model III.   
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This is because all the three equations were developed and implemented using the same 
technique proposed by Anderson et al, (1991).  The difference between the three equations is 
that the data of the CVD risk factor used for conducting the statistical binary logical 
regression analysis are from different countries.   A review of the three equations shows that 
there are minor changes in the values of the constants in the equations but the method of 
computation is the same in all the three equations.  It was established that the UK equation 
model III was original designed only for UK men but had to be modified in this research to 
include female. Therefore there are some differences between the PPR values from the USA 
model I and the UK equation model III.  However, for analytical purposes, this research 
subsumes that the three Framingham equations are the same unless otherwise specified. 
9.4.3 Computations of kappa value for Framingham equations I and II: 
  
The kappa value is used to determine the level of agreement between two prediction models. 
In this section since the three Framingham equations have identical percentage risk values, 
the PPR values for the Framingham equation model I from USA and the International 
equation model II were grouped into hypertension YES and NO using the NICE, (2006) 
benchmark of 20%.  The result of classifying the 3645 selected participants into YES and NO 
groups are presented below in Table 9.6. The computation of the kappa value for the USA 
equation model I and the International equation model II is as follows: 
 
Percentage _YES =      68.1873 
Percentage _NO =   49.5021 
 
Table 9.6: The actual_agree_YES and NO in tabular form 
 Yes No Total 
Yes 833 2812 3645 
No 568 1392 1960 
 1401 4204 5605 
 
The data in Table 9.6 and the formula    
     
    
  were used for the kappa computation and 
the result gives a kappa value of -0.0484.   
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This kappa value is approximately       which indicates that there is a good agreement 
between the USA equation model I and the International equation model II.  However, the 
arithmetical sum of the   Percentage _YES  and Percentage _NO as well as negative kappa 
value are two issues that need further investigation and  are not addressed in the research. 
 
 Comparison of PPR values from Framingham equations with CMAUT model 2. 
 
The PPR values from the three Framingham equations are identical and therefore the 
calculated kappa value of approximately 0.05 indicates a good level agreement between the 
different prediction models.  Again, the PPR values from the Framingham equations were 
compared with the PPR values from the CMAUT framework model 2.   The Framingham 
equation from USA and UK were grouped into hypertension YES and NO using the NICE, 
(2006) benchmark value of 20%.  The outcome of classifying PPR values into the YES and 
NO groups were compared with the results from the CMAUT Prognosis Framework model 2.  
The Kappa value, which indicates the level of agreement between the CMAUT Prognosis 
model II and the Framingham Equation Model I UK_USA is shown: 
 
Percentage _YES =     23.7288 
Percentage _NO =   77.1612 
 
Table 9.7: The for actual_agree_YES and NO in tabular form 
 Yes No Total 
Yes 59 3586 3645 
No 14 2767 2781 
 73 6353 6426 
 
The information in Table 9.7 and the formula    
     
    
  were used for the computation of 
kappa and it gives a kappa value of 0.0097.  The computed kappa value is approximately 0.01 
indicates that there is a slight agreement between the CMAUT Prognosis model 2 and the 
Framingham Equation. 
 
From the above analysis, it is subsumed that there are slight levels of agreement between the 
CMAUT Prognosis framework module 2, Framingham Equations and the NHS Blackheath 
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(Internet model 1). However, there are inconsistences in the PPR values from the other 
prediction models, which are shown in Table 9.8A with more details in Appendix 9. 
 
Table 9.8A: Comparison of 10-years PPR values from CMAUT models, Internet calculators 
and Framingham equations using the first 10 participants: 
Pserial no. Grp Bp1 Age Sex %PR(
M-I 
Absol) 
%PR(
M-II 
Abso) 
%PR(
M-I 
Pre) 
%PR(
M-II 
Pre) 
%PR(I
-I Pr) 
%PR(I
-II Pre) 
%PR(
F-I P) 
13,956,102.00 No No 60 Women 14.6 12.8 15.6 13.1 7 9 17.58 
63,535,102.00 Yes Yes 30 Women 15.4 14.4 16.3 15.4 1 4.3 0.13 
71,831,101.00 No No 66 Women 16.7 12.2 17.7 12.6 8 20.9 22.55 
34,031,101.00 No No 84 Women 18.0 14.4 19.0 15.3 3 17.5 12.87 
72,604,102.00 No No 59 Women 18.9 13.4 19.8 13.8 3 11.8 2.82 
13,008,101.00 Yes Yes 50 Women 20.1 13.5 21.0 14.5 1 9.3 15.12 
39,139,101.00 No No 34 Women 18.5 19.1 19.4 19.3 2 8.7 0.40 
47,856,102.00 No No 51 Women 16.3 19.4 17.2 19.6 11 10 1.22 
37,710,101.00 No No 61 Women 17.4 14.1 18.3 14.4 0 7.5 7.02 
54,256,101.00 No No 31 Women 21.4 11.7 22.2 12.1 1 4.8 0.05 
 
From Table 9.8C, it is subsumed that they are difference between the various CVD risk 
calculators.  This inconsistency led to the recommendation in NICE, (2010).  Again some of 
the calculators give percentage risk values, which can be interpreted as the participant must 
die, while in reality they are alive.  It is therefore recommend that a detail research must be 
conduct on the Web CVD calculator to address the issue of inconsistency in the PPR results. 
There must be standardisation of the input metrics used for developing risk calculator, 
adaptation of acceptable algorithm and all Web CVD calculators must be benchmarked. 
9.5 Prediction models Accuracy with Sensitivity/Selectivity and AUC/ROC 
 
In addition to benchmarking the CMAUT model 2 against existing Framingham equations 
and Web CVD calculators, the following analyses were also conducted.  The accuracy of the 
different prediction models were determine using sensitivity/selectivity, AUC/ROC and 
Likelihood ratio in accordance with success criteria 6. 
9.5.1 Discriminatory ability of three prediction models using sensitivity/selectivity 
 
The CMAUT Prognosis model 1 and 2 were discussed and used to predict the PPR values of 
the 3645 selected participants in chapter 7.   The discrimination accuracy of each of the two 
prediction models was determined by first calculating the sensitivity (aka TPR) and 
specificity or selectivity (aka FPR) values of each of the participant using the NICE, (2006) 
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recommended PPR criterion of 20 %.  In this research, the terms specificity and selectivity 
are the same and are used interchangeably. 
 
In Table 9.9A are the results of computing the TPR and FPR values for CMAUT Prognosis 
models, Internet calculators and Framingham equations for the first 10 participants. In 
Appendix 9 is Table 9.9B that contain the results of the first 30 participants and the results of 
the entire 3645 selected participants are in Table 9.9C in electronic format.  
 
Table 9.9A: Comparison of TPR and FPR for CMAUT models, Internet calculators and 
Framingham equations of the first 10 participants: 
Pserial no. Grp TPR(M-
I) 
FPR(M-
I) 
TPR(M-II) FPR(M-
II) 
TPR(I-I) FPR(I-I) TPR(I-II) FPR(I-
II) 
TPR(F-
I) 
FPR(F-I) 
13,956,102.00 No 1 1.000 1 0.9997 1 0.99968 1 0.9997 1 1.00 
63,535,102.00 Yes 1 0.999 1 0.9994 1 0.99936 1 0.9994 1 1.00 
71,831,101.00 No 1 0.999 1 0.9991 1 0.999041 0.984848 0.9994 0.9988 0.9993 
34,031,101.00 No 1 0.999 1 0.9989 1 0.998721 0.984848 0.9991 0.9988 0.9989 
72,604,102.00 No 1 0.999 1 0.9986 1 0.998401 0.984848 0.9988 0.9988 0.9986 
31,510,102.00 No 0.9983 0.9987 1 0.9983 1 0.998081 0.984848 0.9986 0.9988 0.9982 
18,633,105.00 No 0.9983 0.9984 0.9935 0.9983 1 0.997761 0.984848 0.9983 0.9988 0.9979 
13,008,101.00 Yes 0.9983 0.9981 0.9871 0.9983 1 0.997442 0.984848 0.9980 0.9988 0.9975 
60,417,102.00 No 0.9983 0.9979 0.9871 0.9980 1 0.997122 0.984848 0.9977 0.9988 0.9972 
39,139,101.00 No 0.9966 0.9979 0.9871 0.9977 1 0.996802 0.984848 0.9974 0.9988 0.9968 
 
 Interpretation of sensitivity/selectivity decision plot 
  
Using the results from Table 9.9C in Appendix 9, the sensitivity (TPR) and selectivity (TNR) 
for the CMAUT Prognosis model 1 and 2 were plotted against the selected criterion values. 
In this research, the percentage risk criterion value is the NICE, (2006) criterion of 20 %.  
The x: y interception values of the sensitivity and specificity curves show the degree of 
discrimination accuracy of the prediction models. 
 
The discrimination decision graph assists in the selection of the optimum levels, which are 
the optimum PPR values for each of the model in terms of their sensitivity and selectivity.  
Again, in each graph the point of interception shows the optimum decision PPR value, where 
the maximum number of incidences of the CVD disease is correctly diagnosed or prognoses 
as positive (i.e. present) or negative (i.e. absent).  This denotes that from the graphs, the 
interception point (x:y) is the  decision  criterion value that correctly identifies the  
proposition of the correctly  identified TPR and TNR of the models under consideration. 
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From Figure 9.8 below, the sensitivity and specificity curves of model 1 intercept at the PPR 
percentage and sensitivity/specificity value of  (14, 47%:0, 43).  In model 2 the interception is 
at the PPR  percentage and sensitivity/specificity value of  (13,89% : 0, 58).  This means  that 
for model 1 the decision PPR criterion value is 14.47% and the proposition of TPR and TNR 
is 0, 43 or 43% while model 2 criterion value is 13, 89% with correct proposition of  0, 58 or 
58%.  Therefore it is subsumed that model 2 has approximately 58% of the prediction been 
correct.  However, the PPR criterion value of 13, 89% is low as compared to model 1 of 
14.47% and the NICE recommended percentage risk of 20%. 
 
For the Web Based CVD prediction models, the sensitivity and specificity  curves for Internet 
model 1 intercept at the PPR percentage and the sensitivity/specificity value of  (8%:0,43) 
while the Internet model II intercepts  at  percentage and the sensitivity/specificity value of  
(5.7% : 0, 58).  In contrast, the Framingham equations intercept at PPR percentage and the 
sensitivity/specificity value of (11.6%: 0, 549) as shown in Figure 9.8. 
 
Therefore it is subsumed that the decision criterion values for the Web based CVD 
calculators which are 8%, and 5.7% are lower than the Framingham equation model PPR 
value of 11.6% and still lower than the NICE recommended value of 20%.  However, the 
Web based CVD calculators correctly identify higher proposition of the TPR and TNR of 58, 
9 % and 47% which are more than the three CVD Predictive models. Thus the Internet model 
II has a better discriminatory accuracy and proposition prediction ability as compared to all 
the other prediction models but its decision criterion value of 5.7% is nowhere near the 
CMAUT Prognosis models of 14% and the NICE value of 20%. 
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Figure 9.8: Comparison of Sensitivity and Specificity of Predictive Percentage Risk for the 
3645 Patient PIND. 
 
In summary, it is inferred from Figure 9.8, that the interception values of the Framingham 
equations and the proposed CMAUT frameworks are approximately the same. However, it is 
evident that the Internet Based CVD predictive models give very low interception values as 
compared to the three other models Figure 9.8.  It is difficult to make accurate inference on 
these values because the discrimination accuracy of Health Informatics systems have not 
been deeply investigated therefore it is recommended for future research. 
9.5.2 Prediction accuracy of the Prediction Models using AUC/ROC: 
 
The Prediction accuracy of Prediction models are determined by calculating the area under 
curve (AUC) of the model’s Receiver Operating Characteristic (ROC).   In Chapters 7 and 8, 
the results of the calculation of the TPR (aka sensitivity) and the FPR (aka specificity) were 
used to plot the ROC for the determination of the area under curve (AUC).   
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 To determine the AUC, first the TPR (Sensitivity) was plotted on the y-axis and the FPR 
(specificity) on the x-axis as shown in Figure 9.9. 
  
From the graphs in Figure 9.9, the CMAUT models 1 and 2 curves are located in the positive 
quadrant which means that the curves are in areas that are higher than the reference diagonal 
line.  When the CMAUT graphs are compared with the Internet CVD calculators, it was 
observed that the Internet CVD calculator 1 curve lays in the positive quadrant in relation to 
the reference diagonal line.  However, the curve of the Internet CVD calculator 2 lays on the 
negative quadrant.  This denotes that the Internet CVD calculator 1 is more accurate as 
compared to the Internet CVD calculator 2.  Again, the curves for the USA and UK 
Framingham equations are the same and they both lay in the negative quadrant.  This means 
that the USA and UK Framingham equations are not accurate with respect to the reference 
diagonal line as indicated in the Figure 9.19. 
 
 
 
Figure 9.9: Comparison of ROC/AUC of Predictive Percentage Risk values for the 3645 
Patient PIND. 
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 Comparison of the Area under the Curve (AUC) for the Prediction models  
 
For propose of comparison, first the TPR values were plotted against FPR values  for each 
model and value of the area under each curve with reference to the diagonal line calculated.   
The AUC calculation was done using the Tables 9.10A below that contain the TPR and FPR 
results of the first 10 participants of the CMAUT model 1 and 2, the two Internet CVD 
calculators and the Framingham equations.  The results of first 30 participants are in Table 
9.10B in the Appendix 9, which is the end of the Thesis. The results of the entire 3645 
participants are in Table 9.10C in electronic format Appendix 9.   The terms specificity and 
selectivity will be used interchangeably. 
  
The AUC was computed using the Delong Approximate Trapezoidal method in which, the 
first step is to plot the TPR and FPR curve for each model as indicated in Figure 9.9.  Second, 
the best curve fit method was used to find the equation that best fit each model’s curve. This 
was followed applying the Trapezoidal rule where the area under the curve is split into a 
number of trapeziums and their areas calculated. Finally the summation technique was used 
to determine the approximate value of the area under the given curve. 
  
In medical application, area under the curve AUC is computed using the Trapezoidal method 
as                                                                             
  . In this expression, the diagonal reference line gives a value of 0.5, which is half of the 
square of the area under consideration.  This AUC values for each model was computed using 
the MATLAB software and the results of the calculation are shown in the Figures in 
Appendix 9, at the end of this Thesis.  Figure 9.10.1 is the CMAUT diagnosis model I from 
Chapter 5 and Figure 9.10. 2 is the CMAUT diagnosis model II from chapter 5.  From the 
calculations in Figures 9.10.1 and 9.10.2, it is subsumed that CMAUT diagnosis model II has 
an excellent prediction accuracy of 0.82 while model I has poor prediction ability of 0.22. 
 
Figure 9.10.3 is the CMAUT Prognosis model I from Chapter 7 and Figure 9.10.4 is the 
CMAUT Prognosis model II from Chapter 7.  Inferring from Figures 9.10.3 and 9.10.4, it is 
subsumed that CMAUT Prognosis model I has an excellent prediction accuracy of 0.92 but 
model II is just satisfactory prediction ability of 0.55. 
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Figure 9.10.5 is the Internet CVD model I from Chapter 8 and Figure 9.10.6 is the Internet 
CVD model II from chapter 8. Therefore from Figures 9.10.5 and 9.10.6, it is inferred that 
Internet CVD model I has failed as a prediction model because it has a prediction accuracy of 
0.08, which is less than 0.5. Again, from Figure 9.9 above the curve of the Internet CVD 
model I, lays in the negative quadrant but Internet CVD model II is fair prediction since it has 
prediction ability of 0.675.   Similarly, Figure 9.10.7 was computed with the results from UK 
and USA Framingham equations.  From Figure 9.10.7, it is subsumed that Framingham 
equation models have failed as a prediction model because it has a prediction accuracy of 
0.138, which is less than 0.5 and according to Figure 9.9, they lay in the negative quadrant. 
 
In summary, the AUC is used to measure of the discrimination accuracy of prediction models 
and shows the ability of the models to correctly classify participants with CVD diseases and 
those without the CVD diseases after performing the test.  From the calculations and the 
curves it is inferred that the CMAUT framework model 1 has a higher prediction value for 
prognosis but failed in the diagnosis discrimination ability.  CMAUT model 2 has better 
diagnosis discrimination ability but has poor prognosis ability and CMAUT model 2 is the 
preferred model. This denotes that the CMAUT frameworks can be used as prediction models 
but they still need to be fine turned to enhance their discrimination ability. 
  
Internet model 2 has better prognosis discrimination ability although this is only fair 
according to the discrimination guideline Table Viera, (2005).  However, Internet model 1 
failed because it has a negative value, which means it lays in the negative quadrant and has 
only – 0.088, which is less than the 0.50 reference value.   Similarly, the Framingham 
equation for both UK and USA, gave a value of -0.1389, which is failed and lays in the 
negative quadrant. 
 
These CVD risk calculators are currently been used by people to determine the probability 
that they are hypertensive or not.  According to NICE, (2010), the use of Framingham 
equation to predict CVD risk in UK population is dangerous because it gives over estimated 
percentage risk and therefore QRISK must be used.  This research has confirmed the 
recommendation made by NICE, (2010).  However, ruling out Framingham equation 
completely is inadequate and therefore it is recommended further research work should be 
conducted on this algorithm since the principle is sound but the coefficients may vary from 
country to country (Zgibor et al., 2006).  
                                                                                                 CMAUT-UML Framework for Optimisation of CIS                                                     
 
 
237 
 
Again, a lot of research and benchmarks must be carried on CVD risk calculators before they 
are uploaded to the websites for public consumption.   
9.6 Performance accuracy of Prediction models using Likelihood Ratio. 
 
Likelihood ratio is a technique for evaluating the performance accuracy of diagnosis and 
prognosis models.  Likelihood ratio deals with models with two possible results and handles 
dichotomous test, where the prediction result must be either YES, which indicates the disease 
is present or NO when the disease is absent in the participant. 
 
This Likelihood ratio approach is rarely used in medical applications to determine the 
accuracy of prediction models (Spitalnic, 2004).  This is because Likelihood ratio only 
indicates the interception of the positive Likelihood rate (PLR) and the negative Likelihood 
rate (NLR) for each participant. This paradigm means Likelihood ratio is a method of testing 
the level of certainty of the disease in the participant before and after diagnoses or prognosis.  
This analysis is conducted using the pre-test and post-test probability, which is not covered in 
this research because the CVD clinical report used has no follow-up information on the 
participants.    However, according to Sanderson et al., (2006), the lower values for negative 
LR- are acceptable as satisfactory and the higher values for positive LR+ are also acceptable. 
 
In chapter 3, the procedure for determination of Likelihood ratio using the selectivity (aka 
specificity) and sensitivity approach was outlined as follows: 
 
 Calculate the value of the positive Likelihood ratio                   and the 
negative Likelihood ratio                   for the entire selected 
participants in the population. 
 
 Plot all the values of the positive and negative Likelihood ratios on the Y-axis and 
number of each of the participants PIND on the X-axis as in Figure 9.11. 
 
For comparison reasons, in each graph, the calculated PPR value of each participant was 
plotted against the participant PIND. See the blue coloured plot in Figure 9.10. 
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Table 9.10A: Comparison of LRP and LRN for CMAUT models, Internet calculators and 
Framingham equations for the first 10 participants; 
Pserial no. Grp LRPM-
I) 
LRN(M
-I) 
LRP(M-II) LRN(M
-II) 
LRPI-I) LRN(I-
I) 
LRP(I-II) LRN(I-
II) 
LRP(F-I) LRN(F-
I) 
13,956,102.00 No 
3484.3
2 0 3717.472 0 3125 0 3584.22 0 2808.99 0 
63,535,102.00 Yes 
1745.2
0 0 1862.197 0 1562.5 0 1788.90 0 1406.47 0 
71,831,101.00 No 
1162.7
9 0 1240.695 0 
1042.75
3 0 1761.80 
0.0151
6 1404.7820 0.0012 
34,031,101.00 No 872.60 0 930.233 0 
781.860
8 0 1175.23 
0.0151
6 936.0825 0.0012 
72,604,102.00 No 697.84 0 744.048 0 
625.390
9 0 880.90 
0.0151
6 702.3910 0.0012 
31,510,102.00 No 581.73 0 742.7969 0.0017 
521.104
7 0 704.97 
0.0151
7 561.7548 0.0012 
18,633,105.00 No 577.98 0.0065 619.3046 0.0017 446.628 0 587.61 
0.0151
7 468.0412 0.0012 
13,008,101.00 Yes 574.23 0.0129 530.7384 0.0017 
390.930
4 0 503.50 
0.0151
8 401.2857 0.0012 
60,417,102.00 No 492.07 0.0129 464.3344 0.0017 
347.463
5 0 440.64 
0.0151
8 351.0721 0.0012 
39,139,101.00 No 430.67 0.0129 463.5530 0.0034 
312.695
4 0 391.58 
0.0151
9 312.0275 0.0012 
 
9.6.1 Comparison and Interpretation of Likelihood Ratio Graphs 
 
The performance accuracy of prediction models is determined by using the Recalibration and 
Discrimination techniques discussed in Chapter 3.  In chapters 7, the CMAUT prediction 
models were developed and evaluated using the sensitivity/selectivity, AUC/ROC and 
Likelihood ratios to determine the performance accuracy of the CMAUT models.   In the 
chapter 8, the PPR value of each participant was determined using the two Internet-based 
CVD calculators and evaluated with discrimination techniques.  Again, in Chapter 8, the PPR 
value of each participant was calculated using the three Framingham equations and the results 
evaluated with discrimination techniques. 
 
 Comparison of the CMAUT models 1 and 2 - Observation from the graphs 
 
Figure 9.11 below shows the Likelihood ratios and the PPR values for the CMAUT models 1 
and 2. In Figure 9.11, the interception of the positive Likelihood ratio and negative 
Likelihood ratio curves for the CMAUT model 1 and 2 are on the two participants with PIND 
number 1600 and 1676 respectively.  The Likelihood risk ratio for the participant with PIND 
number 1600 is 0.997 in model 1 while the participant with PIND 1676 is 1.056 that is, they 
both have a ratio of approximately one. 
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According to Spitalnic, (2004), the LR ratio means that the participants with the higher 
positive values for positive LR+  are acceptable while the model, which have participants 
with  lower negative values for negative LR-  are considered as satisfactory.  In Figure 9.11, 
the CMAUT model 1 and 2, all the participants to the left of the point of interception have 
lower level of certainty of the disease while participants to the right have higher level of 
uncertainty of the disease.  Although there have not been any follow –up on this survey, 
according to the HSE, (2006) report, few participants who took part in the survey were 
diagnosed as having hypertension (Craig, et al., 2006b) (Craig, et al., 2008).  The Likelihood 
risk ratios for CMAUT model 1 and 2 are low as compared to the results from the Internet 
CVD calculators and Framingham equations and therefore confirm the HSE, (2006) findings. 
 
9.6.2 Comparison of the two Internet CVD calculators and Framingham Equations 
 
For the Internet CVD calculators, the interceptions are on participants with PIND numbers 
1714 for Internet Model 1 and 2042 for Internet Model 2 while for the Framingham equations 
the interception is at participant with PIND number 2006. The Likelihood risk ratios are 
0.997 and 1.004 for the Internet models 1 and 2 while the Likelihood risk ratio for the 
Framingham equation is 1.002. 
   
The results are interpreted as follows that for the Internet model 1 fewer participants are on 
the left hand side of the Internet model 1 interception where the point is (1714; 0.997) as 
compared to the Internet model 2 interception of (2042; 1.004).  This denotes that for Internet 
model 1 few participants were identified as having hypertension while major of the 
participants do not have hypertension.   The results from Internet model 2 agrees with the 
results of Framingham equation, that is (2006; 1.002), which indicates that many participants 
had hypertension. This does not match the HSE, (2006) report analysis, which states that 
fewer participants were identified as having hypertension during the survey.  
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Figure 9.11: Comparison of the Maximum Likelihood Ratio of Predictive Percentage Risk for 
the 3645 Patient PIND. 
 
From Figure 9.11, it is established that Internet model 2 and Framingham equation results 
have overestimation PPR values when used in UK population and this is confirmed in the 
AUC and Likelihood ratio analysis.  Internet model 1 and the  CMAUT models have good 
level of performance  accuracy in terms of the AUC and Likelihood ratio analysis however 
more research are required to enhance their calibration and discrimination abilities. 
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9.7 Summary 
 
From the analysis in this chapter 9, it is subsumed that the hypothesis in this research has 
been proven with the exception of a few minor issues which are recommended for future 
research and investigations as discussed in the conclusion Chapter 10.   In this chapter, it has 
been proven that the application of CMAUT Optimisation Framework in CIS reduces the 
space complexity of clinical data with complementary organs by half the required storage 
space as compared to non- CMAUT CIS.  When substitutable organs are used in the CMAUT 
Optimisation Framework the result of the space complexity is the same as non- CMAUT CIS. 
The difference between the data size before and after optimisation with the CMAUT 
Framework is statistical significant. 
  
 The CVD percentage risk values from both the CMAUT Diagnosis and Prognosis 
Framework model 2 are comparable with NHS Blackheath results but they are different from 
other existing Risk Prediction models.  It was established that the CMAUT model 2 must be 
enhanced to achieve better prevalence and kappa performance results.  It was subsumed that 
there are inconsistent PPR results from all the CVD risk predictors, therefore more 
investigation are required. 
   
The prediction accuracy of CMAUT diagnosis model II is excellent with a value of 0.82 
while model I is classified as poor prediction model because it has a value of 0.22.  However, 
for Prognosis, the CMAUT model II is just a satisfactory prediction model while the model I 
has an excellent prediction accuracy of 0.92. Again, from the AUC and Likelihood ratio 
analysis it was identified that Internet model 2 and the Framingham equations have 
overestimation PPR values and lay in the negative quadrants.  However, Internet model 1 and 
the CMAUT models have better performance accuracy based on the AUC and Likelihood 
ratio but their calibration and discrimination abilities need improvement. 
 
Therefore this analysis proves the hypothesis that “Clinical data can be captured with UML 
class model and re-represented using CMAUT and logical connectors in mathematical format 
that can be optimised with LP algorithm to reduce the space complexity in CIS and be used 
as CVD decision tool to predict the risk of users been hypertensive or not”.    
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Chapter 10: Conclusions and Recommendations for 
Further Research 
 
10. 0 Introduction: 
 
This chapter summarises the overall research and discusses the hypothesis that has been 
proven as well as the limitations of the proposed CMAUT framework.  This is followed by 
recommendations for future research emanating from the techniques used in this research. 
 
10.1 Conclusions 
 
This research has established that the accumulation of huge amount of data also known as 
Big Data by data intensive organisations has many benefits. Therefore, data intensive 
organisations such as Insurance companies, Financial and Medical institutions capture and 
store gigantic amount of data for their operations and decision making.  Social networking 
websites, such as Facebook and Twitter generate and store the Big Data for marketing and 
advertisement purposes.   Despite these success stories, the storage of data and retrieval of 
information from these Big Data sets, are associated with problems such as  security issues, 
information highway, interoperability, scalability and information overload. 
     
From the literature reviewed, it was established that, in CIS the issue of information overload 
has been addressed by the application of clinical data re-representation techniques 
(Howmotte et al., 1998).   For example, EAV/CR uses the data re-representation technique 
for the design and implementation of CIS.  However, according to Nadkarni et al., (2006), 
experiments conducted prove that EAV/CR has storage and retrieval problems as compared 
to the relational database.  Again, the CISs that use EAV/CR need complex SQL retrieval 
systems that are not user friendly. The other data re-representation technique used in clinical 
application is the hybrid application of Frist Order Logical and Entity Relationship Diagram 
(FOL/ERD) (De Keizer et al., 2000).  The FOL addresses the anomalies and ambiguity issues 
in CIS but it requires an excellent knowledge of Formal Methods.  These models have no 
optimisation mechanism and therefore they cannot address the problem of information 
overload in CIS.   
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This research proposed a new CDSS with UML class model data re-representation and 
CMAUT framework that optimises the CIS and reduces the space complexity created by 
information overload. The CMAUT framework can be used as epidemiological tool to predict 
the percentage risk of a user been hypertensive or not. Based on the proposed solution the 
hypothesis established that “clinical data can be captured using UML class diagram and re-
represented with CMAUT logical connectors to reduce the space complexity in CIS and 
seamless converted them into the mathematical format that is optimised using LP algorithm 
to determine the percentage risk of users been hypertensive or not”. 
 
The aim of the proposed CMAUT CVD optimisation framework and the hypothesis in this 
research were achieved and verified using the following success criteria: - Clinical data was 
modelled with class diagram and represented using CMAUT that are linked with the AND as 
well as OR logical connectors.  The operation of the CMAUT framework was illustrated 
using the complementary organs, which are represented using the AND connectors.  The 
UML model shows the classes in the complementary disease domain and the AND logical 
association between them, which are the heart, kidney and brain.  The substitutable organs, 
kidneys are modelled using super-class and subclasses in the disease domain and their 
attributes are formalised using the OR logical connectors.  The CMAUT statements capture 
the relation between organs and their attributes in the disease domain using formal method.    
 
The CMAUT expressions were converted into Utility Units using the Utility function and the 
beta coefficient from the binary logistic regression analysis.  The CMAUT expression that 
uses the total utility units and the attributes in the disease domain, serve as the input to the 
Optimisation Framework.   This analysis confirms the hypothesis that “UML can be used to 
capture clinical data and the data re-represented with CMAUT technique that can be 
expressed in mathematical format using AND/ OR logic connectors”. The final mathematical 
expression was used to formulate the objective function that must be maximised to obtain the 
optimal value and the comparative variable of each attribute in the combinatory. The 
objective function was optimised subject to the constraint unit matrix that is built into the 
algorithm using the MATLAB Linear Programming Software. 
 
The output from the CMAUT framework gives the optimal evaluated value that is converted 
into Absolute Percentage Risk (APR) and Predictive Percentage Risk (PPR).   
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The framework gives individual comparative attribute variables that are mapped to each of 
the participants’ input attribute values to determine the diseased attribute in the combinatory.   
This confirms the hypothesis that “The CMAUT mathematical expression written as 
objective function can be optimised using LP algorithm subject to the set of inequalities to 
determine the optimal CVD percentage risk and the deviation of each attribute values from 
the norm”.  
 
From the results of the functional performance of the CMAUT Optimisation Framework, it is 
concluded that the complementary organs generate less inequality constraints of         as 
compared to the        for non-CMAUT system.  However, for substitutable organs both 
CMAUT and non-CMAUT systems generate equal amount of inequality constraints of 
       which is expressed as O (x2) and confirms the hypothesis. 
 
From the statistical analysis, it was established that the data sizes before optimisation was 
1216.66 bytes and after optimisation using the CMAUT framework was 463.50 bytes. The T-
test gave a p-value of 0.000, which is less than 0.00.  This confirms that the difference 
between the data sizes before and after optimisation are statistically significant and that there 
is a great reduction in the data size when the CMAUT Optimisation framework is used, 
which proves the hypothesis. 
 
 The APR results from the CVD CMAUT Diagnosis framework models 1 and 2 as well as the 
PPR results from Prognosis framework models 1 and 2 were benchmarked against CVD Risk 
Prediction models. The Web based CVD risk calculators  used in this research were Internet 
model 1 from NHS Blackheath and Internet model 2 from Patient UK. The Framingham 
algorithms used to benchmark the CMAUT framework were the Framingham equation from 
USA as model I, International equation is model II and the UK equation is model III. 
 
On the operational accuracy of the prediction models, it was established that the kappa and 
prevalence values for both CMAUT Diagnosis and Prognosis framework model 2 are 
acceptable. However, the APR and PPR output values from the CMAUT Diagnosis and 
Prognosis framework model 2 needs further enhancement. 
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Critical analysis of each of the PPR values for the entire 3456 participants revealed that the 
results are the same for the Framingham equation model I from USA and the International 
equation model II but are different in some cases from the UK equation model III. This is 
because Framingham equation was designed for the US cohorts and not for UK cohorts. 
 
It was identified that the PPR values from the Internet model 1(NHS Blackheath calculator) 
and the CMAUT Prognosis model 2 are comparable for all the 3564 participants.  However 
the other CVD prediction models reviewed had different PPR values for the same participant 
hence further research is required. 
 
Analysis of the discriminatory ability of the CVD models revealed that the Internet model II 
(Patient UK calculator) has better discriminatory accuracy and prediction ability as compared 
the other models.  Internet model II had a decision criterion value of 5.7%, which is very low 
compared to the 14% from CMAUT models and the NICE recommended value of 20%. To 
address this limitation, Patient UK has redesigned their website using the QRISK algorithm.  
 
The prediction accuracy of each of the CVD prediction models was determined using ROC 
and AUC method.  It is deduced that the CMAUT diagnosis model II has excellent prediction 
accuracy but the CMAUT Prognosis model II is just satisfactory as compared to other 
Prediction models. This means the CMAUT prognosis models can be used as CVD Risk Tool 
but further work is needed to enhance their prediction accuracy and discrimination ability. 
   
The Performance accuracy of the diagnosis and prognosis prediction models were determined 
using the Likelihood Risk ratio technique.  It was identified that the CMAUT model I has less 
participants who have lower level of certainty of having the CVD disease as compared to the 
participants who have higher level of uncertainty of having CVD disease.  Therefore, it is 
deduced that the performance accuracy of the CMAUT models and Internet model 1 (NHS 
Blackheath) are better than the Internet model 2 and all the three Framingham equations. 
 
Limitations of the CMAUT CVD Framework models I and II are: 
 
 The CMAUT Diagnosis Framework model 2 has reliable APR values and good kappa 
value, but its prevalence value of 1.03% is classified as poor therefore further 
improvements are required. 
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  The CMAUT Prognosis framework model I, gives higher PPR values and hence it is not 
recommended to be used as epidemiological prediction tool unless further research is 
conduct on it.   
 
 The discriminatory ability of the CMAUT CVD model 1 is less than 50%; hence it needs 
to be improved even though it has the highest decision criterion value of 14.5%.   
 
 The prediction accuracy of the CMAUT CVD Framework model 1 was 0. 22, which 
means it failed as Prognosis model 1 therefore further research is required.  
10.2 Contribution to Knowledge 
 
This research has addressed the issue of information overload by introducing a novel 
technique that reduces the space complexity and data size in CIS. Another unique 
contribution is the development of a new CMAUT decision making model that can be used as 
epidemiological CVD risk prediction framework. This research makes the following 
contribution to knowledge: 
 
 A new data re-representation technique where problems in the clinical domain are 
captured using UML and formulated with CMAUT and logical expressions. 
 
 This new UML – CMAUT technique is an extension to the concept of clinical data re-
representation proposed by Haimowitz et al., (1998) and De Keizer et al., (2000). 
 
 This unique CMAUT framework has a new algorithm that converts CMAUT logical 
expressions into objective functions, which can be optimise using LP technique. The 
optimal value is seamless converted into percentage risk and comparative attribute values, 
which are presented for medical and clinical decision making. 
 
 This innovative use of CMAUT is unique because the application of combinatorial organs 
and their multiple attributes to describe diseases has not yet been explored in CIS 
(Sanderson et al., 2006).   Again, a CDSS that uses a hybrid of existing MAUT and 
combinatorial technique to create CMAUT model is new in medical application: 
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 A new radical technique in clinical data re-representation using UML class model and 
CMAUT that can be incorporated with other data representation methods to facilitate 
mathematical manipulation of clinical and pathological data for health care analysis that 
is different from other existing methodologies. 
 
 The framework is unique because the in-built algorithm allows the retrieval of optimal 
amount of data to be transmitted for decision making thus reducing the information 
overload in CIS as compared to other existing methods. 
 
 This unique partial data retrieval strategy can be applied in areas where Big Data are 
captured but only partial amount of data are required to be retrieved at any time. This 
strategy also facilitates the mapping and retrieval of multiple attribute data in 
combinatorial data intensive systems. 
 
 The framework can be used by data intensive organisations such as financial institutions, 
and social networking industries to reduce information overload and facilitate data 
retrieval.   
 
 This new epidemiological risk prediction framework can be used to predict the CVD 
percentage risk of people who are under 30 years and over 70 years old.  
 
 A new algorithm for the computation of CVD predictive risk based on the Framingham 
Equation; However, this technique uses measurable CVD attributes to calculate the APR 
for diagnosis and for the determination of  PPR, it uses the arithmetical sum of APR and 
Predictive time factor P(T), which is based on  measurable and non-measurable attributes. 
 
In summary, the proposed new framework will allow medics and medical investigators to 
receive only the relevant data required to solve problems.  This approach localises the clinical 
data so that only needed data are transferred and thus reduces the amount of data transmitted 
over the network.  It also reduces the amount of information transmitted and stored on 
handheld devices for any particular disease.   
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10.3 Further Work and Recommendations 
  
To enhance the predicted output risk values from the diagnosis and predictive frameworks, 
Software Engineering modelling techniques are recommended for the determination of the 
accuracy of prediction models.  The recommended techniques are the Prequential Likelihood 
and u –plot methodology (Fenton et al., 1997).  Other areas that need to be addressed to 
improve the output of the medical prediction models are the prediction accuracy, prediction 
noise and recalibration of the clinical decision support model.  
 
 In Software Engineering, the accuracy of prediction models is determined using the 
Prequential Likelihood function (Fenton et al., 1997).     The Prequential Likelihood (PL) 
method uses three steps to determine the accuracy of prediction models.  However, in this 
research, the Likelihood Ratio method used was recommended for medical application by 
Sanderson, (2006). This Likelihood Ratio method does not include some of the steps 
recommended in Software Engineering reliability test. Therefore in future medical prediction 
models must be benchmarked accordance with the Software Engineering standards. 
 
Another challenge associated with the prediction model is the noisy predicted output values, 
which fluctuates in magnitude from the true median values. Noise is also known as 
fluctuation that occurs in prediction models (Fenton et al., 1997).  In this research, there are 
great fluctuations between the calculated percentage predictive risk (PPR) values for the same 
participants when two different Internet CVD Risk calculators were used, this needs further 
investigation. 
   
To improve the accuracy of the prediction models, the recalibration u-plot technique must be 
used to avoid any prejudice in the models’ outputs.  Different researchers use different 
methods to calculate and recalibrate prediction model therefore the appropriate technique 
must be used to calculate the AUC in medical application (Brocklehurst et al., 1990). 
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 Recommendations for enhancement of CVD Risk Prediction models 
 
There are disagreements between the PPR values from all the CVD Risk Prediction Models, 
which were examined in this research.  Some of the prediction risk calculators gave 
percentage risk values, which can be interpreted as the participant must die, while in reality 
they are alive.  It is recommended that a detail research must be conduct on the different Web 
CVD calculators to address the inconsistency in their results. Again, the input risk factors 
used to design and benchmark CVD Risk Prediction calculators must be standardised. 
   
It was established that the CMAUT diagnosis model 2 has an excellent prediction accuracy of 
0.82 but the Prognosis model is satisfactory as compared to all the other Predictive models 
considered. Therefore the CMAUT models can be used as CVD risk prediction Tool; 
however, further research must be conducted to fine tune the CMAUT algorithm to enhance 
the prediction accuracy and discrimination ability of the Framework. 
   
From the AUC and Likelihood ratio analyses conducted, it is concluded that Internet model 2 
and the Framingham equations give overestimation PPRs and lay in the negative quadrants.  
However, Internet model 1 and the CMAUT models have better prediction accuracy for the 
AUC and Likelihood ratio but their calibration and discrimination abilities need 
improvement. All the prediction models must be recalibrated to improve their performances. 
 
Finally, from the above discussion it is inferred that the interception values of the 
Framingham equations and the results from the proposed CVD CMAUT frameworks are 
comparable. Although, it is evident that the Web Based CVD prediction models give very 
low interception values as compared to the Framingham and  CMAUT models.  It is difficult 
to make an accurate inference on these PPR values because this area of CIS has not been 
investigated in depth: Therefore it is recommended for future research. 
 
In summary, all the issues and challenges discussed in section 10.3 reveal that Clinical 
Decision Support Systems and CVD Risk prediction models must be considered as software 
packages that must meet Software Engineering standards.  Therefore, in future all medical 
and clinical applications must pass reliability test based on Software Engineering principles.  
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Appendix 
 
Appendix 3.0 for Chapter 3 
 
The following appendices are in electronic format on the attached USB 
1. Appredix 3.1C:  hse06ai_Full data with 21299 records  
2. Appredix 3.2C:  hse06ai_sample1_refined_  with 9194 records  
3. Appredix 3.3C: CVD data set  for over 16 years old  Model I _ 4316 records 
4. Appredix 3.4C: CVD data set  for over 30 years old  Model 2_ 3645 records 
 
Appendix 5.0 for Chapter 5 
 
Table 5.8B: Raw data of the first 30 participants used in Chapter 5: 
Pserial no. Grp Bp1 Age Sex Ethnic HB BMI BPH BPL HD
L 
MAP DIA TC SMK CV
D 
ECG 
13,956,102.00 No No 60 Women White 34.00 13.20 122.50 88.50 1.80 100.00 No 5.20 Yes No Yes 
63,535,102.00 Yes Yes 30 Women White 46.00 13.71 120.00 74.00 1.40 89.50 No 4.50 Yes Yes No 
71,831,101.00 No No 66 Women White 89.00 14.32 159.00 70.00 1.90 99.50 No 6.90 No No Yes 
34,031,101.00 No No 84 Women White 48.50 16.17 112.00 63.50 2.20 80.00 No 5.00 Yes Yes Yes 
72,604,102.00 No No 59 Women White 36.50 16.19 109.50 73.00 2.00 85.00 No 6.00 No No No 
13,008,101.00 Yes Yes 50 Women White 43.00 16.65 117.00 74.00 1.70 88.50 No 6.00 Yes Yes Yes 
39,139,101.00 No No 34 Women White 48.00 16.81 102.00 54.00 1.80 70.00 No 6.50 Yes No No 
47,856,102.00 No No 51 Women White 44.00 16.85 100.50 56.50 1.90 71.00 No 5.10 No No No 
37,710,101.00 No No 61 Women White 43.00 17.43 120.00 77.00 1.20 91.50 No 5.50 No No No 
54,256,101.00 No No 31 Women White 40.00 17.72 124.00 84.00 2.00 97.00 No 3.90 Yes No No 
53,817,101.00 No No 43 Women White 39.00 17.72 107.00 68.00 1.70 81.00 No 4.90 Yes No No 
44,633,102.00 No No 39 Women White 39.00 17.87 106.00 67.00 1.40 80.00 No 5.30 No No No 
34,523,102.00 No No 45 Women White 51.50 18.09 120.00 68.50 2.00 85.50 No 4.70 No No No 
72,323,102.00 No No 38 Women White 39.00 18.10 116.00 77.00 1.40 90.00 No 4.20 Yes Yes No 
42,831,101.00 No No 35 Men White 64.50 18.15 135.00 70.50 1.70 92.00 No 4.10 Yes No No 
72,833,102.00 No No 40 Men White 58.50 18.19 117.00 58.50 1.50 78.00 No 4.60 Yes No No 
15,047,101.00 No No 86 Women White 79.00 18.27 138.00 59.00 2.50 85.50 No 8.90 Yes No Yes 
23,202,102.00 No No 58 Women White 48.00 18.29 113.50 65.50 1.10 81.50 No 3.60 Yes No No 
20,408,101.00 No No 44 Women White 38.00 18.41 100.00 62.00 0.90 75.00 No 4.90 No No No 
76,910,102.00 No No 48 Women White 46.00 18.43 110.00 64.00 2.00 79.00 No 8.00 Yes No No 
13,856,101.00 No No 51 Women White 32.50 18.45 92.50 60.00 2.60 70.50 No 6.70 Yes No Yes 
21,413,101.00 Yes Yes 86 Men White 65.50 18.48 149.00 83.50 1.20 105.00 No 5.60 No Yes No 
25,713,101.00 No No 38 Women White 32.50 18.55 103.50 71.00 1.30 81.50 No 4.00 Yes No No 
29,646,101.00 No No 32 Women White 36.00 18.58 113.50 77.50 1.40 89.50 No 4.60 No No No 
59,015,101.00 No No 31 Women Asian or 
Asian 
British 
38.00 18.59 100.00 62.00 1.50 74.50 No 4.50 Yes No No 
48,733,102.00 No No 48 Women White 50.50 18.62 133.00 82.50 2.30 99.50 No 6.10 Yes No No 
51,623,102.00 No No 49 Women White 71.00 18.63 168.50 97.50 1.90 121.50 No 4.80 No No No 
71,718,102.00 No No 57 Women White 38.50 18.63 105.00 66.50 2.20 79.00 No 5.80 No No Yes 
34,846,101.00 No No 32 Women White 44.50 18.65 118.50 74.00 1.20 89.00 No 7.00 No No Yes 
20,023,102.00 No No 77 Women White 57.00 18.66 136.50 79.50 2.00 98.50 No 7.20 Yes No No 
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Table 5.9B: Absolute Percentage Risks and variable attributes values of Model I for the first 
30 participants  
Pserial no. Grp Bp1 Age Sex X1 X2 X3 X4 X5 X6 %PR 
13,956,102.00 No No 60 Women 
50.0 25.5 0.02 0.00 50.00 5.22 -14.6 
63,535,102.00 Yes Yes 30 Women 
45.8 25.9 4.15 0.00 100.19 4.28 -15.4 
71,831,101.00 No No 66 Women 
0.0 25.5 140.00 0.00 100.00 0.00 -16.7 
34,031,101.00 No No 84 Women 
50.0 25.5 0.00 0.00 100.00 5.30 -18.0 
72,604,102.00 No No 59 Women 
50.0 25.5 0.00 0.00 100.00 0.00 -18.9 
13,008,101.00 Yes Yes 50 Women 
50.0 25.5 0.00 0.00 100.00 0.00 -16.3 
39,139,101.00 No No 34 Women 
50.0 25.5 0.00 0.00 100.00 0.00 -21.4 
47,856,102.00 No No 51 Women 
50.0 25.5 0.01 0.00 100.00 5.23 -21.9 
37,710,101.00 No No 61 Women 
50.0 25.5 0.00 0.00 100.00 0.00 -15.2 
54,256,101.00 No No 31 Women 
50.0 25.5 0.00 0.00 100.00 5.30 -14.1 
53,817,101.00 No No 43 Women 
50.0 25.5 0.00 0.00 100.00 5.30 -19.6 
44,633,102.00 No No 39 Women 
50.0 25.4 0.04 0.00 100.01 2.67 -19.9 
34,523,102.00 No No 45 Women 
0.0 25.5 0.00 0.00 100.00 5.30 -15.7 
72,323,102.00 No No 38 Women 
50.0 25.5 0.00 0.00 100.00 5.30 -16.6 
42,831,101.00 No No 35 Men 
0.0 25.5 0.00 0.00 100.00 5.20 -13.6 
72,833,102.00 No No 40 Men 
0.0 25.5 0.00 0.00 100.00 5.20 -18.2 
15,047,101.00 No No 86 Women 
0.0 25.5 0.00 0.00 100.00 0.00 -15.7 
23,202,102.00 No No 58 Women 
50.0 25.5 0.00 0.00 100.00 5.30 -17.6 
20,408,101.00 No No 44 Women 
50.0 25.5 0.00 0.00 100.00 5.30 -21.7 
76,910,102.00 No No 48 Women 
50.0 25.5 0.00 0.00 100.00 0.00 -18.7 
13,856,101.00 No No 51 Women 
50.0 25.5 0.00 0.00 100.00 0.00 -24.4 
21,413,101.00 Yes Yes 86 Men 
10.3 21.9 111.29 0.00 34.49 2.95 -11.5 
25,713,101.00 No No 38 Women 
50.0 25.5 0.00 0.00 100.00 5.30 -20.8 
29,646,101.00 No No 32 Women 
50.0 25.5 0.00 0.00 100.00 5.30 -17.3 
59,015,101.00 No No 31 Women 
50.0 25.5 0.00 0.00 100.00 5.30 -21.9 
48,733,102.00 No No 48 Women 
0.0 25.5 0.00 0.00 100.00 0.00 -11.0 
51,623,102.00 No No 49 Women 
0.0 25.5 140.00 0.00 0.00 5.30 -19.0 
71,718,102.00 No No 57 Women 
50.0 25.5 0.00 0.00 100.00 0.00 -20.3 
34,846,101.00 No No 32 Women 
50.0 25.5 0.00 0.00 100.00 0.00 -15.6 
20,023,102.00 No No 77 Women 
0.0 25.5 0.00 0.00 100.00 0.00 -11.3 
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Table 5.10B: Calculation of TPR, FPR, LRP, and LRN, for the MATLAB Model I for the 
first 30 participants 
Pserial no. Grp Bp1 Age Sex %PR EX NEX TPR FPR LRP LRM 
13,956,102.00 No No 60 Women 
-14.6 0 1 1 0.9997 3574 0 
63,535,102.00 Yes Yes 30 Women 
-15.4 0 1 1 0.9994 1787 0 
71,831,101.00 No No 66 Women 
-16.7 0 1 1 0.9991 1191.33 0 
34,031,101.00 No No 84 Women 
-18.0 0 1 1 0.9988 893.5 0 
72,604,102.00 No No 59 Women 
-18.9 0 1 1 0.9985 714.8 0 
13,008,101.00 Yes Yes 50 Women 
-16.3 0 1 1 0.9982 595.666 0 
39,139,101.00 No No 34 Women 
-21.4 1 0 0.9966 0.9982 510.571 0 
47,856,102.00 No No 51 Women 
-21.9 1 0 0.9932 0.9982 446.75 0 
37,710,101.00 No No 61 Women 
-15.2 0 1 0.9932 0.9979 397.11 0 
54,256,101.00 No No 31 Women 
-14.1 0 1 0.9932 0.9976 357.4 0 
53,817,101.00 No No 43 Women 
-19.6 0 1 0.9932 0.9973 324.90 0 
44,633,102.00 No No 39 Women 
-19.9 0 1 0.9932 0.9970 297.83 0 
34,523,102.00 No No 45 Women 
-15.7 0 1 0.9932 0.9967 274.92 0 
72,323,102.00 No No 38 Women 
-16.6 0 1 0.9932 0.9964 255.28 0 
42,831,101.00 No No 35 Men 
-13.6 0 1 0.9932 0.9961 238.26 0 
72,833,102.00 No No 40 Men 
-18.2 0 1 0.9932 0.9958 223.37 0 
15,047,101.00 No No 86 Women 
-15.7 0 1 0.9932 0.9955 210.23 0 
23,202,102.00 No No 58 Women 
-17.6 0 1 0.9932 0.9952 198.55 0 
20,408,101.00 No No 44 Women 
-21.7 1 0 0.9898 0.9952 188.10 0 
76,910,102.00 No No 48 Women 
-18.7 0 1 0.9898 0.9949 178.7 0 
13,856,101.00 No No 51 Women 
-24.4 1 0 0.9865 0.9949 176.18 0.014 
21,413,101.00 Yes Yes 86 Men 
-11.5 0 1 0.9865 0.9946 167.79 0.014 
25,713,101.00 No No 38 Women 
-20.8 1 0 0.9831 0.9946 160.16 0.014 
29,646,101.00 No No 32 Women 
-17.3 0 1 0.9831 0.9943 153.20 0.014 
59,015,101.00 No No 31 Women 
-21.9 1 0 0.9797 0.9943 146.81 0.014 
48,733,102.00 No No 48 Women 
-11.0 0 1 0.9797 0.9940 140.94 0.014 
51,623,102.00 No No 49 Women 
-19.0 0 1 0.9797 0.9937 135.52 0.014 
71,718,102.00 No No 57 Women 
-20.3 1 0 0.9764 0.9937 130.50 0.014 
34,846,101.00 No No 32 Women 
-15.6 0 1 0.9764 0.9934 125.84 0.014 
20,023,102.00 No No 77 Women 
-11.3 0 1 0.9764 0.9931 121.50 0.014 
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Table 5.11B: Initial Absolute Percentage Risks and attributes variable values for the first 30 
participants Model II 
Pserial no. Grp Bp1 Age Sex X1 X2 X3 X4 X5 X6 %PR 
13,956,102.00 No No 60 Women 50.1 22.6 31.4 1.0 50.3 3.3 12.8 
63,535,102.00 Yes Yes 30 Women 45.1 26.3 4.0 1.0 99.5 4.1 14.4 
71,831,101.00 No No 66 Women 10.3 14.1 102.7 1.0 19.2 6.5 12.2 
34,031,101.00 No No 84 Women 30.8 19.4 30.2 1.0 88.8 3.4 14.4 
72,604,102.00 No No 59 Women 35.7 9.1 34.4 1.0 76.7 6.5 13.4 
13,008,101.00 Yes Yes 50 Women 41.6 21.7 25.4 1.0 89.3 2.9 13.5 
39,139,101.00 No No 34 Women 36.1 21.3 2.4 1.0 100.2 2.7 19.1 
47,856,102.00 No No 51 Women 41.9 21.4 3.8 1.0 100.1 3.4 19.4 
37,710,101.00 No No 61 Women 48.9 24.4 3.4 1.0 98.7 5.4 14.1 
54,256,101.00 No No 31 Women 42.0 19.7 33.6 1.0 68.1 3.9 11.7 
53,817,101.00 No No 43 Women 45.0 20.3 22.6 1.0 99.3 3.5 16.3 
44,633,102.00 No No 39 Women 48.8 22.0 1.7 1.0 100.3 3.2 17.9 
34,523,102.00 No No 45 Women 19.7 19.4 31.3 1.0 87.0 3.5 12.9 
72,323,102.00 No No 38 Women 50.6 23.7 3.2 1.0 99.1 4.3 15.2 
42,831,101.00 No No 35 Men 10.4 20.8 41.0 1.0 82.3 3.9 11.6 
72,833,102.00 No No 40 Men 6.5 21.6 1.9 1.0 100.2 3.6 16.5 
15,047,101.00 No No 86 Women 11.2 17.8 53.6 1.0 78.6 2.5 12.2 
23,202,102.00 No No 58 Women 37.4 22.1 1.4 1.0 100.2 4.4 16.0 
20,408,101.00 No No 44 Women 48.1 21.0 1.7 1.0 100.3 3.5 19.4 
76,910,102.00 No No 48 Women 35.0 19.0 27.5 1.0 93.7 2.5 15.0 
13,856,101.00 No No 51 Women 8.1 10.6 115.0 1.0 0.0 3.3 1.8 
21,413,101.00 Yes Yes 86 Men 15.4 8.8 91.9 1.0 46.6 6.4 10.1 
25,713,101.00 No No 38 Women 50.6 20.9 1.9 1.0 99.9 4.0 18.7 
29,646,101.00 No No 32 Women 50.6 22.4 2.0 1.0 99.2 3.8 15.9 
59,015,101.00 No No 31 Women 48.2 20.8 1.7 1.0 100.3 3.7 19.6 
48,733,102.00 No No 48 Women 23.2 18.5 41.3 1.0 56.9 3.0 10.0 
51,623,102.00 No No 49 Women 10.8 18.8 123.2 1.0 19.9 3.5 14.2 
71,718,102.00 No No 57 Women 40.6 18.3 27.9 1.0 89.0 3.1 15.7 
34,846,101.00 No No 32 Women 47.8 23.6 2.1 1.0 100.2 2.3 14.4 
20,023,102.00 No No 77 Women 15.3 19.3 45.8 1.0 63.5 2.6 10.0 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                 CMAUT-UML Framework for Optimisation of CIS                                                     
 
 
268 
 
Table 5.12B: Calculation of TPR, FPR, LRP, and LRN, for the MATLAB Model II for the 
first 30 participants 
Pserial no. Grp Bp1 Age Sex %PR EX NEX TPR FPR LRP LRM 
13,956,102.00 No No 60 Women 
12.8 0 1 1 1.000 3571.43 0 
63,535,102.00 Yes Yes 30 Women 
14.4 0 1 1 0.999 1785.71 0 
71,831,101.00 No No 66 Women 
12.2 0 1 1 0.999 1191.90 0 
34,031,101.00 No No 84 Women 
14.4 0 1 1 0.999 893.66 0 
72,604,102.00 No No 59 Women 
13.4 0 1 1 0.999 714.80 0 
13,008,101.00 Yes Yes 50 Women 
13.5 0 1 1 0.998 595.59 0 
39,139,101.00 No No 34 Women 
19.1 0 1 1 0.998 510.46 0 
47,856,102.00 No No 51 Women 
19.4 0 1 1 0.998 446.83 0 
37,710,101.00 No No 61 Women 
14.1 0 1 1 0.997 397.14 0 
54,256,101.00 No No 31 Women 
11.7 0 1 1 0.997 357.40 0 
53,817,101.00 No No 43 Women 
16.3 0 1 1 0.997 324.89 0 
44,633,102.00 No No 39 Women 
17.9 0 1 1 0.997 297.80 0 
34,523,102.00 No No 45 Women 
12.9 0 1 1 0.996 274.95 0 
72,323,102.00 No No 38 Women 
15.2 0 1 1 0.996 255.30 0 
42,831,101.00 No No 35 Men 
11.6 0 1 1 0.996 238.27 0 
72,833,102.00 No No 40 Men 
16.5 0 1 1 0.996 223.36 0 
15,047,101.00 No No 86 Women 
12.2 0 1 1 0.995 210.22 0 
23,202,102.00 No No 58 Women 
16.0 0 1 1 0.995 198.57 0 
20,408,101.00 No No 44 Women 
19.4 0 1 1 0.995 188.11 0 
76,910,102.00 No No 48 Women 
15.0 0 1 1 0.994 178.70 0 
13,856,101.00 No No 51 Women 
1.8 1 0 0.986 0.994 176.18 0.0142 
21,413,101.00 Yes Yes 86 Men 
10.1 0 1 0.986 0.994 167.79 0.0142 
25,713,101.00 No No 38 Women 
18.7 0 1 0.986 0.994 160.16 0.0142 
29,646,101.00 No No 32 Women 
15.9 0 1 0.986 0.994 153.21 0.0142 
59,015,101.00 No No 31 Women 
19.6 0 1 0.986 0.993 146.82 0.0142 
48,733,102.00 No No 48 Women 
10.0 0 1 0.986 0.993 140.95 0.0142 
51,623,102.00 No No 49 Women 
14.2 0 1 0.986 0.993 135.52 0.0142 
71,718,102.00 No No 57 Women 
15.7 0 1 0.986 0.992 130.50 0.0142 
34,846,101.00 No No 32 Women 
14.4 0 1 0.986 0.992 125.85 0.0142 
20,023,102.00 No No 77 Women 
10.0 0 1 0.986 0.992 121.51 0.0142 
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Appendix 6.0 for Chapter 6: 
 
Appendix 6.1 
CMAUT Complementary system with three organs 
Example 2:  Similar procedure was used to convert the CMAUT expression with three organs that is 
                                        into a   set of inequalities. First convert the attributes         
             into common attribute utility units                      using the utility formula.   
                              into     and then to a set of inequalities (or constraints). The results of 
simplifying the clauses using the above algorithm are as follows: 
                                                      
                                (6.6) 
The numbers of Clauses that are obtained from the above       expression (6.6) is:  
                  
                
                
                             
To convert the first clause in the expression (6.6) into a set of inequalities, the following operation is carried out. 
Again, the results of transforming the clauses in the     above into a set of inequalities using Table 6.1 are:   
Consider the first three clauses in the expression (6.6) and convert them into set of inequalities; 
                                                 
                                                 
                                               ; 
Consider the fourth clause in the expression (6.6) and convert it into a set of inequalities 
                            
                           
                          
                         
                
               
Putting all the set of inequalities from the example 2 and expression (6.6) together, give the following: 
           
           
           
               
Other examples of how the above algorithm and Table 6.1 were used to solve and convert the       
expressions into set of inequalities are shown in appendix 6. 
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Non- CMAUT Complementary system with three organs 
Example 4:  For the purpose of comparison the blood pressure is set to be equivalent of the utility unit of the 
organ.  This means the utility unit    can take either blood pressure or blood volume values.  In this example the 
expression used is: -                                                          is used and also instead of     
the    is used and result of eliminating high level operations is:  
 (                               )                    
                                                          
The next stage using the algorithm is pushing the     connector to the innermost level and this gives the 
following result: 
 (                               )                    
                                                          
The next step is to push    operator to the innermost level which gives the results: 
                                                                   
                                                                   
                                                            . 
The final list of clauses after simplification is as follows: 
                                                                  
                             
The number of clauses the expression                                            generates is as 
below: 
1.             
2.             
3.             
4.             
5.             
6.             
To transform the clauses in the     into a set of inequalities, Table 6.1 was used and the results are presented 
below as: 
           
           
           
           
           
           
It is note that in all these conversion the number of clauses in the       are equal to the number of inequalities 
the expression generates. 
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CMAUT substitutable system with three organs 
Example 6:  this second example converts three substitutable organs with a common utility unit into a set of 
inequalities.  The example uses the expression                                   to generate the 
constraints.  This expression is rewritten in CMAUT format as  
                                                         
The attributes in the expression are converted into utility units, which are               the finally expression 
is written as                                            .  Upon simplification the list of clauses will 
be as follows: 
1.                                      
2.                                        
3.                                      
4.                                      
5.                                     
6.                                     
7.                                      
8.                                        
The set of inequalities with integer variables would be: 
                     
                     
                     
                     
                     
                     
                     
                     
 
Non- CMAUT substitutable system with three organs (OR) 
Example 8:- Similarly the            with three organs can be expressed as 
                                                and the number of clauses obtained after simplification is 
as follows: 
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The set of inequalities with integer variables would be: 
                     
                     
                     
                     
                     
                     
                     
                     
 
Comparing the above examples with those of the       CIS it can be inferred that the clauses and 
the set of inequalities are the same. Thus for substitutable organs      , where OR is used, the 
same expression can be used for both       and            CIS. 
 In Appendix 9 is Table 9.1 for the comparison of the inequalities constraints generated for 
substitutable and complementary data representation using CMAUT and Non- CMAUT:  
 Table 6.6C: Data sizes of the 402 participants before and after optimisation with CMAUT 
framework in electronic format:   
Table 6.6B: Data sizes for first 30 participants before and after optimisation with CMAUT 
No. Of participants Pserial no. Data size before 
optimisation ( bytes) 
Data size after optimisation 
(bytes) 
1 10,902,101.00 1256 465 
2 10,846,103.00 1251 464 
3 11,039,102.00 1251 463 
4 11,046,101.00 1251 465 
5 11,239,101.00 1245 464 
6 11,249,102.00 1244 464 
7 11,306,101.00 1249 464 
8 11,313,101.00 1245 463 
9 11,349,102.00 1243 464 
10 11,356,101.00 1262 464 
11 11,410,102.00 1260 463 
12 11,410,101.00 1241 465 
13 11,435,101.00 1253 463 
14 11,439,101.00 1231 464 
15 11,449,101.00 1244 463 
16 11,449,102.00 1266 464 
17 11,506,102.00 1606 463 
18 11,547,101.00 1222 464 
19 11,610,102.00 1256 463 
20 11,610,101.00 1248 462 
21 11,618,101.00 1273 463 
22 11,633,101.00 1269 465 
23 11,649,101.00 1230 463 
24 11,714,102.00 1245 465 
25 10,904,101.00 1234 465 
26 10,904,102.00 1252 463 
27 10,908,101.00 1242 464 
28 10,913,101.00 1229 464 
29 10,915,101.00 1266 463 
30 10,927,101.00 1268 463 
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Appendix 7.0 for Chapter 7: 
 
Table 7.3B: The Raw data of the first 30 participants used in Chapter 7: 
Pserial no. Grp Bp1 Age Sex Ethnic HB BMI BPH BPL HDL MAP DIA TC SMK CVD ECG 
13,956,102.00 No No 60 Women White 34.00 13.20 122.50 88.50 1.80 100.00 No 5.20 Yes No Yes 
63,535,102.00 Yes Yes 30 Women White 46.00 13.71 120.00 74.00 1.40 89.50 No 4.50 Yes Yes No 
71,831,101.00 No No 66 Women White 89.00 14.32 159.00 70.00 1.90 99.50 No 6.90 No No Yes 
34,031,101.00 No No 84 Women White 48.50 16.17 112.00 63.50 2.20 80.00 No 5.00 Yes Yes Yes 
72,604,102.00 No No 59 Women White 36.50 16.19 109.50 73.00 2.00 85.00 No 6.00 No No No 
13,008,101.00 Yes Yes 50 Women White 43.00 16.65 117.00 74.00 1.70 88.50 No 6.00 Yes Yes Yes 
39,139,101.00 No No 34 Women White 48.00 16.81 102.00 54.00 1.80 70.00 No 6.50 Yes No No 
47,856,102.00 No No 51 Women White 44.00 16.85 100.50 56.50 1.90 71.00 No 5.10 No No No 
37,710,101.00 No No 61 Women White 43.00 17.43 120.00 77.00 1.20 91.50 No 5.50 No No No 
54,256,101.00 No No 31 Women White 40.00 17.72 124.00 84.00 2.00 97.00 No 3.90 Yes No No 
53,817,101.00 No No 43 Women White 39.00 17.72 107.00 68.00 1.70 81.00 No 4.90 Yes No No 
44,633,102.00 No No 39 Women White 39.00 17.87 106.00 67.00 1.40 80.00 No 5.30 No No No 
34,523,102.00 No No 45 Women White 51.50 18.09 120.00 68.50 2.00 85.50 No 4.70 No No No 
72,323,102.00 No No 38 Women White 39.00 18.10 116.00 77.00 1.40 90.00 No 4.20 Yes Yes No 
42,831,101.00 No No 35 Men White 64.50 18.15 135.00 70.50 1.70 92.00 No 4.10 Yes No No 
72,833,102.00 No No 40 Men White 58.50 18.19 117.00 58.50 1.50 78.00 No 4.60 Yes No No 
15,047,101.00 No No 86 Women White 79.00 18.27 138.00 59.00 2.50 85.50 No 8.90 Yes No Yes 
23,202,102.00 No No 58 Women White 48.00 18.29 113.50 65.50 1.10 81.50 No 3.60 Yes No No 
20,408,101.00 No No 44 Women White 38.00 18.41 100.00 62.00 0.90 75.00 No 4.90 No No No 
76,910,102.00 No No 48 Women White 46.00 18.43 110.00 64.00 2.00 79.00 No 8.00 Yes No No 
13,856,101.00 No No 51 Women White 32.50 18.45 92.50 60.00 2.60 70.50 No 6.70 Yes No Yes 
21,413,101.00 Yes Yes 86 Men White 65.50 18.48 149.00 83.50 1.20 105.00 No 5.60 No Yes No 
25,713,101.00 No No 38 Women White 32.50 18.55 103.50 71.00 1.30 81.50 No 4.00 Yes No No 
29,646,101.00 No No 32 Women White 36.00 18.58 113.50 77.50 1.40 89.50 No 4.60 No No No 
59,015,101.00 No No 31 Women Asian or 
Asian 
British 
38.00 18.59 100.00 62.00 1.50 74.50 No 4.50 Yes No No 
48,733,102.00 No No 48 Women White 50.50 18.62 133.00 82.50 2.30 99.50 No 6.10 Yes No No 
51,623,102.00 No No 49 Women White 71.00 18.63 168.50 97.50 1.90 121.50 No 4.80 No No No 
71,718,102.00 No No 57 Women White 38.50 18.63 105.00 66.50 2.20 79.00 No 5.80 No No Yes 
34,846,101.00 No No 32 Women White 44.50 18.65 118.50 74.00 1.20 89.00 No 7.00 No No Yes 
20,023,102.00 No No 77 Women White 57.00 18.66 136.50 79.50 2.00 98.50 No 7.20 Yes No No 
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Table 7.4B: Predicative Percentage Risks for 10 years and attribute variable values for the 
first 30 participants (from Model I 3645 data sets) 
Pserial no. Grp Bp1 Age Sex X1 X2 X3 X4 X5 X6 %PR 
13,956,102.00 No No 60 Women 50.0 25.5 0.02 0.00 50.00 5.22 14.9 
63,535,102.00 Yes Yes 30 Women 45.8 25.9 4.15 0.00 100.19 4.28 16.3 
71,831,101.00 No No 66 Women 0.0 25.5 140.00 0.00 100.00 0.00 17.1 
34,031,101.00 No No 84 Women 50.0 25.5 0.00 0.00 100.00 5.30 19.0 
72,604,102.00 No No 59 Women 50.0 25.5 0.00 0.00 100.00 0.00 19.2 
13,008,101.00 Yes Yes 50 Women 50.0 25.5 0.00 0.00 100.00 0.00 17.3 
39,139,101.00 No No 34 Women 50.0 25.5 0.00 0.00 100.00 0.00 21.7 
47,856,102.00 No No 51 Women 50.0 25.5 0.01 0.00 100.00 5.23 22.2 
37,710,101.00 No No 61 Women 50.0 25.5 0.00 0.00 100.00 0.00 15.6 
54,256,101.00 No No 31 Women 50.0 25.5 0.00 0.00 100.00 5.30 14.4 
53,817,101.00 No No 43 Women 50.0 25.5 0.00 0.00 100.00 5.30 19.9 
44,633,102.00 No No 39 Women 50.0 25.4 0.04 0.00 100.01 2.67 20.2 
34,523,102.00 No No 45 Women 0.0 25.5 0.00 0.00 100.00 5.30 16.1 
72,323,102.00 No No 38 Women 50.0 25.5 0.00 0.00 100.00 5.30 17.5 
42,831,101.00 No No 35 Men 0.0 25.5 0.00 0.00 100.00 5.20 13.9 
72,833,102.00 No No 40 Men 0.0 25.5 0.00 0.00 100.00 5.20 18.5 
15,047,101.00 No No 86 Women 0.0 25.5 0.00 0.00 100.00 0.00 16.0 
23,202,102.00 No No 58 Women 50.0 25.5 0.00 0.00 100.00 5.30 17.9 
20,408,101.00 No No 44 Women 50.0 25.5 0.00 0.00 100.00 5.30 22.0 
76,910,102.00 No No 48 Women 50.0 25.5 0.00 0.00 100.00 0.00 19.0 
13,856,101.00 No No 51 Women 50.0 25.5 0.00 0.00 100.00 0.00 24.6 
21,413,101.00 Yes Yes 86 Men 10.3 21.9 111.29 0.00 34.49 2.95 11.7 
25,713,101.00 No No 38 Women 50.0 25.5 0.00 0.00 100.00 5.30 21.1 
29,646,101.00 No No 32 Women 50.0 25.5 0.00 0.00 100.00 5.30 17.6 
59,015,101.00 No No 31 Women 50.0 25.5 0.00 0.00 100.00 5.30 22.2 
48,733,102.00 No No 48 Women 0.0 25.5 0.00 0.00 100.00 0.00 11.4 
51,623,102.00 No No 49 Women 0.0 25.5 140.00 0.00 0.00 5.30 19.5 
71,718,102.00 No No 57 Women 50.0 25.5 0.00 0.00 100.00 0.00 20.5 
34,846,101.00 No No 32 Women 50.0 25.5 0.00 0.00 100.00 0.00 15.9 
20,023,102.00 No No 77 Women 0.0 25.5 0.00 0.00 100.00 0.00 14.9 
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Table 7.5B: Calculation of TPR, FPR, LRP, and LRN, for the MATLAB Model I PPR for 10 
years for the first 30 participants (from Model I 3645 data sets) 
Pserial no. Grp Bp1 Age Sex %PR EX NEX TPR FPR LRP LRN 
13,956,102.00 No No 60 Women 15.6 0 1 1 1.000 3278.7 0 
63,535,102.00 Yes Yes 30 Women 16.3 0 1 1 0.999 1639.3 0 
71,831,101.00 No No 66 Women 17.7 0 1 1 0.999 1092.9 0 
34,031,101.00 No No 84 Women 19.0 0 1 1 0.999 819.7 0 
72,604,102.00 No No 59 Women 19.8 0 1 1 0.998 655.7 0 
13,008,101.00 Yes Yes 50 Women 21.0 0 1 1 0.998 546.4 0 
39,139,101.00 No No 34 Women 19.4 1 0 0.997 0.998 545.0 0.0027 
47,856,102.00 No No 51 Women 17.2 1 0 0.995 0.998 543.5 0.0055 
37,710,101.00 No No 61 Women 18.3 0 1 0.995 0.998 465.8 0.0055 
54,256,101.00 No No 31 Women 22.2 0 1 0.995 0.998 407.4 0.0055 
53,817,101.00 No No 43 Women 22.8 0 1 0.995 0.997 362.2 0.0055 
44,633,102.00 No No 39 Women 20.2 1 0 0.992 0.997 361.2 0.0082 
34,523,102.00 No No 45 Women 19.2 0 1 0.992 0.997 325.1 0.0082 
72,323,102.00 No No 38 Women 20.4 0 1 0.992 0.997 295.5 0.0082 
42,831,101.00 No No 35 Men 16.2 0 1 0.992 0.996 270.9 0.0082 
72,833,102.00 No No 40 Men 21.5 0 1 0.992 0.996 250.1 0.0082 
15,047,101.00 No No 86 Women 20.0 0 1 0.992 0.996 232.2 0.0082 
23,202,102.00 No No 58 Women 18.2 0 1 0.992 0.995 216.7 0.0082 
20,408,101.00 No No 44 Women 18.0 1 0 0.989 0.995 216.1 0.0109 
76,910,102.00 No No 48 Women 18.1 0 1 0.989 0.995 202.6 0.0110 
13,856,101.00 No No 51 Women 18.4 1 0 0.986 0.995 202.1 0.0137 
21,413,101.00 Yes Yes 86 Men 15.0 0 1 0.986 0.995 190.2 0.0137 
25,713,101.00 No No 38 Women 20.5 1 0 0.984 0.995 189.7 0.0164 
29,646,101.00 No No 32 Women 15.5 0 1 0.984 0.995 179.1 0.0164 
59,015,101.00 No No 31 Women 22.0 1 0 0.981 0.995 178.6 0.0192 
48,733,102.00 No No 48 Women 20.8 0 1 0.981 0.994 169.2 0.0192 
51,623,102.00 No No 49 Women 23.8 0 1 0.981 0.994 160.8 0.0192 
71,718,102.00 No No 57 Women 21.9 1 0 0.978 0.994 160.3 0.0219 
34,846,101.00 No No 32 Women 16.7 0 1 0.978 0.994 152.7 0.0219 
20,023,102.00 No No 77 Women 11.8 0 1 0.978 0.993 145.8 0.0219 
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Table 7.13B: Predicative Percentage Risks for 10 years and attribute variable values for the 
first 30 participants Model II 
Pserial no. Grp Bp1 Age Sex X1 X2 X3 X4 X5 X6 %PPR 
13,956,102.00 No No 60 Women 50.0 25.5 0.02 0.00 50.00 5.22 14.79 
63,535,102.00 Yes Yes 30 Women 45.8 25.9 4.15 0.00 100.19 4.28 15.53 
71,831,101.00 No No 66 Women 0.0 25.5 140.00 0.00 100.00 0.00 16.42 
34,031,101.00 No No 84 Women 50.0 25.5 0.00 0.00 100.00 5.30 17.64 
72,604,102.00 No No 59 Women 50.0 25.5 0.00 0.00 100.00 0.00 18.26 
13,008,101.00 Yes Yes 50 Women 50.0 25.5 0.00 0.00 100.00 0.00 16.13 
39,139,101.00 No No 34 Women 50.0 25.5 0.00 0.00 100.00 0.00 20.28 
47,856,102.00 No No 51 Women 50.0 25.5 0.01 0.00 100.00 5.23 20.75 
37,710,101.00 No No 61 Women 50.0 25.5 0.00 0.00 100.00 0.00 15.26 
54,256,101.00 No No 31 Women 50.0 25.5 0.00 0.00 100.00 5.30 14.26 
53,817,101.00 No No 43 Women 50.0 25.5 0.00 0.00 100.00 5.30 18.81 
44,633,102.00 No No 39 Women 50.0 25.4 0.04 0.00 100.01 2.67 19.02 
34,523,102.00 No No 45 Women 0.0 25.5 0.00 0.00 100.00 5.30 15.65 
72,323,102.00 No No 38 Women 50.0 25.5 0.00 0.00 100.00 5.30 16.33 
42,831,101.00 No No 35 Men 0.0 25.5 0.00 0.00 100.00 5.20 13.86 
72,833,102.00 No No 40 Men 0.0 25.5 0.00 0.00 100.00 5.20 17.68 
15,047,101.00 No No 86 Women 0.0 25.5 0.00 0.00 100.00 0.00 15.67 
23,202,102.00 No No 58 Women 50.0 25.5 0.00 0.00 100.00 5.30 17.18 
20,408,101.00 No No 44 Women 50.0 25.5 0.00 0.00 100.00 5.30 20.58 
76,910,102.00 No No 48 Women 50.0 25.5 0.00 0.00 100.00 0.00 18.08 
13,856,101.00 No No 51 Women 50.0 25.5 0.00 0.00 100.00 0.00 22.76 
21,413,101.00 Yes Yes 86 Men 10.3 21.9 111.29 0.00 34.49 2.95 13.61 
25,713,101.00 No No 38 Women 50.0 25.5 0.00 0.00 100.00 5.30 19.57 
29,646,101.00 No No 32 Women 50.0 25.5 0.00 0.00 100.00 5.30 16.91 
59,015,101.00 No No 31 Women 50.0 25.5 0.00 0.00 100.00 5.30 20.68 
48,733,102.00 No No 48 Women 0.0 25.5 0.00 0.00 100.00 0.00 11.73 
51,623,102.00 No No 49 Women 0.0 25.5 140.00 0.00 0.00 5.30 18.14 
71,718,102.00 No No 57 Women 50.0 25.5 0.00 0.00 100.00 0.00 19.39 
34,846,101.00 No No 32 Women 50.0 25.5 0.00 0.00 100.00 0.00 15.54 
20,023,102.00 No No 77 Women 0.0 25.5 0.00 0.00 100.00 0.00 12.01 
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Table 7.14B: Calculation of TPR, FPR, LRP, and LRN, for the MATLAB Model II for 10 
years for the PPR first 30 participants 
Pserial no. Grp Bp1 Age Sex %PR EX NEX TPR FPR LRP LRM 
13,956,102.00 No No 60 Women 14.79 0 1 1 0.9997 3484.32 0 
63,535,102.00 Yes Yes 30 Women 15.53 0 1 1 0.9994 1745.20 0 
71,831,101.00 No No 66 Women 16.42 0 1 1 0.9991 1162.79 0 
34,031,101.00 No No 84 Women 17.64 0 1 1 0.9989 872.60 0 
72,604,102.00 No No 59 Women 18.26 0 1 1 0.9986 697.84 0 
13,008,101.00 Yes Yes 50 Women 16.13 0 1 1 0.9983 581.73 0 
39,139,101.00 No No 34 Women 20.28 1 0 0.9935 0.9983 577.98 0.0065 
47,856,102.00 No No 51 Women 20.75 1 0 0.9871 0.9983 574.23 0.0129 
37,710,101.00 No No 61 Women 15.26 0 1 0.9871 0.9980 492.07 0.0129 
54,256,101.00 No No 31 Women 14.26 0 1 0.9871 0.9977 430.67 0.0129 
53,817,101.00 No No 43 Women 18.81 0 1 0.9871 0.9974 382.74 0.0129 
44,633,102.00 No No 39 Women 19.02 0 1 0.9871 0.9971 344.54 0.0129 
34,523,102.00 No No 45 Women 15.65 0 1 0.9871 0.9968 313.17 0.0129 
72,323,102.00 No No 38 Women 16.33 0 1 0.9871 0.9966 287.11 0.0129 
42,831,101.00 No No 35 Men 13.86 0 1 0.9871 0.9963 264.99 0.0130 
72,833,102.00 No No 40 Men 17.68 0 1 0.9871 0.9960 246.10 0.0130 
15,047,101.00 No No 86 Women 15.67 0 1 0.9871 0.9957 229.66 0.0130 
23,202,102.00 No No 58 Women 17.18 0 1 0.9871 0.9954 215.29 0.0130 
20,408,101.00 No No 44 Women 20.58 1 0 0.9806 0.9954 213.88 0.0194 
76,910,102.00 No No 48 Women 18.08 0 1 0.9806 0.9951 201.32 0.0194 
13,856,101.00 No No 51 Women 22.76 1 0 0.9742 0.9951 200.00 0.0259 
21,413,101.00 Yes Yes 86 Men 13.61 0 1 0.9742 0.9948 188.87 0.0259 
25,713,101.00 No No 38 Women 19.57 0 1 0.9742 0.9946 178.95 0.0259 
29,646,101.00 No No 32 Women 16.91 0 1 0.9742 0.9943 169.99 0.0260 
59,015,101.00 No No 31 Women 20.68 1 0 0.9677 0.9943 168.86 0.0324 
48,733,102.00 No No 48 Women 11.73 0 1 0.9677 0.9940 160.83 0.0325 
51,623,102.00 No No 49 Women 18.14 0 1 0.9677 0.9937 153.51 0.0325 
71,718,102.00 No No 57 Women 19.39 0 1 0.9677 0.9934 146.85 0.0325 
34,846,101.00 No No 32 Women 15.54 0 1 0.9677 0.9931 140.72 0.0325 
20,023,102.00 No No 77 Women 12.01 0 1 0.9677 0.9928 135.10 0.0325 
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Appendix 8.0 for Chapter 8 
 
Appendix 8.1  
1. BHS - Cardiovascular Risk Charts and Calculators 
Cardiovascular Risk Charts and Calculators. The JBS CV Risk Assessor software is available 
to download from the Heart UK website with kind permission of ... 
www.bhsoc.org/Cardiovascular_Risk_Charts_and_Calculators.stm - Cached 
2. Primary Cardiovascular Risk Calculator | Doctor | Patient UK 
13 Jan 2011 – Primary Cardiovascular Risk Calculator - Cardiovascular Risk Calculator For 
Primary Prevention This calculator should not be used if patient ... 
www.patient.co.uk › PatientPlus - Cached - Similar 
3. Cardiovascular Risk Calculator and Chart v3.0 
28 May 2010 – There are also a number of alternative graphical displays that may be useful 
in discussing cardiovascular risk. There are a number of ... 
4. Calculator - Guidelines - Contacts cvrisk.mvm.ed.ac.uk/ - Cached - Similar 
 
5. Cardiac Risk Calculator 
The standalone Cardiac Risk Calculator from. Age Gender F M BP / T-chol. HDL ... 
www.cvhealth.ed.ac.uk/othercalcs/cardiacrisk.html - Show more results from ed.ac.uk 
6. QRISK2-2011 
Welcome to the QRISK®2-2011 risk calculator: http://qrisk.org. This calculator is only valid 
if you do not already have a diagnosis. ... Welcome to the QRISK®2-2011 cardiovascular 
disease risk calculator. Welcome to the QRISK®2-2011 Web ... 
qrisk.org/ - Cached 
7. Cardiac risk calculators 
Equates to a risk of complications (ie cardiac death, documented intra- or postoperative MI, 
pulmonary oedema or nonfatal ventricular tachycardia) ... 
www.vasgbi.com/riskdetsky.htm - Cached - Similar 
8. 10-year CVD Risk Calculator (Risk Assessment Tool for Estimating ... 
This tool is designed to estimate risk in adults aged 20 and older who do not have heart 
disease or diabetes. Use the calculator below to estimate 10-year ... 
hp2010.nhlbihin.net/atpiii/calculator.asp?usertype=prof - Cached - Similar 
9. Cardiovascular risk score 
13 Jun 2006 – A Risk Score for Cardiovascular Disease ... For any technical issues with the 
calculator or these web pages, please e-mail ... 
www.riskscore.org.uk/ - Cached - Similar 
10. CVD risk calculators - Clinical Knowledge Summaries 
Note that the QRISK® cardiovascular lifetime risk calculator is different and does not 
calculate 10-year risk of cardiovascular disease. ... 
www.cks.nhs.uk/cvd_risk...risk/cvd_risk_calculators - Cached - Similar 
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Appendix 8.2: 
Output screen shots from the old Version 24 (2009) of the www.patient.co.uk website: 
 
 
The output for participant one from the old version of Patient UK Website 
 
 
The outputs for participant two from the old version of Patient UK Website: 
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Table 8.1B: The Raw data of the first 30 participants used in Chapter 8: 
Pserial no. Grp Bp1 Age Sex Ethnic HB BMI BPH BPL HDL MAP DIA TC SMK CVD ECG 
13,956,102.00 No No 60 Women White 34.00 13.20 122.50 88.50 1.80 100.00 No 5.20 Yes No Yes 
63,535,102.00 Yes Yes 30 Women White 46.00 13.71 120.00 74.00 1.40 89.50 No 4.50 Yes Yes No 
71,831,101.00 No No 66 Women White 89.00 14.32 159.00 70.00 1.90 99.50 No 6.90 No No Yes 
34,031,101.00 No No 84 Women White 48.50 16.17 112.00 63.50 2.20 80.00 No 5.00 Yes Yes Yes 
72,604,102.00 No No 59 Women White 36.50 16.19 109.50 73.00 2.00 85.00 No 6.00 No No No 
13,008,101.00 Yes Yes 50 Women White 43.00 16.65 117.00 74.00 1.70 88.50 No 6.00 Yes Yes Yes 
39,139,101.00 No No 34 Women White 48.00 16.81 102.00 54.00 1.80 70.00 No 6.50 Yes No No 
47,856,102.00 No No 51 Women White 44.00 16.85 100.50 56.50 1.90 71.00 No 5.10 No No No 
37,710,101.00 No No 61 Women White 43.00 17.43 120.00 77.00 1.20 91.50 No 5.50 No No No 
54,256,101.00 No No 31 Women White 40.00 17.72 124.00 84.00 2.00 97.00 No 3.90 Yes No No 
53,817,101.00 No No 43 Women White 39.00 17.72 107.00 68.00 1.70 81.00 No 4.90 Yes No No 
44,633,102.00 No No 39 Women White 39.00 17.87 106.00 67.00 1.40 80.00 No 5.30 No No No 
34,523,102.00 No No 45 Women White 51.50 18.09 120.00 68.50 2.00 85.50 No 4.70 No No No 
72,323,102.00 No No 38 Women White 39.00 18.10 116.00 77.00 1.40 90.00 No 4.20 Yes Yes No 
42,831,101.00 No No 35 Men White 64.50 18.15 135.00 70.50 1.70 92.00 No 4.10 Yes No No 
72,833,102.00 No No 40 Men White 58.50 18.19 117.00 58.50 1.50 78.00 No 4.60 Yes No No 
15,047,101.00 No No 86 Women White 79.00 18.27 138.00 59.00 2.50 85.50 No 8.90 Yes No Yes 
23,202,102.00 No No 58 Women White 48.00 18.29 113.50 65.50 1.10 81.50 No 3.60 Yes No No 
20,408,101.00 No No 44 Women White 38.00 18.41 100.00 62.00 0.90 75.00 No 4.90 No No No 
76,910,102.00 No No 48 Women White 46.00 18.43 110.00 64.00 2.00 79.00 No 8.00 Yes No No 
13,856,101.00 No No 51 Women White 32.50 18.45 92.50 60.00 2.60 70.50 No 6.70 Yes No Yes 
21,413,101.00 Yes Yes 86 Men White 65.50 18.48 149.00 83.50 1.20 105.00 No 5.60 No Yes No 
25,713,101.00 No No 38 Women White 32.50 18.55 103.50 71.00 1.30 81.50 No 4.00 Yes No No 
29,646,101.00 No No 32 Women White 36.00 18.58 113.50 77.50 1.40 89.50 No 4.60 No No No 
59,015,101.00 No No 31 Women Asian 
or 
Asian 
British 
38.00 18.59 100.00 62.00 1.50 74.50 No 4.50 Yes No No 
48,733,102.00 No No 48 Women White 50.50 18.62 133.00 82.50 2.30 99.50 No 6.10 Yes No No 
51,623,102.00 No No 49 Women White 71.00 18.63 168.50 97.50 1.90 121.50 No 4.80 No No No 
71,718,102.00 No No 57 Women White 38.50 18.63 105.00 66.50 2.20 79.00 No 5.80 No No Yes 
34,846,101.00 No No 32 Women White 44.50 18.65 118.50 74.00 1.20 89.00 No 7.00 No No Yes 
20,023,102.00 No No 77 Women White 57.00 18.66 136.50 79.50 2.00 98.50 No 7.20 Yes No No 
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Table 8.2B: Predicative Percentage Risks of 10 years for the first 30 participants based on Internet 
Model – I NHS BlackHeath centre (ref: http://www.bhgp.co.uk/chdriskresult.asp). 
 
Pserial no. Age Sex BMI BPH BPL HDL DIA TC SMK ECG % PR 
13,956,102.00 60 Women 13.20 122.50 88.50 1.80 No 5.20 Yes Yes 7  7 
63,535,102.00 30 Women 13.71 120.00 74.00 1.40 No 4.50 Yes No 1 1 
71,831,101.00 66 Women 14.32 159.00 70.00 1.90 No 6.90 No Yes 8  8 
34,031,101.00 84 Women 16.17 112.00 63.50 2.20 No 5.00 Yes Yes 3  NA 
72,604,102.00 59 Women 16.19 109.50 73.00 2.00 No 6.00 No No 3 3 
13,008,101.00 50 Women 16.65 117.00 74.00 1.70 No 6.00 Yes Yes 1 3 
39,139,101.00 34 Women 16.81 102.00 54.00 1.80 No 6.50 Yes No 2 1 
47,856,102.00 51 Women 16.85 100.50 56.50 1.90 No 5.10 No No 11 2 
37,710,101.00 61 Women 17.43 120.00 77.00 1.20 No 5.50 No No 0 11 
54,256,101.00 31 Women 17.72 124.00 84.00 2.00 No 3.90 Yes No 1 0 
53,817,101.00 43 Women 17.72 107.00 68.00 1.70 No 4.90 Yes No 1 1 
44,633,102.00 39 Women 17.87 106.00 67.00 1.40 No 5.30 No No 2 1 
34,523,102.00 45 Women 18.09 120.00 68.50 2.00 No 4.70 No No 1 2 
72,323,102.00 38 Women 18.10 116.00 77.00 1.40 No 4.20 Yes No 3 1 
42,831,101.00 35 Men 18.15 135.00 70.50 1.70 No 4.10 Yes No (5 ) 3 
72,833,102.00 40 Men 18.19 117.00 58.50 1.50 No 4.60 Yes No 6 5 
15,047,101.00 86 Women 18.27 138.00 59.00 2.50 No 8.90 Yes Yes 3 NA 
23,202,102.00 58 Women 18.29 113.50 65.50 1.10 No 3.60 Yes No 4 8 
20,408,101.00 44 Women 18.41 100.00 62.00 0.90 No 4.90 No No 3 2 
76,910,102.00 48 Women 18.43 110.00 64.00 2.00 No 8.00 Yes No 1 4 
13,856,101.00 51 Women 18.45 92.50 60.00 2.60 No 6.70 Yes Yes 0 3 
21,413,101.00 86 Men 18.48 149.00 83.50 1.20 No 5.60 No No 0 NA 
25,713,101.00 38 Women 18.55 103.50 71.00 1.30 No 4.00 Yes No 4 1 
29,646,101.00 32 Women 18.58 113.50 77.50 1.40 No 4.60 No No 5 0 
59,015,101.00 31 Women 18.59 100.00 62.00 1.50 No 4.50 Yes No 3 0 
48,733,102.00 48 Women 18.62 133.00 82.50 2.30 No 6.10 Yes No 1 4 
51,623,102.00 49 Women 18.63 168.50 97.50 1.90 No 4.80 No No 10 5 
71,718,102.00 57 Women 18.63 105.00 66.50 2.20 No 5.80 No Yes 7 3 
34,846,101.00 32 Women 18.65 118.50 74.00 1.20 No 7.00 No Yes 2 1 
20,023,102.00 77 Women 18.66 136.50 79.50 2.00 No 7.20 Yes No 1NA 
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Table 8.3B: Calculation of TPR, FPR, LRP, and LRN, for the Internet Model I for the first 30 
Participants NHS BlackHeath centre (ref: http://www.bhgp.co.uk/chdriskresult.asp) 
 
Pserial no. Grp Bp1 Age Sex %PR EX NEX TPR FPR LRP LRM 
13,956,102.00 No No 60 Women 7 0 1 1 0.99968 3125 0 
63,535,102.00 Yes Yes 30 Women 1 0 1 1 0.99936 1562.5 0 
71,831,101.00 No No 66 Women 8 0 1 1 0.999041 1042.753 0 
34,031,101.00 No No 84 Women 3 0 1 1 0.998721 781.8608 0 
72,604,102.00 No No 59 Women 3 0 1 1 0.998401 625.3909 0 
13,008,101.00 Yes Yes 50 Women 1 0 1 1 0.998081 521.1047 0 
39,139,101.00 No No 34 Women 2 0 1 1 0.997761 446.628 0 
47,856,102.00 No No 51 Women 11 0 1 1 0.997442 390.9304 0 
37,710,101.00 No No 61 Women 0 0 1 1 0.997122 347.4635 0 
54,256,101.00 No No 31 Women 1 0 1 1 0.996802 312.6954 0 
53,817,101.00 No No 43 Women 1 0 1 1 0.996482 284.2524 0 
44,633,102.00 No No 39 Women 2 0 1 1 0.996162 260.5524 0 
34,523,102.00 No No 45 Women 1 0 1 1 0.995843 240.5581 0 
72,323,102.00 No No 38 Women 3 0 1 1 0.995523 223.3639 0 
42,831,101.00 No No 35 Men 5 0 1 1 0.995203 208.4636 0 
72,833,102.00 No No 40 Men 6 0 1 1 0.994883 195.427 0 
15,047,101.00 No No 86 Women 3 0 1 1 0.994563 183.925 0 
23,202,102.00 No No 58 Women 4 0 1 1 0.994244 173.7318 0 
20,408,101.00 No No 44 Women 3 0 1 1 0.993924 164.582 0 
76,910,102.00 No No 48 Women 1 0 1 1 0.993604 156.3477 0 
13,856,101.00 No No 51 Women 0 0 1 1 0.993284 148.8982 0 
21,413,101.00 Yes Yes 86 Men 0 0 1 1 0.992965 142.1464 0 
25,713,101.00 No No 38 Women 4 0 1 1 0.992645 135.9619 0 
29,646,101.00 No No 32 Women 5 0 1 1 0.992325 130.2932 0 
59,015,101.00 No No 31 Women 3 0 1 1 0.992005 125.0782 0 
48,733,102.00 No No 48 Women 1 0 1 1 0.991685 120.2646 0 
51,623,102.00 No No 49 Women 10 0 1 1 0.991366 115.8212 0 
71,718,102.00 No No 57 Women 7 0 1 1 0.991046 111.6819 0 
34,846,101.00 No No 32 Women 2 0 1 1 0.990726 107.8283 0 
20,023,102.00 No No 77 Women 1 0 1 1 0.990406 104.2318 0 
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Table 8.4B: Predicative Percentage Risks for 10 years for the first 30 participants based on Internet 
Model – II Patient UK User Survey (ref: http://www.patient.co.uk/doctor/Primary-Cardiovascular-
Risk-Calculator.htm) 
Pserial no. Age Sex BMI BPH BPL HDL DIA TC SMK ECG % PR 
13,956,102.00 60 Women 13.20 122.50 88.50 1.80 No 5.20 Yes Yes 9 21 
63,535,102.00 30 Women 13.71 120.00 74.00 1.40 No 4.50 Yes No 4.3 0.5 
71,831,101.00 66 Women 14.32 159.00 70.00 1.90 No 6.90 No Yes 20.9 30 
34,031,101.00 84 Women 16.17 112.00 63.50 2.20 No 5.00 Yes Yes 17.5 NA 
72,604,102.00 59 Women 16.19 109.50 73.00 2.00 No 6.00 No No 11.8 4 
13,008,101.00 50 Women 16.65 117.00 74.00 1.70 No 6.00 Yes Yes 9.3 17* 
39,139,101.00 34 Women 16.81 102.00 54.00 1.80 No 6.50 Yes No 8.7 0.5 
47,856,102.00 51 Women 16.85 100.50 56.50 1.90 No 5.10 No No 10 2 
37,710,101.00 61 Women 17.43 120.00 77.00 1.20 No 5.50 No No 7.5 8 
54,256,101.00 31 Women 17.72 124.00 84.00 2.00 No 3.90 Yes No 4.8 0.5 
53,817,101.00 43 Women 17.72 107.00 68.00 1.70 No 4.90 Yes No 6.8 2* 
44,633,102.00 39 Women 17.87 106.00 67.00 1.40 No 5.30 No No 5.8 1 
34,523,102.00 45 Women 18.09 120.00 68.50 2.00 No 4.70 No No 8.6 1 
72,323,102.00 38 Women 18.10 116.00 77.00 1.40 No 4.20 Yes No 4.6 4 
42,831,101.00 35 Men 18.15 135.00 70.50 1.70 No 4.10 Yes No  1.7 2* 
72,833,102.00 40 Men 18.19 117.00 58.50 1.50 No 4.60 Yes No 2.5 2* 
15,047,101.00 86 Women 18.27 138.00 59.00 2.50 No 8.90 Yes Yes 46 NA 
23,202,102.00 58 Women 18.29 113.50 65.50 1.10 No 3.60 Yes No 5.2 8 
20,408,101.00 44 Women 18.41 100.00 62.00 0.90 No 4.90 No No 4.3 3 
76,910,102.00 48 Women 18.43 110.00 64.00 2.00 No 8.00 Yes No 14.4 6 
13,856,101.00 51 Women 18.45 92.50 60.00 2.60 No 6.70 Yes Yes 14.9 11 
21,413,101.00 86 Men 18.48 149.00 83.50 1.20 No 5.60 No No 7.3 NA 
25,713,101.00 38 Women 18.55 103.50 71.00 1.30 No 4.00 Yes No 4.1 1 
29,646,101.00 32 Women 18.58 113.50 77.50 1.40 No 4.60 No No 4.2 0.5 
59,015,101.00 31 Women 18.59 100.00 62.00 1.50 No 4.50 Yes No 4.6 0.5 
48,733,102.00 48 Women 18.62 133.00 82.50 2.30 No 6.10 Yes No 12.1 5 
51,623,102.00 49 Women 18.63 168.50 97.50 1.90 No 4.80 No No 8.9 5 
71,718,102.00 57 Women 18.63 105.00 66.50 2.20 No 5.80 No Yes 12.7 8 
34,846,101.00 32 Women 18.65 118.50 74.00 1.20 No 7.00 No Yes 5.5 3 
20,023,102.00 77 Women 18.66 136.50 79.50 2.00 No 7.20 Yes No 20.2 NA 
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Table 8.5B: Calculation of TPR, FPR, LRP, and LRN, for the Internet Model – II for the first 
30 participants Patient UK User Survey (ref: http://www.patient.co.uk/doctor/Primary-
Cardiovascular-Risk-Calculator.htm) 
Pserial no. Grp Bp1 Age Sex %PR EX NEX TPR FPR LRP LRN 
13,956,102.00 No No 60 Women 9 0 1 1 0.9997 3584.22 0 
63,535,102.00 Yes Yes 30 Women 4.3 0 1 1 0.9994 1788.90 0 
71,831,101.00 No No 66 Women 20.9 1 0 0.984848 0.9994 1761.80 0.01516 
34,031,101.00 No No 84 Women 17.5 0 1 0.984848 0.9991 1175.23 0.01516 
72,604,102.00 No No 59 Women 11.8 0 1 0.984848 0.9988 880.90 0.01516 
13,008,101.00 Yes Yes 50 Women 9.3 0 1 0.984848 0.9986 704.97 0.01517 
39,139,101.00 No No 34 Women 8.7 0 1 0.984848 0.9983 587.61 0.01517 
47,856,102.00 No No 51 Women 10 0 1 0.984848 0.9980 503.50 0.01518 
37,710,101.00 No No 61 Women 7.5 0 1 0.984848 0.9977 440.64 0.01518 
54,256,101.00 No No 31 Women 4.8 0 1 0.984848 0.9974 391.58 0.01519 
53,817,101.00 No No 43 Women 6.8 0 1 0.984848 0.9972 352.48 0.01519 
44,633,102.00 No No 39 Women 5.8 0 1 0.984848 0.9969 320.48 0.01519 
34,523,102.00 No No 45 Women 8.6 0 1 0.984848 0.9966 293.72 0.01520 
72,323,102.00 No No 38 Women 4.6 0 1 0.984848 0.9963 271.15 0.01520 
42,831,101.00 No No 35 Men 1.7 0 1 0.984848 0.9960 251.75 0.01521 
72,833,102.00 No No 40 Men 2.5 0 1 0.984848 0.9958 234.992 0.01521 
15,047,101.00 No No 86 Women 46 1 0 0.969697 0.9958 231.37 0.03043 
23,202,102.00 No No 58 Women 5.2 0 1 0.969697 0.9955 216.889 0.03043 
20,408,101.00 No No 44 Women 4.3 0 1 0.969697 0.9952 204.14 0.03044 
76,910,102.00 No No 48 Women 14.4 0 1 0.969697 0.9949 192.82 0.03045 
13,856,101.00 No No 51 Women 14.9 0 1 0.969697 0.9946 182.655 0.03046 
21,413,101.00 Yes Yes 86 Men 7.3 0 1 0.969697 0.9944 173.53 0.03047 
25,713,101.00 No No 38 Women 4.1 0 1 0.969697 0.9941 165.257 0.03048 
29,646,101.00 No No 32 Women 4.2 0 1 0.969697 0.9938 157.75 0.03049 
59,015,101.00 No No 31 Women 4.6 0 1 0.969697 0.9935 150.90 0.03049 
48,733,102.00 No No 48 Women 12.1 0 1 0.969697 0.9932 144.60 0.03050 
51,623,102.00 No No 49 Women 8.9 0 1 0.969697 0.9930 138.82 0.03051 
71,718,102.00 No No 57 Women 12.7 0 1 0.969697 0.9927 133.47 0.03052 
34,846,101.00 No No 32 Women 5.5 0 1 0.969697 0.9924 128.53 0.03053 
20,023,102.00 No No 77 Women 20.2 1 0 0.954545 0.9924 126.53 0.04580 
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Table 8.6B: Predicative Percentage Risks of 10 years for the first 30 participants based on 
Framingham equation model I – II – III (I – USA, II – International, III – UK) 
Pserial no. Grp Bp1 Age Sex Ethnic USA_PR INT_PR UKMEN_P
R 
UK_PR 
13,956,102.00 No No 60 Women White 17.58 17.58 0.00 17.58 
63,535,102.00 Yes Yes 30 Women White 0.13 0.13 0.00 0.13 
71,831,101.00 No No 66 Women White 22.55 22.55 0.00 22.55 
34,031,101.00 No No 84 Women White 12.87 12.87 0.00 12.87 
72,604,102.00 No No 59 Women White 2.82 2.82 0.00 2.82 
13,008,101.00 Yes Yes 50 Women White 15.12 15.12 0.00 15.12 
39,139,101.00 No No 34 Women White 0.40 0.40 0.00 0.40 
47,856,102.00 No No 51 Women White 1.22 1.22 0.00 1.22 
37,710,101.00 No No 61 Women White 7.02 7.02 0.00 7.02 
54,256,101.00 No No 31 Women White 0.05 0.05 0.00 0.05 
53,817,101.00 No No 43 Women White 1.59 1.59 0.00 1.59 
44,633,102.00 No No 39 Women White 0.66 0.66 0.00 0.66 
34,523,102.00 No No 45 Women White 0.82 0.82 0.00 0.82 
72,323,102.00 No No 38 Women White 0.97 0.97 0.00 0.97 
42,831,101.00 No No 35 Men White 1.74 1.74 1.74 1.74 
72,833,102.00 No No 40 Men White 3.18 3.18 3.18 3.18 
15,047,101.00 No No 86 Women White 26.00 26.00 0.00 26.00 
23,202,102.00 No No 58 Women White 6.27 6.27 0.00 6.27 
20,408,101.00 No No 44 Women White 2.43 2.43 0.00 2.43 
76,910,102.00 No No 48 Women White 4.85 4.85 0.00 4.85 
13,856,101.00 No No 51 Women White 7.37 7.37 0.00 7.37 
21,413,101.00 Yes Yes 86 Men White 31.65 31.65 31.65 31.65 
25,713,101.00 No No 38 Women White 0.75 0.75 0.00 0.75 
29,646,101.00 No No 32 Women White 0.08 0.08 0.00 0.08 
59,015,101.00 No No 31 Women Asian or 
Asian 
British 0.08 0.08 0.00 0.08 
48,733,102.00 No No 48 Women White 3.69 3.69 0.00 3.69 
51,623,102.00 No No 49 Women White 3.18 3.18 0.00 3.18 
71,718,102.00 No No 57 Women White 7.17 7.17 0.00 7.17 
34,846,101.00 No No 32 Women White 2.37 2.37 0.00 2.37 
20,023,102.00 No No 77 Women White 11.87 11.87 0.00 11.87 
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Table 8.7B: Calculation of TPR, FPR, LRP, and LRN, for the for the first 30 participants 
based on Framingham equation model I – II – III (I – USA, II – International, III – UK) 
Pserial no. Grp Bp1 Age Sex %PR EX NEX TPR FPR LRP LRN 
13,956,102.00 No No 60 Women 17.58 0 1 1 1.00 2808.99 0 
63,535,102.00 Yes Yes 30 Women 0.13 0 1 1 1.00 1406.47 0 
71,831,101.00 No No 66 Women 22.55 1 0 0.9988 0.9993 1404.7820 0.0012 
34,031,101.00 No No 84 Women 12.87 0 1 0.9988 0.9989 936.0825 0.0012 
72,604,102.00 No No 59 Women 2.82 0 1 0.9988 0.9986 702.3910 0.0012 
13,008,101.00 Yes Yes 50 Women 15.12 0 1 0.9988 0.9982 561.7548 0.0012 
39,139,101.00 No No 34 Women 0.40 0 1 0.9988 0.9979 468.0412 0.0012 
47,856,102.00 No No 51 Women 1.22 0 1 0.9988 0.9975 401.2857 0.0012 
37,710,101.00 No No 61 Women 7.02 0 1 0.9988 0.9972 351.0721 0.0012 
54,256,101.00 No No 31 Women 0.05 0 1 0.9988 0.9968 312.0275 0.0012 
53,817,101.00 No No 43 Women 1.59 0 1 0.9988 0.9964 280.8774 0.0012 
44,633,102.00 No No 39 Women 0.66 0 1 0.9988 0.9961 255.3170 0.0012 
34,523,102.00 No No 45 Women 0.82 0 1 0.9988 0.9957 234.0755 0.0012 
72,323,102.00 No No 38 Women 0.97 0 1 0.9988 0.9954 216.0502 0.0012 
42,831,101.00 No No 35 Men 1.74 0 1 0.9988 0.9950 200.6025 0.0012 
72,833,102.00 No No 40 Men 3.18 0 1 0.9988 0.9947 187.2516 0.0012 
15,047,101.00 No No 86 Women 26.00 1 0 0.9976 0.9947 187.0264 0.0024 
23,202,102.00 No No 58 Women 6.27 0 1 0.9976 0.9943 175.3250 0.0024 
20,408,101.00 No No 44 Women 2.43 0 1 0.9976 0.9940 165.0015 0.0024 
76,910,102.00 No No 48 Women 4.85 0 1 0.9976 0.9936 155.8505 0.0024 
13,856,101.00 No No 51 Women 7.37 0 1 0.9976 0.9932 147.6393 0.0024 
21,413,101.00 Yes Yes 86 Men 31.65 1 0 0.9964 0.9932 147.4617 0.0036 
25,713,101.00 No No 38 Women 0.75 0 1 0.9964 0.9929 140.1011 0.0036 
29,646,101.00 No No 32 Women 0.08 0 1 0.9964 0.9925 133.4225 0.0036 
59,015,101.00 No No 31 Women 0.08 0 1 0.9964 0.9922 127.3516 0.0036 
48,733,102.00 No No 48 Women 3.69 0 1 0.9964 0.9918 121.8241 0.0036 
51,623,102.00 No No 49 Women 3.18 0 1 0.9964 0.9915 116.7427 0.0036 
71,718,102.00 No No 57 Women 7.17 0 1 0.9964 0.9911 112.0809 0.0036 
34,846,101.00 No No 32 Women 2.37 0 1 0.9964 0.9908 107.7654 0.0036 
20,023,102.00 No No 77 Women 11.87 0 1 0.9964 0.9904 103.7699 0.0036 
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Appendix 9.0 for Chapter 9 
 
Table 9.1B: No. of CMAUT and Non-CMAUT constraints for substitutable and complementary  
No of organs  (x) in the 
(OR)/(AND)  
combinatorial  
No of  constraints 
(inequalities) (y) for AND 
with CMAUT 
No of  constraints 
(inequalities) (y) for OR with 
and without CMAUT 
No of  constraints 
(inequalities) (y) for AND 
with non- CMAUT 
2 3 4 4 
3 4 8 6 
4 5 16 8 
5 6 32 10 
6 7 64 12 
7 8 128 14 
8 9 256 16 
9 10 512 18 
10 11 1024 20 
11 12 2048 22 
12 13 4096 24 
13 14 8192 26 
14 15 16384 28 
15 16 32768 30 
16 17 65536 32 
 
Table 9.2B: Data sizes for first 30 participants before and after optimisation with CMAUT model: 
Table 9.2C: Data sizes for 402 participants before and after optimisation with CMAUT framework: 
 
Table 9.2B: Data size for first 30 participants before and after optimisation with CMAUT: 
No. Of participants Pserial no. Data size before 
optimisation ( bytes) 
Data size after optimisation 
(bytes) 
1 10102102.00 1191 462 
2 10104102.00 1195 462 
3 10106101.00 1240 464 
4 10117101.00 1213 464 
5 10135101.00 1203 463 
6 10135102.00 1235 464 
7 10147102.00 1227 464 
8 10149101.00 1225 463 
9 10156102.00 1195 463 
10 10206101.00 1220 465 
11 10208101.00 1199 463 
12 10306101.00 1170 464 
13 10314101.00 1208 463 
14 10318101.00 1206 465 
15 10323101.00 1242 462 
16 10333101.00 1215 464 
17 10333102.00 1206 463 
18 10335101.00 1262 463 
19 10408101.00 1243 464 
20 10408102.00 1242 464 
21 10418101.00 1199 464 
22 10418102.00 1223 464 
23 10446101.00 1209 463 
24 10506102.00 1265 465 
25 10608101.00 1218 464 
26 10710101.00 1221 466 
27 10713101.00 1227 464 
28 10806101.00 1219 463 
29 10808101.00 1221 465 
30 10815102.00 1213 463 
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Table 9.4B: Comparison of Absolute Percentage Risk values from CMAUT models 1 and 2 
using the first 30 participants: 
Pserial no. Grp Bp1 Age Sex %PR(M-I Absol) 
%PR(M-
II Abso) 
%PR(M-
I Pre) 
%PR(M-II 
Pre) 
%PR(I-I 
Pr) 
%PR(I-II 
Pre) 
%PR(F-
I P) 
13,956,102.00 No No 60 Women 14.6 13.8 15.6 14.79 7 9 17.58 
63,535,102.00 Yes Yes 30 Women 15.4 14.6 16.3 15.53 1 4.3 0.13 
71,831,101.00 No No 66 Women 16.7 15.4 17.7 16.42 8 20.9 22.55 
34,031,101.00 No No 84 Women 18.0 16.6 19.0 17.64 3 17.5 12.87 
72,604,102.00 No No 59 Women 18.9 17.3 19.8 18.26 3 11.8 2.82 
31,510,102.00 No No 20 Women 20.1 15.2 21.0 16.13 1 9.3 15.12 
18,633,105.00 No No 16 Women 18.5 19.5 19.4 20.28 2 8.7 0.40 
13,008,101.00 Yes Yes 50 Women 16.3 19.9 17.2 20.75 11 10 1.22 
60,417,102.00 No No 16 Men 17.4 14.3 18.3 15.26 0 7.5 7.02 
39,139,101.00 No No 34 Women 21.4 13.3 22.2 14.26 1 4.8 0.05 
47,856,102.00 No No 51 Women 21.9 17.9 22.8 18.81 1 6.8 1.59 
49,147,103.00 No No 16 Women 19.4 18.1 20.2 19.02 2 5.8 0.66 
66,035,102.00 No No 18 Men 18.3 14.7 19.2 15.65 1 8.6 0.82 
80,356,105.00 No No 17 Men 19.5 15.4 20.4 16.33 3 4.6 0.97 
37,710,101.00 No No 61 Women 15.2 12.9 16.2 13.86 5 1.7 1.74 
20,556,101.00 No No 18 Men 20.7 16.8 21.5 17.68 6 2.5 3.18 
64,735,105.00 No No 16 Women 19.1 14.7 20.0 15.67 3 46 26.00 
46,449,104.00 No No 26 Women 17.3 16.2 18.2 17.18 4 5.2 6.27 
66,114,101.00 No No 24 Women 17.1 19.7 18.0 20.58 3 4.3 2.43 
50,956,101.00 No No 23 Women 17.3 17.2 18.1 18.08 1 14.4 4.85 
80,002,104.00 No No 16 Men 17.5 21.9 18.4 22.76 0 14.9 7.37 
54,256,101.00 No No 31 Women 14.1 12.6 15.0 13.61 0 7.3 31.65 
53,817,101.00 No No 43 Women 19.6 18.7 20.5 19.57 4 4.1 0.75 
13,433,101.00 No No 24 Men 14.5 16.0 15.5 16.91 5 4.2 0.08 
42,431,101.00 No No 27 Women 21.2 19.9 22.0 20.68 3 4.6 0.08 
44,633,102.00 No No 39 Women 19.9 10.7 20.8 11.73 1 12.1 3.69 
14,602,104.00 No No 18 Women 23.0 17.2 23.8 18.14 10 8.9 3.18 
77,814,101.00 No No 28 Women 21.1 18.5 21.9 19.39 7 12.7 7.17 
51,506,103.00 No No 21 Men 15.8 14.6 16.7 15.54 2 5.5 2.37 
73,304,103.00 No No 22 Men 10.8 11.0 11.8 12.01 1 20.2 11.87 
 
 
Chapter 9.8 Tables: 
 
Table 9.8A: Comparison of 10-years PPR values from CMAUT models, Internet calculators 
and Framingham equations using the first 10 participants in the Chapter 9: 
Table 9.8B: Comparison of 10-years PPR values from CMAUT models, Internet calculators 
and Framingham equations using the first 30 participants in the Thesis: 
Table 9.8C: Comparison of 10-years PPR values from CMAUT models, Internet calculators 
and Framingham equations for the entire 3645 participants in electronic format: 
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Table 9.8B: Comparison of 10-years PPR values from CMAUT models, Internet calculators 
and Framingham equations using the first 30 participants: 
Pserial no. Grp Bp1 Age Sex %PR(M-I Absol) 
%PR(M-
II Abso) 
%PR(M-
I Pre) 
%PR(M-II 
Pre) 
%PR(I-I 
Pr) 
%PR(I-II 
Pre) 
%PR(F-
I P) 
13,956,102.00 No No 60 Women 14.6 13.8 15.6 14.79 7 9 17.58 
63,535,102.00 Yes Yes 30 Women 15.4 14.6 16.3 15.53 1 4.3 0.13 
71,831,101.00 No No 66 Women 16.7 15.4 17.7 16.42 8 20.9 22.55 
34,031,101.00 No No 84 Women 18.0 16.6 19.0 17.64 3 17.5 12.87 
72,604,102.00 No No 59 Women 18.9 17.3 19.8 18.26 3 11.8 2.82 
31,510,102.00 No No 20 Women 20.1 15.2 21.0 16.13 1 9.3 15.12 
18,633,105.00 No No 16 Women 18.5 19.5 19.4 20.28 2 8.7 0.40 
13,008,101.00 Yes Yes 50 Women 16.3 19.9 17.2 20.75 11 10 1.22 
60,417,102.00 No No 16 Men 17.4 14.3 18.3 15.26 0 7.5 7.02 
39,139,101.00 No No 34 Women 21.4 13.3 22.2 14.26 1 4.8 0.05 
47,856,102.00 No No 51 Women 21.9 17.9 22.8 18.81 1 6.8 1.59 
49,147,103.00 No No 16 Women 19.4 18.1 20.2 19.02 2 5.8 0.66 
66,035,102.00 No No 18 Men 18.3 14.7 19.2 15.65 1 8.6 0.82 
80,356,105.00 No No 17 Men 19.5 15.4 20.4 16.33 3 4.6 0.97 
37,710,101.00 No No 61 Women 15.2 12.9 16.2 13.86 5 1.7 1.74 
20,556,101.00 No No 18 Men 20.7 16.8 21.5 17.68 6 2.5 3.18 
64,735,105.00 No No 16 Women 19.1 14.7 20.0 15.67 3 46 26.00 
46,449,104.00 No No 26 Women 17.3 16.2 18.2 17.18 4 5.2 6.27 
66,114,101.00 No No 24 Women 17.1 19.7 18.0 20.58 3 4.3 2.43 
50,956,101.00 No No 23 Women 17.3 17.2 18.1 18.08 1 14.4 4.85 
80,002,104.00 No No 16 Men 17.5 21.9 18.4 22.76 0 14.9 7.37 
54,256,101.00 No No 31 Women 14.1 12.6 15.0 13.61 0 7.3 31.65 
53,817,101.00 No No 43 Women 19.6 18.7 20.5 19.57 4 4.1 0.75 
13,433,101.00 No No 24 Men 14.5 16.0 15.5 16.91 5 4.2 0.08 
42,431,101.00 No No 27 Women 21.2 19.9 22.0 20.68 3 4.6 0.08 
44,633,102.00 No No 39 Women 19.9 10.7 20.8 11.73 1 12.1 3.69 
14,602,104.00 No No 18 Women 23.0 17.2 23.8 18.14 10 8.9 3.18 
77,814,101.00 No No 28 Women 21.1 18.5 21.9 19.39 7 12.7 7.17 
51,506,103.00 No No 21 Men 15.8 14.6 16.7 15.54 2 5.5 2.37 
73,304,103.00 No No 22 Men 10.8 11.0 11.8 12.01 1 20.2 11.87 
 
 
1. Table 9.9A: Comparison of TPR and FPR for CMAUT models, Internet calculators and 
Framingham equations of the first 10 participants: 
2. Table 9.9B: Comparison of TPR and FPR for CMAUT models, Internet calculators and 
Framingham equations of the first 30 participants  in the Thesis: 
3. Table 9.9C: Comparison of TPR and FPR for CMAUT models, Internet calculators and 
Framingham equations for the entire 3645 participants in electronic format; 
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Table 9.9B: Comparison of TPR and FPR for CMAUT models, Internet calculators and 
Framingham equations of the first 30 participants: 
Pserial no. Grp TPR(M-
I) 
FPR(M-
I) 
TPR(M-II) FPR(M
-II) 
TPR(I-I) FPR(I-I) TPR(I-II) FPR(I-II) TPR(F-I) FPR(F-
I) 
13,956,102.00 No 1 1.000 1 0.9997 1 0.99968 1 0.9997 1 1.00 
63,535,102.00 Yes 1 0.999 1 0.9994 1 0.99936 1 0.9994 1 1.00 
71,831,101.00 No 1 0.999 1 0.9991 1 
0.99904
1 0.984848 0.9994 0.9988 0.9993 
34,031,101.00 No 1 0.999 1 0.9989 1 
0.99872
1 0.984848 0.9991 0.9988 0.9989 
72,604,102.00 No 1 0.999 1 0.9986 1 
0.99840
1 0.984848 0.9988 0.9988 0.9986 
31,510,102.00 No 0.9983 0.9987 1 0.9983 1 
0.99808
1 0.984848 0.9986 0.9988 0.9982 
18,633,105.00 No 0.9983 0.9984 0.9935 0.9983 1 
0.99776
1 0.984848 0.9983 0.9988 0.9979 
13,008,101.00 Yes 0.9983 0.9981 0.9871 0.9983 1 
0.99744
2 0.984848 0.9980 0.9988 0.9975 
60,417,102.00 No 0.9983 0.9979 0.9871 0.9980 1 
0.99712
2 0.984848 0.9977 0.9988 0.9972 
39,139,101.00 No 0.9966 0.9979 0.9871 0.9977 1 
0.99680
2 0.984848 0.9974 0.9988 0.9968 
47,856,102.00 No 0.9950 0.9979 0.9871 0.9974 1 
0.99648
2 0.984848 0.9972 0.9988 0.9964 
49,147,103.00 No 0.9933 0.9979 0.9871 0.9971 1 
0.99616
2 0.984848 0.9969 0.9988 0.9961 
66,035,102.00 No 0.9933 0.9976 0.9871 0.9968 1 
0.99584
3 0.984848 0.9966 0.9988 0.9957 
80,356,105.00 No 0.9916 0.9976 0.9871 0.9966 1 
0.99552
3 0.984848 0.9963 0.9988 0.9954 
37,710,101.00 No 0.9916 0.9973 0.9871 0.9963 1 
0.99520
3 0.984848 0.9960 0.9988 0.9950 
20,556,101.00 No 0.9899 0.9973 0.9871 0.9960 1 
0.99488
3 0.984848 0.9958 0.9988 0.9947 
64,735,105.00 No 0.9899 0.9970 0.9871 0.9957 1 
0.99456
3 0.969697 0.9958 0.9976 0.9947 
46,449,104.00 No 0.9899 0.9968 0.9871 0.9954 1 
0.99424
4 0.969697 0.9955 0.9976 0.9943 
66,114,101.00 No 0.9899 0.9965 0.9806 0.9954 1 
0.99392
4 0.969697 0.9952 0.9976 0.9940 
50,956,101.00 No 0.9899 0.9962 0.9806 0.9951 1 
0.99360
4 0.969697 0.9949 0.9976 0.9936 
80,002,104.00 No 0.9899 0.9960 0.9742 0.9951 1 
0.99328
4 0.969697 0.9946 0.9976 0.9932 
54,256,101.00 No 0.9899 0.9957 0.9742 0.9948 1 
0.99296
5 0.969697 0.9944 0.9964 0.9932 
53,817,101.00 No 0.9882 0.9957 0.9742 0.9946 1 
0.99264
5 0.969697 0.9941 0.9964 0.9929 
13,433,101.00 No 0.9882 0.9954 0.9742 0.9943 1 
0.99232
5 0.969697 0.9938 0.9964 0.9925 
42,431,101.00 No 0.9866 0.9954 0.9677 0.9943 1 
0.99200
5 0.969697 0.9935 0.9964 0.9922 
44,633,102.00 No 0.9849 0.9954 0.9677 0.9940 1 
0.99168
5 0.969697 0.9932 0.9964 0.9918 
14,602,104.00 No 0.9832 0.9954 0.9677 0.9937 1 
0.99136
6 0.969697 0.9930 0.9964 0.9915 
77,814,101.00 No 0.9815 0.9954 0.9677 0.9934 1 
0.99104
6 0.969697 0.9927 0.9964 0.9911 
51,506,103.00 No 0.9815 0.9952 0.9677 0.9931 1 
0.99072
6 0.969697 0.9924 0.9964 0.9908 
73,304,103.00 No 0.9815 0.9949 0.9677 0.9928 1 
0.99040
6 0.954545 0.9924 0.9964 0.9904 
 
 
 
1. Table 9.10A: Comparison of LRP and LRN for CMAUT models, Internet calculators and 
Framingham equations for the first 10 participants in the  Thesis; 
2. Table 9.10B: Comparison of LRP and LRN for CMAUT models, Internet calculators and 
Framingham equations for the first 30 participants below; 
3. Table 9.10C: Comparison of LRP and LRN for CMAUT models, Internet calculators and 
Framingham equations for the entire 3645 participants in electronic format; 
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Table 9.10B: Comparison of LRP and LRN for CMAUT models, Internet calculators and 
Framingham equations for the first 30 participants; 
Pserial no. Grp LRPM-I) LRN(M-
I) 
LRP(M-II) LRN(M
-II) 
LRPI-I) LRN(I-I) LRP(I-II) LRN(I-
II) 
LRP(F-I) LRN(F-I) 
13,956,102.00 No 3484.32 0 3717.472 0 3125 0 3584.22 0 2808.99 0 
63,535,102.00 Yes 1745.20 0 1862.197 0 1562.5 0 1788.90 0 1406.47 0 
71,831,101.00 No 1162.79 0 1240.695 0 1042.753 0 1761.80 0.01516 1404.7820 0.0012 
34,031,101.00 No 872.60 0 930.233 0 781.8608 0 1175.23 0.01516 936.0825 0.0012 
72,604,102.00 No 697.84 0 744.048 0 625.3909 0 880.90 0.01516 702.3910 0.0012 
31,510,102.00 No 581.73 0 742.7969 0.0017 521.1047 0 704.97 0.01517 561.7548 0.0012 
18,633,105.00 No 577.98 0.0065 619.3046 0.0017 446.628 0 587.61 0.01517 468.0412 0.0012 
13,008,101.00 Yes 574.23 0.0129 530.7384 0.0017 390.9304 0 503.50 0.01518 401.2857 0.0012 
60,417,102.00 No 492.07 0.0129 464.3344 0.0017 347.4635 0 440.64 0.01518 351.0721 0.0012 
39,139,101.00 No 430.67 0.0129 463.5530 0.0034 312.6954 0 391.58 0.01519 312.0275 0.0012 
47,856,102.00 No 382.74 0.0129 462.7712 0.0051 284.2524 0 352.48 0.01519 280.8774 0.0012 
49,147,103.00 No 344.54 0.0129 461.9893 0.0067 260.5524 0 320.48 0.01519 255.3170 0.0012 
66,035,102.00 No 313.17 0.0129 410.6147 0.0067 240.5581 0 293.72 0.01520 234.0755 0.0012 
80,356,105.00 No 287.11 0.0129 409.9202 0.0084 223.3639 0 271.15 0.01520 216.0502 0.0012 
37,710,101.00 No 264.99 0.0130 369.0350 0.0084 208.4636 0 251.75 0.01521 200.6025 0.0012 
20,556,101.00 No 246.10 0.0130 368.4094 0.0101 195.427 0 234.992 0.01521 187.2516 0.0012 
64,735,105.00 No 229.66 0.0130 334.8836 0.0101 183.925 0 231.37 0.03043 187.0264 0.0024 
46,449,104.00 No 215.29 0.0130 306.9507 0.0101 173.7318 0 216.889 0.03043 175.3250 0.0024 
66,114,101.00 No 213.88 0.0194 283.3188 0.0101 164.582 0 204.14 0.03044 165.0015 0.0024 
50,956,101.00 No 201.32 0.0194 263.1356 0.0101 156.3477 0 192.82 0.03045 155.8505 0.0024 
80,002,104.00 No 200.00 0.0259 245.5758 0.0101 148.8982 0 182.655 0.03046 147.6393 0.0024 
54,256,101.00 No 188.87 0.0259 230.2130 0.0101 142.1464 0 173.53 0.03047 147.4617 0.0036 
53,817,101.00 No 178.95 0.0259 229.8221 0.0118 135.9619 0 165.257 0.03048 140.1011 0.0036 
13,433,101.00 No 169.99 0.0260 216.2913 0.0118 130.2932 0 157.75 0.03049 133.4225 0.0036 
42,431,101.00 No 168.86 0.0324 215.9236 0.0135 125.0782 0 150.90 0.03049 127.3516 0.0036 
44,633,102.00 No 160.83 0.0325 215.5557 0.0152 120.2646 0 144.60 0.03050 121.8241 0.0036 
14,602,104.00 No 153.51 0.0325 215.1878 0.0169 115.8212 0 138.82 0.03051 116.7427 0.0036 
77,814,101.00 No 146.85 0.0325 214.8201 0.0186 111.6819 0 133.47 0.03052 112.0809 0.0036 
51,506,103.00 No 140.72 0.0325 202.9177 0.0186 107.8283 0 128.53 0.03053 107.7654 0.0036 
73,304,103.00 No 135.10 0.0325 192.2274 0.0186 104.2318 0 126.53 0.04580 103.7699 0.0036 
 
 
Figure 9.10.x: 
 
 This was computed in MATLAB software for each model and the outcomes are shows in the 
figures below based on the PPR results from the calculation conducted in chapter 5 and 7. 
                                                                 
Percentage = 64.2712500000000 22.2047182838361 
Convert into ratio              ; this is fail 
Figure 9.10.1. CMAUT diagnosis model I chapter 5 
                                                                               
                                       
Percentage = 284.875500000000 82.4484731049178 (per) 
Convert into ratio format = 0. 82 this is excellent 
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Figure 9.10. 2. CMAUT diagnosis model II chapter 5 
From Figure 9.10.1 and 9.10.2 calculations, it is subsumed that CMAUT diagnosis model II has an 
excellent Prediction accuracy of 0.82 while model I is a poor predictor. 
                                                                              
            
Percentage = 25.9763500000000 92.4827776034743 (per) 
Convert into ratio format = 0. 92; this is excellent 
Figure  9.10.3. CMAUT 10 years Prognosis model I chapter 7 
                                                                               
                                   
Percentage = 112.008000000000 55.3603314048996 (per) 
Convert into ratio format = 0. 55 this is fair because it is approx. 0.60 
Figure  9.10.4. CMAUT 10 years Prognosis model II chapter 7 
From Figures 9.10.3 and 9.10.4, it is inferred that CMAUT Prognosis model I has an excellent 
prediction accuracy of 0.92 but model II is just satisfactory predictor. 
                                                           
Percentage = -45.9500000000000 -8.81392818280749 (per) 
Convert into ratio format = - 0.088 this is fail because it is negative and less than 0.50 
Figure 9.10.5. Internet CVD model I chapter 8 
                                                            
Percentage = 29.8412500000000 67.5533028944832 (per) 
Convert into ratio format = 0.675 this is fair because it is positive and approx.  0.70 
Figure 9.10.6. Internet CVD model II chapter 8 
From Figures 9.10.5 and 9.10.6 it is inferred that Internet CVD model I has failed as a predictor 
because it has a prediction accuracy of 0.08 less than 0.5 and according to Figure 9.9 above it lays 
negative quadrant but Internet CVD model II is fair predictor. 
                                                                            
                                    
Percentage = -58.0697250000001 -13.8966130802240 (per) 
Convert into ratio format = -0.1389 this is fail because it is negative and less than 0.50. 
Figure 9.10.7: Framingham equation UK_USA 
 
